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Dedicated to my parents, Alan Alexander and Elizabeth Ann St Clair Gibson, 
with thanks for their uncolJditionallove and support during my life, and for the 
patience they showed when on occasions I veered off life's traditional path. 
4 
"People who don't climb mountains '- the greatest majority of humankind, that 
is to say - tend to assume that the sport is a reckless, Dionysian pursuit of 
ever escalating thrills. But the notion that climbers are merely adrenaline 
junkies chasing a righteous fix is a fallacy, at least in the case of Everest. 
What I was doing up there had almost nothing in common with bungee 
jumping or skydiving or riding a motorcycle at 120 miles per hour. 
Above the comforts of Base Camp, the expedition in fact became an almost 
Calvinistic undertaking. The ratio of misery to pleasure was greater by an 
order of magnitude than any other mountain I'd been on; I quickly came to 
understand that climbing Everest was primarily about enduring pain. And in 
subjecting ourselves week after week of toil, tedium, and suffering, it struck 
me that most of us were probably seeking above all else, something like a 
state of grace." 
From "Into Thin Air" by Jon Krakauer 
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PREAMBLE 
The concept behind this thesis originated from three different sources. Firstly, it 
originated in changes in the function of my own lower limb muscles which began 
to be noticed in my late twenties and early thirties. In my late adolescence and 
early twenties, I had been a competitive athlete, competing in canoeing, nJnning 
and triathlon events. As with most men and women of that time of life, all 
activities were performed in excess rather in moderation. As challenges were 
successfully completed, further more difficult and strenuous athletic challenges 
were initiated, and friendly rivalry with my peers maintained this lifestyle for a 
number of years. Running or canoeing different ultramarathons on a weekly 
basis became nonnal, and you were considered of weak disposition if training 
sessions were not perfonned at least two and usually three times per day. 
While it is surprising that with this lifestyle I was able to make acceptable 
progress on the academic front, what was not surprising was that it landed me in 
the office of the world renowned sports medicine phYSician, Professor Tim 
l\Ioakes, on a number of occasions with severe bouts of overtraining syndrome. 
While his advice on various stress fractures and episodes of excessive fatigue 
was that rest and a more conservative training program was needed, this advice; 
unfortunately due to the exuberance of youth was not heeded, and often I would 
continue training and racing against his good advice, and in a chronic state of 
exhaustion. 
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While this lifestyle did lead to some success in the sporting world, and helped 
placate a fragile male ego, unfortunately it lead to some not so pleasurable 
consequences. After approximately a decade of this high volume and high 
intensity training and racing, I slowly began to notice that my body was not 
performing as optimally as it used to, and needed increasingly more time to 
recover from routine training bouts. Getting out of bed became a difficult task in 
my late twenties, with muscle stiffness and whole body aching sensations which 
would require half an hour to subside to acceptable levels, and these eventually 
became present throughout the entire day. Gradually it dawned on me that 
perhaps I was paying the price for the years of excessive physical activity, and 
my body was aging at a seemingly excessive rate. This was contrary to the 
concepts which I entertained,in my youth, when without the wisdom of hindsight I 
presumed that this lifestyle was beneficial, and would actually delay the approach 
of old age and the associated decrements in physical performance. 
Secondly, at the time these changes were occurring, I was working full time in 
Professor Noakes' laboratory as a neophyte scientist, and perhaps because of 
these negative changes I was noticing in myself, I was drawn to an article in 
Scientific American which described similar changes in the three time Tour de 
France winner and two time world cycling champion, Greg Le Mond. In his early 
thirties, he experienced a precipitous decline in his cycling performance, 
excessive fatigue which caused him to abandon several cycling races, and an 
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inability to tolerate high training loads. While conventional medical testing could 
not detect any abnormalities, muscle biopsies of his lower limb muscles revealed 
grossly abnormal mitochondria in large subsarcolemmal aggregations. His 
doctors diagnosed him as having an acquired mitochondrial myopathy, and 
speculated that this pathology was caused either by his excessive exercise, or 
lead pellets which were embedded in his body after he was involved in a 
shooting accident, and which they felt may have contributed to the presence of 
the abnormal muscle biopsy and decrements in phYSical performance. 
Thirdly, at the same time, Professors Wayne Derman, Tim Noakes, Martin 
Schwellnus, Mike Lambert and Doctor Malcolm Collins, Liesl Grobler and myself 
were investigating causes of muscle damage and fatigue in athletes, as part of 
our routine laboratory research. We performed muscle biopsies and other 
investigations similar to those performed on Greg LeMond on athletes who 
presented to our laboratory with similar symptoms. 
Linking these three factors led us to the conclusion that excessive exercise 
activity, or indeed routine exercise activity in susceptible individuals, may lead to 
pathological physiological and anatomical changes. This was contrary to the 
accepted paradigm that exercise was always beneficial, and was difficult for us to 
initially accept, given that our laboratory was an Exercise Science Unit, dedicated 
to exploring the positive link between exercise activity and a variety of health 
conditions. 
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This thesis therefore is the fruition of four years of work which was based on this 
premise which we were at first reluctant to accept, but which evidence showed 
over the four years may be true. It is hoped that the findings of this thesis may in 
some way, apart from contributing to basic research in the field of fatigue and 
muscle damage, help educate young athletes that excessive or high intensity 
exercise activity, which was such a part of my own youth, may result in 
permanent pathological physical consequences. 
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ABSTRACT 
The aim of this thesis was to investigate the relationship between chronic 
exercise activity, aging, the neuromuscular system and the symptom of 
fatigue in a series of studies. The hypothesis of the thesis was that in contrast 
to the accepted dogma that exercise is beneficial to an individual, increasing 
longevity and improving quality of life, excessive or chronic exercise activity 
may accelerate the aging process, lead to neuromuscular damage, and cause 
the development of pathological symptoms or levels of fatigue. 
The first study was a case report study of a 28 year old international level 
male runner who developed symptoms of excessive fatigue and progressive 
decline in running performance, associated with an increasing inability to 
tolerate high-mileage training. Apart from a history of a transient Ebstein-Barr 
virus (EBV) infection at age 23, which was not related to the onset of the 
decline of his athletic performance, there were no abnormal signs or 
symptoms on medical examination or abnormal results from routine medical 
blood testing. Muscle biopsies performed on the athlete revealed 
mitochondrial abnormalities which were confined to the vastus lateralis 
muscle and were not present in the triceps muscle. The mitochondrial 
abnormalities were shown both histologically using light and electron 
microscopy, and biochemically by decreased enzymatic activity which was 
limited to the markers of the oxidative, but not glycolytic pathway. 
Mitochondrial DNA analysis showed no evidence of deletions associated with 
Kearns-Sayre syndrome or any other syndrome pathognomonic of classical 
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mitochondrial myopathy. The conclusion from this study was that the athlete 
had a myopathy which either i) existed previously undiagnosed, although this 
was unlikely given his athletic competitive success; ii) was acquired from his 
prolonged high volume physical activity, or iii) was acquired as a result of 
unknown infective or intrinsic toxic agents. 
The second study examined the prevalence of muscle pathology in athletes 
who presented with similar symptoms to that described in the first case report 
study. Twenty athletes with a previous history of high training or racing 
volume, excessive fatigue symptoms and a reduced capacity for exercise 
were assessed over a three year period. Of these subjects, 16 were runners, 
2 were triathletes, 1 a cyclist and 1 a rower. The competitive ability of the 
subjects ranged from club to international level. Muscle biopsies of the vastus 
lateralis muscle revealed that 19 of the 20 subjects had muscle pathology, 
including abnormal subsarcolemmal aggregations of mitochondria, abnormal 
NADH staining patterns, abnormal fibre size variation, the presence of 
necrosis, inflammation, regeneration, degeneration and excessive internal 
nuclei on light microscopy examination. Electron microscopy analysis 
performed on 11 of the 20 subjects revealed that all 11 of these 11 subjects 
had evidence of myofibrillar degeneration, enlarged or abnormal 
mitochondria, abnormal subsarcolemmal aggregations of mitochondria, 
abnormal lipid and glycogen accumulations, and z-disc streaming. Seven of 
the 20 subjects were suffering from clinical depression, as diagnosed with the 
Beck inventory scale, and 7 of the 20 subjects had suffered lifestyle stresses 
or an eating disorder during their athletic careers. All of 14 subjects tested for 
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EBV infection had evidence of previous infection, and 8 of 15 subjects tested 
for cytomegalovirus (CMV) or Coxsackie virus infection had evidence of 
previous infection from one or both of these viruses. The athlete who did not 
have muscle pathology was the youngest subject on the trial, and had been 
running for a relatively short period. This indicates that while something else 
apart from lower limb muscle pathology had caused the symptoms of fatigue 
in this case, a long period of exercise activity may be necessary for the 
muscle pathology to develop. It was concluded from these findings that as 19 
of the 20 subjects tested had evidence of muscle pathology, there may be a 
causal relationship between the muscle pathology and the excessive 
symptoms of fatigue and decrements in athletic performance. The viral 
infections and psychological factors present in a number of subjects may also 
have been related to "the symptoms of fatigue, but it was not clear if these 
were a cause or consequence of the muscle pathology and the psychological 
symptoms of fatigue. 
The third study examined the differences in medical, physiological and 
neuromuscular profiles between the 20 subjects in the previous trial and 10 
control subjects. The controls were matched for age, height, mass and current 
training levels. The fatigued athletes reported a significantly higher number of 
previous episodes of biomechanical injuries (P < 0.05), respiratory illnesses 
(P < 0.05) and viral infections (P < 0.05) than the controls. While a higher 
percentage of overtraining episodes were reported by the fatigued subjects 
compared to controls, the differences between groups were not significant. 
Theoverall score for the Beck psychological scale was higher in the fatigued 
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subjects (7.7 ± 6.6 arbitrary units) than in the control (1.7 ± 1.5 arbitrary units) 
(P < 0.05). There were no differences in resting heart rate or blood pressure, 
maximal drop jump capacity, maximal isometric force output, neuromuscular 
activity, peak treadmill running speed (PTRS), maximal aerobic capacity 
(V02max), maximal heart rate (HRmax), blood lactate concentration at rest or 
after maximal aerobic capacity testing or vastus lateralis muscle fibre type 
composition between the fatigued athletes and controls. The fatigued athletes 
had significantly higher pathology scores for the vastus lateralis muscle 
biopsy sample, including overall score (P < 0.01), presence of staining 
abnormalities (P < 0.01), fibre size variation (P < 0.01), and presence of 
internal nuclei (P < 0.01) than in the controls. Although the scores for the 
presence of abnormal mitochondria and necrosislinflammation were higher in 
the fatigued athlete than control group, these differences were not significant. 
The relationships between physical and physiological parameters of the 
fatigued subjects and controls were different. In the control group, the 
relationship between stride frequency (SF) during a submaximal treadmill run 
at 70% of PTRS and age (r = 0.81; P < 0.01), SF and lean thigh volume (LTV) 
(r = -0.76; P < 0.01), SF and drop jump height (DJdiff) (r = -0.58; P < 0.05), 
and SF and V02max (r = - 0.58; P < 0.05) were all significant. In contrast, in 
the fatigued athletes, the relationship between SF and age (r = - 0.06, NS), SF 
and LTV (r = -0.02, NS), SF and DJdiff (r = 0.11, NS), and SF and V02max (r 
= 0.22; NS) were all not significant. Similarly, the relationship between DJdiff 
and V02max was significant in the control group (r = 0.65; P < 0.01 ), while the 
relationship was not significant in the fatigued subjects (r = 0.34, NS). The 
'findings of this study suggest that while the symptoms of fatigue and muscle 
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pathology do not have an affect on maximal force output, maximal aerobic 
capacity and other absolute physiological parameters, there appears to be 
differences which occur during submaximal running activity, specifically a 
dissociation between various physiological factors and particularly those 
related to stride frequency. An interpretation of these findings is that the 
muscle damage may interfere with the ability to produce complex muscular 
activity or coordinated gait activity, and that the symptoms of fatigue and poor 
physical performance described by the subjects may be related to these 
submaximal findings. However, the finding that similar power output, V02max, 
and blood lactate concentrations occurred in both fatigued athletes and 
control subjects indicates that the symptom of fatigue is not directly related to 
any of these factors, which have previously been associated with the cause of 
fatigue. Finally, it cannot be determined from the design of the study whether 
the significantly rligher episodes of previous viral infections, respiratory 
illnesses, biomechanical problems and higher Beck psychological scores are 
a cause, or a consequence, of the muscle pathology or other undiagnosed 
aetiological factors. 
In the fourth study, the 20 fatigued athletes described in the previous chapter 
were part of a placebo-controlled, double-blind drug trial using antioxidant 
therapy, to assess whether these drugs could attenuate or improved the 
excessive symptoms of fatigue and decrements in athletic performance. The 
drugs tested were vitamin C 500 mg, vitamin E 200 iu, Flavenoid complex and 
Carotenoid complex. The entire trial for each subject was of 6 months 
duration, with each subject ingesting either drug or placebo in random order, 
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for three month periods. The subjects were tested at the beginn ing of the trial 
and after 3 and 6 months. The data was analyzed as differences between the 
data from the end time point of the drug and placebo parts of the trial, and the 
data from the initial visit of each individual. Four subjects withdrew during the 
trial due to problems with the number of tablets required to be ingested on a 
daily basis during the trial, or due to the duration of the trial. There were a 
similar percentage of incorrect responses for subjective knowledge of whether 
subjects were ingesting drug or placebo during both drug and placebo trials. 
There was no Significant differences between drug and placebo groups for 
subjective symptom improvement or training improvement in the 16 subjects 
who completed the trial. There were also no significant differences in changes 
in Beck psychological score, LTV, DJdiff, maximal isometric force output, 
submaximal isometric endurance capacity, V02max, PTRS, or SF during 
submaximal treadmill running at 70% PTRS between drug and placebo 
groups. In contrast, resting diastolic blood pressure (BP) was significantly 
lower (P < 0.01) in the drug compared to placebo group. Systolic BP was also 
lower in the drug group, although the differences were not significant. Resting 
HR (P < 0.01) and HR during submaximal treadmill running at 70% of PTRS 
(P < 0.01) were both significantly higher in the drug compared to placebo 
group. Blood lactate concentrations were lower in the drug (-15%) compared 
to placebo (-5%) group after the V02max test, but these differences were not 
significant. The findings of this study indicate that antioxidant therapy did not 
improve symptoms of fatigue, or decrements in physical performance. An 
interpretation of these data was that the muscle damage was too profound, or 
was irreversible, and therefore could not be improved by the antioxidant drug 
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therapy. The mechanism for the decrease in diastolic BP is not clear, but the 
increased resting HR and HR during submaximal treadmill running may be 
related to this reduced blood pressure and the need to maintain cardiac stroke 
volume. 
The fifth study examined age related decrements in athletic performance 
during running and cycling activities. The rationale for this study was that the 
data from the previous studies indicated that excessive exercise may be the 
cause of lower limb pathology, associated decrements in athletic performance 
and symptoms of fatigue. Therefore, an exercise activity such as running, 
which involves weightbearing and a large degree of eccentric muscle activity, 
would predispose an individual to greater long term muscle damage than an 
exercise activity such as cycling, which is non-weightbearing and involves 
relatively little eccentric activity. If this hypothesis was correct, then the age-
related performance times should slow at a faster rate during running 
compared to cycling activity. Therefore, the age group winning times for males 
aged between 18-70 during the 1999 Argus cycle tour (103 km) and 1999 
Comrades running marathon (90 km), South Africa's premier endurance 
cycling and running events, were examined. There were 11 285 competitors 
in the running marathon and 28 440 competitors in the cycle tour. The fastest 
time for the running marathon was 5 h 30 min 10 s by a 32 year old 
competitor and the fastest time for the cycle tour was 2 h 31 min 26 s by a 24 
year old male competitor. Because of the bunch nature of cycling, 12 other 
age categories had similar finishing times for the cycling race, the oldest being 
a 36 year old competitor. The function describing the relationship between 
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speed (cycling and running respectively) and age was calculated using a 4th 
order polynomial function. The derivative of each of these functions was 
determined and then the slope corresponding to each age was calculated. 
The rate of decline occurred at an earlier age (- 32 years) during the running 
race as compared to the cycling tour (- 55 years). While rate of improvement 
in running time was maintained until age - 32, and declined at an increasing 
rate after this age. There was minimal change in cycling time until age - 55, 
after which time the rate of change of cycling time increased. These findings 
support the hypothesis that running caused more profound changes in 
anatomical structures or physiological mechanisms necessary to maintain 
pacing strategies during racing, and may lead to "premature" or "accelerated" 
aging at an earlier age than that found in cyclists. Confounding variables of 
this study were firstly that training quantity could not be measured in this trial, 
and may have been different in the running and cycling groups. Secondly, the 
duration of the two events were different, with the cycle tour being completed 
in a shorter time than the running marathon. 
The sixth study examined the force output, neuromuscular activity and muscle 
anthropometric differences in the arm flexors and leg extensor muscles of 
individuals of different ages, in order to assess the affect of age on these 
variables. The hypothesis of this study was that if exercise activity was .found 
to cause "accelerated" aging, as described in the previous chapter, then the 
leg muscles would show a greater decrement in force output with age than the 
arm muscles which are not actively recruited in walking and running activities 
or the majority of activities of daily living. Seventy four subjects who were all 
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previously or currently involved in sport participation, with a range of qges 
from 16 to 71 years, participated in this study. Peak force output had a 
significant negative relationship with increasing age in the leg extensor 
muscles (r = - 0.46; P < 0.05), while in the arm flexor muscles this relationship 
was not significant (r = -0.16; NS). Lean volume was also significantly 
negatively correlated with age in the leg muscles (r = - 0.46, P < 0.05), while 
in the arm muscles this correlation was not significant (r = 0.04, NS). Peak 
force was positively correlated with lean volume in both leg (r = 0.64; P < 
0.05) and arm (r = 0.74; P < 0.05) muscles, indicating that loss of muscle 
mass in the lower leg may be the main cause of the decrements in force 
output with increasing age in the legs compared to the arm muscles. There 
were no significant correlations between age and force output, integrated 
EMG (IEMG) or mean percentile 'frequency shift (MPFS) during the maximal 
endurance isometric 25 s tests. This finding indicated that age had no effect 
on the neuromuscular system, and that neural mechanisms controlling force 
output associated with fatigue are not altered with age. The IEMG/force ratio 
at the final point of the 25 s isometric endurance test was higher in the arm 
than the leg muscles, indicating that more fatigue occurred in the arm 
muscles. This finding may be related to the possible higher relative force 
output in the arm muscles at the start of the endurance test, or to greater 
force decrements relative to neural recruitment in the arm compared to in the 
leg. This may be caused by different muscle fibre types and resultant 
differences in fatigue resistance capacity in the leg compared to arm muscles, 
or to different neuromuscular recruitment patterns in the arm compared to the 
leg muscles during the fatiguing process. These findings suggest that 
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changes in force output in the leg muscles which occur with age were related 
to decreases in lean volume of the muscles of the lower limb, and not due to 
neuromuscular system changes. These findings may be due to pathological 
changes in the lower limb muscles from excessive use, or because of a 
greater effect of decreased activity associated with reduced activities of daily 
" 
living in the lower limb muscles of older individuals. 
The seventh study examined heart rate during exercise activity and duration 
of exercise activity in veteran and young,(senior level) runners and squash 
players during competitive activity. The aim of the study was to assess 
whether decrements in performance with age were similar in a continuous 
intensity sport such as running compared to an intermittent intensity sport 
such as squash. Ten senior league squash players, 10 veteran league squash 
players, 10 senior club endurance runners and 10 veteran club endurance 
runners participated in this study. The veteran and senior runners ran the 
same 5 km time trial race on 2 separate occasions, while the veteran and 
senior squash players played 2 league games against varying opposition. The 
veteran runners (- 22 min) were significantly slower (P < 0.01) than the senior 
runners (- 18 min), and the time for each group were not significantly different 
for the two time trials. In contrast, the time taken for the veteran squash 
players games (- 28 min) were significantly shorter (P < 0.01) than the time 
taken for the senior squash players games (- 44 min), and the time taken for 
each of these groups was also not significantly different for the two games. 
The maximum HR were similar in both veteran squash players and veteran 
runners (- 173 beats/min) and was significantly lower (P < 0.01) than the 
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maximal HR in both the senior squash players and senior runners (- 192 
beats/min), which were also not significantly different. Similarly, the mean HR 
was not significantly different in veteran squash players and veteran runners 
(- 158 beats/min) in both trials, and was significantly lower than the mean HR 
in the senior squash players and senior runners (- 178 beats/min). These 
findings indicate that level of activity in veteran athletes was reduced in both 
continuous and intermittent intensity exercise activity compared to the senior 
runners. The findings that times were slower in the veterans participating in 
continuous intensity activity and that time played was shorter in intermittent 
intensity activity where hand-eye coordination and proprioceptive skills are 
important may indicate that the aging process occurs in all body systems, as a 
generalized pathological process. However, the finding that both maximum 
and mean HR were similar in the veteran athletes participating in both 
continuous and intermittent activity, indicates that afferents from weakened or 
damaged peripheral musculoskeletal systems may reduce activity in the 
veteran population to a "safe" limit, with secondary reduction in athletic 
performance times based on a subconscious mental calculation using heart 
rate as one of the pace-setting factors. Another interpretation was that these 
reductions in activity in squash players and runners were part of an age-
associated pacing strategy, where feedforward commands would restrict 
activity in veteran athletes to a "safe" relative maximal limit based on HR 
and/or other variables, as part of protective teleological mechanisms. The 
findings of similar mean HR in the different veteran groups playing different 
sporting activities would in particular support the latter interpretation. 
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The eighth study examined the cardiovascular performance of veteran 
athletes during both laboratory and field testing. The aims of the study were to 
assess whether veteran athletes of different competitive levels who 
participated in different sports competed at similar levels of intensity, whether 
veteran athletes competed at the same level in the field as they did during 
laboratory testing, and to assess whether veteran athletes participated in 
sport with undiagnosed cardiovascular risk factors, or played sport at a level 
of intensity which would predispose them to cardiovascular embarrassment. 
Ten veteran league squash players, 10 veteran social squash players, 10 
veteran league runners, 10 social runners and 10 veteran sedentary controls 
participated in this study. All subjects underwent medical screening, a routine 
stress EGG on a cycle ergometer, and heart rate monitoring during their 
exercise activity. Although differences between groups were found on routine 
medical testing, with the running groups having significantly lower resting HR 
than squash players (P < 0.05) and sedentary (P < 0.01) groups, there were 
no significant differences between either maximal (- 172 beats/min) or mean 
(- 157 beats/min) HR during field testing between social and competitive 
runners and squash players. While mean HR during field testing was not 
significantly different from maximal heart rate during the laboratory stress 
EGG test, maximal HR during field testing was significantly higher (P < 0.01) 
in all athletic groups compared to the maximal HR during stress EGG testing. 
Two sedentary subjects and 2 squash players had abnormal EGG traces at 
rest, but there were no further exercise-induced ST segment changes in any 
subject. The conclusion of this study was that veteran athletes at both social 
and competitive levels perform exercise at similar HR intensities. These 
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findings indicate that as the athletes compete or train at similar relative 
intensities, they may have similar levels of metabolic stress during exercise, 
despite competing at different levels of athletic performance, and thus may 
have similar predisposition to the development of exercise related muscle or 
other system pathology. A further finding of this study was that the maximal 
heart rate of veteran athletes participating in squash or running activities was 
higher than the maximal HR during routine stress ECG testing. This is an 
important finding as it may predispose them to risk of cardiovascular crisis, 
which cannot be diagnosed by clinicians during routine stress ECG testing. 
In summary, this thesis has described the findings of pathological muscle 
changes in the vastus lateralis muscle of athletes who presented with 
symptoms of excessive fatigue and decrements in athletic performance, which 
were not present in age and exercise matched control subjects. This muscle 
pathology may be a form of "accelerated" aging caused by excessive or high 
intensity exercise activity. This is supported by the findings that (i) muscle 
pathology was localized to the lower limb muscles, (ii) that the lower limb was 
more affected by the "accelerated" aging process than the upper limb, and (iii) 
that age-related endurance performance times in a weight-bearing sport 
(running) occurred at a faster rate than in a non-weightbearing sport (cycling). 
The pathological changes in the muscle were not improved by antioxidant 
therapy, indicating that the muscle damage may be irreversible and/or not 
related to oxidative processes. The muscle damage was found in athletes of 
different competitive levels and different sporting backgrounds. This may be 
related to the finding that veteran athletes of different levels of competition 
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and sporting backgrounds exercise at similar levels of heart rate intensity, as 
was evident by the similar heart rates found during field testing of social and 
competitive squash players and runners. Finally, the 'finding that mean heart 
rate was similar during both intermittent intensity and continuous intensity 
sports, and is reduced in veteran athletes compared to younger athletes, 
indicates that veteran athletes may adopt a pacing strategy during all sporting 
activity. This pacing strategy may be controlled by either a feedforward 
teleoanticipatory mechanism or a feedback mechanism using afferent input 
from damaged or aging musculoskeletal system, to reduce the possibility of 
further musculoskeletal damage. 
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LIST OF ABBREVIATIONS 
ADP Adenine diphosphate 
ATP Adenine triphosphate 
AZT Azathioprine 
BP Blood pressure 
CFS Chronic fatigue syndrome 
CMV Cytomegalovirus 
DJdiff Drop jump height 
DNA Deoxyribonucleic acid 
DOMS Delayed onset muscle soreness 
EBV Ebstein-Barr virus 
ECG Electrocardiogram 
FAMS Fatigue athlete myopathic syndrome 
HIV Human immunodeficiency virus 
HR Heart rate 
IEIVIG Integrated electromyography 
IMP Inosine monophosphate 
iP Inorganic phosphate 
LV Lean volume 
LTV Lean thigh volume 
MELAS Mitochondrial myopathy, encephalomyopathy, lactic 
acidosis and stroke-like episodes 
NlERFF Myoclonic epilepsy witl1 ragged red fibres 
MF Mean force 














Maximal voluntary contraction 
Molecular weight 
Reduced nicotinamide adenine dinuceotide 
Neurogenic muscle weakness, ataxia and retinitis 
pigmentosa 
Mean force 
Polymerase chain reaction 
Perception of mood score 
Peak treadmill running speed 
Reactive oxygen species 
Succinyl dehydrogenase 
Sarcoplasmic reticulum 
Time to peak force 
Maximal aerobic capacity 
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CHAPTER 1. INTRODUCTION 
Since the 1800's, when sport was popularized as entertainment for working-
and middle-class populations, exercise has become increasingly important in 
our daily lifestyle. Sport has been used to both engender and manipulate 
national pride, as a method of disciplining and preparing adolescents and 
young adults for military activity, and as a way of providing mental and 
physical "toughness" for the challenges in life. As societies became 
industrialized, the occupations of a number of people became sedentary and 
non-physical. It was perhaps because of this that sport in the last century 
became a means to maintain physical fitness, and exercise was, and is today 
used, to maintain physical "fitness" or aesthetic desirability. This trend was 
probably exacerbated by the media and advertising, which propagated the 
notion that athleticism in both men and women was a sign of social success 
and positive self-discipline. 
In the last few decades, the financial turnover in sport has increased 
dramatically. As it became obvious that watching sport had become a form of 
relaxation and leisure activity for a number of societies, the economic sector 
realized that sport had the potential to be a source of revenue. With the 
advent of pay-channel television, sport has become a multi-billion dollar 
industry, and as a result athletes have become professionals. Sport, and in 
particular success in sport, has become the source of income for a number of 
athletes today. 
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Associated with these financial changes was a substantial increase in the size 
of the health industry related to sport and exercise activity. Gymnasiums and 
dietary supplements have become industries, and fitness trainers and 
dieticians have become recognized professionals. The medical sector also 
focused on the relationship between exercise and health in the last few 
decades, with a number of research and medical units being developed 
specifically to examine the role of sport and exercise in population health and 
individual fitness. Almost all of the research generated from this medical 
interest in sport and exercise showed that exercise was beneficial to individual 
health and to societal health demographics. Exercise has been described as 
the panacea for virtually all disease~, from diabetes, obesity and cardiac 
disease to depression, decreased libido and also the negative effects of 
aging. Similarly, research on ergogenic aids such as carbohydrate and fluid 
supplementation has also increased, with findings often showing that these 
ergogenic aids are beneficial and necessary for sporting success. 
Unfortunately, a concern is that much of this research has been performed by 
researchers who have not maintained the necessary scientific detachment, 
perhaps because they have been sponsored by the medical health and 
dietary supplementation industries, whose profit margins would be increased 
by research proving the efficacy of their own particular dietary supplement or 
medical/exercise intervention. Similarly, a further concern is that research 
examining exercise may have been directed or designed to show that 
exercise has positive benefits. 
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These three factors, namely the growth of exercise as a method to maintain 
physical "fitness" and social desirability, the increased financial reward from 
sport participation, and the increase in medical research showing exercise to 
have health benefits, have created pressure on individuals to participate in 
exercise activity with increasing frequency and intensity in the last few 
decades. This mindset is encapsulated in the philosophy of "no pain, no gain", 
which was the catch-phrase of coaches and athletes in the last three decades 
in Western societies. 
While these changes in the dynamics and scope of exercise activity has led to 
sports performances improving, and an increased prevalence of participation 
in sport or exercise activity, few individuals or studies have questioned 
whether there may be negative consequences related to this increase in 
exercise activity for the individual, or society in general. 
Firstly, the incidence of illicit, performance enhancing drug use has increased 
in the last three decades. As the financial and social rewards of success in 
sport competition have increased, so has the pressure on athletes increased 
to use drugs such as anabolic steroids and various stimulants such as 
ephedrine and caffeine. Although the ergogenic effect of these drugs proved 
to be so successful that they have been banned, competitors still use a 
number of methods to continue illicit drug use while preventing detection of 
their use, and newer ergogenic drugs such as erythropoeitin, which are 
difficult to detect, have been developed. The use of these drugs, while 
improving physical performances, have paradoxically had a negative impact 
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on sport, with a number of sports observers believing that drugs have tainted 
the spectacle and magic of sport forever. A number research articles have 
also suggested that these ergogenic aids may be physically harmful to 
athletes, and predispose them to diseases like cardiac disease and cancer, 
which ironically are diseases which studies have shown are prevented or 
reduced by habitual exercise. 
Secondly, increased sports participation has led to a number of psychological 
side effects. While previously the pleasurable sensation associated with 
exercise activity was tho~ght of as a positive and desirable consequence of 
exercise activity, recent work has suggested that a number of individuals 
become addicted to exercise, or use exercise as a coping mechanism to 
avoid the reality of routine life. A number of studies have suggested that 
anorexia nervosa in women is associated with exercise. Recently, a new 
psychological syndrome known as the Adonis complex, or the reverse 
anorexia syndrome has been described in males. In this illness, males 
exercise not for competitive success, but to develop better physiques, and 
eventually become addicted to exercise because of the positive aesthetic side 
effects of exercise. These individuals develop a dysmorphic body awareness, 
and increase exercise activity to levels which may have pathological 
consequences. 
Thirdly, the possibility that sport may cause harmful effects to anatomical or 
physiological structures has not been adequately assessed. Few studies have 
examined the negative affect of exercise on adult populations. While, 
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research has shown that excessive exercise may cause the overtraining 
syndrome with a resultant decrement in performance, it has been suggested 
that with adequate rest, the systems in the body recover. Also, studies have 
shown that long and short duration exercise may cause functional and 
histological signs of damage. Yet again it is suggested that these changes are 
reversible with rest. 
Our interest in the concept that exercise may have long term negative 
physical consequences began when an international level 27 year old runner, 
described in the first research chapter of this thesis, presented with symptoms 
of chronic excessive exercise-related fatigue and reduced exercise capacity. 
Serial muscle biopsies of the subject's vastus lateralis muscle showed the 
presence of muscle pathology. Tbis pathology was similar to that found in the 
muscles of old individuals, as ascribed to the normal aging process. The 
subject's triceps muscle was normal and did not show any pathology. The 
hypothesis of this thesis therefore, was that excessive exercise, or routine 
exercise activity in susceptible individuals, may initiate a process of 
"accelerated" aging due to repeated bouts of physiological stress, with 
associated long term or permanent decrements in physical activity. 
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Aim and scope of the thesis 
The aim of this thesis, based on the observations described in the 
introduction, are: 
i) To describe the case report study of a fatigued athlete. 
ii) To examine the prevalence of lower limb muscle pathology in chronically 
fatigued athletes. 
iii) To assess whether similar lower limb muscle pathology was present in 
currently active athletes with no overt symptoms of excessive fatigue. 
iv) To determine whether the symptoms of excessive fatigue and decrements 
in physical performance could be reduced or attenuated by antioxidant drug 
therapy. 
v) To assess the age-related changes in exercise performance in 
weightbearing and non-weightbearing sports. 
vi) To assess age-related changes in neuromuscular activity in the lower limb 
compared to upper limb. 
vii) To assess the age-related changes in physical activity levels during 
continuous intensity exercise as compared to intermittent intensity exercise. 
viii) To examine the age-related changes in exercise performance in social as 
compared to competitive sporting activity, and age-related changes in 
exercise performance during laboratory as opposed to field testing. 
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CHAPTER 2. LITERATURE REVIEW 
2.A. FATIGUE 
2.A.1. Introduction 
One of life's major unsolved mysteries is the concept of fatigue. Firstly from a 
physiological perspective, it is not clear whether fatigue is caused by 
substrate deficiency or metabolite accumulation in peripheral tissue (Fitts, 
1994), or from central command processes inhibiting further activity (Davis 
and Bailey, 1997; Gandevia 1998). Secondly, from a mechanistic 
perspective, it is not clear whether fatigue is a sensory manifestation of 
underlying physiological processes, or is a "governor" or signal from 
subconscious controlling centres in the brain circuitry actively directing 
conscious control of effort as part of a protective feedforward mechanism 
(Hampson et al 2001; St Clair Gibson et al 2001 (a)). Thirdly, from a 
philosophical perspective, it is not clear whether fatigue is a physical process, 
or an indefinable concept or emotion similar to other emotions such as love or 
anger, residing either in the "soul" of an individual or above the level of the 
higher cortical brain structures. It is also not clear whether the principle 
function of fatigue is to maintain homeostasis, or whether fatigue is a 
describable emotion felt by all individuals in a similar context and thus is a. 
communicatory tool identifying our state of being to others. 
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In this section of the literature review, the different definitions of fatigue are 
discussed. Fatigue is first examined from the physiological perspective that 
termination of exercise is caused by metabolic or "peripheral" skeletal muscle 
factors. Fatigue is also examined as a brain mediated feedforward "governor" 
mechanism, where in a mechanistic perspective, the brain and neural control 
processes are involved directly in fatigue as protective or homeostatic 
mechanisms. These central neural subconscious mechanisms provide 
"constrainers" which pre-set levels of exercise which can be sustained for the 
expected duration of activity. In this model fatigue becomes a relative rather 
than an absolute concept. 
Finally the relationship between the sensation of fatigue and underlying 
physical factors, including afferent pathways and receptors, brain regions, and 
efferent command structures controlling fatigue and associated changes in 
exercise performance and level of activity is examined. 
2.A.2. Peripheral fatigue 
Fatigue has been defined as a decrease in force production (Gandevia et al 
1995; Hagberg et al 1981), or an inability to regenerate the original force 
(Bigland-Ritchie 1981) in the presence of an increased perception of effort 
(Enoka and Stuart 1992). The causes of fatigue have been classi'fied as either 
"peripheral" or "central" in origin. Peripheral skeletal muscle fatigue has been 
defined as a decrease in the force generation capacity of the skeletal muscle· 
due to action potential failure, or excitation-contraction coupling failure, or 
38 
impairment of cross-bridge cycling, in the presence of unchanged or 
increasing neural drive (Hakkinen and Komi 1983; Taylor et al 1997). In 
contrast, central fatigue has been defined as a reduction in neu ral drive or 
motor command to the muscle resulting in a decline in force production or 
tension development (Enoka and Stuart 1992). 
Metabolic changes, or peripheral factors, suggested to be associated with 
fatigue during maximal short-term voluntary contractions include the relative 
contributions of lactic acid concentration increases, pH decreases and 
associated proton accumulation, ATP and creatine phosphate depletion, ADP, 
IMP and iP accumulation (Sahlin et aI1998), skeletal muscle Na+/K+ ATPase 
pump changes, and sarcolemmal, t-tubule and SR Ca2+ mediated functional 
changes (Fitts 1994; Green 1997; Greenhaff and Timmons 1998; Hargreaves 
et al 1998; Korge 1995; Lannergren et al 1996; Vollestad and Verburg 1996). 
Similarly, during maximal aerobic exercise, an inability to consume further 
oxygen and resultant skeletal muscle anaerobiosis (Myers and Ashley 1997; 
Nioka et al 1998), or excessive heat accumulation (Coyle 1999; Parkin et al 
1999) have been suggested to be the cause of fatigue in these exercise 
protocols (Basset and Howley 1997; Howley et al 1995; Shephard 1984; Van 
Lunteren et al 1998). 
During submaximalendurance exercise, lack of availability of muscle or liver 
glycogen stores, or inadequate ingestion of carbohydrates or fats have been 
suggested to be the determinants of fatigue (Balsom et al 1999; Coggan and 
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Coyle, 1987; Costill et al 1973; Coyle et al 1986; McConnell et al 1999; 
Tsil1tzas 1996). 
In the peripheral model of fatigue therefore, changes in the substrates or 
metabolites listed above would lead to system failure in either the peripheral 
muscles, the heart or other peripheral organs. This system failure would 
cause the cessation of exercise activity independent of any input from the 
central nervous system. As described previously, these substrate or 
metabolite changes would occur in the presence of increasing motor 
command from the brain to the peripheral muscle (Hakkinen and Komi 1983; 
Taylor et al 1997). This increasing motor command would be an attempt to 
increase utilization of peripheral muscle to it's maximal capacity in the face of 
looming metabolic crisis. However, as the capacity of the peripheral skeletal 
muscle or other physiological system was maximally extended, and at 
maximal muscle recruitment capacity, the system would fail, and an absolute 
prerequisite for rest would occur. 
The peripheral fatigue model can therefore be described as an absolute 
event. Absolute physiological changes are an example of a linear dynamic 
system (Pitt 1975). In a linear dynamic system changes which occur in a 
system are directly related to an input variable. The system's maximal and 
minimal capacities are related to the minimal and maximal capacity of the 
input variable. In the linear dynamic model of fatigue therefore, an individual 
or physiological system commencing activity would start from a rest point and 
increase to an absolute endpoint. This endpoint would depend on the maximal 
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possible concentration or 'flux rate of the peripheral metabolite or substrate at 
which the physiological system can operate. After this maximal point is 
reached in a linear model, a period of rest would be required for the system to 
recover. This period of recovery would allow the metabolites causing fatigue 
to be moved out of the peripheral organ involved, or for the depleted 
substrates to be brought back to an acceptable level. After a suitable period of 
time further activity is possible (Baker et al 1993; Favero et al 1997). In this 
model therefore, fatigue is a negative and unavoidable consequence of 
physical activity (Kirkendall 1990). This has been the definition which most 
appropriately defines the model used to explain fatigue in exercise physiology 
for the past several decades. 
However, there are several problem with this linear dynamic model. Firstly, 
these changes of either absolute substrate depletion or metabolite 
accumulation have been demonstrated during either in-vitro or in artificially 
stimulated conditions (Lamb and Cellini 1999; Favero et al 1997). None of 
these absolute metabolic changes has been shown to directly cause or lead 
to "fatigue" during static or dynamic physical activity in the in-vivo human 
model when central nervous system control mechanisms exist (Febbraio and 
Dancey 1999; Fitts 1994; Noakes 2000; Spriet et al 1987; St Clair Gibson et al 
2001 (b); Tonkonogi et al 1999; Woledge 1998). 
Secondly, in the peripheral fatigue model, the purpose of the conscious 
sensation of fatigue would be to convey to one's conscious perception what 
was occurring at that moment in the underlying peripheral physiological 
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processes. The conscious perception of fatigue in this model would be 
directly related to the peripheral changes or perturbations (Skinner et al 
1973). Therefore, in the peripheral model of fatigue, changes in peripheral 
organs would cause fatigue, and the sensation of fatigue would be a directly 
related sensory copy occurring as a result of these underlying peripheral 
changes. 
The majority of previous research of the perception of effort and fatigue has 
examined this relationship (Borg 1982; Caferelli 1977; Jameson et al 2000; 
Lamb et al 1999; Mihevic 1981; Noble 1982; Pando If et al 1978; Skinner et al 
1973). But no study has clearly shown a relationship between a single 
peripheral physiological factor and the perception of effort and fatigue 
(Hampson et al 2001). In contrast, several studies have shown the direct 
opposite. For example, in the chronic fatigue syndrome, individuals describe 
symptoms of marked fatigue in the resting state, to a degree that any activity 
is difficult to initiate and is reluctantly initiated (Barker et al 1995; Coetzer et al 
2000). However, these individuals have normal maximal aerobic capacity and 
muscle function relative to control subjects, despite having symptoms of 
excessive fatigue (Gibson et al 1993; Mullis et al 1999). The pathological 
entity causing chronic fatigue syndrome has not been isolated or identified. 
However, this "mismatch" between symptoms of fatigue and physical 
performance parameters indicates that fatigue in these individuals is 
associated with alterations in central motor drive (Sacco et al 1999) or 
originates "above the level" of the motor cortex (Enoka and Stuart 1992; 
Gibson et al 1993). 
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These findings would indicate that the conscious sensation of fatigue may not 
be a successful reference point for the level of exercise activity at all times. In 
these individuals suffering from chronic fatigue, either brain circuitry activation 
or neurotransmitters in the brain area or processes responsible for producing 
the symptom of fatigue are either over-stimulated or pathologically altered. 
Thus fatigue as a symptom itself cannot be completely correlated with the 
underlying peripheral process, as is described in the linear peripheral fatigue 
model (Davis et al 1998). 
Similar to individuals with chronic fatigue syndrome, individuals with illnesses 
which have an ,associated febrile state there also describe profound 
symptoms of fatigue in the resting state (Perkins and Siklos 1993). It has 
been hypothesized that during illness, cytokines released from the immune 
cells may cause the symptoms of fatigue at the brain fatigue locus, as part of 
"sickness" behaviour which causes mood and activity changes which would 
enhance the resolution of the illness (Smith 2000). This would cause exercise 
not to be initiated, as exercising in a febrile state has been showed to lead to 
further medical pathology such as viral myocarditis. Therefore, in this 
condition the dissociation itself of the symptom of fatigue from physical activity 
has a mechanistic or teleological purpose as an inhibitory protective 
response. 
Therefore, as no evidence has shown that absolute depletion of peripheral 
substrates occurs, and as the cognitive perception of effort is not directly 
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related to fatigue, some other mechanism apart from peripheral factors may 
prevent the development of absolute fatigue and result in the conscious 
perception of fatigue. 
2.A.3. Central fatigue 
In the central fatigue model, therefore, fatigue is defined as reduction in power 
output during exercise or cessation of exercise which is not caused by any 
limiting physiological changes in the muscle, or indeed any peripheral organ. 
Rather, these reductions in power output are caused by changes in (Brasil-
Neto et al 1993; Brasil-Neto et al 1994), or altered efferent command from 
(Gandevia 1998) brain structures. 
Neural control mechanisms which are activated by, or regulate the fatigue 
state can be defined as being either related to, or above, the level of the 
motor unit. The motor unit includes the motor nerve to a particular peripheral 
skeletal muscle group fibres, and all the muscle fibres innervated by the 
particular nerve (Latash 1998). Control of motion and changes in recruited 
strategies during fatigue at the level of individual muscle groups occur by 
altering recruitment strategies of these motor units (Latash 1998). General 
control of this motor unit activity occurs either from descending corticospinal, 
rubrospinal, reticulospinal or other descending tracts (Pritchard and Alloway 
1999). Alterations to these commands can occur at various levels in the brain 
....J 
and spinal cord. The include in~libitory "damping" neural synapses in the brain 
cortical circuitry from which the signals originated, or cerebellar, reticular 
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formation, and basal ganglion - associated alterations to the efferent 
command signal, or interneuronal and renshaw cell inhibitory or excitatory 
control at the level of the spinal cord (Latash 1998; Pritchard and Alloway 
1999). However, once the final "command signal" generates an excitatory 
post-synaptic potential at the motor unit motor neuron axon body, very little 
known control of neural efferent command can occur (Gandevia et al 1995). 
The quantity of excitatory post-synaptic potential at the level of the motor 
neuron is therefore the final reflection at the one instant of the conscious or 
subconscious command generated or altered by the central nervous system. 
The are several mechanisms which have been proposed to alter these central 
descending commands during fatigue states. Alterations in neurotransmitter 
concentrations in various brain structures have been suggested to cause 
fatigue. For example, brain serotonin (5-hydroxytryptamine) concentrations 
have been shown to increase during exercise in animal models and to be 
related to the development of fatigue (Blomstrand et al 1991; Blomstrand et al 
2001; Davis 1995; Davis and Bailey 1997; Gastmann and Lehmann 1998; 
Strachan and Maughan 1998; Wilson and Maughan 1992). Similarly, 
dopamine (Bailey et al 1993; Chaouloff 1989; Ziv et al 1998) and 
acetylcholine (Conlay et al 1992) have been shown to decline, while cytokines 
(Smith 2000) and ammonia (Guezennec et al 1998) increase during fatiguing 
exercise. Inoue et al (1996) have suggested that substances in the 
cerebrospinal fluid, such as actively transforming growth factor beta, which 
increases during exercise, might also be responsible for decreases in 
exercise performance. 
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In the neurotransmitter model of fatigue during exercise, it is not clear if the 
changes in concentration of the neurotransmitters are caused by changes in 
precursor concentrations in peripheral tissue which cross the blood brain 
barrier (Blomstrand et al 1991; Guezzenec et al 1998), or due to increased 
"thought" activity processing in brain tissue which leads to the changes in 
concentrations of neurotransmitters described above, which hinder further 
"thought" activity and lead to decrements in force output. These alterations in 
neurotransmitter concentrations in various brain structures may also 
paradoxically be a form of "peripheral" fatigue, where increases or decreases 
in neurotransmitter concentrations would cause fatigue in a linear model type 
manner. In this model, the neurotransmitters would be "toxic" by-product of 
thought processes, as would metabolite accumulation in the cerebrospinal 
fluid, and these changes would lead reduced capacity for force generating 
"thought" capacity. The conscious desire to increase aGtivity would have no 
effect once these neural "metabolic" changes or perturbations had occurred. 
In the second central model of fatigue, therefore, reductions in power output 
during exercise or cessation of exercise are not caused by any limiting 
physical changes in central nervous system (eNS) structures, but are caused 
by active processing in the eNS. This active eNS processing leads to 
decreased neural efferent commands and a reduction of exercise activity prior 
to the occurrence of maximal activity and resultant absolute fatigue in the 
peripheral tissues. 
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The majority of research investigating central fatigue has used surface or 
invasive electromyographic (EMG) techniques during submaximal or maximal 
contractions (Bigland Ritchie 1981, Brody et al 1991, Pedrinelli et al 1998) as 
a proxy for efferent neural command. A large quantity of research of central 
fatigue has examined the relationship between afferent input from the 
peripheral structures and the reduced efferent neural command and EMG 
activity which is a feature of central fatigue (Bigland-Ritchie et al1981, 
Williamson et al1999, Taylor et al 2000 (a)). These studies have shown that 
fatigue and reduced force output may be due to decreased efferent output 
from the motor cortex secondary to inhibitory influences arising from active 
muscle or elsewhere in the body (Arbogast et al 2000; Gandevia 1998; 
Garl,and et al 1988; Haouzi et al 1999; Kent-Braun 1999; Rotto and Kaufman 
1988; Woods et al 1987) or to reflex muscle recruitment changes arising 
directly from group III or IV metaboreceptor afferent input from the peripheral 
muscles at the spinal cord level (Bongiovanni and Hagbarth 1990; Hayward et 
a11988; Pettorrossi et aI1994). 
Other studies which examined cortical and efferent output changes during 
isometric contractions (Gandevia et al 1996; Gandevia 1998; Gandevia 1999, 
Taylor et al 2000 (b)) have found that fatigue in the motor cortex was not 
responsible the decreased efferent command. Rather, changes in motor 
command were regulated by changes "upstream" from the motor cortex, 
either excitatory or inhibitory changes in other brain-structures, or as a result 
of failure to recruit corticospinal neurons due to decreased afferent input from 
type III and IV afferents in the exercising muscles. Changes in neuromuscular 
47 
activity could therefore be due to commands generated in the higher cortical 
structures or in response to afferent input from metabolic changes in the 
peripheral organs, or to changes from both sources. 
2.A.4. Central motor unit control mechanisms 
During isometric activity, at the level of the motor unit, there are two 
mechanisms to control muscle recruitment and force output. The first 
mechanism is to alter whole motor unit recruitment strategy, and the second 
mechanism is to change the conduction velocity or frequency content of the 
nerve signals to individual motor units (Enoka 1995; Ertas et al 1995; Kukulka 
and Clamann 1981). During submaximal isometric activity, an individual is 
able to both increase motor unit recruitment and/or change conduction 
velocity to counteract reduction of force output associated with "fatigue" 
(Enoka 1995; Esposito et al 1998; Hagberg 1981; Hakkinen and Komi 1983). 
During maximal isometric activity, an individual theoretically has no further 
capacity to increase motor unit recruitment, and must rely on changes in 
conduction velocity to the individual motor units to attenuate decline in force 
production. It is beyond the scope of this review to discuss how these efferent 
command signals are matched to spatial and temporal muscle and joint 
position or force output changes, as described in the equilibrium point and 
other hypotheses of muscle control (Latash 1998). 
As described previously, in the classical theory of peripheral muscle fatigue, 
peripheral skeletal muscles fibres fatigue due to increased metabolic 
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accumulation or substrate depletion. Sensory afferents, presumably type III 
and IV chemoreceptors, or other receptor types, transmit this information to 
the central nervous system (Gerdle and Fugl-Meyer 1992; Kaufman et al 
1984; Taylor et al 2000 (c)). In response, excitatory efferent commands 
increase both motor unit recruitment and conduction velocity in the individual 
motor units. These newly recruited motor units supplement the fatigued motor 
units, and as nerve conduction velocity increases, larger fibres and type II 
fibres are recruited to generate greater force output and thus maintain force 
output until eventually even these later recruited muscle fibres experience 
excessive metabolic accumulation or substrate depletion and "fatigue" 
(Hakkinen and Komi 1983). 
In this model of fatigue, specific muscle fibres are recruited initially, followed 
by different fibres being recruited later in the fatiguing process. This causes 
an increase or maintenance of force generation by the summation of later and 
initially recruited muscle fibres (Desmedt and Godaux 1978). This model was 
first proposed by Henneman (1957), although it may have been proposed 
earlier by Denny-Brown and Pennybacker (1938) (Vilensky and Gilman 1998). 
Henneman (1957) examined amplitude changes of action potentials in motor 
neurons after electrical stimulation at increasing voltages of dorsal roots in 
spinalized cats. At increasing voltage, motor neurons with greater amplitude 
spiked at the same time as motor neurons of lesser amplitude, while at lower 
voltage, only smaller amplitude neurons fired. The lower amplitude neurons 
were able to fire for a longer period. 
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Although not all later studies have agreed with these 'findings, particulary in 
the human model (Ertas et a11995), this model became accepted as the 
central model of motor unit control strategy, and was described as the 
Henneman size principal (Akaboshi et al 2000; Bawa et al 1984; Conwit et al 
1999; Henneman 1985). In this model, therefore, motor units with low 
recruitment thresholds are always recruited 'first, followed by motor units with 
higher recruitment thresholds. The low recruitment thresholds comprise the 
smaller, fatigue-resistant slow twitch type I fibres, and the higher threshold 
motor units are the larger, more fatigue prone, fast twitch type II fibres. Also, 
the same low threshold motor units supplying type I fibres must always be 
recruited first, followed by higher threshold motor units comprising type" 
muscle fibres. With decreasing activity, the higher threshold motor units (type 
" muscle fibres), will be de-recruited first while the same lower threshold (type 
I muscle fibres), which were firing initially throughout the movement activity, 
will be maintained until the isometric activity is terminated. 
For motor unit firing to be regulated according to the Henneman size principle, 
the recruitment pattern must necessarily be constant and immutable. 
However, this is not necessarily the case as several studies show that other 
control systems or firing patterns may exist. It has been suggested that the 
pattern of motor unit recruitment is not strictly maintained, as described by 
Henneman (1957), but rather different motor units within the same muscle are 
cyclically turned on or off dependant on their firing history or level substrate 
availability present in the muscle cell (Fallentin et al 1993; Sjogaard 1988). 
This would be a protective mechanism to prevent muscle cells from being 
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damaged from excessive activity causing complete substrate depletion or 
temperature increases too great for the individual muscle fibres as part of a 
"cooling" strategy. 
Recently, Westgaard and De Luca (1999) showed that this cyclical rotation 
activity occurs during isometric activity. They examined motor unit 
substitution during long-duration contractions of the human trapezius muscle. 
They found that during these contractions, low threshold motor units showed 
periods of inactivity during w~lich they were substituted by other motor units 
during the ongoing contraction. Several of the previously de-recruited motor 
units were then re-activated during the later stages of the contraction. This 
phenomenon was not observed during the first few minutes of the contraction. 
In several cases, this substitution pattern coincided with a short period of 
inactivity in the surface EMG pattern. 
Westgaard and De Luca (1999) suggested that these observations were 
explained by time-variant recruitment thresholds of the motor units, sensitive 
to their activation history and to a planned temporal variation in the activity 
patterns. They speculated that this substitution phenomenon protected motor 
units in postural muscles from excessive "fatigue" when there is a demand for 
sustained low-level activity. 
De Luca and Erim (1994) examined single motor unit firing activities during 
isometric contractions, and found that firing rates of earlier recruited motor 
units were greater than those of later recruited motor units during in vivo 
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compared to artificially stimulated conditions. At any time point, earlier motor 
units maintained higher firing rates than later recruited motor un its, resulting in 
an ordered nesting of firing rate curves under one another, perhaps related to 
rheobase-related fibre recruitment thresholds. However, in this case higher 
threshold motor units would be recruited before lower recruitment thresholds 
which is paradoxical compared to Henneman's size principle model. De Luca 
and Erim (1994) described this orderly resting of firing rate curves under one 
another as an "onion skin" pl1enomenon, and suggested that this represented 
an apparent paradox in conventional knowledge of motor control, as the 
finding contradicted Henneman's conventional theory of muscle recruitment. 
De Luca and Erim (1994) concluded that a possible reason for their findings 
was that the higher threshold motor units would fatigue more quickly than the 
lower threshold motor units, and would not be able to sustain a continued 
contraction. Therefore, this later firing of lower threshold motor units was 
described as being part of a system designed to have an optimal combination 
of force and duration over which the force was sustained, and the "onion skin" 
phenomenon implied that under voluntary control, the neuromuscular system 
maintained a reserve capacity for generating high force levels for brief periods 
of time, and therefore the lower threshold motor units used preferentially in 
the later phases of contraction may have been part of a protective mechanism 
to prevent damage to the fast twitch fibres from excessive use and possibly to 
allow some reserve capacity for "fight or flight" dangerous situation. 
2.A.S. Motor unit recruitment during fatiguing contractions 
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Bigland-Ritct"lie et al (1981) examined the relations~lip between conduction 
velocity and EMG frequency spectrum during maximal intermittent "fatiguing" 
and "non-fatiguing" contractions. They found that while the frequency . 
spectrum was not significantly different between tests, the conduction velocity 
changes required to generate changes in EMG were ten times greater in the 
absence of fatigue compared to during a muscle contraction which caused 
fatigue. They concluded that factors other than changes in wave form of 
individual action potentials may contribute to this shift in conduction velocity. 
They suggested that the likely reason for these changes was that during 
"fatigue" resulting from maximal short term activity, the normal random 
distribution of motor neuron activity became altered, with grouping or 
synchronization of motor unit firing. This resulted in large, low frequency 
oscillations which increased the relative power in the low frequency bands of 
the EMG spectrum, the function of which was to maintain force and protect 
muscle fibres. This model would clearly not be compatible with Henneman's 
original size theory principle. 
Research performed using electrical stimulation during fatiguing muscle 
contractions demonstrated that the decline in force during a 60 s volitionally 
controlled maximal isometric voluntary contraction (MVC) of the adductor 
pollicis muscle could be reproduced by a decrease in stimulation frequency 
from 60 Hz to 20 Hz used for electrically stimulated force generation (Jones et 
ai, 1979). Furthermore, when stimulus frequency was held constant, force 
declined more rapidly than when stimulation frequency was reduced during 
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the fatiguing contraction (Binder Macleod et al 1990; Binder Macleod et al 
1992). Windhorst and Boorman (1995) suggested that this decrease in firing 
rate was counter-intuitive, as during steady state force frequency activity, 
firing rate would be expected to increase. This mechanism has been 
described as "muscle wisdom" (Enoka and Stuart 1992). Enoka and Stuart 
(1992) suggested that the functional significance of muscle wisdom was 
optimisation of force output and economical activation of fatiguing muscle 
fibres by the CNS. Although further work is needed to confirm this 
hypothesis, decreases in force output during a volitionally controlled maximal 
isometric MVC may therefore be due to this CNS controlled mechanism, 
rather than due to maximal substrate depletion or metabolite accumulation. 
Gandevia et al (1995) suggested that the concept of "muscle wisdom" is a 
misnomer, as the regulation of this system would occur proximal to the 
muscle itself, in the brain or neural control pathways. The "muscle wisdom", 
and possibly motor unit rotation strategies, may be part of a programmed 
feedforward centrally driven command process which is initiated immediately 
at the onset of a muscle contraction and is an attempt to maintain force output 
while protecting fatiguing fibres from damage incurred by ongoing muscle 
contraction and ATP and phosphocreatine depletion. Indeed, Belhaz Sahif et 
al (1996) recorded discharge patterns 'from brain cortical cells of monkeys as 
they exerted repetitive isometric activity. Cortical activity was shown to either 
decrease, increase or remain constant in the same way as the EMG power 
spectrum changed. They concluded that the motor neural discharges may be 
modulated by descending signals from the motor cortical areas. 
54 
A number of efferent neural command strategies therefore exist which would 
reduce force output in muscles being utilised during an isometric contraction. 
These strategies would in effect reduce "maximal" force output to submaximal 
activity, thereby not allowing a system of maximal substrate utilisation or 
metabolite accumulation. It may be argued that, using the Henneman size 
principal theory, that during submaximal contractions, if the same fibres were 
activated t~lroughout the submaximal contraction, with the inactive fibres 
continuously remaining inactivated, then those activated fibres may eventually 
show signs of "peripheral" type fatigue. However, as described previously, 
eNS controlled mechanisms such as substitution/rotation of muscle fibres and 
muscle wisdom may occur, and these mechanism would protect individual 
fibres from the development of rigor due to substrate depletion or excessive 
metabolite concentration increases. Further work is needed to clarify the 
relationship between these different motor unit control strategies in the in-vivo 
human model. 
It must be noted that these central fatigue mechanisms would lead to 
downregulation of motor firing during muscle activity from a starting "maximal" 
initial level of motor unit and muscle recruitment. However, it is not clear 
whether muscles are ever maximally recruited, even during a maximal 
isometric contraction (Gandevia 2001). 
2.A.6. Motor unit recruitment and muscle reserve capacity 
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There are three reasons for this. Firstly, it is necessary to artificially stimulate 
muscle at a higher frequency of firing to achieve maximum force output than 
the observed maximum discharge rate of motor units under voluntary 
command (Enoka 1995). For example, the required discharge rate during 
artificial electrical stimulation of skeletal muscle is between 50-120 Hz, 
whereas maximum discharge registered in the deltoid is 29 ± 3 Hz (De Luca 
et al 1982); 20-25 Hz for the biceps brachii (Kukulka and Clamann 1981) and 
11 ± 3 Hz for the soleus muscle (Bellemere et al 1983). There are exceptions 
to this, with Marsden et al (1983) describing a peak discharge rate of 100 Hz 
for single motor units in adductor pollicis. The findings of lower maximal 
compared to artificial discharge rates led Enoka (1995) to speculate whether 
the force achieved during maximum contraction is the absolute maximum 
force which a muscle can possibly exert. 
The second reason is that even with twitch interpolation during an MVC, 
muscles may not be maximally stimulated (Taylor et al 2000 (c)), particularly 
during dynamic activity (Yue et al 2000). While it has been suggested that in 
certain individuals who are highly motivated it is possible to "maximally" recruit 
all possible muscle available for contraction (Enoka and Stuart 1992), it has 
been shown using magnetic resonance imaging techniques that only - 70% of 
available muscle involved in generating force output during a maximal 
isometric contraction is recruited (Adams et al 1993), It must also be noted 
that it is not clear whether electrically stimulated muscle contractions can ever 
be maximally tested, as it is not safe to increase electrical current beyond a 
certain point when testing maximal capacity, for fear of tearing either the 
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muscle being tested or the tendon or bone insertions of the muscles and 
related joints around which forces are created. Therefore, theoretically there 
may be a degree of muscle reserve. between maximal twitch interpolation 
induced by maximal voluntary contractions, and the force necessary to 
rupture a muscle. 
The third reason is that it is now well established that during maximal 
isometric and concentric activity, less force is generated using more muscle 
fibres than during eccentric muscle activity (Kay et al 2000; Tesch et al 1990). 
Therefore, when muscles are induced under volitional control to perform 
maximal isometric contractions, the force output cannot be maximal, as the 
same absolute quantity of muscle generates less force output than during 
eccentric contractions (Kay et al 2000). It is as yet not clear why the same 
muscle produces different "maximal" force outputs during different activity 
patterns. The exact mechanism of muscle activity at the actin/myosin level as 
well as neural control mechanisms in the different muscle activities is not well 
understood (Enoka 1996). 
All these different mechanisms described above indicate that a number of 
physical control structures, or programmed neural commands, are available to 
inhibit or reduce maximal force output during maximal voluntary isometric 
contractions. These mechanisms appear to allow a degree of "muscle 
reserve" to occur. There are more obvious examples of the complexity of the 
relationship between generation of force output, fatigue and perception of 
effort. When subjects are not encouraged during maximal contractions, their 
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force output is less than when sustained vocal encouragement is given during 
the fatiguing process (St Clair Gibson et al2001 (a)). Similarly, the duration or 
length of time which the contraction can be maintained is prolonged in the 
presence of verbal encouragement. Therefore, higher cortical structures 
involved in motivation and effort perception playa role in setting "maximal" 
force output in different environmental situations. Voluntary reduction in force 
output or inability to generate maximal contractions may be related to either a 
lack of perceived reward or reason to perform beyond a comfortable limit in 
certain subjects, or due to a fear of harm or damage which subjects perceive 
may be the outcome of excessive force generation. It is therefore apparent 
that at a number of levels, neural pathways and command structures may be 
available to moderate force output, thus ensuring the presence of a muscle 
reserve with the teleological function of preventing any muscle fibres from the 
consequences of excessive metabolic activity during short term "maximal" 
isometric activity. 
2.A.7. Central pattern generators and control of multi-joint activity 
The majority of the research of the influence of central brain regulation in 
fatigue described above have used isometric or single muscle protocols. 
However, exercise involves more complex and dynamic control of activity, 
more complex control systems are required. The reason for this is that during 
more functional activity such as walking or running the majority of muscles in 
the body are recruited, and coordinated sequences are required to control 
these different muscles, and to adjust not only each muscle's neural firing 
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profile, but also to adjust or change the sequential activity of different muscles 
in different limbs as pace is altered, or muscle patterns are modified to 
maintain force output. 
In the peripheral metabolite model of fatigue discussed earlier in the literature 
review, changes in peripheral substrate or metabolite concentrations would 
cause muscular fatigue and result in termination of exercise. The logical 
assumption would be that only the muscles in which the metabolic rate were 
highest would suffer "fatigue," and alterations in potential would occur in order 
to perform activity. In reality, if this were to occur the termination of exercise 
would involve an uncoordinated gait pattern with spastic walk patterns. An 
example of this would be that during running, the gastrocnemius and soleus 
muscles are mainly recruited, and if fatigue occurred, these muscles would no 
longer work efficiently. In contrast, the quadriceps, hamstrings, and tibialis 
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anterior muscles would still have normal function. The imbalance between 
fatigued and non-fatigued muscle would lead to the development of a spastic 
gait. In reality this does not occur. Instead, the individual's exercise intensity 
decreases, with no obvious spastic gait cycle. This "smooth" decrement in 
intensity appears to be effected by central pattern generators (Dimitrijevic et al 
1998; Guadagnoli et al 2000). 
Central pattern generators are located in the lower brainstem and upper 
spinal cord, and their function is to generate locomotor patterns that control 
activity. An example of central pattern generator activity is found in 
decerebrate cats (Duysens et al 1998; Latash 1998), which, if their bodies are 
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supported, are able to perform walking, trotting, and running activities in a' 
coordinated manner. The value of central pattern generators is that they are 
"intellectually" efficient because they reduce the efferent output that would be 
necessary to control individual muscle groups or muscle fibres. Therefore, 
using the central teleoanticipation model, efferent neural command descends 
not to individual muscles but to central pattern generators, allowing single 
commands on levels of activity from either conscious or subconscious 
mechanisms to occur. From the central pattern generator, the intricate system 
of control to each muscle is generated as part of central pattern generator-
related predetermined patterns of activity. This system is obviously more 
efficient and reduces the burden of calculation required in the actual brain 
structures themselves. 
Beyond the level of central pattern generator control of activity, the control of 
exercise activity involves choices of whole muscle or limb activity and variable 
recruitment of individual motor units. In the central pattern generator (or area 
of the brain responsible for selecting the gait patterns that would create a 
certain level of exercise intensity), a number of possible combinations of 
multiple-joint activity are available to achieve the same required goal. 
Bernstein (1923) defined this choice as redundancy, whereas Latash (2000) 
later defined it as "abundancy." 
An example of this abundancy is seen in the multi-joint muscle activity 
observed when a limb moves from one point to another. During different 
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temporal activities, a number of spatial patterns can be used. For example, in 
the lower limb, different angles of the knee, hip, and ankle joints would use 
different muscle groups but would generate similar movement from an 
arbitrary point A to arbitrary point B. There are a number of permutations of 
muscle patterns available during motion, which increase exponentially as 
more joints are involved in the motion. Bernstein (1923) defined this as 
redundancy because some of the patterns are not used, but it is not clear 
whether certain patterns are used more than others during activity (Latash 
2000). Nonetheless, this redundancy, or abundancy, of strategy choices could 
be interpreted as a type of fatigue-reduction mechanism, maintaining a similar 
force output and exercise intensity while using different muscle groups at 
different times. If similar "redundancy" occurs at the level of individual motor 
units recruited during cyclical activity, the amount of "abundancy" of choices of 
recruitment strategy is enormous, and the calculations and command 
processes required to regulate this firing process, if not a random procedure, 
even more complex. 
It must also be noted that during the gait cycle of walking and running 
activities, no muscle is continuously activated. During isometric activity, the 
same muscles are continuously recruited until "exhaustion" occurs, although 
as previously described, motor unit substitution/rotation occurs even during 
these activities. In contrast, during cycling, running, or any "usual" activities of 
daily living, whole muscle groups are cyclically turned on and off as part of the 
routine gait cycle. Thus, during even maximal dynamic activity, an individual 
muscle fibre would not be continuously activated, but for up to half of the 
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activity would be quiescent. It is also not clear if exactly the same muscles 
are recruited when muscles are reactivated at the desired point in subsequent 
gait cycles. Further work is needed to examine the effect of this cyclical 
control activity on cellular metabolism. 
2.A.8. Central neural control during submaximal dynamic endurance 
activity 
A problem when examining active brain control mechanisms is how to 
measure neural recruitment changes during dynamic exercise activity, when 
power output and neural efferent command are essentially non-monotonic, 
increasing and decreasing throughout the activity. One method used 
previously was to measure force output and EMG activity during a maximal 
voluntary contraction (MVC) at the beginning and end of an exercise bout, in 
order to determine changes in maximal capacity (Bentley et aI2000). For 
example, Nicol et al ( 1991 (b)) found that force output and integrated EMG 
(lEMG) during a MVC decreased by - 30% in subjects studied after a 42 km 
marathon foot race. They speculated that these changes were caused either 
by insufficient conscious effort or altered central recruitment strategies. 
Similarly, Sacco et al (1997) found that after a fatiguing protocol involving the 
lower limb, efferent output to the synergistic muscles, which were not involved 
in the fatiguing process, were also inhibited or derecruited after fatiguing 
contractions. 
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However, as described by Lewis and Fulco (1988) and Kay et al (2001), such 
research protocols do not make provision for the continuous assessment of 
muscle power and neural recruitment, and permit only a "snapshot" of the 
physiological events associated with muscle activity. Indeed, it is this 
"snapshot" quality of testing in exercise physiology research which has 
perhaps lead to the generation of linear models of fatigue, as one cannot 
observe the stochastic, non-monotonic nature of exercise activity due to 
limitations in data capture rate during these trials. 
A protocol was developed in our laboratory (Schabort et al 1998) to 
circumvent this technical problem, by adding high intensity sprint bouts to an 
endurance 100 km cycling time trial. Using this methodology, maximal force 
output and neuromuscular activity could be determined during different stages 
of the endurance event, given that subjects were instructed to complete these 
sprints as fast as possible in the context of completing the entire 100 km 
endurance event. 
In a recent trial performed using this protocol (St Clair Gibson et al 2001 (c); 
despite subjects being encouraged to perform at maximal intensity, power 
output decreased incrementally and significantly during the high intensity 
sprint bouts which formed part of the 100 km endurance cycling protocol. 
IEMG activity declined in parallel with these decreases in power output. These 
changes occurred despite only- 20% or less of possible muscle fibres being 
recruited that were recruited during a MVC performed prior to starting the 
endurance capacity trial. Heart rate was maintained during the sprint bouts, 
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indicating that these changes were not a result of a conscious desire to 
reduce power output. 
Muscle biopsies performed prior to and after the trial showed th at muscle 
glycogen values decreased by - 80% during this trial, despite only - 20% or 
less of available muscle fibres being recruited at any time during the trial. If 
the same 20% of muscle fibres were recruited continuously for the entire 
duration of the trial, there would be absolute muscle glycogen depletion in 
these muscles, and completion of the entire trial would not be possible. 
Therefore, either recruitment strategies of the entire limb were altered during 
this trial, or the more likely explanation is that different muscle fibres in the 
same muscle group were recruited at different times during the endurance 
trial. In accordance with this explanation the fibres recruited early in the trial 
were replaced by fresh non-utilized muscle fibres at the same time as efferent 
neural command decreased. As described previously, this process has been 
described as motor unit substitution/rotation (Westgaard and De Luca 2000). 
These findings appear to indicate that the eNS down-regulates power output 
by decreasing motor command to the peripheral muscles during this 
stochastic exercise, despite all conscious attempts by the participants to 
maintain power output. The finding that power output decreased in the 
presence of a large muscle "reserve" allows one to speculate that this 
decreased neural command was a protective response performed by 
subconscious brain structures. This protective function would prevent muscle 
damage from occurring which would be the consequence of complete 
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substrate depletion during the exercise activity and which may have occurred 
if the efferent neural command signal was excitatory rather than inhibitory (St 
Clair Gibson et al 2001 (c)). 
Further work has supported these findings and theory. In a recent study by 
Kay et al (2001), six maximal sprints were evenly interspersed within a 60 
minute time trial bicycle ride, and power output, EMG activity, and ratings of 
perceived exertion were assessed during these 6 sprints. During sprints 2-5, 
there was a reduction in power output and associated reduction in EMG 
activity. However, there was a increase in EMG activity and concomitant 
increase in power output during sprint 6, which occurred in the last minute of 
the ride. This again suggested the existence of a subconsciously controlled 
maintenance of muscle reserve during the initial 5 sprints, and also the ability 
to activate the muscle to greater levels if required, w~lich would not be 
possible if substrate depletion or metabolite accumulation was responsible for 
the decrease in force output and EMG activity during sprints 1-5. These 
findings also showed that IEMG activity was "tracking" power output changes 
and that decrements in IEMG during the first few sprints could not be 
explained solely by temperature, conductivity or EMG electrode placement 
changes during the trial. Therefore the decrements in IEMG activity during 
both trials were not an artefact of the testing methods used. It has been 
previously shown that EMG activity during cycling ergometry is both reliable 
and repeatable (Moritaniet al 1993; Taylor and 8ronks 1995). 
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A further finding from the study of Kay et al (2001) was that during the sprint 
bouts, rating of perceived exertion (RPE) ranged from - 14 for the first sprint 
to - 18 for the last sprint, out of a possible maximal score of 20 on the Borg 
RPE scale (Borg 1982). This indicates that despite encouragement to exert 
themselves "as hard as possible" during the sprint bouts, the subjects 
maintained a reserve capacity in order to complete the entire 60 minute time 
trial ride. As the RPE is the overall conscious perception or "gestalt" of all the 
underlying physiological activity and body processes (Foster - personal 
communication), this finding indicates that regulation must occur at a 
subconscious level, as the exercise intensity set-point over-rode the 
conscious desire of the subject, and the overt instructions given to the subject, 
to go as "hard as possible". Most interesting was that during the last sprint, 
although the subjects knew that this was the last minute of the trial, as well as 
the last sprint, they still rated a maximal RPE score of - 18 out of a possible 
score of 20. An interpretation of these data was that a maintenance of 
subconscious reserve capacity, even at the endpoint. An explanation for this 
finding was that the subjects did not exhaust themselves completely, in 
anticipation of activities of daily living continuing after the trial. 
2.A.9. The central teleoanticipation model of exercise activity 
In the central teleoanticipation system integration model therefore, in contrast 
to the peripheral fatigue model, fatigue is a relative rather than an absolute 
event. In this model, the individual performs subconscious calculations of 
metabolic activity and environmental conditions in order to complete the 
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required activity while maintaining functional metabolic reserve. This theory is 
an extension of a theory proposed previously by Ulmer (!996). Ulmer (1996) 
defined this "resetting" of power output or speed as "teleoanticipation". He 
suggested that in the teleoanticipation model,a central "programmer", 
probably working at a subconscious level, would take into consideration the 
length of time necessary to complete the sprint, or any planned activity, and 
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include in a calculation of required power output to complete the task the 
metabolic requirements which would prevent damage to the cellular structures 
due to substrate depletion or metabolite accumulation. The teleoanticipation 
system integration mechanism would therefore decrease power output during 
dynamic activity despite seemingly adequate supplies or reserves of 
metabolic fuel, as part of a subconscious mental calculation, with the cognitive 
feeling of fatigue being the outward manifestation of the efferent inhibitory 
command processes derived from this "mental calculation." 
In this model, the symptom of fatigue may have a cognitive function, where 
the conscious brain is sent a signal creating the sensory perception of fatigue 
from the subconscious region of the brain involved in deriving mental 
calculations (St Clair Gibson et al(a». The function of this fatigue symptom 
would be to override, or inhibit, the conscious desire to go faster than the 
planned level of activity, which may occur due to distracting or overriding 
sensory input, such as vocal support from spectators. This vocal support, 
which would be a positive stimulus to increase exercise intensity, may cause 
conscious "motivation" to override subconscious teleoanticipation, and may 
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lead to later metabolic insufficiency. Therefore, in this model, the symptoms of 
fatigue may have an active controlling teleological function. 
What would perhaps be the most important component to the setting of 
teleoanticipatory mechanisms would be the length of time or distance involved 
in the exercise, or indeed any type of physical activity. In this theory, for the 
calculations to be performed, this distance or anticipated time is the important 
factor for the calculation of the pacing strategy which would allow the distance 
to be covered at the highest power output which would not disrupt cellular 
homeostasis (Ulmer 1996). When the distance or time is known to the 
individual, this has been defined as "closed loop" activity. In contrast, if the 
duration or distance is unknown, or there is no fixed end-point to the activity, 
this has been defined as open loop activity (St Clair Gibson et al(a». The 
teleoanticipatory central integrative strategies would be very different for the 
closed as opposed to open loop activity, due to knowledge or lack of 
knowledge of an endpoint on which metabolic calculations could be based. 
During closed loop activity, the ability of an individual to gauge the exercise 
intensity or to complete an exercise test with similar times on separate 
occasions, as has been found in different repeatability testing studies (Dunbar 
et al 1992; Schabort et al 1997) is remarkable and clear evidence for the 
presence of teleoanticipation. 
Evidence for the teleoanticipation integration system can be found in the 
activity patterns of different animal populations. In a recent study 
(Wohlegemuth et al 2001; Srinivasan 2001), it was shown that ants can gauge 
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distances travelled accurately over a range of different terrains. It was found 
that their pacing strategy was related to proprioceptive input from the various 
body segments of the ants to a greater degree than to changes in metabolic 
rate or visual input. It has also been shown that prior to long distance 
migration, birds successfully calculate the metabolic requirements of their 
flight and increase both quantity and alter the composition of their fuel stores. 
They also modulate their flight speed and flying patterns during the migratory 
flight to accommodate the extra body weight caused by having increased fuel 
reserve (Kvist et al 2001). It is also interesting that entire flocks of birds 
migrate as a unit. Therefore their pacing and teleoanticipation strategies. 
appear to be universal or commonly linked (Ulmer 1996). 
2.A.10. Brain structures and the origin of the sensation of fatigue 
As described previously in the literature review, efferent control mechanisms 
appear to modulate activity using a number of different mechanisms. It is not 
clear in these central control mechanisms what level of interaction with 
afferent information is needed for the teleoanticipatory and central pattern 
generator mechanisms to be regulated. However, as suggested previously, 
the teleoanticipatory sytem integrates and controls all metabolic, locomotor 
and perceptive variables in an algorithmic process. Therefore, receptors and 
afferent input which would be involved in this central integrative system would 
include type III and IVchemoreceptors located in peripheral muscle, liver and 
other organs for metabolic perturbations, muscle spindle and golgi tendon 
organs to indicate changes in spatial and temporal locomotor activity, and 
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thermoreceptors and nociceptors for pain and temperature assimilation of 
sensory input (Kaufman et a11984; Latash 1998; Taylor et al2000 (c); Vissing 
2000). It is not clear if there is one receptor type responsible for sensing 
perception of effort and fatigue, or whether perception of effort is an 
amalgamation of all these sensory receptive inputs (Hampson at al 2001 ). 
Recent work in our laboratory (Hampson et ai, unpublished data) has 
indicated that perception of fatigue and perception of exercise intensity may 
have separate pathways or sensory control mechanisms. Further work is 
needed to examine this concept, although as described previously, if fatigue is 
an emotion or sensation perceived or generated by higher cortical structures, 
it is more likely that this cortical or central nervous system structure would 
integrate these different sensory inputs rather than have one "fatigue" 
receptor. As discussed previously, a number of metabolites or substrates or 
enzymatic changes may be signalling factors generating these afferent 
signals. 
The precise regions of the brain involved in the teleoanticipatory integrative 
system and fatigue generating systems are similarly difficult to assess, as 
neuroscience techniques are unable to accurately determing whether function 
is localised to areas of the brain, or whether more general processes involving 
energy changes throughout the brain are responsible. 
There are several brain areas and mechanisms which may alter or control 
central descending commands during fatigue states. Different cortical areas 
have been associated with different functions. For example, for volitional 
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control of activity, the motor cortex, premotor cortex, supplementary motor 
cortex, basal ganglia, cerebellum, cingulated cortex, visual cortex, reticular 
formation may be involved (Latash 1998; Pritchard and Alloway 1999). For 
emotional control of activity;. including motivation and drive, the limbic system 
and hippocampus may be involved (Eichenbaum 2000). For cognitive control 
of activity, including planning; prior experience, the prefrontal cortex may be 
involved (Miller 2000). The hypothalamus may be the region involved in 
integration of hormonal, metabolic, and motor functions during the fatiguing 
process (Vissing 2000). Through it's connections with the reticular system and 
nucleus accumbens it may be able to initiate motor behavioral responses 
(Parvizi and Damasio 2001). Through its association with the association 
cortex of the frontal lobe, the hypothalamus may also impinge on cognitive 
behavioral function, which would be relevant in terminating, initiating or 
altering exercise activity. Williamson et al (1999) have suggested that the 
insula and brainstem regions are responsible for control of cardiorespiratory 
function, and connection with the insula regions would be integrated into the 
control structures described above, although possibly as a "pattern generator" 
function rather than an actual command generator function. All these area 
could therefore linked to the fatigue state. 
The brainstem and spinal cord may also be the areas of the brain where the 
fatigue control mechanisms, afferent information for the teleoanticipatory 
- systems, and central pattern generator mechanisms interact. Parvizi and 
Damasio (2001) have suggested that the emotions and feeling such as fatigue 
are generated at the level of the brainstem. The reasons they proposed that 
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this area was important were firstly because the reticular activating system, 
which sets level of electrophysiological activity in the cortex and most other 
areas of the brain, arises from the reticular nuclei of the brainstem, and 
individuals with damage to the brainstem region have impaired 
consciousness. Secondly, the brainstem is the site of arrival of afferent input 
from nociceptors, vestibular system, muscucoskeletal system, and integrative 
interneurones, and therefore would be an area where integration of these 
signals may occur. Thirdly, there is a number of connections between the 
hypothalamus and brainstem nuclei, and through these connections afferent 
knowledge of and immediate efferent responses to homeostatic perturbations 
can be initiated via a "body loop". Finally, a number of nuclei are involved in 
the dopaminergic, cholinergic and other neurotransmitter systems which alter 
the mode of processing of other brain structures and areas responsible for 
mood or perceptual changes, are located in the brainstem and would affect 
motivation and drive via upregulation of a "mind loop". 
A different method of classifying the brain's involvement in the fatigue 
generating process would be to use the classification system for memory 
formation in the brain, and thus describe functional activity rather as a proxy 
of cOliical areas of activity. Eichenbaum (2000) has defined the different brain 
mechanisms and structures involved in memory formation and storage, and 
as a comparison between current activity and prior activity is one of the 
fundamental principle of teleoanticipation, it is necessary to assess these 
components of memory. 
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Declarative memory involves the process regulating immediate and long term 
memory, and is located in the hippocampus, parahippocampus and 
surrounding areas of neocortex (Eichenbaum 2000) and is associated with 
activity in the prefrontal cortex (Miller 2000). In declarative memory, a 
synthesis of episodic representations, where neural firing patterns which 
encode a sequence of events comprising a unique single experience, such as 
a specific exercise activity, are regulated within a framework of general 
semantic knowledge. In the declarative memory model, current activity would 
be compared to previous stored memories; and activity would be altered 
appropriately based on memory of successful past events. Similar to 
declarative memory is working memory. In the working memory model, 
representations of activity patterns are held in consciousness both during and 
after the experience, and are involved with active manipulation of memory. In 
the cortical areas involved with declarative and working memory may be the 
origin of conscious perception of effort and fatigue lies. 
Procedural memory involves the acquisition and improvement of motor skills 
and habits, and involves the neostriatum and cerebellum. In this memory 
model, the representation of a series of actions or perceptual processing 
functions are analysed subconsciously, and results in improved speed or 
accuracy with repetitive activity or training (Miall 2001; Pritchard and Alloway 
1999). These regulatory areas are also important in locomotor generation, 
and improved regulation of motor function (Latash 1998). 
73 
Emotional memory regulates the strength and consolidation of memories in 
other memory systems, and it is postulated that this activity is controlled by 
the amygdala (LeDoux 1998). This model involves the representation of a 
positive or negative consequence associated with a certain stimulus, and is 
generally not involved in conscious recollection but rather in habitual activity 
such as avoidance of or attraction to a later stimulus, or regulation of 
autonomic system responses. If fatigue is generated from aversive emotional 
stimuli, then the location of fatigue and aversive associated feelings or 
symptoms related to fatigue would be generated in the amygdala. Fatigue 
does not always have negative associations, and may' be related to opioid 
induced or more complex behavioural/emotional activity related to 
achievement of goal behaviour. Thus fatigue would have both aversive and 
positive consequences in memory formation derived possibly from this 
emotional centre. 
It has also been suggested that no regional classification of the brain is 
correct, as all areas of the brain are involved during activities, albeit to 
different degrees (Bassin et al 1999). This concept is encapsulated by the 
"binding problem", which describes the problem of binding together 
representations of different properties of an object or physical state such as 
it's colour, form or location (Salinas and Sejnowski 2001), and suggests that 
large areas of the brain must be involved in complex cognitive tasks or motor 
activities. It has been suggested that large scale synchronization of oscillatory 
electrical activity in the neural circuitry of different brain areas or in local brain 
areas (Engel et al 2001; Varela et al 2001) controls the temporal sequences 
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of task activity. This phase synchrony, or coherence of activity in different 
brain regions is also found to occur in EEG and EMG activity during motor 
tasks, generally in the gamma rhythm range (25-70 Hz) (Engel et al 2001 ; 
Salinas and Sejnowski 2001; Varela et al 2001), indicating that central and 
peripheral neural systems may communicate using synchronization processes 
or activity. It is not clear how fatigue influences this synchronization of 
electrical activity during functional activities, and further work is necessary in 
this field. 
As described previously, alterations in neurotransmitter concentrations in 
various brain structures have been suggested to cause fatigue. It is not clear if 
these neurotransmitter concentration changes are caused by changes in 
precursor concentrations in peripheral tissue which cross the blood brain 
barrier (Blomstrand et al 1991; Guezzenec et al 1998), or due to increased 
thought activity processing in brain tissue which leads to the changes in 
concentrations of neurotransmitters described above, or whether activation of 
brainstem structures which control release of neurotransmitters in the higher 
cortical structures are altered or initiated by fatiguing activity and lead to the 
release of excitatory or inhibitory neurotransmitters which may alter cognitive 
function or perception of the fatigue state. For example monoaminergic nuclei 
of the reticular formation in the brainstem are responsible for serotonin, 
dopamine and noradrenaline changes in the cortical mantle, and these 
neurotransmitters are involved in the modulation of global activity in the 
cortex, and lead to changes in attentiveness and behavioral responses to 
external stimuli (Parvizi and Damasio 2001). Neurotransmitters such as 
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acetylcholine have also been found to modulate synchronization and 
generation of cortical electrical activity in a concentration dependent manner 
(Salinas and Sejnowski 2001). However, it is unlikely that neurotransmitter 
concentration changes would directly cause fatigue, but they may alter the 
cognitive response to the subconscious fatigue generating mechanisms. 
In summary, if fatigue is an important component of cognitive decision-making 
or active setting of exercise intensity as a component of declarative memory 
based on prior experience, the most likely region involved would be the 
prefrontal cortex (Miller, 2000). If fatigue is an emotional state of being, the 
amygdala or hippocampus or a combination of these areas would be involved 
(Eichenbaum, 2000; LeDoux 1998). If fatigue is a integrative regulatory 
system balancing afferent input with efferent command, the cerebellum may 
be the site of origin (Pritchard and Alloway, 1999). Williamson et al (1999) 
have shown variation in the activity of the insular cortex associated with 
varying intensities of effort, which they described to be related to 
cardiovascular changes and the associated perception of effort during the 
exercise activity. Alternatively, as the process of thought as a physical entity 
has not been deconstructed to any real degree, fatigue as a sensation may 
occur as activity processes in the brain which are currently not determined 
and which involve many different areas of the brain at anyone time point. 
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2.A.11. Summary 
In this review, research has been described which shows that fatigue may be 
a relative, rather than an absolute entity. Therefore, the sensation of fatigue 
may be a sensory representation of underlying central nervous system 
integrative processes rather than a physical entity, and exercise activity may 
be controlled as part of a teleoanticipatory pacing strategy involving active 
brain calculations integrating peripheral signals and environmental changes 
with desired levels of activity with the relative end-point of the exercise bout 
being the controlling variable. 
Control mechanisms available to generate this regulatory strategy which 
prevents absolute activity and maximal substrate depletion or metabolite 
accumulation included descending regulatory commands of pacing strategies, 
central pattern generators controlling whole limb recruitment patterns, and 
motor unit recruitment strategies such as motor unit substitution/rotation and 
muscle wisdom. 
This model allows a better explanation of chronic fatigue, in which the 
sensation of fatigue is dissociated from exercise-related physiological 
processes, and which will be examined in more detail in the following section. 
77 
2.8. CHRONIC FATIGUE 
2.8.1. Introduction 
In the previous section of the literature review, the relationship between the 
active control of force output and the sensation of fatigue during exercise was 
examined. It was suggested that in the chronic fatigue syndrome there is a 
dissociation of the symptoms of fatigue from underlying physiological 
metabolic processes. Chronic fatigue is a symptom described in a number of 
different medical conditions, and is also a symptom of the overtraining 
syndromes. In this section of the literature review we examine the association 
between fatigue and these different pathological conditions. 
2.8.2. Overreaching and training induced fatigue 
Overreaching and training-induced fatigue refers to the symptoms of tiredness 
which develop when the athlete undertakes a high volume of training. Indeed, 
athletes commonly use the process of overload, or gradually increased 
workload as a stimulus for adaptation (Fry et al 1991). During this process, an 
imbalance between exercise and recovery occurs which lead to symptoms of 
fatigue. 
Training overload and overreaching are terms describing the process of 
undergoing training loads which are greater than the accustomed training load 
of the athlete (Fry et al 1991). These are caused by altering training intensity, 
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frequency and duration or by reducing the recovery period between training 
sessions. Excessive fatigue may arise from this form of training. The 
characteristic feature of chronic fatigue arising from overreaching is that it is 
reversed by a reduction in training load or a few days of rest (Jeukendrup et al 
1992; Snyder et al 1993). 
Minor and transient changes in immune function after an acute bout of 
exercise may be a marker of overreaching (Verde et al 1992). However, the 
Profile Of Mood States (POMS) questionnaire was the single best marker 
indicating imminent fatigue during a period of overreact-ling (Verde et al 1992). 
Snyder et al (1993) found that during a period of intense training, a decrease 
in the ratio of blood lactate concentration to relative perceived exertion ratio 
was a sensitive marker preceding the manifestation of symptoms of training 
induced fatigue. 
It has been suggested that insufficient ingestion of carbohydrate during 
recovery from a prior exercise bout may be responsible for the symptoms of 
chronic fatigue (Fallowfield and Williams 1993). Furthermore, dietary 
carbohydrates are important in maintaining exercise performance during 
periods of chronic exercise training (Simonsen et al 1991). More glycogen is 
stored in the muscle if the athlete's diet is high in carbohydrate (Costill et al 
1988). Skeletal muscle glycogen resynthesis is impaired for up to 10 days 
following certain forms of exercise, particularly exercise causing delayed 
onset muscle soreness (DaMS) (Sherman et al 1983; Blom et al 1987). 
Indeed, it appears that inadequate ingestion of carbohydrate, skeletal muscle 
79 
damage (Sherman et aI1983), and symptoms of overreaching are related 
(Costill et aI1988). Amino acids, vitamins, micronutrients and anti-oxidants 
may playa role in the prevention and treatment of the symptoms of 
overreaching (Cordova and Alvarez-Mon 1995; Alessio 1993). As discussed 
in the previous section of the literature review, the symptom of fatigue in 
overreaching may have the teleological function of reducing the desire of the 
athlete to initiate training or racing, and thus allow altered abnormal physical 
function associated with overreaching to normalise. 
Interestingly, Scharf and Barr (1988) have proposed that abnormal eating 
patterns, including bingeing, in athletes who are overreaching, may be caused 
by decreased concentrations of circulating tryptophan which is thought to lead 
to deficiencies in brain serotonin concentrations. This theory remains to be 
explored, for as described in the previous section, the relationship between 
neurotransmitters and the symptoms of fatigue is not completely proven. 
Other causes of chronic fatigue associated with exercise include inadequate 
quality and quantity of sleep, international travel across time zones and 
occasionally, undiagnosed pregnancy (O'Connor and Morgan 1990; Jehue et 
al 1993; Biedermann and Schoch 1995; Pugh and Milligan 1995). 
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2.8.3. Pathological fatigue 
Pathological fatigue may be defined as fatigue and tiredness which cannot be 
attributed to physiological adaptations (Newham and Edwards 1979). 
Pathological causes of fatigue are outlined in Table 2.C.1. 
Table 2.C.1. Putative causes of chronic pathological fatigue 
a) Medical conditions 
i) chronic infective conditions: viral, bacterial or paracytic 
(including hepatitis, infectious mononucleosis, HIV, malaria, 
tuberculosis, brucellossis) 
ii) haematologic conditions (including iron deficiency anaemia) 
iii) neoplastic conditions 
iv) cardio-respiratory conditions (including coronary artery disease, 
cardiac failure, bacterial endocarditis asthma, exercise induced 
asthma) 
v) neurogenic-neuromuscular (including post-concussive syndromes, 
multiple sclerosis, myasthenia, myotonia, paramyotonia) 
vi) endocrine-metabolic conditions (including diabetes, hypothyroidism, 
hyperthyroid Addison's disease, Simmond's disease, 
hyperparathyroidism, hypophosphataemia, hypokalaemic periodic 
paralyses, Cushing's syndrome, hypogonadism) 
vii) Psychiatric-psychological conditions (including anxiety, depression, 
psychoneuroses, eating disorders) 
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viii) Drug induced (including beta-blockers, other anti-hypertensive 
agents, agents acting on the central nervous system, antihistamines, 
lipid lowering agents, alcohol, antibiotic agents) 
ix) Other (including malabsorption syndromes, allergic conditions, 
spondyloarthropathies) 
b) Overtraining syndrome 
c) Chronic fatigue syndrome 
As described above, medical causes of pathological fatigue include infections, 
neoplasias and disorders of the haematological, cardio-respiratory, 
neuromuscular, or endocrine systems (Packer et al 1994; St Pierre at al 1992; 
Schroeder and Hill 1991; Seiler et al 1989; Weight et al 1992; Wilson et al 
1985). Psychological or psychiatric disorders including depression, excessive 
anxiety related to sporting performance or other problems, bulimia and 
anorexia nervosa could also present as chronic fatigue (Gibson et al 1993). 
Several commonly'prescribed medications have the potential to cause chronic 
fatigue. These medications include beta-adrenergic blockers, other anti-
hypertensive agents, agents acting on the central nervous system, 
antibiotics, anti-histamines and lipid lowering agents (Derman et al 1991; 
Derman et al 1992). 
2.B.4. The overtraining syndrome 
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The overtraining syndrome refers to a symptom complex characterised by 
non-adaptation to training, decreased physical performance and chronic 
fatigue following high volume and/or high intensity training and inadequate 
recovery (Eichner 1995; Fry et al 1991). The overtraining syndrome requires 
weeks or months of rest or greatly reduced training for complete recovery 
(Hooper and Mackinnon 1995), as compared to the overreaching syndrome 
where fatigue symptoms normalise within a few days. Whilst decreased 
physical performance associated with chronic fatigue has been most 
commonly used to diagnose the overtraining syndrome, there is still little 
consensus as how to diagnose this disorder. 
Clinical features of the overtraining syndrome vary greatly (Fry et al 1991; 
Eichner 1995). However, the symptoms of "heavy legs", increased waking 
pulse rate, lack of motivation, decreased enjoyment of exercise, sleep 
disorders, painful skeletal muscles, dizziness upon standing, 'frequent 
infections, weight loss, depression, decreased libido, and increased effort 
, 
during exercise training without improvement in performance, are commonly 
described features of the overtraining syndrome (Eichner 1995; Hooper and 
McKinnon 1995). 
Changes in body mass, and heart rate, blood pressure, serum or urine 
glucose, urea, glutamine and various enzymes and hormone concentrations, 
increased concentrations of serum creatinine kinase (CK), low erythrocyte 
count, and decreased haemoglobin and serum ferritin concentrations have 
been documented in some studies of overtrained athletes (Barron et al 1985; 
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Fry et al1993 (a); Fry et al1993 (b); Smith and Roberts 1994; Urhausen et al 
1995), but not in others (Hooper and Mackinnon 1995; Lehmann et a11991; 
Verde et al 1992). 
Effective monitoring of the overtrained athlete has recently been reviewed 
(Hooper and Mackinnon 1995; Boulay 1995). Whilst the most appropriate 
medical tests for monitoring the overtraining syndrome are still unclear, it 
appears that performance during standardised exercise testing, including 
serial measurement of heart rate, oxygen consumption and blood lactate 
concentration during a submaximal exercise test, the POMS inventory and a 
log of training and symptoms are possibly the best tools for monitoring and 
managing recovery from the overtraining syndrome ( Eichner et al 1995; 
Hooper and Mackinnon 1995; Verde et al 1992) . 
. 2.B.5. The chronic fatigue syndrome 
Criteria for the diagnosis of the chronic fatigue syndrome have been 
previously well described (Coetzer et al 2000; Holmes et al 1988). Symptoms 
include chronic fatigue of at least six months duration that does not resolve 
with bed rest and is severe enough to reduce aver~ge daily activity to below 
50% of normal (Holmes et al 1988). 
Coetzer et al (2000) proposed the following criteria for the diagnosis of 
chronic fatigue syndrome. Firstly, clinically evaluated, unexplained, persistent 
or relapsing fatigue that is of new or definite onset; is not the result of ongoing 
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exertion; is not alleviated by rest; and results in substantial reduction of 
previous levels of occupational, educational, social or personal activities. 
Secondly, four or more of the following symptoms that persist or recur during 
6 or more consecutive months of illness and that do not predate the fatigue 
symptoms are required: a) Self-reported impairment in short term memory or 
concentration, b) sore throat, c) tender cervical or axillary nodes, d) muscle 
pain, e) multi-joint pain without redness or swelling, f) headaches of a new 
pattern or severity, g) unrefreshing sleep or h) post-exertional malaise lasting. 
longer than 24 hours. However, whilst these diagnostic criteria may be 
appropriate for the general population, very few fatigued athletes fulfil these 
criteria (Derman et al 2000). 
2.B.6. Summary 
In summary, chronic fatigue may be caused by a number of training related 
and medical conditions~ Chronic fatigue associated with excessive training or 
over-reaching may be successfully treated with adequate rest or a reduction 
in training activity. Chronic fatigue associated with medical conditions may be 
attenuated by treatment of the underlying condition. The chronic fatigue 
syndrome is a disease of unknown aetiology with formal diagnostic criteria. At 
present there is no known successful management for this condition. 
However, a number of athletes who present with chronic fatigue which is not 
successfully treated with rest do not fulfil the criteria for chronic fatigue 
syndrome, and further work is needed to examine the cause of the chronic or 
excessive exercise related fatigue in these at~lIetes. To examine this 
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relationship, it is necessary to examine whether long term exercise activity 
has been shown to damage or excessively stress the neuromuscular system. 
2.C. MUSCLE DAMAGE 
2.C.1. Depletion of muscle glycogen concentrations 
Sherman et al (1983) showed that immediately after a marathon, muscle 
glycogen stores were depleted to 40% of pre-race levels in both type I and II 
fibres. Five days later the muscle glycogen levels were still below the pre-race 
values although glycogen synthase activity was normal. Kirwan et al (1992) 
showed that 48 hours after performing exercise which caused muscle 
damage, subjects had ongoing insulin resistance, with a 37% decrease in 
insulin-mediated whole body glucose disposal. The low muscle glycogen 
concentrations in the recovery period were attributed to either decreased . 
uptake of glucose through the disrupted sarcolemma in the damaged cells or 
an increased insulin resistance. An alternative explanation is that there is 
competition for blood glucose between the inflammatory cells within the 
muscle fibres and the glycogen depleted damaged fibres (Costill et al 1990). 
The time taken to normalise muscle glycogen concentrations after a marathon 
is not well known, but is expected to be 10 days or longer, based on the data 
of O'Reilly et al (1987). 
86 
2.C.2. Skeletal muscle damage 
Several studies show that muscle damage occurs after marathon and ultra-
marathon races. Matin et al (1983) injected technetium 99m pyrophosphate, 
which is taken up by damaged cells, into the blood of 11 ultramarathoners 
after 80 and 160 km races and found that large quantities of this radiolabelled 
substance appeared in the painful muscles of the subjects' lower limbs. 
Subjects who complained of the most pain after the races had the highest 
concentrations of technetium 99m pyrophosphate in their painful muscles. 
Using different methodology, Hidika et al (1983) showed that severe muscle 
damage with signs of fibre necrosis and inflammation occurred in muscle 
biopsies performed on runners after a marathon. In a similar study up to 25% 
of the muscle fibres of runners after a marathon race showed areas of 
myofibrillar loss (Warhol et al 1985). Intra- and extracellular edema with 
endothelial injury, myofibrillar lysis, dilation and disruption of the t-tubule 
system, and focal mitochondrial degeneration without inflammatory infiltrate 
was also present in the muscle samples of these runners. 
It has been suggested that this muscle damage may perhaps be a result of 
oxygen-derived free radical damage (Sen 1995; Duarte et al 1993) or muscle 
cell membrane disruption caused by eccentric muscle activity (Clarkson and 
Sayers 1999) leading to calcium-mediated cell damage to the individual 
muscle fibres, cytoplasmic structures such as mitochondria, and mitochondrial 
and nuclear DNA (Jones and Round 1990). 
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Free oxygen radicals and other reactive oxygen species (ROS) are formed 
during normal cellular respiration in the electron transfer pathway of the 
mitochondrial cell wall, and are associated with increases in metabolic rate 
(Pulverer and Turner 2000; Weindruch and Walford 1988). While free oxygen 
radicals are important in cellular signalling processes (Essig and Nosek 
1997), due to their oxidative capacity (Davies 2000) they have been 
associated with both aging (Finkel and Holbrook 2000; Harman 1957), 
exercise associated muscle damage (Ashton et al 1988; Bejma and Li 1999; 
Best et al 1999; Jenkins 2000; Ji 1999; Hartmann et al 1994; Niess et al 1998; 
Poulsen et al 1996) and pathological processes such as atherosclerosis and 
coronary heart disease (Ubbink et al 1995). It has been speculated that during 
exercise the endogenous antioxidant system is overwhelmed by the increased 
ROS production associated with the increased metabolic rate, and that 
exogenous antioxidant supplementation may have a beneficial effect in 
reducing ROS associated muscle damage (Clarkson and Thompson 2000; 
Jones and Round 1990; Packer et al 1994). However, ROS are also 
increased after prolonged immobilization (Oishi et al 1999). Exercise has 
either no effect (Margaritis et al 1997) or may improve endogenous 
antioxidant status (Kostka et al 1998). There is also considerable inter-
individual variation in endogenous antioxidant response to exercise activity 
(Dufaux et al 1996). Therefore, the relationship between ROS and exercise 
activity is complex. 
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Mechanical disruption of muscle fibres caused by excessive or prolonged 
eccentric muscle activity has also been proposed as a cause of exercise 
associated muscle damage (Clarkson and Sayers 1999; Jones and Round 
1990). However, as an inflammatory reaction and alteration in ROS and heat 
shock protein activity is also associated with eccentric activity induced muscle 
damage (Clarkson and Sayers 1999; Semark et al 1999; Thompson et al 
2001), it is not clear whether mechanical stress is a direct or indirect cause of 
muscle damage. 
Tissues other than the locomotor muscles also show signs of overuse stress 
after an ultra-marathon race. Matin et al (1983) showed that in addition to the 
muscles of the lower limb, the bones of the lower limbs also showed signs of 
overuse stress. A discussion of these side effects are beyond the scope of the 
literature review. 
2.C.3. Cytoskeleton 
Structural proteins in skeletal muscle (for example desmin, titin, nebulin) 
comprise the cytoskeleton and maintain the structural integrity of the 
myo"fibrillar lattice (Patel and Lieber 1997). Although most research on muscle 
damage has focused on changes in the contractile proteins actin and myosin, 
other studies have also implicated structural proteins in the process of muscle 
damage. A study described longitudinal desmin extensions in muscle samples 
collected from subjects who had delayed onset muscle soreness (DOMS), 
suggesting that there was some disruption to the structural integrity of the 
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muscle fibres (Friden et aI1984). More recently, this group showed in a rabbit 
model that a significant amount of desmin was lost in 2.5% of the muscle 
recruited during 5 minutes of eccentric contractions (Lieber et al 1996). 
Disruption of the desmin network in skeletal muscle affects the function of the 
muscle because these proteins form intermediate filaments which link 
adjacent Z discs and maintain structural cross-sectional integrity of the muscle 
fibres (McComas 1996). 
Titin is a large structural protein with a chain length of approximately 27000 
amino acids and a MW of about 3 million (8arinaga 1995). Titin is designed 
to act as a spring in the muscle by connecting the thick filaments and the Z-
disks, preventing the thick filaments from moving from the centre of the 
sarcomere. Titin's unique structure allows it to accommodate physiological 
stretch by first straightening without unfolding, and then unfolding a portion of 
the molecule called the PEVK domain (Erickson 1997). The unfolding of the 
PEVK portion of the molecule increases the capacity of the muscle to stretch 
further. The length of the PEVK sequence varies depending on the type of 
muscle and determines the stiffness of the muscle tissue. For example, the 
more elastic fast twitch fibres have a higher titin:actin ratio than the less 
elastic slow twitch fibres (Askter et al 1989). Although speculative, muscle 
damage may cause a reduction of the elastic potential of the muscle by 
damaging of the titin molecule. This hypothesis needs to be studied further. 
The significance of how the structural proteins, which comprise the 
cytoskeleton, influence muscle function has been underestimated (Waterman-
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Storer 1991). A potentially greater role of the cytoskeleton on muscle function 
is supported by the work of Roberts et al (1997) who showed that the 
locomotor muscles during horizontal running functioned to hold the "springs" 
(tendons) rigid so they can store energy with each step. Perhaps this ability to 
store energy with each step may have a greater role in influencing running 
performance than was previously thought. Similarly, perhaps the extent of 
damage and regeneration of these structural proteins after a long distance 
running event may influence the time taken to recover completely. 
2.C.4. Decrement in performance: acute and during recovery 
Marathon runners are advised to refrain from racing for 3 - 6 months between 
marathons for optimal performance (Noakes 1992). These recommendations 
are based on anecdotal observations, as there are few scientific studies 
providing the optimal time for the recovery of muscle function after a 
marathon. Sherman et a I (1983) showed that leg extensor strength measured 
isokinetically decreased immediately after a marathon and was not fully 
recovered after 7 days. Chambers et al (1998) showed that the vertical jump 
height, a measure of leg extensor muscle power, was significantly decreased 
immediately after a 90 km race, and remained significantly lower than pre-
race values for 18 days. However, the lack of specificity of the assessments of 
muscle function in both these studies limits their application to muscle 
recovery after running a marathon. Based on the findings of Warhol et al 
(1985) wrlich showed signs of regeneration in muscle 12 weeks after a 
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marathon, it can be implied that normal muscle function was not fully restored 
at tl-lis stage. 
Changes in neuromuscular function have similarly been reported after a 
marathon race (Nicol et al 1991 (a); Nicol et al 1991 (b)). These data showed 
that modifications of the neural activation of muscle may occur to compensate 
for the exercise-induced contractile fatigue which occurs towards the end of a 
marathon (Nicol et al1991 (a); Nicol et aI1991(b)). The modification of the 
neural activation results in an increase in the duration of both the braking and 
push-off phases in the running stride. There is also an increased EMG activity 
in all the locomotor muscles, especially during the push-off phase of the 
running stride (Komi et al 1986). These neuromuscular changes may remain 
for several weeks after a marathon race and account for the decrement in 
running performance in the recovery phase after a marathon. 
Skeletal muscles, other than those specifically recruited during running, are 
also affected after an ultra-endurance race. For example, the endurance 
capacity of the inspiratory muscles decreased by 27% three days after an 87 
km race (Ker and Schultz 1996). It is quite likely that this change in the 
endurance capacity of the inspiratory muscles would negatively effect on 
running performance. 
At present, however, there are no studies which have systematically 
examined the time course of changes in running performance immediately 
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after a race until the runner has fully recovered and is able to train and race 
optimally. 
2.C.S. Skeletal muscle regeneration 
Injured muscle has the capacity to repair and regenerate. Anecdotal 
observations show that functional skeletal muscle regeneration occurs after 
an ultra-endurance race, as runners with severe muscular pain for several 
days after a race make a full recovery and are able to race again after an 
adequate recovery period (Noakes 1992). These observations are supported 
by studies which show a progressive repair of the mitochondrial and 
myofibrillar damage 3 to 4 weeks after a marathon race. After 8 to 12 weeks 
there are still signs of muscle regeneration including central nuclei and 
increased satellite cells in the biopsy samples (Warhol et al 1985). 
The process of muscle regeneration is initiated by the acute phase response 
to muscle injury which occurs immediately after the race (Strachan et al 
1992). Mononucleated cells, which usually reside in muscle cells and are 
quiescent are activated by the muscle injury and subsequently provide a 
chemotactic signal to circulating inflammatory cells. Neutrophils then invade 
the injured site and promote inflammation by releasing cytokines that attract 
and activate additional inflammatory cells (Tidball 1995}. Satellite cells located 
beneath the basal lamina undergo an initial activation reaction which results in 
the enlargement of the nucleus and an increase in DNA synthesis (Carlson 
and Faulkner 1983). Neutrophils may also release oxygen-derived free 
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radicals which may further damage cell membranes. There is an increase in 
circulating macrophages which invade the damaged tissue and remove the 
tissue debris by phagocytosis (Carlson and Faulkner 1983). After the removal 
of the damaged muscles fibres, the regeneration of new muscle fibres begins 
within the remaining intact basal lamina. Studies have shown that in the 
complete absence of the basal lamina, no muscle regeneration can occur. 
The population of myoblastic cells established beneath the old basal lamina 
then develop as in normal myogenesis, resulting in mature fibres with 
peripheral nuclei (Carlson and Faulkner 1983). Newly regenerated fibres are 
thinner than normal (Carlson 1995) and are characterised by central nuclei 
(Carlson and Faulkner, 1983) 
If the skeletal muscle regenerative process is incomplete, as occurs with non-
innervation of the new muscle fibres, the regenerating fibres will atrophy. This 
may explain the loss in muscle mass which occurs with ageing after years of 
repetitive muscle regeneration (Faulkner and Brooks 1995). 
2.C.6. Morphological changes with training 
Evidence disclJssed earlier shows that skeletal muscle is damaged after 
marathons and ultra-marathons, and that muscle regeneration occurs in the 
recovery period. However, this leads to many questions, for which at present 
there are no clear answers. For example, it is not clear whether muscle has a 
finite ability to adapt and regenerate, whether repetitive muscle damage and 
regeneration lead to any associated muscle pathology or whether the 
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repetitive muscle damage influence the natural ageing process. Perhaps 
years of training are as stressful as the racing event itself. 
The anecdotal evidence from top class marathon runners suggests that they 
have about a 10 year period during which they can expect to perform well in 
their age-group (Noakes 1992). Thereafter, their decline in marathon running 
performance may be expected to occur at a faster rate than is expected for 
their age. T~lis anecdotal observation supports the hypothesis that there is 
cumulative fatigue after several years of training and racing marathons which 
results in the skeletal muscle "ageing" at a faster rate than is expected. 
Recently, Sharwood et al (2000) found that runners who had raced an 
accul11ulated distance of greater than 5 000 km showed a significant 
dissociation in neuromuscular efficiency after a downhill run compared to less 
experienced runners. They concluded that cumulative muscle damage may 
negatively affect central responses during fatigue caused by an exercise 
protocol with a large eccentric component. 
Scientific proof to support this anecdotal observation is emerging. Kuipers et 
al (1989) studied runners over a 7 month period while they trained for a 
marathon. They found a gradual increase in degenerative changes in both 
type I and type II fibres in the subjects' vastus lateralis muscles over this 
period. They suggested that these pathological changes were minor and were 
related to the total distance covered in training rather the intensity of training. 
However, abnormal mitochondria and signs of muscle fibre regeneration and 
inflammation were found in the "resting" muscle biopsies of experienced 
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marathon runners (Goodman et al 1997; Hikida et al 1983; Wa rl'lO I et aI1985). 
Sjostrom et al (1988) studied national class runners and found that the overall 
morphological picture of the marathon runners varied between subjects. Only 
one of the five runners in the study had normal muscle structure. The 
abnormalities in the muscle biopsies collected before the race included a poor 
organisation of muscle fasciculi, abundant connective tissue and the majority 
of fibres showing one or more central nuclei. Other abnormalities included flat 
angular fibres and signs of fibre type grouping. Both these signs are 
pathognomonic of denervation atrophy (Oubowitz 1985; St Clair Gibson 1997) 
and suggest incomplete regeneration. 
Sjostrom et al (1988) suggested that the type II fibres are more vulnerable to 
damage as the two runners in their study with the lowest numbers of type II 
fibres had the least muscle pathology. The suggestion of increased 
vulnerability of type II fibres is derived from another report in which a well 
trained 46 year old runner ran 3529 km in 7 weeks (Sjostrom et al 1987). The 
relative amount of type I fibres was higher after the 7 weeks, suggesting either 
that the number of type II fibres had been reduced after the long run, or the 
number of type I fibres had increased. This may bea simple training effect. 
However, the biopsy samples in this study were also characterised by fibres 
of varying sizes and an increase in central nuclei in approximately 30% of the 
fibres. 
But there are examples in the literature of experienced runners with no 
apparent abnormalities for their age. For example, Maud et al (1981) studied 
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a 70 year old, previously world class long distance runner, who had been 
training for 52 years. He was still training, had no orthopaedic abnormalities 
and apart from thickened heel pads was declared healthy. Unfortunately no 
data are available on his muscle morphology. In addition a recent study of the 
top 10 finishers in each group of a 56 km race showed that some of the 
runners who were the top performers in the 60 year old category had been 
running for up to 30 years, in contrast to other runners in this group who had 
recently started running (Lambert and Key tel 2000). One must suggest that 
the runners who had been running for 3 decades in this study may represent 
runners who have better biomechanics than those runners who have 
decrements in performance with a shorter running career, and/or may have 
muscle and connective tissue which is resistant to the long term changes 
which have been described above. Further work is needed to examine this 
suggestion. 
2.C.7. Summary 
Much research has addressed the causes of fatigue arising during ultra-
endurance marathon running. However, less is known about the acute effects 
an ultra-endurance marathon has on muscle and running performance, how 
muscle regenerates after severe damage, and whether repetitive skeletal 
muscle damage induced by long term training and racing induces any chronic 
pathological and morphological changes. 
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· Previous studies have shown that runnerS had signs of pathology in their 
muscles after a race. This muscle damage was characterised by myofibrillar 
loss, intra- and extracellular edema and disruption of the t-tubule system. 
Evidence of progressive repair of the mitochondrial and myofibrillar damage 
were visible 3 to 4 weeks after the marathon with signs of regeneration in the 
muscle still evident after 12 weeks. These scientific data tend to support the 
anecdotal observations that marathon runners need about 3 or more months 
to recover from a marathon race. 
Recent data show that muscle and connective tissue units function as springs 
which absorb the forces on impact with each stride. However, the elastic 
properties of muscle have not been well studied. Many structural proteins in 
muscle have been identified but their function and contribution to the 
cytoskeleton is not well.understood. However, as more information becomes 
available about the cytoskeleton in skeletal muscle, it is evident that the 
structural proteins, desmin and titin in particular, have an important role in 
maintaining the myofibrillar lattice, and in contributing to the elastic properties 
in muscle. The maintenance of structural integrity is important for optimal 
muscle function, and is disrupted when muscle is damaged. 
Studies show that training for marathons may be as physically stressful as the 
race itself. The literature has some evidence that experienced runners have 
skeletal muscle pathology, even in the "rested" state, suggesting that there is 
some cumulative effect of years of training. Whether these changes in the 
skeletal muscle are merely a form of chronic adaptation or whether they have 
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pathophysiological manifestions remains to be determined. However, the 
anecdotal observations are that runners have a period of time during which 
they can adapt to training and perform well, followed by a difficulty in 
sustaining ~Iigh training loads which coincides with a decline in running 
performance. This decline in performance appears to occurs at a rate which 
exceeds that rate which can be accounted for by the normal ageing process. 
It is therefore necessary to examine the normal aging process to determine 
the effect of aging on the neuromuscular system. 
2.0. AGING 
2.0.1 General theories of aging 
Aging is generally defined as a progressive loss of function, increasing 
susceptibility to age-related disease and an associated transition from 
independent to dependent lifestyles (Cannon et al 2001), and increasing 
mortality associated with increasing age (Kirkwood and Austad 2000). Before 
examining the affect of aging on athletic performance, it is necessary to 
examine the theories of how and why aging occurs. These theories can be 
summarized as the disposable soma and free radical theories. 
The first theory, the disposable soma theory, explains aging as part of an 
evolutionary process. In this theory, aging is associated with programmed cell 
death, and this programmed limit to longevity occurs to limit population size or 
to accelerate the turnover of different generations of a species, thereby aiding 
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the incidence of positive mutations to allow the adaptation of organisms to 
changing environments (Kirkwood and Austad 2000). Explained differently, 
evolutionary history may have determined that individuals thrive only long 
enough to produce and nurture their offspring (Pulverer and Turner 2000). 
Thereafter, the aging process and programmed death ensures that successful 
or unsuccessful parents do not use up food or environmental space for 
eternity. 
While this is an appealing teleological argument, there are flaws to the theory. 
Firstly, while certain species like the Pacific salmon die immediately after a 
once-only reproductive cell cycle, other organisms, such as bacteria and 
Hydra species, show no evidence of programmed cell death and aging, and 
can generate a new individual from any part of the organism. Similarly, the 
turtle shows very little evidence of senescence (Kirkwood and Austad 2000). 
Secondly, few species live long enough to be able to predict whether 
senescence occurs. In the wild, extrinsic factors such as infections, predation, 
starvation or excessive cold environment cause death at some point in the life 
of all wild animals. Similarly, in humans, it has been predicted, based on 
extrapolations of changes in maximal aerobic capacity as a proxy for decline 
in metabolic rate (Booth 1989), that the "natural" life span is 100-125 years. 
Although extrinsic factors causing mortality have generally been reduced, 
diseases cause death at an earlier age (Noakes 1992). 
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These concepts have lead to the free radical theory as a development of the 
disposable soma theory (Kirkwood 1977; Kirkwood 1996), which suggests 
that species benefit by investing any spare metabolic resources into 
thermogenesis and reproduction, rather than better cellular repair capacity. 
According to this theory aging is caused by ongoing cellular damage which 
eventually accumulates and leads to the loss of function associ ated with 
aging. As described previously, this theory was related to the finding that 
animals with higher metabolic rate generally have shorter life spans than 
animals with lower metabolic rate (Finkel and Holbrook 2000). Increased 
metabolic rate causes increased production of reactive oxygen species 
(ROS), or free radicals. Harman (1957) first suggested in the "free radical 
theory" of aging that endogenous oxygen radicals were generated in cells and 
resulted in oxidative-derived cumulative stress and cell damage. Mechanistic 
evidence for this theory was found a decade later when superoxide dismutase 
was identified, whose function is to remove superoxide ions, a type of ROS 
(McCord and Fridovich 1969). 
As suggested by Davies (2000), oxidative stress in an unavoidable 
consequence of life in an oxygen-rich atmosphere. Oxygen radicals and other 
ROS compounds are generated as by products of aerobic metabolism. The 
"oxygen paradox" is that oxygen is dangerous to the very life forms for which it 
is an essential component of energy production (Davies 2000). As described 
previously, the principle source of ROS production is the electron transfer 
chain complexes, and particularly complex III, in the mitochondria. Although 
ROS are important cellular Signallers, the ROS causes cell damage either 
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directly to cellular structures or through mutations induced in either 
mitochondrial or nuclear DNA (Finkel and Holbrook 2000). These cellular 
structure mutations or DNA mutations lead to diseases associated with aging 
such as cancer and cardiac disease (DePinho 2000, Esterbauer et al 1993; 
Ubbink and Vermaak 1995). Alternatively, by altering gene chronotrophic 
function (Guarente and Kenyon 2000) or via complex gene mutations (Martin 
and Oshima 2000) such as occurs in the accelerated aging progeria 
syndromes, ROS induced DNA mutations may lead to the onset of the aging 
process. 
This free radical theory of aging postulates that aging is caused by cellular 
damage related to the production of ROS or other endogenolJs or exogenous 
toxins. As ROS are produced in the mitochondria and are associated with 
increased metabolic rate, one may postulate that exercise activity which 
increases metabolic rate, may be harmful and in this model may predispose 
one to an increased susceptibility to these aging processes. Indeed, as 
described previously, activities which reduce metabolic activity, such as 
caloric restriction (Pulverer and Turner 2000; Weindruch and Walford 1988), 
and the "dauer" behaviour of larvae in time of food shortage or high larval 
density increase longevity. Dauer behaviour involves a form of hibernation 
where metabolic rate is reduced, and is associated with increased longevity 
(Kirkwood and Austad 2000). Previous work has shown there is a progressive 
increase in mitochondrial deletions and mitochondrial cellular pathology with 
increasing age (Ozawa 1995; Johnston et al 1995; Katayama et al 1991) and 
as described previously, similar changes have also been described after high 
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intensity or high volume exercise activity (Geller 1973; Poulsen et al 1996). 
Therefore, it is necessary to examine further the relationship between 
exercise and aging. 
2.0.2. Aging and athletic performance 
Despite these negative consequences associated with aging, a number of 
individuals participate in sporting activities late into their geriatric life. Spirduso 
(1995) suggests that these veteran athletes perform at levels of activity with 
greater success than younger sedentary individuals. Furthermore, exercise 
has been shown to reduce age related declines in strength, aerobic capacity, 
flexibility and physical function (Keysor and Jette 2001). However, while 
exercise can reduce the rate of decline in age related function, it cannot 
reduce the absolute effect of aging on reduction functional capacity (Noakes 
1992). An examination of the changes in athletic performances associated 
with aging, and particularly age group records for athletic activity, provides an 
assessment of the effect of age on physical performance. This analysis of 
athletic performance and age was first performed by Bottiger (1971; 1973) and 
has been repeated more recently by Noakes (1992) and Spirduso (1995). 
Spirduso (1995) found that that running performance deteriorated from the 
mid-thirties, and decreased by approximately 1 % per year from this point. By 
the age of 80 years, running performance was approximately 50% of the best 
performances achieved in the late 20's and early 30's. Notably, she also 
found that world class athletes deteriorated at a greater rate that more 
average runners (Spirduso 1995). Relatively similar deteriorations in veteran 
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performances were found for all veteran athletes in swimming, rowing and 
other sports. Endurance running activity was more affected than short 
distance activity, similarly described by Noakes (1992). The deterioration in 
performance was also greater with age for sports that required a degree of 
hand-eye co-ordination such as throwing or complex action sports such as 
jumping compared to sports not requiring hand-eye co-ordination or complex 
muscle actions. 
There are several confounding variables to the type of cross-sectional study 
that analyses age group records. Firstly, as suggested by Spirduso (1995), it 
is difficult to quantify whether the older athletes have a similar level of training 
activity as their younger competitors, and thus the age related decrements in 
performances may be related to a decrease in training capacity. However, the 
corollary of this is that the physiological deterioration associated with age may 
also be responsible for a decreased capacity for training. Therefore, if training 
is the cause of this decline in performance, this may be an indirect 
consequence of the aging process itself 
Secondly, there may be a sampling bias responsible for these decrements in 
performance (Spirduso 1995). Either due to natural population dynamics or 
due to social influences, there are less competitors in the veteran and masters 
categories than there are younger competitors. Therefore, this lower sample 
and social influences may be responsible for the decrements in performance 
in the older age categories. There is also the likelihood that older age 
categories may not contain the best at~lIetes, as these athletes may have 
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"dropped out" or retired from sport due to adjustment of life goa Is, injuries or 
other reasons. As suggested previously, possibly there are a finite number of 
years an individual can tolerate the physical effects of athletic activity, and the 
performance of the top athletes deteriorate accordingly as they age (Lambert 
et al 1999; Noakes 1992). 
Thirdly, as suggested by Noakes (1992) and Spirduso (1995), the competitive 
drive of older athletes may have decreased. It is not clear if this is related to 
changes in hormonal levels, such as the age related decrements in 
testosterone found in males, or is a psychological change due to less ego-
driven reasons for exercise. Older athletes may also decrease physical 
performance involuntarily as a protective mechanism to prevent exercise 
related muscle injury. Further work is necessary to examine this concept. 
Finally; there is individual variation to the age related reduction in physical 
performances described above (Spirduso 1995; Westerterp 2000). The study 
of age-related records, as described above, are by necessity cross-sectional 
studies and not longitudinal studies of the same athlete over their lifetime. 
Different athletes respond differently to the aging process, with several 
veteran athletes maintaining their performances and competing in marathon 
running events for a longer period of time than their peers (Lambert et al 
1999; Noakes 1992, Spirduso 1995). This may be related to the superior 
physiological capacities of these athletes to resist the oxidative processes -
responsible for the aging process, or to superior mental capacity to continue 
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athletic activity despite the aging process and reduced physical capacity. 
Further work is also needed to examine tl1is issue. 
2.0.3. Aging and the neuromusclJlar system 
As described previously, reductions in athletic performance begin in the fourth 
decade of life. These are associated with changes in body com position 
(Semben et a11995), decline in skeletal muscle mass (Sooth et al 1994) and 
decline in maximal aerobic capacity (Astrand 1960; Robinson et al 1976). 
Researchers who have suggested that maximal aerobic capacity is the major 
limiting factor in fatigue, as discussed previously, have suggested that the age 
related declines in performance and maximal aerobic capacity are linked, with 
the deterioration in performance caused by the deterioration in maximal 
aerobic capacity (Noakes 1992). However, Rogers et al (1990) showed that 
with training, age-related decrements in maximal aerobic capacity was 50% 
less than in age matched untrained populations. Therefore, maximal aerobic 
capacity, while being reduced by age related processes, cannot be a direct 
cause of the age related decline in athletic peformance. 
These findings led to the suggestion that the deterioration in muscle function 
and age related decrease in muscle mass was responsible for the decrements 
in maximal aerobic capacity and athletic performance (Fleg and Lakatta 1988; 
Noakes 1992). In t~lis model, therefore, changes in muscle function result in 
reductions in athletic performance, with reduced aerobic capacity being an 
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indirect result of the reduced athletic performance controlled by decreased 
skeletal muscle force output capacity. 
It has been suggested that decrements in skeletal muscle performance is 
caused either by a loss of muscle mass, a decline in specific tension (the ratio 
between force output and muscle cross sectional area), and/or a reduced 
capacity to activate muscle maximally (Cannon et al 2001; Grabiner and 
Enoka 1995). Skeletal muscle force output capacity increase until the late 
twenties, stabilises until the mid forties and then decreases by'" 1 0-15 % 
each decade from the fifties (Doherty et al 1993; Hakkinen et al 1996; Larrson 
et aI1978). 
The age related reductions in force output and reduced muscle volume is 
associated with loss of both type I and type II muscle fibres, and in particular 
type II fibres, and atrophy of the remaining fibres (Aniansson et al 1986; 
Klitgaard et al 1990; Larsson et al 1978; Lexell et al 1988, Lexell et al 1991). 
There is variability in the extent of muscle atrophy in elderly individuals of 
similar age (Grabiner and Enoka 1995). This may be related to different levels 
of activity during their lifespan, orto genetic differences in susceptibility to 
muscle damage and regeneration which may be responsible for earlier onset 
of muscle-atrophy or strength reductions in susceptible individuals. 
The muscle atrophy appears to be related to death or apoptosis of alpha 
motor neurons and ventral horn cells, particularly in the lumbosacral spinal 
cord region, particularly from the seventh decade of life (Lexell et al 1988). 
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This leads to the death of a number of motor units (Campbell et al 1973; 
Lexell et al 1991) which lose their nerve supply. However, intact motor units 
are able to reinnervate some, but not all of the "orphan" muscle fibres (Brown 
1984). Therefore these motor units have greater innervation ratios, which may 
reduce the co-ordinated strategy of motor unit activity and lead to unstable 
force output, characteristic of aged populations (Ishihara and Araki 1988). The 
type II fibres are more affected by this aging fibres, and possibly the greater 
number of "orphan" muscle fibres undergo transformation to type I fibres after 
this reinnervation process (Ishihara et al 1988; Kanda and Hashizume 1989), 
which may also lead to a decrease in absolute force output and specific 
tension with age. 
However, it must be noted that there may be other reasons for the muscle 
atrophy associated with aging (sarcopenia). For example, Veldhuizen (1993) 
cast immobilized healthy volunteers for four weeks and found atrophy of both 
type I and type II fibres, decreased thigh cross sectional area and decreased 
force output after the period of cast immobilisation. Similar muscle atrophy 
has been found in other disuse (Soares et al 1993; Kauhanen et al 1996; 
Takekura et al 1996), denervation (D'Albis et al 1995; Hayat , DeMello et al 
1996) and paraplegic/hemiplegic (Mathieu 1995) models. Therefore, the age 
associated muscle atrophy and decreased force output may be related to a 
relative disuse atrophy due to reduced activity associated with increased age. 
Another reason for reduction in force output is reduced specific force, with 
older muscle having reduced force per cross sectional area (Bruce et al 
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1989). However, this explanation is controversial, and Cannon et al (2001), 
using different correction factors for cross sectional area which accounted for 
increases in subcutaneous fat, showed that aging was not related to changes 
in specific tension. They suggested that reduction in peak strength with age 
was essentially related to quantitative changes in cross sectional mass rather 
than qualitative changes in muscle. However, the finding that older individuals 
are less able to maximally activate muscle fibres during concentric activity as 
compared to eccentric activity than younger subjects (Poulin et al 1992) 
suggest that other factors, such as changes in neural command, may indeed 
result in changes in specific tension. It must be noted that after anterior 
cruciate ligament injury (Solomonow et al 1987), osteoarthritis in the knee 
joint (Hurley and Newham 1993), or an artificially induced saline knee joint 
effusion (Kennedy et al 1982), there is inl"libition of the quadriceps muscle and 
decreases in the quadriceps specific tension. Thus, if there are reductions in 
specific tension associated with aging, they may be related to inhibitory 
changes in neural command, possibly as a protective or preventive 
mechanism to reduce the risk of musculoskeletal injury which may be caused 
by maximal force output. Further work is needed to explore this concept. 
Strength training programs cause increased muscle force output and to a 
lesser degree increased muscle size in elder individuals (Fiatorone et al 1990; 
Laidlaw et al 1999). The exact mechanisms of these improvements in 
functional capacity with training in the aged are not clear. These may be due 
to either muscle or neural factors, and may involve changes in activity in 
synergist muscles, differences in the co-ordination of muscles and synergist 
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activity of muscles involved in a task, and possibly alterations in discharge 
rate of motor units after training (Grabiner and Enoka 1995). 
The neuromuscular mechanisms activated during fatigue processes during 
voluntary contractions do not appear to change with age (Grabi ner and Enoka 
1995). This is somewhat surprising, as studies have shown that due to the 
muscle atrophy and muscle fibre apoptosis there are decreases in motor unit 
numbers (de Koning et al 1988); increases in motor unit size (Stalberg and 
Fawcett 1982) and changes in the amplitude of motor unit action potentials 
(Stalberg and Fawcett 1982). Further work is necessary to examine age 
associated changes in efferent neural command during fatiguing processes. 
There are also alterations in control of preCision gripping, with greater and 
more variable pinch force being applied to maintain gripping (Cole and Beck 
1994). This may be related to increased coefficient of variation for normalized 
fluctuations in force output, particularly at low force output (Laidlaw et al 2000; 
Semmler et al 2000) in older individuals. These changes may explain 
performance decrements in both uni-directional activities such as running and 
multi-directional sports such as squash, where both co-ordinating structure 
and strength capacity are important. 
2.0.4. Aging and the brain 
It has also been suggested that aging may affect memory (Rypma and 
D'Esposito (2000). In previous sections of the literature it was suggested that 
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fatigue may not be a peripheral process, but instead be controll ed by central 
brain processes integrating multiple systems, with the symptom s of fatigue 
being the result of interaction between these unconscious regulating 
processes and conscious cognitive functions. Rypma and D'Esposito (2000) 
found that during cognitive tasks involving encoding, maintenance and 
retrieval functions of memory, there were distinct changes in the dorsolateral 
prefrontal cortex in aged individuals compared to young controls. They 
suggested that this decline in cognitive function may be related to reduction of 
neural efficiency and changes in neural firing probability, or possibly to 
generalised cortical atrophy associated with aging. The decreases in athletic 
function, therefore, may also be related to decreased function of working 
memory and cognitive processes, if athletic function is associated with 
alterations in the perception of fatigue. 
Other evidence that changes in brain structures themselves rather than 
changes in peripheral muscle function are responsible for decrements in 
physical performance can be found in age related diseases which affect brain 
function and impinge on motor activity and control, such as Alzheimers and 
Parkinsons disease. In Parkinsons disease there is progressive alteration in 
gait and motor control associated with changes particularly in brainstem and 
basal ganglia regions of the brain (Morris et al 2001 ;Ouchi et al 2001). In 
Alzheimers disease, in which particularly working and cognitive function is 
affected (Bland and Newman 2001; Chen et al; 2001), there is decreased 
activity related to lack of cognitive function, as the planning of tasks and 
decision making which are necessary to initiate motor behaviours is absent. 
III 
The syndromes of Dementia, Alzheimers and Parkinsons have similar 
reductions in motor control and gait abnormalities (Waite et al 2001). It has 
been suggested that Alzheimers disease and Dementia may be an extreme of 
the continuum of the aging process, rather than disease processes (Meguro 
et al 2001). This interpretation is however controversial (8alat et al 2001). 
Nevertheless, as the changes in motor function in these brain related 
diseases are similar to those described earlier as part of the decrements in 
athletic function associated with aging, one may speculate that decrements in 
performance associated with aging may also be related to changes in brain 
related functions such as cognitive abilities and volitional motor commands. 
2.0.5. Summary 
In conclusion, the findings of this section suggest that aging has profound 
implications for athletic activity, with reductions in athletic performance, 
particularly in endurance sports and sport requiring motor skills. The 
decrements in performance associated with aging are greater in elite than 
average runners. These decrements in performance may be related to 
cumulative tissue damage associated with increased metabolic rate, rather 
than to programmed cellular destruction. This cellular damage may occur in 
muscle tissue or brain tissue, or a combination of both. However, one may 
also speculate that reductions in physical performance may be secondary to 
reduction in physiological function. Rather, the reductions in physical 
performance may be a result of actively planned central commands which 
reduce levels of activity in a feedforward manner to protect damaged 
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structures from further harm, by reducing the increases in metabolic rate 
associated with athletic activity. Further work is necessary to explore these 
concepts. 
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2.E. AIMS AND OBJECTIVES 
The overall aim of this thesis, in accordance with the questions outlined in the 
literature review, was to examine the hypothesis that excessive exercise 
activity induced a form of accelerated aging of the peripheral skeletal muscles 
with associated reductions in physical performance and symptoms of 
excessive and chronic fatigue. This was done using a number of different 
models. The specific aims of this thesis were to: 
i) Describe the history, symptoms and physiological findings in an elite athlete 
with excessive fatigue and performance decrements which initiated the work 
presented in this thesis. 
ii) To examine the prevalence of muscle damage and other physiological and 
psychological changes in at~lletes presenting with similar symptoms to the 
initial case report study, and whether these changes were present in age and 
training matched controls without symptoms of excessive or chronic fatigue or 
decrements in exercise performance 
iii) To examine whether the symptoms and physiological changes found in 
these fatigued athletes could be attenuated or reversed by high doses of 
antioxidant therapy. 
iv) To examine the age related changes in the physical performance of 
athletes in weightbearing and non-weightbearing limbs and in different 
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weightbearing and non-weightbearing activity, to assess whether sporting 
activity may indeed induce a form of accelerated aging of the lower limb 
musculature. 
iv) To examine whether veteran athletes adopt pacing strategies of reduced 
activity as a protective strategy to prevent muscle and musculoskeletal 
damage, or as a result of previous musculoskeletal damage, or whether the 
reductions of exercise activity is part of the generalised aging process. 
v) To examine whether veteran athletes of different athletic abilities exercise 
at similar or different intensities, and thus have similar or different 
predisposition to the development of exercise induced pathology. 
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CHAPTER 3. EXPERIMENTAL WORK 
3.A. Case report study of fatigued athlete with myopathy 
Introduction 
As described in the introduction and literature review, although regular exercise 
is widely regarded as being beneficial to an individual, reducing cardio-vascular 
risk factors and increasing longevity (paffenbarger et al 1984; Morris et al 1990), 
recently there has been speculation that excessive exercise may be deleterious 
to various biological systems (Sjostrom et al 1988; Poulsen et al 1996). Studies 
have shown that acute high intenSity exercise causes short-term damage to 
mitochondria (Friden et al 1988), and the transient short term muscle fibre 
damage as a consequence of unaccustomed exercise are well documented 
(l'Jewnham et al 1987; Ebbeling and Clarkson 1989). Although there has been 
speculation that this damage may decrease longevity and cause premature 
aging (Poulsen et al 1996), there is no consensus. In this first study a case 
report of an athlete with a history o'f long term, high-volume exercise training is 
described. Data are presented which suggest that this subject had permanent 
damage to his lower limb skeletal musculature, perhaps due to oxidative or 
mechanical damage to his mitochondria. 
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Methods 
The subject was an international level athlete who presented to our Unit 
complaining of symptoms of excessive fatigue associated with exercise and 
decrements in his physical and athletic performance which were not improved by 
rest. These symptoms had been ongoing for several years, and he had 
consulted a variety of medical practitioners for treatment with no success. 
The subject has recorded a detailed training and racing history for the previous 
13 years in a training diary. This self reported data from the training diary were 
used to compare his performance and training changes against age-matched 
international level race times. 
A general history and medical examination was performed on the subject. 
Resting heart rate (HR) and blood pressure (BP) measurements were examined. 
Resting HR and HR measurement during subsequent performance test was 
measured continuously using a portable HR monitor (SportTester heart rate 
monitor, Polar Electro, Kempele, Finland). HR testing using portable HR monitor 
devices have been shown to be reliable and repeatable (Leger and Thivierge 
1988; Seaward et al 1990) Both resting HR and resting BP were performed with 
the subject lying down in a supine position. Resting BP was measured by means 
of audible sphygmomanometry using a calibrated mercury column 
sphygmomanometer with an appropriately sized cuff. Korotkoff phases I and IV 
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were measured at all time periods representing systolic BP and diastolic BP 
readings. The BP recordings were all performed using the same apparatus on 
the right arm of the subject. The measurement of blood pressure is sometimes 
difficult. However, when phase IV of the Korotkoff sounds is taken the results are 
reproducible (Derman 1995). 
A blood sample was taken from the subjects subcutaneous veins of the 
antecubital fossa region of the forearm prior to performing the physiological 
testing. A 22 gauge needle and 5 ml syringe was used to withdraw the blood 
sample. Prior to venepuncture, the skin was cleaned with an alcohol swab. Thirty 
millilitres of venous blood was collected. The blood was stored in EDTA 
collecting tubes and sent to a private chemical pathology laboratory for routine 
evaluation of different blood parameters. These included: i) Hormone assays 
(thyroid stimulating hormone, thyroxine, tri-iodothyronine, total and free 
testosterone, 24 hour urinary cortisol, 24 hour urinary creatinine, growth 
hormone, parathyroid hormone); ii) Liver enzyme activity assays (total and 
conjugated bilirubin, lactate dehydrogenase, aspartate transaminase, alanine 
transaminase, gamma-glutamyl transpeptidase, alkaline phosphatase); iii) 
Skeletal muscle enzyme activity in serum (creatine kinase) and blood (post-
exercise lactate); iv) Blood parameters (haemoglobin, haematocrit, red blood cell 
count, mean corpuscular volume, mean corpuscular haemoglobin concentation, 
white blood cell count); v) Viral screen (HIV1 and HIV2 antibodies, Bilharzia 
antibodies, Brucella agglutinens; Hepatitis A and B antibodies, Ebsteil1-Barr 
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virus capsid and early antigen antibodies); vi) Micronutrient studies (serum iron, 
transferrin and ferritin concentrations, total iron binding capacity and percentage 
saturation, vitamin B12 and folate concentrations); vii) Immune function studies 
(lymphocyte CD3, CD4(helper), CD4(absolute), CD8, CD4/CD8 ratio, CD14, 
natural killer cells, B cells); and viii) Auto-immune studies (enzyme sediment 
rate, anti-nuclear factor, rheumatoid factor, anti-mitochondrial factor, anti- . 
neutrophil cytoplasmic antibody -c and -p) 
The subject's age, height and mass was recorded. Body fat content and muscle 
mass were predicted using the procedures of Durnin and Womersley (1974)-and 
• i: . Martin et al (1990) respectively. The anterior mid-thigh skinfold measurem~nt, 
'0 . the sub-gluteal, mid-thigh and.above-knee circumferences were'recordedirrthe 
right leg to calculate the lean thigh volume (LTV) of the right leg. This technique 
for estimating L TV assumes the upper section of the lower leg has the shape of 
a truncated cone. The technique was adapted from the technique described by 
Katch and Katch (1974) by. Coetzer et al (1993) and has been validated:against 
L TV assessed by magnetic resonance imaging (Knapik et al 1996). The 
subject's anthropometric data in this trial were compared against this previous 
data to analyze changes in his performance after his deterioration in 
performance and onset of symptoms. 
The subject underwent a maximal oxygen consumption (V02max) test on a 
treadmill according to the incremental protocol described by Coetzer et al (1993) 
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on a motor-driven treadmill (Quinton Instruments, Seattle, WA, USA), as a 
modification of a protocol previously developed by Noakes et al (1990). Prior to 
beginning the trial, the subject warmed up and was familiarized to treadmill 
running by running at 8 km/h for 5 minutes. During the V02max test, the subject 
started running at 8 km/h on a horizontal treadmill for 60 s, after which the speed 
was increased by 1 kmlh every minute. The exercise was terminated when the 
subject was unable to maintain the required treadmill speed. Peak treadmill 
running speed (PTRS) was defined as the fastest running speed the subject 
could maintain for 30 s. 
Throughout the treadmill test, the subjectwore an air-tight mask covering his 
nose and mouth. Oxygen consumption (V02) was measured continuously 
(OxyconSigma, Mijnhardt, Bunnik, The Netherlands). Before each test, the gas 
meters were calibrated with a 3-L syringe (Hans--Rudolf5530,.Kansas City, MO; 
USA), and the analyzers were calibrated with a gas mixture containing 4.5% CO2 
With the remainder made of a N2/02 mixture., During the test; the highest V02 
recorded during any 60 s interval was recorded as the V02max. The subject had 
been tested 7 years prior to the current investigation in our laboratories using 
the same testing apparatus but by different investigators. The subject's V02max 
data in this trial were compared against these previous data to analyze changes 
in running performance after the onset of symptoms. 
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During the test, HR was also recorded continuously a portable HR monitor 
described previously. Maximal HR (HRmax) was defined as the heart rate at the 
point of complete exhaustion when the subject terminated the test. 
Prior to the V02peak protocol, a 20-gauge Jelco cannula (Critikon, Halfway 
House, RSA) was inserted into the subjects' antecubital vein. Blood samples 
were obtained from the cannula immediately prior to commencement of the 
testing protocol, immediately after termination of exercise, and three minutes 
after,termination of exercise. The blood sampleswere collected in tubes 
containing sodium 'Huoride and potassium oxalate; and centrifuged at 3000 
rev/min for 1-0 min; Plasma was separated and frozen at~20°C until analysis. 
Plasma lactate concentrations for each subject at each time point were 
determined using a spectrophometric enzyme assay (Bio Merieux, Marcy-L 
Etiole,' France). The coefficient of variation for this assay in our laboratory is < . 
3% for duplicate lactate samples. 
Needle muscle biopsies were performed on the patient's left vastus lateralis 
muscle on two separate occasions, 4 months apart, using the technique of 
Bergstrom as described by Dubowitz (1985). On the second occasion the 
patient's right triceps muscle was also biopsied. The biopsy site was first 
anaesthetized using 2% lignocaine. A small incision was made prior to insertion 
of the biopsy needle. The biopsy sample was immediately divided into two 
portions. Half of the portion was orientated and imbedded in Tissue-tek, frozen 
~. '.~ 
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in liquid nitrogen, and stored at -20°C for later histological and morphological 
analyses. The remaining sample was stored in buffered 30/0 liquid gluteraldehyde 
for later electron microscopic histological analyses. 
The muscle tissue was prepared for histological assessment as described by 
Dubovitz (1985). 2-7 11m sections of frozen muscle were cut and stained with 
haemotoxylin and eosin, ATPase at pH 4.2,4.6 and 9.4. Nicotinamide adenine 
dinucleotide (reduced) (NAOH), succinate dehydogenase (SOH) and a modified .. 
Gomori stain were performed. An oil-Ted 0 and periodic acid Schiff stain allowed, 
. assessment of fat and glycogen content respectively. Cytochrome c oxidase ' ',' 
,','1",. "stain (GOX) was performed separately as well as beingcounterstainedwith SOH 
,,' , .. ',' 'in order to more easily identify COX negative fibres. Sections of triceps and· ',. 
,vastus lateralis muscle were placed on the same slide and clearly labeled 
sections of both muscles were therefore stained under exactly the same, 
conditions. The muscle fibre pathology present in the different samples were 
",' . scored by a specialist pathOlogist with expertise in myopathies who was blinded 
to the group identity of the samples. 
Fibre size and number quantification was performed using VIO-3 morphometry 
software. Field counting size was 462 292,7 square microns, and the number of 
fibres of either fibre type I or fibre type II in t~lis field were counted at ATP pH 
4.3. Where possible, 50 fibres of type I and 50 fibres of type II were measured 
for fibre size. The maximum diameter of the minimum aspect was measured to 
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prevent problems with oblique fibres. This methodology is described in detail in 
Dubovitz (1985). 
longitudinal and transverse sections of muscle were fixed in 3% phosphate 
buffered gluteraldehyde, post-fixed in 1 % buffered osmium tetroxide and 
processed by standard methods into Spurrs epoxy resin. Ultra-thin sections were 
examined using a Philips 201 electron microscope. The muscle fibre pathology 
visualized using eletron microscopy was also scored by the same pathologist 
who was blinded to the group identity of the samples . 
. The muscle sampled were homogenized in a potassium phosphate :buffer;·pH 
7.4 as described by Weston et el (1997). Phosphofructokinase (EC 2.7.11) 
(PFK) and citrate synthase (EC 4.1.3.7) (CS) activity were assayed 
spectrophometrically at 25°C (Beckman DU-62; Beckman Instruments Inc., 
USA.). Prior to performing the assays on the study sampletissue,the assays 
., 
were performed on control rat tissue until the coefficient of variability was less 
than 2% for the entire procedure from homogenisation of the muscle specimen 
to CS and PFK assays. CS, an oxidative enzyme in the tricarboxylic acid cycle, 
was assayed using a modified Srere technique (Srere, 1969). The reaction 
mixture consisted of 80 mM Tris-HCl, pH 8.4; 0.1 mM 5,5'- dithiobis[2-
nitobenzoic acid] (DTNB); 0.3 mM acetyl-CoA, 0.5mM oxaloacetate and 5 ~I of 
homogenate. Changes in optical density were recorded at 412 nm using a DTNB 
extinction coefficient of 13.6. PFK, an enzyme in the glycolytic pathway, was 
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assayed using the method of Ling et al (1965). The assay mixture contained 50 
mM Tris, pH 8.2, 2rnM EDTA, 5 rnM MgCb, 20mM 2-mercaptoethanol, 2rnM F6P, 
40 J.1g aldolase, 10 Ilg of TPI and GlyPDH, 0.16 rnM NADH, 10 III of homogenate 
and 2 rnM ATP. The disappearance of NADH was monitored at 340 nm using an 
NADH extinction coefficient of 6.22. 
Muscle and leucocyte DNA were assessed to exclude specific mitochondrial 
DNA abnormalities. Total DNA was extracted from approximately 10 mg of 
muscle from the left vastus lateralis and right triceps' muscles and from 
peripheralleucocytes (QIAamp Tissue Kit,Qiagen, Germany). Mitochondrial 
,,,'. DNA,was,Smplified:using the Expand Long·Template,pe~ System (Boehringer 
. 'Mannheim,Germany), with the primer pairsdasignedspecifically to detect large 
.> deletions of mitochondrial DNA. PCR products were separated on a 0.6% 
'agarosegel, stained with ethidium bromide and visualised on along wave length' 
UV light box. Mitochondrial DNA point mutations ~ssociated with the syndromes 
of mitochondrial myopathy, encephalomyopathY,lacticacidosis and stroke'-like-
episodes (MELAS) at nt3243 and nt3271, myoclonic epilepsy with ragged red 
fibres (MERFF) at nt8344 and nt8356, and neurogenic muscle weakness, ataxia 
and retinitis pigmentosa (NARP) at nt8993 were screened for, as previously 
described (Owen et al 1995). 
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Results 
In this study, a 28 year old male athlete presented complaining of a long-term 
progressive decline in running performance, associated with an increasing 
inability to tolerate high-mileage training. He began competitive running at age 
12 years; at 17 years he won the South African national under-19 cross-country 
championships, and subsequently became a professional athlete. At 19 years he . 
ran 10 km in 28:35 min. During his 23rd year he completed his greatest volume of 
training (6537 kmlyear) (Figure 3.A.1.). At 24 years he ran his fastest 10 km time 
(28: 10 min). In the same year he developed a medial tibial stress syndrome, and 
'. did not train for 3 months. On recovery, he rapidly increased-his training volume 
., .. and developed the classic symptoms of overtraining (Barron et a11985; Friden . 
et a11988; Kuipers and Keizer 1988), including physical exhaustion, weakness 
in his lower limbs and recurrent upper respiratory tract infections. He rested for 
several weeks but developed similar symptoms when he resumed excessive 
training. He was never able to return to the level of racing and training which he 
had achieved earlier, with his yearly training distance and 10 km running 
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Figure 3.A.1 :(a) Patient's fastest average running speed during a 10 km for each 
year from the age of 17 to 28 years compared to the USA record for each age. 
(b) Patient's total training distance for each year 
The skeletal muscle symptoms he described were that whenever his training 
distance increased to more than 100 km/week, a distance he had run regularly 
for the preceding 7 years, his legs became progressively weaker and he felt he 
could not tolerate his normal training workload. 
126 
The patient had no medical history besides a single, transient Ebstein-Barr virus 
infection, at age 23 years which was not related to the onset of decline of his 
athletic performance. There was no family history of myopathy or muscular 
dystrophy. When 27 years old, on the advice of running contemporaries, he 
used Prozac® (Fluoxetine hydrochloride) for three months in an attempt to 
improve his physical training capacity, but halted this treatment after no . 
improvement in athletic performance was noted. 
The patient was comprehensively investigated to establish the underlying cause 
of his symptoms. Clinical examination revealed no obvious signs of pathology or'· 
;". disease. The cardiovascular, respiratory, abdominal, musculoskel.etal.and·· '. 
centralnervous system examinations were all unremarkable. There was no 
visible muscle wasting or palpable lower limb muscle pain at rest orduring 
clinical examination. 
The athlete's maximal aerobic capacity (V02max) was 71 rnl02/kg/min, lower 
than the value of 76 ml02/kg/min measured in the laboratory under similar 
conditions seven years earlier. Figure 3.A.1. shows his 10 km running 
performance and training distance from the age of 18 to 28 years compared to 
the age-related USA 10km records. The patient's 10 km running performance 
was close to the USA national record until age 26. Figure 3.A.1. also shows a 
steady decline in annual running distance after age 23. Table 3.A.1. shows that 
although the patient's body mass remained constant between the two 
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examinations at 21 and 28 years, skeletal muscle mass and lean thigh volume 
decreased markedly whilst percentage body fat increased. 
Table 3.A.1. Anthropometrical changes in the patient between the ages of 21 
and 28 years. 
21yr 28yr % Change 
Body mass (kg) 68.8 67.8 -1.5 
Muscle mass(kg) 42.7 38.5 - 9.9 
Fat (%) 10.8 12.4 + 11.4 
Lean thigh volume (ee) 6218 5499 -,11.7 
ApartJromcertain liver and muscle function tests,.all blood and urine hormones, . 
. immune functions, autoimmune functions, viral, iron and micronutrient 
,measurements were within the normal range: Total bilirubin was measured as 47 ' " 
U/L (normal 8-21 U/L) , lactate dehydrogenase 330 U/L(120-290 U/L). aspartate 
transaminase 28 U/L (0-25 U/L) and creatine kinase 141 U/L (15-130 U/L).· 
Ebstein-Barr virus (EBV) capsid IgG antibodies were positive while EBV capsid 
IgM antibodies and EBVearly antigen antibodies were negative, indicating a 
previous EBV infection with no active pathology. 
A muscle biopsy was performed on the patient's left vastus lateralis. Four 
months later a second muscle biopsy was performed on the same vastus 
lateralis and also on the left triceps muscle. Histological analysis of the muscle 
128 
biopsy from the vastus lateralis revealed no inflammation, necrosi s or 
regeneration of muscle fibres. The muscle interstitium and capillary vessels 
appeared normal. Type I fibres had a mean diameter of 67.2 Ilm and type II 
fibres had a mean diameter of 76.7 Ilm. Both these measurements were within 
the normal range. 
Histochemical analysis of the same muscle sample showed a marked fibre type I 
predominance, as expected in an elite endurance-trained athlete (Saltin and 
Gollnick 1990). The Gomori stain showed uneven mitochondrial distribution with 
subsarcolemmal mitochondrial aggregation, several fibres having a 'ragged red' 
appearance in both fibre types. The NAOH stain showed striking linear to 
nodular subsarcolemmal accentuation of the NAOH enzyme imparting a lobular 
pattern to the fibres (Figure 3.A.2). The cytochrome c oxidase and SOH studies 
showed similar subsarcolemmal mitochondrial accentuation. The lipid and 
glycogen content appeared normal. The second vastus lateralis muscle biopsy 
showed similar results. Figure 3.A.2. shows that no such abnormalities were 
present in the biopsy of the triceps muscle sample. 
Electron microscopic analysis showed that the mitochondria in both the first and 
second vastus lateralis muscle biopsy samples displayed variation in size and 
contained a dense matrix with increased number of coarse and broad cristae 
(Figure 3.A.3.). The abnormal mitochondria were seen in large subsarcolemmal 
aggregates as well as along the sarcomere. Myelin bodies and lipofuschin 
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pigments were visible. The sarcomere and t-tubular system appeared normal. 
No abnormalities were detected by electron microscopy of the triceps muscle 
biopsy. 
Figure 3.A.2.2a:NADH stain of patient's vastus lateralis muscle showing lobular 
subsarcolemmal accumulation of the oxidative enzyme (X400) . 2b: NADH stain 
of patient's triceps muscle showing a fairly even distribution of the oxidative 
enzyme throughout the fibres; type I being more intensely stained than type II 
(X400) 
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Figure 3.A.3. Electron micrograph from the patient's vastus lateralis muscle 
showing large mitochondria with dense matrices and coarse, abnormal cristae. A 
normal mitochondria is visible in the centre of the figure (X35040) 
Citrate synthase activity in the vastus lateralis muscle was markedly lower than 
the values in endurance trained athletes and resembled those of sedentary 
controls, whereas phosphofructokinase activity was similar to that measured in 
endurance-trained athletes (Table 3.A.2) . 
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Table 3.A.2. Enzyme activities of the patient's vastus lateralis muscle 
(Ilmol.gww-1. min-\ 
Patient Endurance* Sedentary* 
Athletes (n=4) Controls (n=6) 
Citrate synthase 9.9 18.5±2.7 10.3±1.0 
Phosphofructokinase 34.1 34.7 ± 12.6 48.7 ± 10.5 
* Mean ± SD obtained in this laboratory 
Large deletions associated with Kearns-Sayre syndrome were not detected in 
approximately 13000bp of the mitochondrial genome extracted from the patient's 
vastus lateralis or triceps muscle samples or in peripheralleucocytes. DNA 
isolated from a lymphoblast culture established from a previously described 
Kearns-Sayre syndrome patient (Owen et al 1995) with a 4977bp deletion 
associated with 13bp repeats at nt8470-8482 and nt13447-13459 was used as 
an amplification control. Both normal and abnormal mitochondrial DNA 
populations consistent with a 4977 base pair deletion were amplified from the 
positive control. An indication of the sensitivity of the PCR system used for this 
assay is that mutant mitochondrial DNA in Iymphoblasts from the Kearns-Sayre 
patient was not detectable on a Southern blot. Mitochondrial DNA point 
mutations associated with the syndromes of mitochondrial myopathy, 
encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS), 
myoclonic epilepsy with ragged red fibres (MERFF), and neurogenic muscle 
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weakness, ataxia and retinitis pigmentosa (NARP) were not detected in mtDNA 
amplified from left vastus muscle, right triceps muscle or peripheral leucocytes of 
the patient. 
Discussion 
In this case report study, a young elite athlete is described whose professional 
athletic career was terminated by a condition that was not detectable by 
conventional medical examination and screening. In view of the predominance of 
symptoms related to the skeletal muscles, skeletal muscle biopsies of the vastus 
lateralis and triceps muscles were performed. The important finding on skeletal 
muscle biopsy were mitochondrial abnormalities which were confined to the 
vastus lateralis muscle, and were not present in the triceps muscle. This damage 
was shown both histologically on light and electron microscopy, and functionally 
by decreased enzymatic activity to be limited only to the markers of the 
oxidative, but not glycolytic pathways. 
One might speculate that the patient's deterioration in his physical capabilities 
may have resulted from these abnormalities. His skeletal muscle citrate synthase 
activity, and by implication muscle oxidative activity, was markedly decreased 
relative to healthy elite athletes tested in this laboratory. His physical 
parameters, notably aerobic capacity (V02max), skeletal muscle mass, lean 
thigh volume, athletic performance and training capacity had all deteriorated, 
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and a causal link between these parameters and his underlying muscular 
pathology must be considered. 
One may also speculate that his decline in performance and physiological 
changes may have been due to disuse-type atrophy. However, the magnitude of 
his physiological deterioration is not expected in a person of his age, as studies 
show that the earliest changes in body composition (Bemben et al 1995), muscle 
(Booth et a11994) and sporting performance (Trappe et a11995) do not occur 
until the fourth decade of life. Also, he still trained 60-80 km per week, which 
should have prevented a disuse-type atrophy from occurring. It is surprising that 
with the lower limb skeletal muscle mitochondrial pathology described he was 
still able to perform at a relatively high level of athletic performance. This 
indicates that factors other than just oxidative capacity of skeletal muscle 
contribute to endurance running performance. 
There were three likely explanations for these findings. Either the patient had a 
mitochondrial myopathy wrlich (i) was previously existed undiagnosed, (ii) was 
acquired after his prolonged physical activity, or (iii) was acquired as a result of 
unknown agents. 
The absence of large mitochondrial DNA deletions and because the findings 
were localized to the lower limb indicates that this was not a classical 
mitochondrial myopathy, even though the histochemical features were similar to 
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those found in Kearns-Sayre syndrome and other classical mitochondrial 
myopathies (Jackson et al 1995; Petty et al 1986). 
The second possibility was that the condition was due to the patient's excessive 
exercise routine which occurred for much of his adolescent and early adult life 
must be considered. One may speculate that exercise-induced damage may 
have caused the mitochondrial abnormalities in this patient because i) damage 
was limited to the lower limb muscles, but not the arm muscles, in this athlete; ii) 
abnormalities were present in two muscle biopsies taken four months apart, 
indicating that the damage was consistent and could be long term or permanent; 
iii) accumUlation of mitochondria in the patient's subsarcolemmal space (Figure 
2) is an exaggerated example of the normal response to endurance training 
(Barron et aI1985); (iv) the mitochondria which have accumulated in the 
subsarcolemmal space are histologically (Figure 4) and functionally (Table 3) 
impaired. There is evidence that exercise may impair skeletal muscle function 
(Duarte et a11992; Geller 1973; Hochli et a11995; Kuipers 1994), perhaps as a 
result of oxygen-derived free radical damage (Duarte et a11993; Sen 1995) or 
muscle cell membrane disruption leading to calcium-mediated cell damage to the 
individual muscle fibres (Jones and Round 1990). 
The third possibility was that unknown infective or toxic agents caused the 
pathology. However, if the agents were of a infective ~r toxic origin, as 
suggested by other investigators (Derr 1995), one would expect that all 
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musculature to be similarly affected. The fact that the pathology was localized to 
his vastus lateralis musculature and not present in his triceps musculature would 
indicate that the pathology is not of infective or toxic origin. 
Similar pathology as described in this patient, although not localized to specific 
limb musculature, has been described in HIV-positive patients treated with AZT 
(Zidovudine) (Dalakas 1993), in an exercising thoroughbred horse (Valberg et al 
1994), in patients with inclusion body myositis (Oldfos et al 1995), and in elderly 
individuals as part of the normal aging process (Johnston et al 1995; Katayama 
et aI1991). 
In conclusion, in this case report study a patient in whom a prolonged high level 
of running training may have lead to skeletal muscle mitochondrial pathology 
localized to the vastus lateralis and not triceps musculature was described. It 
was unclear why the patient's muscles appear to have been damaged by a 
training load which has been well tolerated by other elite athletes. It may be 
suggested that the ·findings in tt-lis patient explain the accelerated decrements in 
performance experienced by some elite athletes after many years of heavy 
training and competition. Further work is necessary to examine this hypothesis. 
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3.B. Case series study of fatigued athletes 
Introduction 
In the previous chapter, a case report study of an international level athlete 
with excessive fatigue and an associated reduction in exercise performance 
was described. Muscle biopsies revealed the presence of muscle pathology 
which was present only in the vastus lateralis muscle and not in the triceps 
muscle. The muscle pathology remained present in a further vastus lateralis 
muscle biopsy performed three months after the first biopsy. It was concluded 
that either this muscle pathology i) existed previously but was undiagnosed, ii) 
was a result of unknown infective or metabolic agents, or iii) was acquired 
after his prolonged training and was a form of "accelerated" aging caused by 
excessive exercise. The 'finding that the myopathy was located to the lower 
limbs suggested that this was not a classical mitochondrial myopathy, but was 
caused by either ii) or iii). 
It was hypothesized also in the previous chapter that this finding may explain 
the accelerated decrements in performance experienced by other athletes 
after years of heavy training and competition. Derman et al (1997) suggested 
that this clinical condition may be prevalent in other athletes, and named this 
condition the fatigued athlete myopathic syndrome (FAMS). They suggested 
that the common feature of atrlletes with this condition were i) they had a . 
history of high volume training for many years, ii) they presented with chronic 
fatigue, decreased physical performance and a clinical picture which was 
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dominated by skeletal muscle symptoms including excessive delayed onset 
muscle soreness, stiffness, tenderness or skeletal muscle cram ps, and iii) 
they had often consulted many clinicians unsuccessfully (Derman et al 1997). 
Based on these observation and the findings of the first case report study, the 
aim of this study was to examine the prevalence of muscle pathology in 
athletes who presented to sports medicine pllysicians with the symptoms of 
excessive exercise related fatigue and decrements in performance suggestive 
of the development of FAMS. 
Methods 
Twenty subjects were recruited from a Sports Medicine Clinic located at the 
Sports Science Institute of South Africa. All subjects were involved in exercise 
activity either currently or prior to the onset of their symptoms. Subjects were 
referred by sports medicine physicians to the trial over a three year period. 
Inclusion criteria were that they had a history of high volume training for 
several years, a history of chronic or excessive exercise related fatigue, and 
decreased physical performance during exercise activity and a clinical picture 
which was dominated by skeletal muscle symptoms including excessive 
DOMS after exercise, stiffness, tenderness and skeletal muscle cramps. 
The same three investigators, including the author, examined each athlete 
over the three year period, and the author performed the medical 
examinations on each athlete. 
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Each subject filled out data questionnaires subjectively describing their type of 
sporting activity, current training and racing performance (Appendix), and 
previous medical, injury and running history (Appendix). In addition, the FAMS 
subjects described their medical, injury and running history both prior to and 
after the onset of their symptoms. 
All subjects completed a Beck psychological inventory (Appendix). The same 
investigator assisted the subjects with completion of the inventory. While 
advice was given on the method of completion of the form, no input was given 
to the subjects about the content of the questionnaire. This was controlled to 
prevent any bias in the responses of the subjects. 
The medical testing, anthropometry, blood testing, V02max testing and 
muscle biopsy analyses were performed as described in the previous chapter 
(Ch 3.A.). 
In addition, the force output of the right knee extensor muscles of each 
subject was measured using a Kin-Com isokinetic dynamometer 
(Chattanooga Group Inc., USA). Subjects were secured to the dynamometer 
via shoulder and waist strapping. To avoid interference with the placement of 
EMG electrodes the active limb was not stabilized. The axis of rotation of the 
dynamometer was visually aligned with the lateral femoral epicondyle, with 
the lower leg attached to the lever arm slightly above the level of the lateral 
malleolus. The knee was positioned at an angle of 60° of flexion, with the 
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reference point being full knee extension. All subjects performed isometric 
maximal voluntary contractions (MVC). 
Prior to MVC testing, the subjects performed four sub-maximal familiarization 
trials. EMG and force output data were subsequently collected during four 
MVC trials. Subjects were verbally encouraged throughout all trials to exert 
maximal effort. The ~Iighest of the four MVC trials was used for subsequent 
analysis. 
Because of the different sporting and medical histories of each subject, the 
results are described as a case series rather than as pooled data. Due to 
technical problems, electron microscopy results were only avai lable for 11 of 
the 20 subjects. Subjects were requested to supply their own blood medical 
investigations from tests performed in the week prior to the start of the trial. 
Results 
Case Report 1 
Subject #1 was a 27 year old male triathlete who presented with c~lronic 
exercise-associated fatigue. He started running at age 13, and at age 17 
started competing competitively at national and international level. 
At age 23 he first noticed symptoms while racing in Italy for a season. While 
training and racing heavily, he developed "flu-like" symptoms and a "bronchial 
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infection", became excessively fatigued and noted mouth ulcers. He rested for 
a period, but on return found he was "flat" when training, with ongoing 
excessive fatigue and increased effort for routine training activity. 
After these symptoms were 'first noticed, the symptoms were ongoing during 
high intensity training, and a year later, aged 24, a general practitioner 
diagnosed him as having both Coxsackie viral infection and bilhzarzia. The 
bilharzia was treated and he was placed on antioxidants. After this treatment 
he attempted to train at his previous level, and broke down again after 6 
weeks and was completely bedridden for 2 months with similar symptoms 
after this episode. 
From this time point, and at the time of testing, he was able to train or race at 
low levels of intensity, but if he increased his training volume or race intensity, 
he again developed symptoms of profound fatigue, muscle weakness and 
mouth ulcers. This continued for the ~our years up until he was recruited for 
this study. 
Apart from episodes of plantar fasciitis, runners knee and an orthopaedic 
ankle injury, there were no contributing medical, surgical or other factors 
related to his problem. 
His Beck psychological score was 13. This indicates that he was suffering 
from a mild clinical depression. 
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Prior to the deterioration in his performance, he trained 6-7 days a week with 
2-3 exercise sessions per day. His training distances were 15-25 km/week 
swimming, 240-500 km/week cycling, and 40-80 km/week running and his 
average running training speed was 15 km/hr. His best 10 km race times 
(Figure 3.B.1.) and yearly training distances for running (Figure 3.B.2.), 
cycling (Figure 3.B.3.) and swimming (Figure 3.B.4.) are described below. He 
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Figure 3. B.1. Subject #1's 10 km race times. Onset of symptoms was at age 
24 (dashed vertical line). He was unable to race any distance from age 26 
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Figure 3. B.2. Subject #1's yearly running training distances (km/year). Onset 
of symptoms was at age 24 (dashed vertical line). He was unable to train any 
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Figure 3. B.3. Subject #1's yearly cycling training distances (km/year). Onset of 
symptoms was at age 24 (dashed vertical line). He was unable to train any 
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Figure 3.B.4. Subject #1's yearly swimming training distances (km/year). 
Onset of symptoms was at age 24 (dashed vertical line). He was unable to 
train any distance in the year prior to him being tested in our Unit (solid 
vertical line). 
Medical examination revealed no abnormalities. Blood pressure was 140/80 
mmHg and resting heart rate 52 beats/min. Particularly, there was no obvious 
myopathy, muscle atrophy, myalgia or obvious musculoskeletal deformities. 
His height was 178 cm, mass 76.7 kg, percentage body fat 13%, V02max 
55.6 rnl 02/kg/min, maximum heart rate was 193 beats/min and maximum 
quadriceps force output 496 N. 
Routine blood tests revealed normal ESR, blood glucose, haemoglobin, white 
cell count and thyroid function. Apart 'from a raised AST (4 U/L), liver function 
was normal. Creatine kinase was within normal limits (126 U/L). 
Brucella, HIV, CMV, Coxsackie, Bilharzia and Infectious Mononucleosis 
screening were all negative. Ebstein-Barr virus (EBV) capsid IgG, nuclear IgG 
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and early antigen antibody were positive, indicating a current or recent 
activation of EBV infection. He described a positive Coxsackie virus test on 
several different occasions, diagnosed by his general practitioner using blood 
tests, in the years after he first noticed his symptoms developing, despite the 
negative result for this test at the time of his testing at our Unit. 
Vastus lateralis muscle biopsy showed that subject #1 had 53% type I fibres, 
31 % type IIA fibres, 9% type liB and 7% type IIC fibres. Haematoxylin and 
Eosin (H&E) stain revealed a degree of variation in fibre size that was not 
within normal limits. Group atrophy was present, as well as more than 3% 
internal nuclei. There was no obvious inflammation, necrosis or regeneration 
of the muscle fibres. 
NADH stain showed abnormal subsarcolemmal aggregates of mitochondria 
around the periphery of the cell, to levels which were abnormal even for an 
athlete. The staining pattern of the mitochondria appeared abnormal, and the 
muscle fibres appeared to be of "moth eaten" appearance. 
Electron microscopy showed the presence of myofibrillar degeneration and 
abnormal subsarcolemmal mitochondrial aggregations. Mitochondria were 
enlarged, and there were abnormal lipid and glycogen accumulations in the 
muscle fibres. 
Representative figures of normal muscle from a control subject (Figure 
3.B.5.), and atrophied fibres (Figure 3.B.6.), internal nuclei (Figure 3.B.7.), 
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subsarcolemmal aggregations (Figure 3.B.8.), myofibrillar degeneration 
(Figure 3.B.9.) and enlarged mitochondria (Figure 3.B.10.) from the FAMS 
subjects are shown on the following pages. 
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Figure 3.B.5. H&E stain of a control subject's vastus lateralis muscle showing 
normal muscle fibres (X400) 
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Figure 3.8.6. H&E stain of the vastus lateralis muscle from a FAMS subject 
showing fibre size variation and an atrophied muscle fibre (X400). 
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Figure 3.B.7. H&E stain of the vastus lateralis muscle from a FAMS subject 
showing internal nuclei (X400) . 
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Figure 3.B.8. Electron micrograph from the vastus lateralis muscle of a FAMS 
subject showing abnormal subsarcolemmal aggregations of mitochondria 
(X35040). 
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Figure 3.B.9. Electron micrograph from the vastus lateralis muscle sample of a 
FAMS subject showing abnormal myofibrillar degeneration (X35040). 
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Figure 3. B.1 O. Electron micrograph from the vastus lateralis muscle sample of a 
FAMS subject showing abnormal enlarged mitochondria (X35040). 
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Summary 
Subject #1 was a national level athlete with a previous history of high training 
volume, abnormal fatigue symptoms and muscle damage associated with the 
fatigued athlete myopathic syndrome (FAMS). Contributing factors may have 
been the recurrent active EBV infection, and the previous history of Coxsackie 
virus infections at the time of, and after the onset of his symptoms. 
Case Report 2 
Subject #2 was a 36 year old female national level female runner who 
presented with chronic performance deterioration and excessive fatigue 
associated with exercise activity. She started running competitively at age 18, 
and competed successfully for 12 years in long-distance endurance events at 
national level, during which time she won a number of races, including South 
Africa's premier ultra-endurance event, the Comrades 90 km Marathon. 
She first noticed the onset of symptoms and deterioration in performance at 
age 30, and related them to a poor performance during the Comrades 90 km 
running marathon she participated in that year. From that time point, her 
symptoms of excessive fatigue increased and performance deteriorated for 
the next 6 years until the tests were conducted at our Unit. She is currently 
able to train, but at a markedly reduced quantity and level of intensity. 
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Prior to her deterioration in performance, she was diagnosed as being 
chronically overtrained on a number of occasions, but chose to continue 
training and racing through these periods of overtraining. At age 22 and 23 
she suffered two episodes of pelvic stress fractures, related to her running 
activity. In her late adolescence and early 20's she suffered from anorexia 
nervosa which required nine episodes of hospitalization and sedation. During 
this similar period, and while running competitively, she moved between two 
countries and four cities, which were perceived by her to be lifestyle stressors. 
After her deterioration in performance, she suffered recurrent anterior tibialis 
muscle tears, and recurrent episodes of upper respiratory tract infections, 
which occurred with increasing frequency in the 3 years prior to testing in our 
Unit. 
Apart from an episode of viral meningitis at age 35, she has no contributing 
medical, surgical or other history or factors related to her problem. 
Her Beck psychological score was 1. This score is within the normal range 
and indicates no clinical depression. 
Prior to her deterioration in performance, she trained 7 days/week, an 
average distance of 130 km/week at a training speed of 13.5 km/h. After her 
deterioration in performance, and at the time of testing, she trained 5 
days/week, an average of 45 km/week, at a training speed of about 11.5 
km/h. Her best 5 km time trial time prior to her deterioration in performance 
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was 17.10 min, and this decreased to 22.01 min after her deteri oration in 
performance. Her best 10 km race times (Figure 3. B.11.), 90 km race times 
(Figure 3.B.12) and yearly training distances (Figure 3.B.13) are described in 
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Figure 3.B.11. Subject #2's 10 km race times. Onset of symptoms was at age 
30 (dashed vertical line). She was tested in our Unit at age 36 (solid vertical 
line). 
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Figure 3.B.12. Subject #2's 90 km race times. Onset of symptoms was at age 
30 (dashed vertical line). She did not compete in this event (Comrades 
marathon) from the onset of her symptoms to being tested in our Unit at age 
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Figure 3. B.13. Subject #2's yearly training distances (km/year). Onset of 
symptoms was at age 30 (dashed vertical line). She was tested in our Unit at 
age 36 (solid vertical line). 
Medical examination revealed no abnormalities. Blood pressure was 110/75 
mmHg and heart rate 56 beats/min. Particularly, there were no obvious 
myopathy, muscle atrophy, myalgia or obvious musculoskeletal deformities. 
Her height was 168 cm, mass 54.2 kg, percentage body fat 19.9%, V02max 
59.7 ml 02/kg/min, maximum heart rate was 187 beats/min and maximum 
quadriceps force output 321 N. 
Routine blood tests revealed normal ESR, blood glucose, white cell count and 
thyroid function. Although her haemoglobin level (13.5 g/dl), serum iron (23 
umol/L), transferrin (3.47 gIL), total iron binding capacity (76 umol/L) were 
normal, serum ferritin was low (15 ug/L). Apart from a raised total bilirubin 
level (27), liver function was normal. Creatine kinase was within normal limits 
(55 U/L). 
156 
Brucella, HIV, CMV, Coxsackie, Bilharzia and Infectious Mononucleosis 
screening were all negative. EBV capid IgG and nuclear IgG were positive, 
while EBV capsid IgMand Early Antigen antibody were negative, indicating a 
past EBV infection with no evidence of reactivation . 
. Vastus lateralis muscle biopsy showed that subject #2 had 91 % type I fibres, 
9% type IIA fibres, 0% type liB fibres and 0% type IIC fibres. H&E stain 
revealed a degree of variation in fibre size which was not within normal limits. 
There was no obvious inflammation, necrosis or regeneration of the muscle 
fibres. Although the muscle biopsy revealed no internal nuclei, a repeat biopsy 
revealed the presence of more than 3% internal nuclei. 
NADH stain showed fibres to have abnormal shapes, with type I fibre 
predominance and type II fibre atrophy. Abnormal subsarcolemmal 
aggregates of mitochondria were present around the periphery of the cells, to 
levels which were abnormal even for an athlete. The staining patterns of the 
mitochondria were abnormal, with type I fibres having "strings" of 
mitochondria with a linear pattern of staining instead of the normal hatched 
pattern. 
SDH staining also showed muscle fibres to have peripheral accumulation of 
mitochondria, along with a large quantity of lipofuscin pigment, representative 
of lysosomal degradation. 
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Electron microscopy showed the presence of myofibrillar degeneration. z disc 
streaming and abnormal subsarcolemmal mitochondrial aggregations. The 
mitochondria were abnormally enlarged. 
Summary 
Subject #2 was a national level runner with a previous history of high training 
and racing volume. abnormal fatigue symptoms. reduced capacity for exercise 
and muscle damage associated with FAMS. Contributing factors may be the 
previous episodes of eating disorders and nutritional insufficiency. as shown 
by repeated episodes of pelvic stress fractures and reduced iron stores. 
Previous episode of EBV may also have been a contributing factor. 
Case Report 3 
Subject #3 was a 44 year old female international level squash player who 
presented with excessive fatigue and myalgia associated with exercise 
activity. She was a provincial schools hockey player from age 14 to 21. She 
started playing competitive squash at age 21. and won the South African 
Senior Title at age 24. She competed successfully for 12 years both nationally 
and internationally. At age 36 she developed "'flu-like" symptoms but played 
squash through this initial episode. Symptoms included marked fatigue during 
exercise. muscle aches particularly in her upper body musculature. shortness 
of breath during exercise. chest pains during exercise. headaches during and 
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after exercise, and "burning" pain of the skin of the upper body and arms 
during exercise. 
She was unable to continue playing competitive sport because of these 
symptoms, which were ongoing and occurred with intermittent periods of 
either less or more severity. At age 39 she was diagnosed by a general 
practitioner as suffering from chronic fatigue syndrome (CFS), and viral 
screening showed an active Coxsackie virus infection. She was treated with 
the tricyclic antidepressant Tryptanol® (Amitriptyline) with no obvious success 
or change in symptoms. There were no changes in symptoms, and no 
improvement in ability to exercise in the period since then,and she did not 
train at all in the year prior to being tested. 
Prior to her deterioration in performance, she had no contributing medical, 
surgical or psychological problems except for an episode of bronchitis at age 
36 in the months prior to the onset of her symptoms which was successfully 
treated with antibiotics. 
After her deterioration in performance, she suffered an orthopaedic knee 
injury at age 39, and an orthopaedic shoulder injury at age 42, both of which 
were successfully treated with cortisone injections. There were no contributing 
medical or surgical factors related to her problem. 
Her Beck psychological score was 4. This score is within the normal range 
and indicates no clinical depression. 
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Prior to her deterioration in performance, she trained 6 days/week, 4 
hours/day. Her training sessions included squash matches and skills training, 
sprint training and gymnasium strength sessions. After her deterioration in 
performance, she was not able to train at all, except for social activity such as 
action cricket, and other low intensity activities. 
Medical examination showed that she had clinical pallor. Blood pressure was 
105/70 mrnHg and resting heart rate 71 beats/min. No other clinical 
abnormalities were detected. Importantly, there was no obvious myopathy, 
muscle atrophy, myalgia or obvious musculoskeletal deformities. 
Her height was 161 cm, mass 54.5 kg, percentage body fat 31.3%, V02max 
38.8 ml 02/kg/min, maximum heart rate 182 beats/min and maximum 
quadriceps force output 346 N. 
Routine blood tests showed a low haemoglobin (11.0 g/dl) and low 
haematocrit (33 %), indicating a normochromic anaemia. White cell count, 
reticulocyte count Vit B12 and folate levels were all normal. Thyroid function, 
liver function and blood glucose were all normal. Creatine kinase was within 
normal limits (126 U/L). 
Brucella, HIV, Coxsackie and Infectious Mononucleosis screening were all 
normal. EBV capid IgG and nuclear IgG were positive, while EBV capsid IgM 
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and Early Antigen antibody were negative, indicating a past EBV infection with 
no evidence of reactivation. 
Vastus lateralis muscle biopsy showed that subject #3 had 56% type I fibres, 
38% type IIA fibres, 4% type liB fibres, and 2% type lie fibres. H&E revealed 
a degree of variation in muscle size which was not within normal range. There 
was no inflammation, necrosis or regeneration of muscle fibres. 
NADH stain showed fibres to have abnormal shapes, with fibre type I 
predominance and fibre type II atrophy. Abnormal sub-sarcolemmal 
aggregates of mitochondria were present around the periphery of the cells. 
The staining pattern of the mitochondria appeared to be abnormal, with type I 
fibres having "strings" of mitochondria with a linear pattern of staining rather 
than a normal hatched pattern. "Moth eaten" fibres were also present. 
SDH stain showed a peripheral accumulation of mitochondria within the cells. 
Electron microscopy showed the presence of myofibrillar degeneration, sub-
sarcolemmal mitochondrial aggregations and z-disc streaming. Mitochondria 
were regular sizes and shapes. Satellite cells were also present. 
Summary 
Subject #3 was an international level squash player with a previous history of 
high training volume, who developed abnormal symptoms of excessive fatigue 
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and muscle pain related to exercise, and resultant deterioration in 
performance, associated with FAMS. Contributing factors may have been a 
previous Coxsackie virus infection and chronic normochromic anaemia. She 
had been previously diagnosed and unsuccessfully treated as chronic fatigue 
syndrome. 
Case Report 4 
Subject #4 was a 46 year old male club level runner who presented with 
excessive fatiglJe during running, localized particularly to the lower limbs 
during uphill running. He started running socially at age 25 after playing rugby 
and cricket, and ran competitively from the age of 35. He had 1 0 years of 
optimal performance,competing in 8 Comrades 90 km marathons, 40-5042.2 
km marathons and 80-10021.1 km marathons during this period. 
He first noticed the symptoms in the 2 years prior to his presentation at our 
Unit. He had a period of over-training, where he felt he was "unable to lift his 
legs," "running 1 km felt like running 100 km," and he had "no spring in bis 
legs." He rested for a period, and attempted a Comrades Marathon 
subsequently. However, he was not successful and developed excessive 
fatigue and heavy legs, which forced him to abandon and not complete this 
race. From this time on, his excessive fatigue and heavy legs have remained 
present, particularly during uphill running. He felt his upper body was 
functioning normally, and the problems were localized particularly to the lower 
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limbs and occurred particularly during lower body activities. These symptoms 
did not improve after rest periods of up to three months. 
Prior to his deterioration in performance, he had several episodes of 
overtraining, with similar symptoms to those described above, all of which 
were successfully treated by rest. and multivitamin and food supplements. He 
was diagnosed with depression at age 38 and treated with Prozac®, wl-lich he 
has been using continuously the last 8 years, and which he felt successfully 
treated the symptoms of depression. 
Apart from this depression, he had no other contributing medical or surgical 
history or factors relating to his problem. 
His Beck psychological score was 14. This indicates that he was suffering 
from a mild clinical depression. 
Prior to his deterioration in performance, he trained 5-6 days/week, an 
average distance of 83 km/week, at a training speed of 12 km/h. After his 
deterioration in performance, he trained 3-4 days/week, an average distance 
of 40 km/week, at a training speed of 10 km/h. His best 5 km time trial time 
prior to his deterioration in performance was 20:00 min, and this decreased to 
22:56 min after his deterioration in performanc~. His best 42.2 km race times 
(Figure 3. B.14.), 90 km race times (Figure 3. B.15. )and yearly training 
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Figure 3. B. 14. Subject #4's 42.2 km race times. Onset of symptoms was at 












35 36 37 38 39 40 41 42 43 44 45 46 47 
Age 
Figure 3.B.15. Subject #4's 90 km race times. Onset of symptoms was at age 
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Figure 3.B.16. Subject #4's yearly training distances (km/year). Onset of 
symptoms was at age 44 (dashed vertical line). He was tested in our Unit at 
age 46 (solid vertical line). 
Medical examination revealed no abnormalities. Blood pressure was 118/70 
mmHg and resting heart rate 60 beats/min. Particularly, there were no 
obvious myopathy, muscle atrophy, myalgia or obvious musculoskeletal 
deformities. 
His height was 166 cm, mass 76 kg, percentage body fat 26.5%, V02max 
42.2 ml 02/kg/min, maximum heart rate 183 beats/min and maximum 
quadriceps force output 469 N. 
Routine blood testing revealed a normal ESR, blood glucose, haemoglobin 
and thyroid function. However, white cell indices revealed stimulated 
lymphocyte (3.0 th/cmm) and monocyte (2.0 th/cmm) levels to be raised, 
indicating a possible post viral syndrome. Liver function tests were normal. 
Creatine kinase was within normal limits (129 U/L). 
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Brucella, HIV, CMV, Coxsackie and Bilharzia screening were all negative. 
EBV capsid IgG and nuclear IgG were positive, while EBV capsid IgM and 
early antigen antibody were negative, indicating a past EBV infection with no 
evidence of reactivation. 
Vastus lateralis muscle biopsy showed that subject #4 had 66% type I fibres, 
33% type IIA fibres, 0% type liB fibres and 1 % type IIC fibres. H&E stain 
revealed a degree of variation in muscle fibre size that was not within normal 
limits. There was no obvious inflammation, necrosis or regeneration of muscle 
fibres. More than 3% internal nuclei were visible. 
NAOH stain showed fibres to have abnormal shapes, with fibre type I 
predominance and type II fibre atrophy. Abnormal subsarcolemmal 
aggregates of mitochondria were present around the periphery of the cells, to 
levels which were abnormal even for athletes. The staining pattern of the 
mitochondria were abnormal, with "moth eaten" fibres present. 
SOH stain showed a peripheral accumulation of mitochondria. 
Electron microscopy showed the presence of myofibrillar degeneration and 
some evidence of subsarcolemmal aggregations of mitochondria. 
Mitochondria were enlarged, and there were abnormal levels of lipid and 
glycogen accumulations in the muscle fibres. 
Summary 
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Subject #4 was club level runner with a previous history of successful 
completion of a number of marathons and ultramarathons, abnormal fatigue 
symptoms particularly in the lower limbs, reduced capacity for exercise 
particularly during uphill running and muscle damage associated with FAMS. 
Contributing factors could be his history of depression, and evidence of a post 
viral syndrome from his blood analysis, which may have been related to a 
previous undiagnosed EBV infection. 
Case Report 5 
Subject #5 was a 39 year old male club level runner who presented with 
excessive fatigue, "heavy legs" and episodes of cramping in the latter stages 
o'f long distance races, and his performances during these events had 
decreased in the year prior to being tested. He had run socially until age 31, 
and ran competitively from the age of 32. He had 7 years of optimal 
performance, competing in 6 Comrades 90 km marathons, 30 42.2 km 
marathons and numerous 21.1 km marathons during this period. 
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His symptoms began approximately a year prior to him being tested in our 
Unit. He first noticed that he was taking longer time periods than usual to 
recover from long distance races. He further noticed that he got "heavy" legs, 
excessive fatigue and muscle cramps during the endurance events he 
competed in. These symptoms are now present chronically and have 
worsened through the year until his visit to our Unit. 
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During the previous year he noted that he had emigrated to a new country, 
which he felt was stress and may have contributed to his symptoms. He also 
suffered a torn hamstring 6 months prior to being tested. 
Prior to the onset of his symptoms, he had suffered two episodes of sciatic 
nerve injuries, which were successfully treated with physiotherapy. 
He had a rlistory of migraines, which were recurrent and treated with 
analgesic medication. He also had a herpes simplex 2 infection since the 
early 1980's. Apart from these illnesses, there were no other contributing 
medical, surgical or psychological history or factors relating to his problem. 
His Beck psychological score was 4. This score is within the normal range 
and indicates no clinical depression. 
Prior to his deterioration in performance, he trained 5-6 days/week, an 
average distance of 55 km/week, at a training speed of 12 km/h. After his 
deterioration in performance, he trained 3-4 days/week, an average distance 
of 45 km/week, at a training speed of 11 km/h. His best 5 km time trial time 
prior to his deterioration in performance was 19:35 min, and trlis decreased to 
19:57 min at the time of testing. His 42.2 km race times (Figure 3.8.17.), 90 
km race times (Figure 3.8.18.) and yearly training distances (Figure 3.8.19.) 
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Figure 3.B.17. Subject #5's 42.2 km race times. Onset of symptoms was at 
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Figure 3.B.18. Subject #5's 90 km race times. Onset of symptoms was at age 
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Figure 3. B.19. Subject #5'5 yearly training distances (km/year). Onset of 
symptoms was at age 38 (dashed vertical line). He was tested in our Unit at 
age 39 (solid vertical line). 
Medical examination revealed no abnormalities. Blood pressure was 120/75 
mmHg and resting heart rate 52 beats/min. Particularly, there was no obvious 
myopathy, muscle atrophy, myalgia or obvious musculoskeletal deformities. 
His height was 177 cm, mass 79.1 kg, percentage body fat 18.1 %, V02max 
59.2 ml 02/kg/min, maximum heart rate 205 beats/min and maximum 
quadriceps force output 555 N. 
Routine blood testing revealed normal ESR, blood glucose and thyroid 
function. Although his haemoglobin and white blood cell count were normal, 
his neutrophil count was 1.6 th/cmm, which was low and indicated a 
neutropenia. Liver function tests were normal. Creatine kinase was within 
normal limits (110 U/L). 
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Brucella, HIV, Coxsackie, Bilharzia and Infectious mononucleosis screening 
were all negative. EBV capsid IgG and nuclear IgG were positive, while EBV 
capsid IgM and early antigen antibody were negative, indicating a past EBV 
infection with no evidence of reactivation. CMV IgG was positive while IgM 
was negative, indicating a previous CMV infection. 
Vastus lateralis muscle biopsy showed that subject #5 had 51 % type I fibres, 
29% type IIA fibres, 15% type liB fibres and 5% type IIC fibres. H&E stain 
showed that fibres were within the normal range for the degree of variation in 
muscle fibre size. There was no obvious inflammation, necrosis, or 
regeneration of muscle fibres. A repeat biopsy showed fibre splitting and 
degeneration of fibres. More than 3% internal nuclei were present. 
NADH stain revealed abnormal sub-sarcolemmal aggregates of the enzyme 
around the periphery of the cell which were abnormal even for an athlete. The 
pattern of mitochondrial staining within the cell appeared normal. Areas of no 
staining were present in the center of the fibres, predominantly of type I fibres, 
caused either by degeneration of myo'fibrils or artifact staining. 
SDH stain revealed peripheral accumulation of mitochondria. A large amount 
of lipofuscin pigmentation was present, representative of lysosomal 
degradation. 
Electron microscopy revealed areas of myofibrillar degeneration filled with 
glycogen, lipid deposits and enlarged mitochondria greater than one 
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sarcomere in length. In these areas focal deletions, or absent z bands 
occurred. The subsarcolemmal mitochondria appeared normal. 
Summary 
Subject #5 was a club level runner with a previous history of successful 
completion of a number of marathons and ultramarathons, abnormal fatigue 
and cramping symptoms and muscle damage associated with FAMS. 
Contributing symptoms could be the psychological stress of his international 
relocation witrlin the last year, and the evidence of previous CMV and EBV 
infections associated with mild neutropenia, which may indicate the presence 
of a chronic undiagnosed viral infection. It is not clear if his musculoskeletal 
problems in the last year are related to his symptoms. 
Case Report #6 
Subject #6 was a 38 year old male social runner who developed abnormal 
symptoms of excessive fatigue, and muscle ache localized to the lower limbs, 
and particularly the quadriceps muscles. He had trained 3 days/week for most 
of his life, and after a strenuous mountain hike at age 35 noticed that he had 
excessive fatigue which remained after the hike for a longer period than usual. 
The symptoms of muscle ache in his quadriceps muscles and excessive 
fatigue subsequently occurred during every training session. 
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He was examined by a general practitioner who recommended massage 
therapy and yoga, but these did not improve his condition. He went to a 
number of different general practitioners, and the symptoms we re diagnosed 
as having a psychological basis. 
At age 36 he was seen in our Unit, and a muscle biopsy revealed muscle 
damage in his quadriceps muscle with no obvious aetiology, and a period of 
rest was recommended. 
Until his current visit to our Unit for this trial, two years later, there was no 
improvement in his symptoms, and he had not exercised consistently in the 
two years prior to his current visit. 
He has no contributing medical, surgical or psychological factors relating to 
his problem. 
His Beck psychological score was 4. T~lis score is within the normal range 
and indicates no clinical depression. 
Prior to his deterioration he trained 3 days/week at a recreational level. He did 
not participate in any races either prior to or during the onset of his symptoms, 
and his training intensity was always of a low level. 
Medical examination revealed no abnormalities. Blood pressure was 110/70 
mmHg and resting heart rate was 62 beats/min. Particularly, there were no 
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obvious myopathy, muscle atrophy, myalgia or obvious musculoskeletal 
deformities. 
His percentage body fat was 21.2%, V02max 49.3 ml 02/kg/min, maximum 
heart rate 209 beats/min and maximum quadriceps force output 467 N. 
Routine blood testing revealed a normal ESR, blood glucose, haemoglobin, 
white cell count and thyroid function. Liver function tests were normal. 
Creatine kinase was within normal limits (109 U/L). 
Brucella, HIV, Coxsackie and Bilharzia viral screening were all negative. EBV 
capsid IgG and nuclear IgG were positive, while EBV capsid IgM and early 
antigen antibody were negative, indicating a past EBV infection with no 
evidence of reactivation. CMV IgG was positive while IgM was negative, 
indicating a previous CMV infection. 
Vastus lateralis muscle biopsy showed that subject #6 had 31 % type I fibres, 
49% type IIA fibres, 18% type liB fibres and 2% type IIC fibres. H&E stain 
showed that muscle fibres were within the normal range for the degree of 
variation in muscle fibre size. There was no inflammation, necrosis or 
regeneration of muscle fibres. Internal nuclei were present, but not to 
abnormal levels. 
NADH stain revealed some subsarcolemmal aggregates of mitochondria. The 
staining pattern of the mitochondria within the cells appeared normal, with 
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type I fibres being hatched and type II fibres being linear. However, areas of 
staining were present in the centers of some of the muscle fibres, which may 
have been caused by degeneration of myofibrils. 
SOH stain revealed peripheral accumulation of mitochondria within the cells. 
A large amount of lipofuscin (wear and tear) pigmentation was present, which 
is representative of lysosomal degradation. 
Electron microscopy revealed numerous areas of degeneration filled with 
glycogen, lipid deposits and enlarged mitochondria greater than one 
sarcomere in length. In these areas, focal deletions of z bands were present. 
The subsarcolemmal aggregations were filled with glycogen and 
mitochondria. 
Summary 
Subject #6 was a social runner with abnormal fatigue symptoms, muscle pain 
localized to his quadriceps, and muscle damage associated with FAMS. 
Contributing factors could have been the evidence of previous CMV and EBV 
infections. 
Case Report 7 
Subject #7 was a 52 year old male club level runner who presented with 
excessive fatigue, "tiredness" in his legs and excessive sweating and 
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exhaustion in the latter stages of long distances races. He had run socially for 
several years up until age 44, and ran competitively from age 45. He had run 
6 Comrades 90 km marathons, and a number of21.1 km and 42.1 km 
marathons since then. He raced frequently during the period before the onset 
of his symptoms, running 12 42.2 km marathons in the year prior to his 
deterioration in performance. 
The symptoms began approximately a year prior to him being tested in our 
Unit. He noticed that after a "bad cold" he suffered excessive symptoms of 
fatigue in his subsequent two races. In his following race he noted that he 
suffered from exhaustion, "tiredness in the legs" and excessive sweating 
which he felt was associated with the other symptoms. He was forced to walk 
for the last few kilQmeters of these marathons due to the excessive fatigue, 
which was completely abnormal for him. 
He consulted a Sports Medicine Specialist Practitioner, and was diagnosed as 
having exercise induced asthma, and managed conservatively. The 
symptoms did not improve, and in the months following, he found he was 
unable to train without development of the symptoms. He consulted a 
neurologist and chest specialist, and had a surgical operation to correct a 
"deviated nasal septum," none of which improved his symptoms. At the time 
of testing, all running was difficult, and he had excessive fatigue, particularly 
when running uphill. 
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Prior to the onset of ~Iis symptoms, as described above, he had a severe 
chest infection and flu-like symptoms. At age 47, he had a back injury wrlich 
required hospitalization, but was treated and improved by conservative 
physiotherapy treatment. He was not sure of the exact diagnosi s of his back 
problem. At age 47, he also suffered an Achilles tendon injury, and at age 49 
a calf injury, both treated conservatively with physiotherapy. At age 50 he 
suffered a severe episode of kidney stone related problems, for which he was 
also hospitalized and managed conservatively. 
Apart from these injuries and illnesses, he had no other contributing medical, 
surgical or psychological history or factors related to his problem. 
His Beck psychological score was 1. This score is within the normal range 
and indicates no clinical depression. 
Prior to and after his deterioration in performance, he trained 5 days/week, an 
average of 45 km/week. Prior to his deterioration in performance, he trained at 
an average speed of 12 km/hour. After his deterioration in performance, he 
trained at an average speed of 11 km/hour. Prior to his deterioration in 
performance, his best 5 km time trial time was 21 :00 min, and this decreased 
to 29:00 min at the time of testing. His best 21.1 km race times (Figure 
3.B.20), 42.2 km race times (Figure 3.B.21) and yearly training distances 
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Figure 3. B.20. Subject #7's 21.1 km race times. Onset of symptoms was at 
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Figure 3.B.21. Subject #7's 42.2 km race times. Onset of symptoms was at 
age 51 (dashed vertical line). He was tested in our Unit at age 52 (solid 
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Figure 3.B.22. Subject #7's yearly training distances (km/year). Onset of 
symptoms was at age 51 (dashed vertical line). He was tested in our Unit at 
age 52 (solid vertical line). 
Medical examinationrevealed that he had the facial appearance of a chronic 
rhinitis sufferer. He had a line tremor in his upper limb peripheries, which he 
felt had been present since childhood. He had a 5 cm scar in the epigastric 
region of his abdomen, which was caused by an operation to repair pyloric 
stenosis in his first year of life. There were no complications related to this 
operation or problem. Blood pressure was 140/80 mmHg and resting heart 
rate 60 beats/min. Particularly, there were no obvious myopathy, muscle 
atrophy, myalgia or obvious musculoskeletal abnormalities. 
His height was 187 cm, mass 85.0 kg, percentage body fat 27.2%, V02max 
47.4 mI02/kg/min, maximum heart rate 175 beats/min and maximum 
quadriceps force output 624 N. 
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Routine blood testing revealed normal ESR, blood glucose, haemoglobin, 
white cell count, iron studies and thyroid function. Liver function tests were 
normal. Creatine kinase was within normal limits (160 U/L). 
Brucella, HIV, Coxsackie, Bilharzia, CMV and Infectious Mononucleosis 
screening were all negative. EBV capsid IgG and nuclear IgG were positive, 
while EBV capsid IgM and early antigen antibody were negative, indicating a 
past EBV infection with no evidence of reactivation. 
Vastus lateralis muscle biopsy showed that subject #7 had 61 % type I fibres, 
36% type IIA fibres, 0% type liB fibres and 3% type IIC fibres. H&E stain 
showed that there was a degree of variation in muscle fibre size that was not 
within the normal range. Fibre atrophy was present. Abundant internal nuclei 
were present, with fibres splitting and nuclear clumping, which are indicative 
of necrosis or regeneration of muscle fibres. Necrotic fibres were present 
together with phagocyte cells. There was no obvious inflammation present. 
NAOH stain showed abnormal subsarcolernmal aggregates of the enzyme 
around the periphery of the cells, which were abnormal even for an athlete. 
The staining pattern of the mitochondria appeared to be abnormal. The fibres 
appeared to be "moth eaten." Type II fibre atrophy was present. 
SOH stain showed peripheral accumulation of mitochondria within the cells. 
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Electron microscopy showed mild focal myofibrillar loss with local 
enlargement of mitochondria. A small increase in lipid vacuoles were present. 
No large subsarcolemmal mitochondrial accumulation or reserve cells were 
present. 
Summary 
Subject #7 was a club level runner with a previous history of completion of a 
number of marathons and ultramarathons, abnormal fatigue and muscle 
damage associated with FAMS. Contributing factors may have been a history 
of allergiC rhinitis and other nasal problems, several orthopaedic problems to 
his back and lower limbs, and the evidence of previous EBV infection, which 
may indicate the presence of a chronic undiagnosed viral infection. 
Case Report 8 
Subject #8 was a 48 year old male club level runner who presented with 
excessive fatigue and "weakness" in the lower limb muscles associated with 
exercise. He played soccer and ran socially until age 39, and took up running 
competitively at age 40, completing a number of 42.2 km and 21.1 km 
marathons in the following 3 years. 
During a 42.2 km marathon run at age 42, he developed muscle cramps and 
chest pains, which caused him to abandon the race. An ECG performed by a 
physician revealed no abnormalities, and he was advised to rest. When he 
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returned to running training and racing, he found he fatigued abnormally 
quickly, and developed cold and "flu-like" symptoms if he tried to push through 
the fatigue during training. 
At age 42, he visited a psychiatrist for depression related to his chronic 
symptoms, and was diagnosed as having chronic fatigue syndrome, and 
treated with Prozac®. He has been on Prozac® for the last 7 years, and if he 
discontinued the drug, he felt the symptoms were exacerbated and were 
present even at rest. He has not been able to train at all for any continuous 
period for the last 7 years. 
At age 40 he was diagnosed as having early degeneration of the lumbar disc 
region of his spine and was managed conservatively. At age 45, he was 
diagnosed as having a hiatus hernia, which was treated surgically. At age 46, 
he was diagnosed as having adult onset diabetes, and treated for this with 
Diamicron® (Gliclazide). His diabetes was apparently well controlled. Apart 
from these illnesses, there were no other major contributing medical, surgical, 
or psychological history or factors relating to his problem. 
His Beck psychological score was 11. T~lis indicates that he was suffering 
from a mild clinical depression. It must be noted that he was on Prozac® when 
performing this test, which may have misled the true extent of his depression 
score. 
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Prior to his deterioration in performance, he trained 4 days/week, and an 
average distance of 50 km/week. After his deterioration in performance, he 
was not able to train with any continuity at all. His best 5km time was 21 :58 
min, his best 21.1 km marathon time was 1 h:43 min, and his best 42.2 km 
marathon time was 4 h: 52 min. His yearly training distances (Figure 3.B.23.) 
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Figure 3.B.23. Subject #8's yearly training distances (km/year). Onset of 
symptoms was at age 42 (dashed vertical line). He was tested in our Unit at 
age 48 (solid vertical line). 
Medical examination revealed no general abnormalities. His blood pressure 
was 130/90 mmHg and his resting heart rate 60 beats/min. There was visible 
muscle atrophy of his quadriceps muscles and the upper section of his lower 
limbs bilatera"y. Apart from this, there were no clinical myalgia or 
musculoskeletal deformities. 
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His height was 179.5 cm, mass 103.3 kg, percentage body fat 30.7%, 
V02max 31.1 ml 02/kg/min, maximum heart rate 167 beats/min and maximum 
quadriceps force output 603 N. 
Routine blood testing revealed normal ESR, blood glucose (4.8 mmol/L), 
haemoglobin, and white cell count. Liver function tests were normal. Creatine 
kinase levels were abnormally raised (1012 U/L). 
Bilharzia, HIV and Coxsackie screening were all negative. EBV capsid IgG 
and nuclear IgG were positive, while EBV capsid IgM and early antigen 
antibody were negative, indicating a past EBV infection with no evidence of 
reactivation. CMVlgG was-positive while IgM was negative,indicating a 
.... previous CMV infection. , . . k: .~ 
Vastus lateralis muscle biopsy showed that subject #8 had 41 % type I fibres, 
58% type IIA fibres, 1 % type liB fibres and 0% type IIC fibres. H&E stain 
showed an abundance of dead and necrotic fibres. Internal nuclei were 
present together with nuclear knots, proliferation and fibre splitting, all 
indicative of a degenerative process. Severe fibre atrophy, with pathological 
necrosis of the muscle fibres, were present. 
NADH stain showed the presence of a small quantity of subsarcolemmal 
mitochondria. The staining pattern of the mitochondria appeared to be 
abnormal. Fibres had a "moth eaten" appearance. 
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SOH stain showed a peripheral accumulation of mitochondria within the cells. 
Electron microscopy showed a mild increase in lipid accumulation, and 
mitochondria with normal morphology with no obvious pathological 
subsarcolemmal aggregation. 
Summary 
Subject #8 was a club level runner with a previous history of successful 
completion of marathons, who after a short competitive career developed 
abnormal fatigue, "flu-like" symptoms and muscle damage associated with 
FAMS. Contributing factors could be the history of psychological problems for 
. which:.he was currently being treated with Prozac~, his diabetes for which he. 
was currently-being treated with Oiamicron@,'and the evidence of previous 
CMVand EBV infections. His abnormal creatine kinase and visible quadriceps 
muscle atrophy suggested that the pathological muscle changes were 
ongoing. 
Case Report 9 
Subject #9 was a 42 year old male provincial runner and cyclist who 
presented with excessive fatigue during exercise and at rest, to a level which 
impaired his daily lifestyle and capacity to work. He had run competitively at 
school and university, winning provincial titles. In his 20's he ran competitively 
at marathon and ultra-marathon distances. His best 42.2 marathon time was 
-".'" .: 
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2h: 26 min, and best 56 km marathon 3h: 56 min. He trained approximately 
80-100 km/week during this period. 
At age 31 he stopped running for 7 years due to business demands, and 
walked 6 km/day. At age 38 he began cycling socially, and age 39 started 
racing competitively in cycling and supplemented this training with swimming 
and gym training. He trained approximately 40 km/day at a cycling speed of 
29-35 krn/h. He completed the Argus 104 km cycle tour in 3h: 29 min at age 
40, and competed in several other cycling tours. 
L·: At age 41 he noticed during a swimming -session that he had abnormal 
,. fatigue; He went to a general practitioner 'afterthis excessive fatigue 
'.; continued for some time and was given vitamins and gamma.;.globulin. He 
continued training, but symptoms did not improve until eventually after a short 
walk he felt abnormally fatigued and was bedridden due to this "exhaustion" 
for 10 days. The fatigue symptoms were subsequently present at rest, and 
soon his entire work and social life was affected by the fatigue symptoms. 
He was diagnosed with chronic fatigue symptom and depression. He was 
treated with a variety of homeopathic and dietary remedies without success. 
His symptoms remained present up until he was seen on our Unit age 42. 
Other symptoms included 15 kg of weight loss, muscle cramps during routine 
activity particularly in the calves, quadriceps and triceps, headaches, chest 
pains and episodes of anxiety attacks. He also had episodes of diarrhoea. It 
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was not clear if the diarrhoea was related to the other symptoms or was 
caused by changes to his eating habits after the diagnosis of his condition as 
chronic fatigue syndrome. 
Prior to the onset of his symptoms, at age 27 he had symptoms caused by 
biomechanical problems in his lower limbs, including hamstring tears and 
heel/arch pain. He attributed these symptoms to his running and was treated 
conservatively. He reported that he had 2 episodes of overtraining at age 30 
while running and age 40 while cycling training, although these were not 
diagnosed by a physician. He was diagnosed with clinical depression at ~ge 
38, 41 and 42. He was treated conservatively for the first two episodes, and, 
with Eglynol® (Sulpiride) for the third episode. At age 40 he had an episode of 
glandular fever which, was managed with B-complex injections 'and ;.~; 
multivitamins. At age 42 he had an episode of bronchitis which was treated 
with homeopathic "vapors," injections and physiotherapy. 
His Beck psychological score was 11. This indicates that he was suffering 
from a mild clinical depression at the time of testing. 
Prior to his deterioration in performance, he cycled 7 days/week, an average 
distance of 280-300 kmlweek, at a cycling speed of 28-35 km/h. After his 
deterioration in performance he trained with no continuity, an average 
distance of 14 km/week at a cycling speed of 5-6 km/h. 
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Medical examination revealed no general abnormalities, and no symptoms of 
current viral infection or major symptoms diagnostic of chronic fatigue 
syndrome. His blood pressure was 130/82 mmHg and his resting pulse rate 
was 83 beats/min. There was visible atrophy of his quadriceps muscles, and 
his muscles generally had decreased tone. Apart from this, he had no clinical 
myalgia or musculoskeletal deformities. 
His percentage body fat was 16.6%, V02max 46.8 ml 02/kg/min, maximum 
heart rate 179 beats/min, and maximum force output 739 N. 
Vastus lateralis muscle biopsy showed that subject #9 had 43% type I fibres, 
38% type IIA fibres, 19% type liB fibres and 0% type lie fibres. H&E stain 
showed a degree of variation in muscle fibre size that w~swithinnormal 
limits. There was no inflammation, necrosis or regeneration of muscle fibres; 
NADH stain showed abnormal subsarcolemmal aggregates of the enzyme 
around the periphery of the cells which were abnormal even for an athlete, 
mainly in the type I fibres. The staining pattern of the mitochondria appeared 
to be abnormal. The type II fibres appeared to be "moth eaten, n with areas of 
no staining. 
SDH stain showed a peripheral accumulation of mitochondria within the cells. 
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Electron microscopy showed evidence of myofibrillar degeneration, some 
areas of abnormal subsarcolemmal mitochondrial aggregations and abnormal 
lipid and glycogen accumulations in the muscle fibres. 
Summary 
Subject #9 was a provincial level marathon runner and cyclist, who developed 
abnormal fatigue and muscle damage associated with FAMS. Contributing 
factors could be a history of psychological problems, including three episodes 
of depression, and the two periods of overtraining earlier in his career. The 
weight loss and episodes of diarrhoea were probably relatedto the change in 
diet and homeopathic remedies he has use.d in the last year. 
Case Report 10 
Subject #10 was a 48 year old male club level runner who presented with 
excessive fatigue and "no power" in the legs during marathon running for the 
previous 4 years, and his performance during these events had decreased in 
the last year. He had run and played squash socially until age 39, and started 
competing from age 40. He had 5 years of optimal performance, although 
eventually competing in 8 Comrades 90 km marathons and a number of 21.1 
and 42.2 km marathons. 
At age 44 he got a viral infection, and when he began training after the acute 
phase of this illness he found he had difficulty running, with marked 
189 
exhaustion and weak leg muscles. In the next three years he improved but 
had intermittent episodes of this muscle weakness and fatigue symptoms. At 
age 47, a year before being examined at our Unit, he attempted a 21.1 km 
marathon and did not finish, and had the symptoms continuously since this 
race. The symptoms did not occur at rest or during slow jogging, but occurred 
when he increased his running pace or attempted to race. The symptoms 
were worse when running downhill rather than uphill. He also described that in 
the last year before testing he "overheated" during intense running, with no 
change in his sweat rate. 
At age 45, he suffered marital-related problems, which were ongoing and ,; 
which he described as being extremely,stressful. Apart from this psychological 
stress, he had no other contributing medical or surgical history or .factors 
related to his problem. 
His Beck psychological score was 15. This indicates that he was suffering 
from a mild clinical depression. 
Prior to his deterioration in performance, he trained 6 days/week, an average 
distance of 80 km/week, at a training speed of 12 km/hr. After his deterioration 
in performance, he trained 6 days/week, an average distance of 30 km/hr, at a 
training speed of 10 krn/hr. His best 5 km time trial prior to his deterioration in 
performance was 28:00 min, and this decreased to 33:00 min after his 
deterioration in performance. His best 21.1 km race times (Figure 3.B.24.), 90 
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km race times (Figure 3.8.25.) and yearly training distances (Figure 3.8.26.) 
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Figure 3.8.24. Subject #10's 21.1 km race times. Onset of s.ymptomswas at 
age 44 (dashed vertical line). He was tested in our Unit at age 48 (solid 
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Figure 3.8.25. Subject #1 D's 90 km race times. Onset of symptoms was at 
age 44 (dashed vertical line). He was tested in our Unit at age 48 (solid 
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Figure 3.8.26. Subject #1 O's yearly training distances (km/year). Onset of 
symptoms occurred at age 44 (dashed vertical line). He was tested in our Unit 
at age,48 (solid vertical line) . 
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Medical examination revealed no general abnormalities. His blood pressure 
was 140/80 mmHg and his resting pulse rate was 66 beats/min. There was 
",." ~..... " , ..... . . , -, '." ....... ~~~ 
mild myalgia localized to his calf muscles. There was no obvious myopathy, 
muscle atrophy, or obvious musculoskeletal abnormalities. 
His weight was 81 kg, percentage body fat 21.5%, V02max was 48.3 ml 
02/kg/min, maximum heart rate was 201 beats/min and maximum quadriceps 
force output 629 N. 
Routine blood testing revealed normal ESR, blood glucose, haemoglobin, 
white cell count and thyroid function. Serum creatine kinase was within normal 
limits (75 U/L). 
Coxsackie virus screening was negative. EBV capsid IgG and nuclear IgG 
were positive, while EBV capsid IgM and early antigen antibody were 
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negative, indicating a past EBV infection with no evidence of reactivation. 
CMV IgG was positive while IgM was negative, indicating a previous CMV 
infection. 
Vastus lateralis muscle biopsy showed that subject #10 had 42% type I fibres, 
32% type IIA fibres, 25% type liB fibres, and 1 % type IIC fibres. H&E stain 
showed that there was a degree of variation in muscle fibre size that was 
within the normal range. More than 3% internal nuclei were present. There 
was no inflammation, necrosis or regeneration of muscle fibres. 
NAOH stain showed abnormal subsarcolemmal aggregates of mitochondria •. 
around the periphery of the cells, particularly in the type I fibres, to a level that . 
was abnormal even for an athlete. The staining pattern of the mitochondria-
appeared to be abnormal. The type II fibres appeared to be "moth eaten" with 
areas of no staining. 
SOH staining revealed a peripheral accumulation of enlarged mitochondria 
within the cells. 
Electron microscopy showed the presence of myofibrillar degeneration and 
abnormal subsarcolemmal mitochondrial aggregations. There were abnormal 
lipid and glycogen accumulations and z disc streaming in the muscle fibres. 
Summary 
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Subject #10 was a club level athlete with a history of completing marathons 
and ultramarathons, abnormal fatigue symptoms particularly when racing and 
running downhill, and muscle damage associated with FAMS. Contributing 
factors may be his history of social stresses, and evidence of a previously 
undiagnosed EBV infection. 
Case Report #11 
Subject #11 was a 42 year old male club level cyclist who presented with 
excessive fatigue, and "lack of strength" in the lower limbs during exercise. 
These symptoms had been present for the previous 3 years. He had run cross 
country events at provincial level at school and during his army service, and in 
his late twenties and early thirties had been involved with competitive 
bodybuilding. He started cycling at age 31 and enjoyed 8 years of successful 
cycling, training 500 km/week and racing a number of endurance cycle events 
during this period. 
At age 39 he was injured after colliding with a car while training, and after a 
short period of rest attempted to train with the injury. After this he noted that 
he had excessive fatigue during his routine training activities, and that his 
lower limb muscles lost power. He also noted muscle aches and postural 
hypotension occurred occasionally even at rest. A blood test revealed that he 
had an active Coxsackie virus and he was told to rest by a general 
practitioner. After he resumed training, he found that his symptoms had 
worsened, and a sports medicine specialist diagnosed him as suffering from 
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chronic fatigue syndrome, and he was treated with homeopathic remedies 
and dietary intervention. When this treatment did not cause any improvement, 
a different general practitioner diagnosed him as suffering from major 
depression, and treated him with Prozac® for 10 days, also without success. 
His symptoms of excessive fatigue and lower limb weakness persisted up 
until the visit to our Unit, and the only sport he was able to perform was 
occasional social swimming. 
At age 26, he suffered an episode of active EBV associated glandular fever. 
At age 37, he was diagnosed as being overtrained due to excessive cycling 
by a sports medicine specialist, and treated this with. a short period of rest. He 
felt he did not rest enough and "pushed through" these symptoms against the 
advice' of-his doctor. Apart from these illnesses; he had no other contributing 
medical or surgical history or factors related to his problem. 
His Beck psychological score was 25. This indicates that he was suffering 
from a moderate-severe clinical depression.' ,'" 
Prior to the deterioration in his performance, he trqined 6-7 days/week, an 
average distance of 500 km/week, at a training speed of 30 km/h. After his 
deterioration in performance, he was not able to cycle to any degree due to 
his symptoms. He swam socially to maintain fitness after his deterioration in 
performance. 
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Medical examination revealed no abnormalities. His blood pressure was 
110/70 mrnHg and his resting pulse rate 68 beats/min. Particularly, there were 
no obvious myopathy, muscle atrophy, myalgia or obvious musculoskeletal 
deformities. 
His height was 176 cm, mass 73 kg, percentage body fat 13.3 kg, V02max 
55.9 ml 02/kg/min, maximum heart rate was 183 beats/min and maximum 
quadriceps force output 577 N. 
, . Routine blood testing revealed normal ESR, haemoglobin, white cell count, 
'" blood glucose and thyroid function. Liver function tests were normal. 
" 
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Bilharzia, toxoplasma and CMV screening were all negative. EBV capsid IgG ' 1 
and nuclear IgG were positive, while EBV capsid IgM and early antigen' 
antibody were negative, indicating a past EBV infection with no evidence of 
reactivation. Coxsackie B3 screen was raised, indicating either a recent or 
chronic infection. 
Vastus lateralis muscle biopsy showed that subject #11 had 59% type I fibres, 
41 % type IIA fibres, 0% type liB fibres, and 0% type IIC fibres. H&E stain 
revealed a degree in variation in fibre size which was not within normal limits. 
There was both fibre atrophy and hypertrophy. More than 3% internal nuclei 
were present. There was nuclear clumping and proliferation, indicative of fibre 
degeneration. 
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NAOH stain showed abnormal subsarcolemmal aggregates of mitochondria, 
to levels which were abnormal even for an athlete, mainly in type I fibres. The 
staining pattern of the mitochondria within the cells appeared to be abnormal. 
The type II fibres appeared to be "moth eaten," with areas of no staining and 
areas of fibre clumping and grouping. 
SOH staining showed a peripheral accumulation of enlarged mitochondria 
within the cells . 
. . Electron microscopy showed z-disc streaming indicative of muscle dam~ge. . ; . 
. There was also myofibrillar degeneration and increased glycogen and lipid 
:.' deposition. Extensive sub-sarcolemmal mjtochondrial accumulations were 
··i ')visible,and the mitochondria appeared normal. . 
" ~-
Summary 
Subject #11 was a club level cyclist with a previous history of high volume 
training and racing, abnormal fatigue symptoms and reduced capacity for 
exercise,and muscle damage associated with FAMS. Contributing factors 
may have been the clinical depression, previous episode of EBV infection and 
recurrent episodes of Coxsackie virus infections. 
Case Report 12 
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Subject #12 was a 34 year old international level rower who presented with 
excessive fatigue and muscle weakness associated with exercise. He 
represented his country at the Olympic Games at-Atlanta, and his rowing 
team made it to the semi-finals. He won numerous national and international 
events in a 20 year career which began at age 14. 
At age 27, he began training more than 1 hour/day, 7 days/week, and 
continued this level of intensity even after being diagnosed as being 
overtrained on several occasions in the 7 years prior to him being tested. A 
year before presenting to the Unit, age 33, he developed ''flu-like'' symptoms. 
He trained through these symptoms, and developed symptoms of excessive 
fatigue and weakness in his active muscles. A physician diagnosed this as 
myocarditision.the basis of an abnormal ECG: However, repeat ECG's 
normalized in the presence of the symptoms, 'indicating that this diagnosis 
was incorrect. 
He attempted to return to training at his usual level of intensity, but the 
symptoms of excessive fatigue remained, and he felt as if he had "no petrol in 
the engine." These symptoms were ongoing at the time of his visit to our Unit 
age 34. 
From age 28-31 he suffered intermittently from lower back spasms, which 
were treated conservatively. From age 29 he has followed a high 
carbohydrate, low fat diet, which he perceived to be difficult to adhere to and 
may have impacted negatively on his physical status, although it allowed him 
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to maintain his weight at the level required for his("Jowing discipline. There 
were no other contributing medical, surgical or psychological factors related to 
his problem. 
His Beck psychological score was 8. This score is within the normal range 
and indicates no clinical depression. 
Prior to his deterioration in performance, he trained 7 days/week, 15 
hours/week, at an average pace of 2:25 min/500 m. After his deterioration in 
performance, he trained 6 days/week, 7.5 hours/week, at an average pace of 
2:35 min/500 m. His best times for 2000m rowing time trials are described 
,..p'~ 
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Figure 3.B.27. Subject #12's rowing times for a 2000m trial time. Onset of 
symptoms was at age 33.5 years (dashed vertical line). He was tested in our 
Unit at age 34.5 years (solid vertical line). -
Medical examination revealed no abnormalities. His blood pressure was 
125/85 mmHg, and resting heart rate 64 beats/min. Particularly, there were no 
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obvious myopathy, muscle atrophy, myalgia or obvious musculoskeletal 
deformities. 
His height was 184 cm, mass 80.5 kg, percentage body fat 20.7%, maximum 
heart rate 194 beats/min and maximum quadriceps force output 818 N. 
Routine blood tests revealed normal haemoglobin and white cell count. 
EBV nuclear IgG was positive, while EBV capsid IgM, capsid IgG and early 
antigen antibody were negative, indicating a past EBV infection with no 
evidence of reactivation. 
Vastus lateralis muscle biopsy showed that subject #12 had 83% type I fibres, 
17% type IIA fibres, 0% type liB fibres and 0% type lie 'fibres. H&E stain 
showed that there was a degree of variation in muscle fibre size that was not 
within the normal range. There was both fibre atrophy and hypertrophy, as 
well as more than 3% internal nuclei. There was also nuclear clumping and 
nuclear proliferation, indicative of fibre degeneration. 
NADH stain showed abnormal subsarcolemmal aggregates of the enzyme 
around the periphery of the type I fibres, to a level that was abnormal even for 
athletes. The staining pattern within the cells appeared to be abnormal. The 
type II fibres appeared to be "moth eaten," with areas of no staining. Areas of 
fibre clumping and grouping were present. 
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SDH stain showed a peripheral accumulation of mitochondria within the cells, 
indicative of enlarged mitochondria. 
Summary 
Subject #12 was an international rower with a history of competition at 
Olympic level, who developed symptoms of excessive fatigue, muscle 
weakness and muscle damage associated with FAMS. Contributing 
symptoms could have been the history of dietary manipulation, training 
through a period of illness, and evidence of previous EBV infections. 
Case Report 13 
Subject #13 was a 32 year old female club level runner who presented with 
excessive fatigue and decreased performance capacity. She had run 
competitively for 10 years, completing 10 Comrades 90 km marathons, 80-
100 42.2 km running marathons, and numerous canoeing and cycling 
endurance events between ages 20 and 30. 
At age 31, she developed "fl~-like" symptoms after a canoe marathon, but 
trained through the symptoms. Six days after the canoe marathon, she 
competed in a 42.2 km running marathon and did not complete the race, with 
symptoms of excessive fatigue, muscle weakness and chest pains. 
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She continued training and racing with similar symptoms, until a general 
practitioner diagnosed her as having EBV related glandular fever after 
performing blood tests. After resting for several months she began training 
again, but with no improvement in symptoms or performance, until she was 
tested in our Unit age 32. 
During her 10 year running career, she had numerous bouts of colds and 
influenza, but trained through these illnesses. At age 24 she was diagnosed 
as having iliotibial band syndrome, at age 27 runners knee, and at age 30 
Achilles tendonitis, all of which were treated conservatively with 
physiotherapy. At age 31 she changed work to become self-employed, and 
felt the related stress had impacted negatively on her symptoms. Apart from 
these illnesses, she had no other contributing medical, surgical or 
psychological history or factors related to her problems. 
Her Beck psychological score was 16. This indicates that she was suffering 
from a mild-moderate depression. 
Prior to her deterioration in performance, she trained 5-6 days/week, an 
average distance of 55 km/week, at a training speed of 10.5 km/h. After her 
deterioration in performance, she trained 4-5 days/week, an average distance 
of 20 kmlweek, at a training speed of 8 km/h. Prior to her deterioration in 
performance, her best 5 km time trial time was 24 min. After her deterioration 
in performance, her best 5 km time trial time was 30 min. Her best 42.2 km 
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race times (Figure 3.B.28.), 90 km race times (Figure 3.B.29.) and yearly 
training distances (Figure 3.B.30.) are described in the figures below. 
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Figure 3.B.28. Subject #13's 42.2 km race times. Onset of symptoms was at 
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Figure 3.B.29. Subject #13's 90 km race times. Onset of symptoms was at 
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Figure 3. B.30. Subject #13's yearly training distances (km/year). Onset of 
symptoms was at age 31 (dashed vertical line). She was tested in our Unit at 
age 32 (solid vertical line). 
Medical examination revealed no abnormalities. Blood pressure was 113/65 
mmHg and resting heart rate 64 beats/min. Particularly, there were no 
obvious myopathy, muscle atrophy, myalgia or obvious musculoskeletal 
deformities. 
Her height was 153 cm, mass 51 kg, percentage body fat 25.6%, V02max 49 
ml 02/kg/min, maximum heart rate 187 beats/min, and maximum quadriceps 
fore output 370 N. 
EBV capsid IgG and nuclear IgG were positive, while EBV capsid IgM and 
early antigen antibody were negative, indicating a past EBV infection with no 
evidence of reactivation. 
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Vastus lateralis muscle biopsy showed that subject #13 had 76% type I fibres, 
23% type IIA fibres, 1% type liB fibres, and 0% type IIC fibres. H&E stained 
sl10wed there to be minor variation in muscle fibre size. There was no 
evidence of inflammation, necrosis or regeneration of muscle fibres. There 
was evidence of "cracking" within'the fibres which may have been caused by 
glycogen accumulation or artefact. 
NAOH stain showed significant subsarcolemmal aggregations of mitochondria 
around the periphery of the cells. The staining pattern of the mitochondria 
within the cells appeared to be normal. 
SOH showed a peripheral accumulation of mitochondria within the cells. 
Summary 
Subject #13 was a female club level runner with a history of successful 
completion of a number of marathons and ultramarathons, abnormal fatigue 
symptoms, reduced capacity for exercise and muscle damage associated with 
FAMS. Contributing factors could be the evidence of moderate depression, 
stressful lifestyle, inability to rest adequately when ill, and a previous history of 
EBV infection. 
Case Report #14 
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Subject #14 was a 43 year old male club level runner and triathlete who 
presented with symptoms of excessive fatigue, lower limb muscle weakness 
and decreased performance during training and racing for the last 7 years. He 
trained and raced competitively in a number of 42.1 km and 21. 1 km running 
marathons, and a number of "ultra" distance and standard triathlons, in the 10 
years prior to the onset of his symptoms. 
At age 37, he developed excessive fatigue, lower limb muscle weakness and 
decreased performance capacity in an "ultra" distance triathlon and had 
difficulty completing the race. He rested after this event, but subsequently the 
symptoms of excessive fatigue and lower limb muscle weakness developed in 
both training and racing events. He attempted to rest for long periods, and 
then return to active training, but the symptoms recurred whenever he 
attempted any serious training. This pattern continued up until his visit to our 
unit age 43. 
At age 32, he had an episode of plantar fasciitis, which was treated 
conservatively with orthotics and rest. At age 35, he had a severe episode of 
influenza before competing in an "ultra" distance triathlon. He completed this. 
race in an unfit state, and he felt this episode may have contributed to his 
symptoms, although he was to train and race for two years up until the 
development of his symptoms two years later. Apart from these problems, he 
had no contributing medical, surgical or psychological history of factors 
related to his problem. 
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His Beck psychological score was 5. This score is within normal range and 
indicates no clinical depression. 
Prior to his deterioration in performance, he trained 6 days/week, an average 
distance of 60 km/week, at a training speed of 12 km/h. After his deterioration 
in performance, he trained 1 day/week, an average distance of 10 km/h, at a 
training speed of 6 km/h. Prior to his deterioration in performance, his best 5 
km time trial time was 17:50 min. After his deterioration in performance, he 
was not able to race at any intensity. His best 21.1 km race times (Figure 









Figure 3.B.31. Subject #14's 21.1 km race times. Onset of symptoms was at 
age 37 (dashed vertical line). He was tested in our Unit at age 43 (solid 
















Figure 3. B.32. Subject #13's yearly training distances (km/year). Onset of 
symptoms was at age 37 (dashed vertical line). He was tested in our Unit at 
age 43 (solid vertical line). 
Medical examination revealed no abnormalities, except a degree of peripheral 
oedema in both lower limbs. Blood pressure was 120/75 mm Hg, and resting 
heart rate 52 beats/min. Particularly, there was no obvious myopathy, muscle 
atrophy, myalgia or obvious musculoskeletal deformities. 
His height was 185 cm, weight 92 kg, percentage body fat 19.2%, V02max 39 
ml 02/kg/min, maximum heart rate 175 beats/min and maximum quadriceps 
force output 640 N. 
Routine blood testing revealed normal ESR, blood glucose, haemoglobin, 
white cell count and thyroid function. Creatine kinase was within normal limits 
(109 U/L). 
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Coxsackie virus screening was negative. EBV capsid IgG and nuclear IgG 
were positive, while EBV capsid IgM and early antigen antibodies were 
negative, indicating a past EBV infection with no evidence of reactivation. 
Vastus lateralis muscle biopsy showed that subject #14 had 25% type I fibres, 
74% type IIA fibres, 0% type liB fibres and 0% type IIC fibres. H&E stain 
revealed a degree of variation in fibre size which was not within normal limits. 
There was no obviolJs inflammation, necrosis, regeneration or internal nuclei. 
NADH staining showed abnormal subsarcolemmal aggregates of 
mitochondria around the periphery of the cell, to levels which were abnormal 
even for an athlete. The staining pattern of the mitochondria appeared 
abnormal. 
Summary 
Subject #14 was a club level runner and triathlete with a previous history of 
completing a number of marathons and ultramarathons, abnormal fatigue 
symptoms, muscle weakness, reduced exercise capacity and muscle damage 
associated with FAMS. Contributing factors may have included a previously 
undiagnosed EBV infection. 
Case Report #15 
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Subject #15 was a 57 year old female national veteran level run ner who 
presented with excessive fatigue, muscle weakness and decreased 
performance capacity. She was a social tennis player and runner until age 39, 
when she started running competitively. She competed in cross country, track, 
and 42.2 km marathon running for 18 years. In this time she competed a 
number of times at national veteran running championships, setting age 
records in 5 km and 10 km events. 
At age 55, she suffered a lower back strain after a fall when running, and 
rested for 3 weeks until the injury was healed. When she resumed running, 
she trained hard and developed an "influenza type" illness, which 
necessitated a further 3 week rest. On return to training and racing, during a 
21 km training run she noticed excessive fatigue symptoms and "heavy legs." 
From this time point until being tested in our Unit age 57, she had similar 
symptoms when running, particularly when running uphill. A general 
practitioner found no medical abnormalities, and an exercise physiologist 
suggested that she may have had an EBV related low grade viral infection, 
but no active treatment was recommended. 
From age 50, she had several episodes of lower back pain and hamstring 
injuries, which were diagnosed by a general practitioner as being caused by 
biomechanical imbalances, and treated conservatively with orthotics and 
physiotherapy. She had a similar short episode of excessive fatigue 
symptoms and "heavy legs" at age 52 which was treated successfully by rest. 
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Apart from these problems, there were no other contributing medical, surgical 
of psychological history or factors related to her problem. 
Her Beck psychological score was 1. This score is within the normal range 
and indicates no clinical depression. 
Prior to her deterioration in performance, she trained 6 days/week, 65 
km/week at an average speed of 12 km/h. After her deterioration in 
performance, she was not able to train at any level. Prior to her deterioration 
in performance, her best 5 km time trial time was 21 min. Her best 21.1 km 
race time (Figure 3.B.33.) and weekly training distances (Figure 3.B.34.) are 
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Figure 23. B.33. Subject #15's 21.1 km race times. Onset of symptoms was at 
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Figure 3. B. 34. Subject #15's weekly training distances (km/week). Onset of 
symptoms was at age 55 (dashed vertical line). She was tested in our Unit at 
age 57 (solid vertical line). 
Medical examination revealed no abnormalities. Her blood pressure 137/76 
mrryHg and resting pulse rate 61 beats/min. Particularly, there was no obvious 
myopathy, muscle atrophy, or obvious musculoskeletal abnormalities. 
Her height was 165 cm, mass 54.5 kg, percentage body fat 24.3%, V02max 
50.8 ml 02/kg/min, maximum heart rate was 172 beats/min and maximum 
quadriceps force output 270 N. 
Routine blood testing revealed normal thyroid function, haemoglobin, white 
cell count and liver function tests. 
EBV capsid IgG, nuclear IgG and early antigen antibody were positive, while 
EBV capsid IgM was negative, indicating a recurrent or current reactivation of 
an EBV infection. CMV IgG was positive while IgM was negative, indicating a 
previous CIVIV infection. 
212 
Vastus lateralis muscle biopsy showed that subject #15 had 67% type I fibres, 
32% type IIA fibres, 0% type liB fibres, and 1 % type IIC fibres. H&E stain 
revealed a degree of variation in fibre size that was not within normal limits. 
There was visible necrosis of several muscle fibres as well as more than 3% 
internal nuclei. 
NADH stain showed abnormal subsarcolemmal aggregations of mitochondria 
around the periphery of the cell, to levels that were abnormal even for an 
athlete. The staining pattern of the mitochondria appeared to be abnormal. 
Summary 
Subject #15 was a national level veteran runner, with a previous completion of 
a number of cross country and marathon events, abnormal fatigue symptoms, 
lower limb muscle weakness particularly when running uphill, reduced 
exercise capacity and muscle damage associated with FAMS. Contributing 
factors may have been an active or recurrent EBV infection, a previously 
undiagnosed CMV infection, and a history of biomechanical running injuries. 
Case Report 16 
Subject #16 was a 43 year old male club level runner who presented with 
syr~lptoms of excessive fatigue, muscle weakness and decreased 
performance before and after training and racing for the last 2 years before 
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being tested in our Unit. He had run socially from age 21 to 32. At age 33 he 
began racing competitively in long marathons up to 56 km in length, and 
completed a number of 21.1 km, 42.2 km and 56 km marathon events 
successfully. 
At age 41, he developed a "cold" 3 weeks before running a 56 km marathon. 
He rested and recovered 1 week before the race, but felt exhausted during 
the race, with excessive fatigue and muscle cramps in the last 12 km of the 
race. He rested for 2 weeks and returned to training. Three months later he 
attempted to race a 42.2 km marathon, but again had symptoms of excessive 
fatigue, muscle cramps, and "weak legs." The symptoms persisted, with 
muscle weakness in the quadriceps muscles and excessive fatigue during 
training sessions. He also found that recovery after training was a problem, 
with muscle weakness and "stiffness" occurring for several days after a 
normal length training run, which prior to the onset of his symptoms would 
have caused no such symptoms. He consulted a sports physician age 42 who 
diagnosed "iron deficiency," but iron supplementation did not improve the 
symptoms. 
Prior to the onset of these symptoms he had no contributing medical, surgical 
or psychological history related to his problem. He reported that he had a 
stressful work life the previous few years due to him doing a part time Masters 
degree in Business Administration, which he felt caused an increase in his 
level of stress. 
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His Beck psychological score was 2. This score is within normal range and 
indicates no clinical depression. 
Prior to his deterioration in running performance, he trained 5 days/week, an 
average distance of 70 km/week, at a training speed of 12 km/h. After his 
deterioration in performance, he was not able to train at any consistent level 
or intensity. Prior to his deterioration in performance, his best 5 km time trial 
time was 21 :30 min. After his deterioration in performance, he was not able to 
race at all. His best 21.1 km race times (Figure 3.B.35.) and average weekly 
training distances (Figure 3.B.36) are described in the figures below. 
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Figure 3.B.35. Subject #16's 21.1 km race times. Onset of symptoms was at 
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Figure 3.B.36. Subject #16's weekly training distances (km/weekly). Onset of 
symptoms was at age 41 (dashed vertical line). He was tested in our Unit at 
age 43 (solid vertical line). 
Medical examination revealed no abnormalities. Blood pressure was 110170 
mmHg, and resting heart rate 61 beats/min. Particularly, there were no 
obvious myopathy, muscle atrophy, myalgia, or obvious musculoskeletal 
abnormalities. 
His height was 177 cm, mass 79.5 kg, percentage body fat 26.1 %, V02max 
39.9 ml 02/kg/min, maximum heart rate 186 beats/min and maximum 
quadriceps force output 643 N. 
Vastus lateralis muscle biopsy showed that subject #16 had 39% type I fibres, 
56% type IIA fibres, 4% type liB fibres, and 1 % type lie fibres. H&E stain 
showed a degree of variation in fibre size that was not within normal limits. 
There was muscle fibre necrosis and more than 3% internal nuclei. 
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NADH stain showed the presence of abnormal subsarcolemmal aggregations 
of mitochondria, to levels that were abnormal even for an athlete. The staining 
pattern of the mitochondria appeared abnormal. 
Summary 
Subject #16 was a club level runner with a history of successful completion of 
a number of marathons, abnormal fatigue symptoms, muscle weakness 
during and after running and muscle damage associated with F AMS. 
Contributing factors may have included the increased social stresses in his life 
around the time of the development of his symptoms. 
Case Report 17 
Subject #17 was a 33 year old male provincial level canoeist and club level 
runner who presented with symptoms of excessive fatigue, muscle pain and 
decreased performance during training and racing in the previous 7 years 
prior to being tested in our Unit. He had competed at national level canoeing 
and club level running from age 18 to 25. He completed in a number of 21.1 
km, 42.2 km running races and two Comrades 90 km running events, as well 
as a number of canoeing endurance events and national sprint regattas 
during this time period. 
At age 25 he took off a year from training and racing due to work 
commitments. When he started training again he trained at a high intensity to 
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regain his previous form. He subsequently suffered a bout of overtraining and 
on his return, noted that after a normal running training session his lower limb 
muscles ached for a number of days after the session. This occurred even 
though his training speed and distance were lower than before the onset of 
his symptoms. At age 27 he had a vastus lateralis muscle biopsy after a visit 
to a sports medicine specialist. The biopsy had pathological changes of 
unknown aetiology. He reduced his training and raced intermittently after 
these muscle biopsy abnormalities were described. For the 7 years prior to 
visiting our Unit, he had trained sporadically and raced intermittently at a low 
intensity, but found that his symptoms did not improve, and his performance 
deterioration was not improved during this period. 
Prior to his deterioration in performance, he was diagnosed as being 
chronically overtrained on a number of occasions, but chose to continue 
activity through these periods of overtraining. In his late adolescence he 
suffered an episode of anorexia nervosa and depression which required 
hospitalization. At age 23 he was diagnosed with herpes simplex viral 
infection. At age 25, coincident with his year of no training, he underwent 
medical internship training, which he perceived to be a lifestyle stressor. At 
age 26 he suffered a further bout of depression related to work pressures and 
a divorce. 
After his deterioration in performance, at age 30 he was diagnosed with an 
episode of plantar fasciitis which was treated conservatively. At age 31 he 
suffered alcohol-related hepatitis which was managed conservatively. 
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Apart from these psychological and medical problems, there was no other 
contributing medical, surgical or other history or factors related to his problem. 
His Beck psychological score was 5. This score was within normal range and 
indicated no clinical depression. 
Prior to rlis deterioration in performance, he trained 7 days/week, an average 
of 60 km/week running and 100 km/week canoeing, at a running training 
speed of about 13 km/h. After his deterioration in performance he trained 6 
days/week, an average of 30 km/week running and 30 km/week canoeing, at 
a running training speed of about 9 km/h. Prior to his deterioration in 
performance, his best 5 km running time trial 17:50 min. After his deterioration 
in performance, his best 5 km time was 26:50 min. 
Medical examination revealed no clinical abnormalities. Blood pressure was 
130/70 mm Hg, and resting heart rate 60 beats/min. There was muscle pain 
present on palpation, but no obvious myopathy, muscle atrophy, or obvious 
musculoskeletal abnormalities. 
His height was 184 cm, mass 110 kg, percentage body fat 24.1 %, V02max 
47.2 ml 02/kg/min, maximum heart rate 168 beats/min and maximum 
quadriceps force output 843 N. 
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Vastus lateralis muscle biopsy showed that subject #17 had 53% type I fibres, 
39% type IIA 'fibres, 8% type liB fibres and 0% type IIC 'fibres. H&E stain 
revealed a degree of variation in 'fibre size which was not witllin normal limits, 
and the presence of more than 3% internal nuclei. There was no obvious 
necrosis, inflammation or regeneration of the muscle fibres. 
NADH stain showed abnormal subsarcolemmal aggregates of mitochondria 
around the periphery of the cell, to levels which were abnormal even for an 
athlete. The staining pattern of the mitochondria appeared to be abnormal. 
Summary 
Subject #17 was a provincial level canoeist and club level runner with a 
history of successful completion of marathons, abnormal fatigue symptoms, 
muscle pain after running, and muscle damage associated with FAMS. 
Contributing factors may have been the previous history of eating and 
psychological disorders. 
Case Report 18 
Subject #18 was a 22 year old male social runner and club level cricketer who 
presented with symptoms of excessive fatigue and "flu-like" symptoms after 
running training for the previous 4 years prior to him being tested in our unit. 
He ran 2-4 days/week for most of his life to complement his cricket career. 
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The symptoms did not manifest when playing cricket. He could not describe a 
distinct event associated with the onset of his symptoms. 
The symptoms occurred after, rather than during, his training bouts. 
Immediately after the training bout he had excessive symptoms of fatigue, and 
the following day he would develop a sore throat and "flu-like" symptoms that 
would persist for several days, and cause him to be bed-ridden for several 
days. 
He consulted several doctors who could not diagnose his problem, and 
recommended vitamin supplementation and rest. Until his current visit to our 
Unit for this trial, four years after the symptoms began, there was no 
improvement in his symptoms, and he was not able to train consistently for 
running during this period. 
He had no contributing medical, surgical, or psychological factors related to 
his problem. 
His Beck psychological score was 1. This score is within the normal range 
and indicates no clinical depression. 
Medical examination revealed no abnormalities. Blood pressure was 120/70 
mm Hg, and resting heart rate was 72 beats/min.· Particularly, there were no 
obvious myopathy, muscle atrophy, myalgia or obvious musculoskeletal 
deformities. 
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His height was 172.5 cm, mass 58.5 kg, percentage body fat 14.3%, V02max 
58.8 ml 02/kg/min, maximum heart rate 195 beats/min, and maximum 
quadriceps force output 480 N. 
Vastus lateralis muscle biopsy revealed that subject #18 had 39% type I 
fibres, 54% type IIA fibres, 7% type liB fibres, and 0% type lie fibres. H&E 
stain revealed no abnormalities or damaged fibres. 
NADH showed no abnormalities and normal mitochondria. 
Summary 
Subject #18 was a social runner with abnormal fatigue symptoms and "flu-like" 
illness which presented after, rather than during a running bout, but without 
the muscle damage associated with FAMS. An undiagnosed viral infection or 
other Ur1diagnosed factors may have been responsible for his symptoms. 
Case Report 19 
Subject #19 was a 49 year old male club level runner who presented with 
excessive fatigue and muscle pain in his lower limbs in the latter stages of a 
marathon and after marathon running. He had started running socially to 
maintain fitness at age 20, and ran competitively from age 27. He had 15 
years during which time is running was consistent with his training. During this 
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time he competed in a number of 21.1 km, 42.2 km, 56 km and 2 Comrades 
90 km marathons during this period. 
He noted that after running these marathons, he took longer than his running 
peers to recover, with sore legs for several days after each marathon. At age 
41, eight years prior to being tested in our Unit, he noted that his limbs began 
aching excessively in the latter stages of endurance races, associated with 
symptoms of excessive fatigue. He reported that he first felt a change in his 
symptoms in a 56 km marathon run at age 42. In the last 2 years prior to 
being tested, the muscle ache in his legs during endurance races were of 
such intensity that he felt he could not complete the event without taking pain 
killers during the event. The muscle pain occurred for several days after the 
event but improved with complete rest. 
In the two years prior to being tested, from age 47, he had episodes of calf 
muscle tears, hamstring strains, and lower back pain. He was diagnosed as 
having different length limbs by a chiropodist, and given shoe orthotics. He 
ran for a year with the orthotics in the wrong shoes, which would have 
worsened the limb length discrepancy, but correction of trlis error did not alter 
his symptoms. During his running career he had a number of self-diagnosed 
bouts of overtraining. He reduced his training and racing when overtraining 
symptoms occurred. He reported that in the last 4 years prior to being tested 
in our Unit, he became overtrained more easily with a lower level of training 
distance and racing intensity inducing the symptoms. He also noted that he 
had a number of episodes of chest colds, associated with excessive racing 
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and training, which had worsened in severity and incidence in the previous 4 
years. 
He had a history of stress and exercise-induced asthma which was managed 
medically with inhalants. He felt the asthma was worse when he was 
overtrained or under stress. Apart from this asthma, there were no 
contributing medical, surgical or psychological history or factors relating to his 
problem. 
His Beck psychological score was O. This score is within normal range and 
indicates no clinical depression. 
Prior to his deterioration in performance, he trained 6 days/week, 105 
km/week at a training speed of 14 km/h. After his deterioration, he trained 6 
days/week, 100 km/week at a training speed of 11.5 km/h. His best 5 km time 
trial time prior to his deterioration in performance was 18: 1 0 min, and this 
decreased to 19:20 min at the time of testing. His best 42.2 km race times 
(Figure 3.B.37.), best 56 km race times (Figure 3.B.38.) and yearly training 
distances (Figure 3.B.39.) are described in the figures below. 
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Figure 3.B.37. Subject #19's 42.2 km race times. Onset of symptoms was at 
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Figure 3.B.38. Subject #19's 56 km race times. Onset of symptoms was at 
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Figure 3.B.39. Subject #19's yearly training distances (km/year). Onset of 
symptoms was at age 42 (dashed vertical line). He was tested in our Unit at 
age 49 (solid vertical line). 
Medical examination revealed no abnormalities. Blood pressure was 130/80 
mm Hg and resting heart rate 56 beats/min. Particularly, there was no obvious 
myopathy, muscle atrophy, myalgia, or obvious musculoskeletal deformities. 
His height was 185 cm, mass 88.5 kg, percentage body fat 19.7%, V02max 
55.6 ml 02/kg/min, maximum heart rate 179 beats/min and maximum 
quadriceps force output 588 N. 
Vastus lateralis muscle biopsy showed that subject #19 had 71 % type I fibres, 
25% type IIA fibres, 2% type liB fibres and 2% type lie fibres. H&E stain 
revealed abnormal variation in muscle fibre size. No internal fibres were 
present. There was no inflammation, reinfiltration, necrosis or regeneration of 
muscle fibres. 
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NADH stain revealed abnormal subsarcolemmal aggregations of mitochondria 
around the periphery of the cells, to levels which were abnorma I even for an 
athlete. 
SDH stain showed a peripheral accumulation of mitochondria within the cells. 
Summary 
Subject #19 was a club level runner with a previous history of successful 
completion of a number of marathons and ultramarathons, abnormal fatigue 
and muscle damage associated with FAMS. Contributing symptoms could 
have been the ~Iistory of repeated bouts of overtraining, muscle tears, lower 
limb length discrepancies, and stress-induced asthma. It is not clear from this 
study whether the history or colds and respiratory tract infections associated 
with excessive training and racing was related to a viral infection. 
Case Report 20 
Subject #20 was a 32 year old male club level runner who presented with 
excessive fatigue during and after distance running races. He started running 
competitively at age 15, and age 29 increased his training substantially to 
become more competitive. He had 17 years of optimal running performance, 
running a number of -1 0 km, 21 km and 42 km marathons during this period; 
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He noted that compared to his running peers, he always had greater 
symptoms of fatigue during and after racing. In the last year before testing in 
our unit, the symptoms worsened and he noted excessive fatigue during and 
after any race he participated in, which led to a decrement in his running 
performance. Before, during and after the onset of thes symptoms, he 
suffered a number of episodes of "flu-like" symptoms and chest colds, which 
were related to periods of increased training distance or intensity. He 
attempted to rest for long periods on several occasions, but when returning to 
racing and training, the symptoms recurred. He consulted a number of 
general practitioners and coaches who advised him that he needed to begin 
vitamin supplementation. This treatment was not effective. 
Apart from an orthopaedic injury to his right arm, there was no contributing 
medical, surgical or psychological factors relating to his problem. 
His Beck psychological score was 8. This score is within normal range and 
indicates no clinical depression. 
Prior to his deterioration in performance, he trained 6 days/week, 100 
km/week at a training speed of 15 km/h. After his deterioration in 
performance, he trained 6 days/week, 100 km/week, at a training speed of 15 
km/h, but in a sporadic fashion when he was not resting because of running 
induced fatigue. His best 5 km time trial time prior to his deterioration in 
performance was 18:00 min, and this decreased to 19:00 by the time of 
testing. 
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His best time for 10 km was 38: 15 min, for 21.1 km 86 min, and for 42.2 km 3 
h 30 mins. 
Medical examination revealed no abnormalities, except for evidence of the 
orthopaedic trauma injury to his right forearm and evidence of a skin-graft 
donor site on his right leg. Blood pressure was 130/89 mm Hg, and resting 
heart rate 55 beats/min. Particularly, there were no obvious myopathy, muscle 
atrophy, myalgia or obvious musculoskeletal deformities. 
His height was 172 cm, weight 67.5 kg, percentage body fat 14.6%, V02max 
68 ml 02/kg/min, maximum heart rate 184 beats/min, and maximum 
quadriceps force output 740 N. 
Vastus lateralis muscle biopsy revealed that subject #20 had 54% type I 
fibres, 38% type IIA fibres, 0% type liB fibres and 8% type lie fibres. H&E 
stain revealed a degree of variation in fibre size that was not witt-lin normal 
limits, as well as more than 3% internal nuclei. There was no obvious 
inflammation, necrosis or regeneration. 
NADH stain showed abnormal subsarcolemmal aggregations of mitochondria 




Subject #20 was a club level runner with a previous history of successful 
completion of a number of half and full marathons, abnormal fatigue 
symptoms and muscle damaged associated with FAMS. 
Discussion 
The first finding of this study was that 19 of the 20 athletes examined in this 
case series study, who had symptoms of excessive or chronic fatigue and 
associated decrements in athletic performance, also had muscle pathology in 
a sample of the vastus lateralis muscle biopsy. The muscle pathology 
included the presence of abnormal fibre size variation, fibre atrophy, fibre 
necrosis, myofibrillar degeneration and z band streaming, abnormal 
subsarcolemmal aggregations of mitochondria which were either enlarged or 
had abnormal staining patterns, and abnormal accumulation of lipofuscin 
pigments, lipid or glycogen deposits. These findings are indicative of acute or 
chronic muscle damage, and have been described in earlier studies to be 
present after both high intensity sprint bouts (Geller 1973; Friden et al 1988) 
and endurance exercise (Hikida et al 1983; Hochli et al 1994; Warhol et at 
1985). Muscle pathology has also been described in the trapezius muscles, 
as part of an occupational related myalgia (Hagg 2000), and in mouse muscle 
fibres as a result of excessive exercise activity (Salminen and Vihko 1984). It 
is therefore reasonable to assume that there is a relationship between the 
muscle pathology and the previous high volume exercise intensity performed 
by the athletes. As the symptoms of the athletes were generally chronic, 
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usually of a year or more duration, and not removed by rest, one may also 
speculate that the muscle changes may be permanent patholog ical changes. 
The findings of the initial case report study, where the vastus lateralis muscle 
pathology was present in repeat biopsy samples, would support this 
suggestion. 
The muscle pathology was found in subjects of different competitive level and 
with different sporting backgrounds. Several subjects ran at club level and had 
times for races which were relatively slow, while other subjects were 
marathon and ultra-marathon winners, or were of international competitive 
level. In the previous case report study, it was suggested that the muscle 
pathology may be unique to that athlete because of the high level of intensity 
of his training and racing. The findings of this case series study, in contrast, 
would suggest the level of intensity or even large volume of training is not the 
only important factor, and that these individuals may be more susceptible to 
muscle damage than their athletic peers who may be able to tolerate similar 
exercise intensities or training loads. However, as is obvious from the training 
histories of the majority of the subjects in the trial, all had trained for a number 
years in their sporting activity. Therefore, duration of participation in exercise 
activity may be a factor in triggering the precipitating factors causing the 
muscle pathology. 
While 19 of the 20 subjects had muscle pathology, the type of muscle 
pathology varied in each subject. In the previous case report study, the elite 
athlete only had evidence of mitochondrial abnormalities and it was suggested 
231 
that either oxygen-derived free radical damage (Duarte 1993; Sen 1995) or 
cell membrane disruption leading to calcium-mediated cell damage (Jones 
and Round 1990) were responsible for damage to the athletes mitochondria. 
In contrast, the athletes in this study had either mitochondrial damage, or 
muscle fibre damage, or a combination of both. This would indicate that either 
a combination of different processes, such as exercise-associated mechanical 
damage from eccentric activity (Cleak and Eston 1992; Lieber et al 1996; 
Semark et al 1999), other mechanical changes which lead to calcium 
concentration increases and/or activation of proteases such as calpain 
(Belcastro et al 1998) and free-radical mediated damage from increased 
metabolic rate and increased energy production requirements on the electron 
transport chain in the mitochondria during exercise activity (Appel et al 1992; 
Essig and Nosek 1997; Sen 1995) are responsible for the muscle pathology 
described in this case series study. The alternative explanation is that the 
muscle fibres and muscle organelles of different individuals are affected 
differently by the same physiological or pathological processes (Lambert et al 
1999). Further work is needed to assess which of these explanations, or 
whether a combination of both, are responsible for the muscle pathology. The 
finding of lipofuscin pigment deposits in the muscle fibres of several of the 
subjects would support the suggestion that the muscle pathology is of chronic 
duration. 
The next finding was the variability of the affect of the muscle pathology and 
symptoms on fatigue on training capacity and exercise performance. All 
twenty athletes were certain that the fatigue symptoms were excessive, and 
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negatively affected their exercise performance, For example, subject #4 
suggested that he had "no ammo in his guns", that he had "no spring in his 
legs", and that" 1 km now equaled 100 km previously'. Subject #11 suggested 
that "the strength in his legs was gone, and it does not take much effort to get 
to a high heart rate", Subject #9 suggested that "at it's peak, the fatigue left 
me halfway between sleeping and waking most of the time". While there is 
obviously a degree of hubris to these symptoms and perhaps their own 
abilities, the subjects felt that the symptoms profoundly affected their exercise 
performances and therefore their lifestyles. However, in contrast, while some 
athletes indeed did not participate in any activity after the onset of their 
symptoms, several athletes still trained consistently, albeit to a lesser volume 
or degree of intensity, as is evident from the figures describing the training 
and racing histories of the fatigued athletes in this study. 
Similarly, the results of the maximal aerobic capacity and maximal isometric 
force output testing showed that there were no obvious muscle weakness or 
marked reduction in maximal aerobic exercise capacity, as would be found in 
classical mitochondrial and other myopathies (Jackson et al 1995; Petty et al 
1986). In individuals with chronic fatigue syndrome (Mullis et al 1999) or with 
fatigue associated with post-viral syndrome (Lloyd et al 1988; Rutherford 
1991), there is also a dissociation between the symptoms of fatigue and 
maximal exercise capacity, with these individuals producing similar force 
outputs to contro~ subjects despite excessive symptoms of fatigue. These 
findings indicate that the symptoms of fatigue are loosely related at best with 
the capacity for maximal force output, and supports the concept that fatigue is 
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a sensory manifestation of underlying cognitive processes and not a direct 
physical activity or process (8t Clair Gibson 2001 (b)). It also indicates that the 
athletes have a portion of fibres which are undamaged, and one can postulate 
that because "their absolute function is relatively normal, the reduction in 
activity and fatigue symptoms themselves may be serving teleological function 
in reducing their desire to further participate in activities which may be 
damaging such as ongoing exercise activity. 
A high proportion of subjects (7 of 20 subjects) had clinical depression as 
diagnosed form the Beck inventory score, and several had been medically 
treated for depression by medical practitioners prior to participation in the trial. 
A number of subjects also described episodes of lifestyle stresses or eating 
disorders which they felt may have been related to the development of the 
symptoms. However, it is not clear these psychological factors were a cause 
of or a consequence of the muscle pathology, symptoms of fatigue and 
deterioration of exercise performance. 
It has been previously speculated that there may be a link between 
psychological disturbances and athletic disorders (De La Torre 1995; 
Hitzeroth et al 2001; Noakes 1992; Olivardia et al 2000; Yates et al 1983). 
Indeed, a number of subjects in the trial appeared to have 
obsessive/compulsive and possibly egotistical or delusional personality types. 
For example, subject #13 stated "I used to be superwoman. I've been known 
. to do the Iron Man (170 km), and 2 weeks later run the Two Oceans 56 km 
marathon and 6 days later run a 42 km marathon. No problem. If I wanted to 
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do a race, it was as good as done the moment the thought came into my 
head." Subject #11 stated that, when told by a sports medicine physician to 
rest, "I did (rest) except that I did power walking as well which did not rest the 
legs." One must suggest that there may be a link between the psychological 
profile of these athletes, and possibly all athletes in general, and the 
development of the muscle pathology described in this study and the 
symptoms of excessive fatigue. Although speculative, it is possibly the very 
capacity which athletes have to "push through" the pain threshold and 
continue for as long as possible also predisposes them to negative 
consequences from excessive exercise or athletic competition. However, as 
suggested previously (St Clair Gibson et al 2001 (b)), the origins of 
differences in mental capacity between individuals to resist the symptoms of 
fatigue and physical manifestations of fatigue have as yet not been identified 
in any structure in the brain. Indeed, the physical processes of concentration 
and mental "toughness" during athletic activity has not been deconstructed to 
any degree, and research in the future should examine these concepts, to 
understand how these higher mental functions influence the individual's 
physical and physiological capacity. It must be noted also that not all subjects 
described in this case series were suffering from depression or psychological 
impairment, thus a direct link between the psychological symptoms and the 
muscle pathology is not completely obvious. 
A number of the subjects had evidence of a previous Ebstein Barr virus 
infection (14 of 14 subjects tested), and several had evidence of previous 
Coxackie or CMV infection (8 of 15 subject tested). Several subjects also 
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subjectively described the onset of their symptoms to be related to a viral 
infection or "flu-like" illness. Therefore, one must suggest that viral infections, 
and particularly EBV, may also have been a cause of the muscle pathology 
and symptoms of excessive and abnormal fatigue (Osamah et al 1995). 
However, the viral illnesses may also have been caused by changes in 
immune function caused by the high volume training (Smith 2000), and thus 
not related to the muscle pathology directly. It may also be that the muscle 
pathology was present prior to the episodes of illness, and it was the change 
in training activity around the time of the episodes of illness which triggered a 
conscious perception of the decrements in athletic performance, which may 
have already been occurring unnoticed prior to the episodes of infection. 
Again, not all subjects linked viral illnesses to the development of their 
symptoms, so a causal link between the two is only speculative. 
Several of the subjects were diagnosed by medical practitioners as having 
chronic fatigue syndrome after the onset of their symptoms. However, the 
medical examination showed all subjects were generally well at rest, and no 
individuals had enoug~1 major or minor criteria for a diagnosis of the chronic 
fatigue syndrome (Coetzer et al 2000). Rather, given their athletic 
background, the symptoms of excessive fatigue, reduction in competitive 
capacity and muscle damage, they fulfill the criteria for the fatigued at~llete 
myopathic syndrome, as diagnosed by Derman et al (1997). 
It must also be noted that while a number of medical investigations were 
performed on the majority of subjects to exclude viral, blood, hormonal, 
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autoimmune and liver function abnormalities, the possibility exists that 
pathogens or disorders other than those investigated may be responsible for 
the symptoms and muscle pathology described. However, there were no 
obvious abnormalities noted on comprehensive clinical examination and no 
subject had signs of a classic myopathy. As all subjects participated in athletic 
activity with a relatively high level of success, it is unlikely that an inherited 
muscle disorder was the cause of their muscle pathology, and if an unknown 
pathogen or disorder was responsible for the muscle abnormalities, it would 
likely be an acquired condition. 
Subject #12 was principally from a rowing background, and was the only 
individual who participated in a sport which did not require specific lower limb 
activity. However, rowing utilizes lower limb movements to help generate 
power output in the upper limb (Spirduso 1995), and the subject cross-trained 
using a variety of sports. Thus while the finding of a lower limb myopathy in 
this subject who participated primarily in an upper body sport was somewhat 
surprising, this can be explained by the fact that he was an international level 
athlete who had participated at an Olympic games, and had a high volume of 
training. This training recruited predominantly upper limb muscles during 
rowing, but as explained above, lower limbs are used during rowing and lower 
limb activity would have occurred during his running training. Further studies 
should examine changes in muscle histology in the upper limb as well as the 
lower limbs of .rowers. 
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While the muscle pathology findings were not present in one athlete, it is 
interesting to note that this athlete, while having similar symptoms to the other 
19 athletes, had participated in running activity for a relatively short period at 
low intensities, and was of a younger age than the other athletes. This would 
support the anecdotal evidence that at least a decade or more of exercise 
activity may be necessary to cause chronic pathological muscle changes, and 
that aging processes are a factor in the aetiology of the muscle pathology. 
(Lambert et al 1999; Noakes 1992). One must also suggest that in this 
athlete, processes other than musCle pathology must playa role in the 
development of the symptoms of fatigue. It must also be noted that not all 
studies have found muscle pathology associated with chronic fatigue 
(Rowbottom et al 1998). These authors concluded that the physiological 
deterioration in performance and symptoms of excessive fatigue in the athlete 
described in their study was related to detraining rather than muscular 
pathology. Further work is needed to assess the reason for these different 
'findings. 
In conclusion, the finding of this case series study was that as 19 of 20 
subjects tested had muscle pathology, there may be an association between 
the muscle pathology and the excessive symptoms of fatigue and decrements 
in athletic performance described by these subjects. The viral infections and 
psychological factors present in a number of athletes may also have been 
related to the symptoms of fatigue, but it was not clear if these were a cause, 
or a consequence of the history of excessive exercise, muscle pathology and 
the symptoms of fatigue. The finding that the symptoms of fatigue are only 
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loosely related to physical performance during maximal aerobic testing and 
maximal force output in these FAMS subjects indicates that fatigue is 
probably not a physiological entity, but rather a sensory manifestation of 
underlying cognitive process or afferent input integration. 
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3.e. Fatigued athletes versus control subjects 
Introduction 
In the previous chapter, a case series study examined the medical, 
physiological, and psychological changes in twenty athletes with symptoms of 
excessive fatigue and decrements in athletic performance. This study found 
that 19 of the 20 subjects had evidence of vastus lateralis muscle pathology. 
A high proportion of these subjects had evidence of previous viral infections 
and psychological pathology. However, this study was not designed to relate 
these changes to decrements in exercise performance. 
A possibility exists that all athletes participating in regular exercise training 
may have similar changes in muscle morphology and similar psychological 
profiles, but which are not associated with decrements in performance. 
Therefore, the aim of this study was to examine the functional and 
physiological differences between the group of fatigued athletes described in 
the previous chapter and a group of asymptomatic control subjects who were 
matched for age and current athletic activity. 
Methods 
The collective data from the 20 fatigued athletes (FAMS) described in the 
previous study were compared against data from 10 age matched and activity 
matched controls (CON). The CON group were recruited by advertisement in 
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running clubs and from individuals either working or training at the Sport 
Science Institute of South Africa. CON was matched for current level of 
training in the FAMS group, rather than for level of training prior to onset of 
FAMS symptoms. Exclusion criteria included recent injuries which precluded 
training activity, previous episodes of chronic fatigue or impaired exercise 
tolerance, and the presence of any major illness which would prejudice their 
health by participation in the study. 
The medical and Beck psychological questionnaire analysis, medical testing, 
anthropometry, blood testing, maximal voluntary force (MVC) output testing, 
V02max testing and muscle biopsy analyses were performed as described in 
the previous chapters (Ch 3.A. and Ch 3.B.) for both FAMS and CON 
subjects. 
In addition, the leg length (cm) of both left and right legs was measured in all 
subjects. Distances measured included the length from the anterior superior 
iliac spine to ankle medial malleolus to assess full leg length, and length from 
the tibial promontory below the knee joint to the medial malleolus of the ankle 
joint, to assess lower limb length. The difference in both full and lower leg 
lengths between left and right legs was assessed by subtracting the right leg 
length 'from the left leg length in all subjects. 
The subjects subsequently performed a drop jump (OJ) test to assess the 
elastic recoil capacity of the quadriceps muscle (Sharwood et al 2000). 
Subjects standing height was measured with their arms fully extended above 
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their head. Subjects were required to jump as high as possible up against the 
wall, after having jumped off a 50 cm bench that was placed 150 cm away 
from the wall. The standing height, absolute OJ height, and differences 
between the subjects height while standing and maximal height while 
performing the OJ was recorded. The subjects were allowed two warm up 
jumps and allowed to stretch prior to performing the test. They subsequently 
performed four OJ, the best of which were used for subsequent analysis. 
Electromyographic (EMG) activity was measured during all OJ trials. 
After the DJ test, force output and EMG analysis of the knee extensors was 
measured. All subjects performed MVC's as described previously and a 25 s 
fatigue protocol. This fatigue protocol was performed after the MVC tests, the 
subjects rested for a five minute period and then performed the isometric 25 s 
fatigue tests. The subjects were instructed to begin maximal effort 
immediately, and not to "save" effort for the final seconds of the test. Subjects 
were again verbally encouraged throughout all trials to exert maximal effort. 
The subjects performed two 25 s isometric fatigue tests, with a one minute 
rest between tests. The force output and EMG data from both fatigue tests 
were used for subsequent analysis. Throughout all sessions, force output (N) 
was recorded using the Kin-Com data analysis software, at a capture rate of 
100 HZ. 
The peak force (PF, N) and time to peak force (TIP, s) was measured during 
the MVC. The PF, rrp and mean force (MF, N) attained during both 25 s 
isometric test was also measured. The difference in PF, TIP and MF between 
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the two trials were analyzed by subtracting the values obtained in the second 
trial from those in the first trial in both FAMS and CON subjects. 
Prior to the first drop jump, active EMG electrodes with a bandwidth of 20-500 
Hz and sensitivity of <0.08 JlVN were attached to the belly of the vastus 
medialis muscle. The skin overlying these muscles was carefully prepared. 
Hair was shaved off, the outer layer of epidermal cells abraded, and oil and 
dirt removed from the skin with an alcohol swab. Triode electrodes' (Thought 
Technology Triode™ MIEP01-00) were placed on the muscle belly, and 
linked via a fibre-optic cable to a Flexcomp/DSP EMG signal acquisition 
apparatus (Thought Technology, Montreal, Canada) and host computer. A 50 
Hz line filter was applied during data collection to prevent interference from 
electrical sources. 
EMG data was collected throughout each DJ, MVC and isometric fatigue test 
in all subjects, thus yielding raw signals. To analyze integrated EMG (lEMG) 
activity. raw EMG signals were full wave rectified. movement artifact removed 
using a high-pass second order Butterworth filter with a cut-off frequency of 5 
Hz. This was performed using MATLABTM gait analysis software (The 
MathWorks Inc .• USA). 
Frequency spectrum shifts for each epoch of EMG data were analyzed using 
a fast Fourier transformation algorithm. The frequency spectrum analysiS was 
restricted to frequencies in the range 5-500 Hz, as the EMGsignal content 
outside of this range consists mostly of noise. The 'frequency spectrum from 
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each epoch of data was compared with that from the first epoch, and the 
amount of spectral compression was estimated. This was performed using the 
technique described by Lowery et al (1998), as a modification of the work of 
LoConte and Merletti (1996) and Merletti and LoConte (1997). The spectrum 
of the raw signal of each epoch was obtained and the normalized cumulative 
power at each frequency was calculated. The shift in each percentile 
frequency (Le. at 0% ... 50% ... 100% of the total cumulative) was examined. 
The frequency shift was then estimated by calculating the mean shift in all 
percentile frequencies (MPFS) throughout the mid-frequency range, that is 5-
500 Hz. This method is considered a more accurate estimation of spectral 
compression than median frequency analysis, which uses the value of a 
single (50th) percentile frequency only (Lowery et ai, 1998; LoConte and 
Merletti, 1996; Merletti and LoConte, 1997). 
For the drop jump IEMG and MPFS values for FAMS and CON groups were 
derived from the ratio between MVC and DJ values, with the MVC data being 
used as representing the first epoch data. A toggle switch was activated at the 
initiation point of the drop jump to mark the start point of the test procedure. 
Corresponding data for force output, IEMG and MPFS during the fatigue tests 
were subsequently divided into three 5 s epochs. The first epoch included all 
data collected between 2 and 6 s, the second epoch all data from 11 to 16 s, 
and the third epoch all data from 20 to 25 s of the fatigue test. The first 
second of data was not analyzed because of the possibility that there may 
have been a variation, or a possible lag phase, in the time to peak force 
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output in the first second of the test. Mean values for torque and IEMG were 
calculated for these time epochs. All data from the first epoch was described 
as 1.00, with all subsequent data from epochs 2 and 3 being normalized by 
using this first epoch as the denominator. In this manner, the relative fatigue 
data from the fatigue tests could be analyzed. 
The EMG/Force fatigue ratio was calculated for both knee extensor data in 
FAMS and CON groups. This was calculated by dividing the normalized IEMG 
value for the third epoch of the second 25 s isometric fatigue test by the 
normalized force output for the same third epoch of the second 25 s isometric 
fatigue test. 
After performing the MVC, drop jump and V02max testing, all subjects 
performed a submaximal downhill running test on the same motorized 
treadmill to assess the effect of eccentric lower limb activity on stride 
frequency and HR. The test started with the subjects running for 3 minutes on 
a horizontal treadmill at a speed corresponding to 70% of their PTRS 
calculated during the V02peak test. The front of the treadmill was then 
lowered to an angle of -100 from horizontal, and the subjects continued to run 
downhill for 15 minutes at the same speed. Heart rate was measured using 
the same portable HR monitor at minutes 4, 9 and 14 of the downhill run. 
Stride frequency (steps/min) was also recorded at minutes 4, 9 and 14. 
After the downhill run, a muscle biopsy was performed, and the muscle 
histology analyzed as described previously. The muscle fibre pathology 
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present in the muscle samples were scored by a specialist path ologist with 
expertise in myopathies who was blinded to the group identity of the samples. 
The scoring scale examined changes in quantity of subsarcolemmal 
mitochondrial aggregations, staining pattern abnormalities, fibre size variation, 
internal nuclei and fibre necrosis, inflammation and re/degeneration. Scores 
were from 1-3 for severity, with 1 being less severe and 3 being the most 
severe category, for all parameters except staining pattern abnormalities, 
which were scored either 0 or 1 based on the presence or absence of 
abnormalities. The total score for all of these parameters was calculated for 
each individual as an overall light microscopy pathology score. 
Statistics 
All data are presented as means ± standard deviation (SD). An unpaired t-test 
was used to evaluate the differences between FAMS and CON parametric 
data. A paired t-test was used to evaluate the differences between the FAMS 
group data before and after the onset of their symptoms. A Mann-Whitney U 
test was used to evaluated the differences between FAMS and CON non-
parametric data. A Chi-squared test was used to evaluated the differences 
between FAMS and CON non-parametric count data. An analysis of variance 
(ANOVA) with repeated measures was used to detect differences between 
knee extensors in FAMS and CON group for the 25 s fatigue data. A Scheffe's 
post hoc test was used to detect significant differences between groups. A 
Pearson's product moment correlation was calculated to determine 
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relationships between variables. Statistical significance was accepted when P 
< 0.05. 
Results 
The general characteristic of the FAMS and CON subjects are described in 
table 3. C.1. There were no significant differences in age, height, mass, 
percentage body fat, sum of skinfolds, LTV or mid-thigh girth. The FAMS 
group consisted of 16 males and 4 females, while CON group consisted of 9 
males and 1 female. Using the Chi squared test, there were no significant 
differences in the ratios between males and females in FAMS and CON 
groups. 
Table 3. C.1. General characteristics and anthropometrical values for FAMS 
and CON groups. 
FAMS CON 
Age (y) 40.4 ± 8.7 (20) 38.1 ± 12.8 (10) 
Gender (M/F) 16/4 614 
Height (cm) 175±10(17) 172 ± 9 (9) 
Mass (kg) 75.3 ± 16.6 (19) 70.9 ± 9.9 (9) 
Body fat (%) 21.4 ± 5.5 (20) 20.3 ± 5.6 (10) 
Sum skinfolds (cm) 58.2 ± 24.4 (20) 51.2 ± 14.4 (10) 
LTV (cc) 3847 ± 821 (20) 3514 ± 720 (9) . 
Mid-thigh girth (cm) 51.4 ± 4.7 (20) 48.1 ± 3.3 (10) 
247 
Table 3.C.2. describes the sporting activities of subjects in FAMS and CON 
groups. The majority of subjects in both FAMS (75 %) and CON (90 %) 
groups were runners. There were no significant differences in the ratio of 
different sport activities performed by the subjects in FAIVIS and CON groups. 














Table 3.C.3. describes the current training and race performance 
characteristics in the FAMS and CON group. There were no significant 
differences in training times per week between groups. For the runners, there 
were no significant differences in training distance per week, training speed or 
best 5 km time trial times between groups (Figure 3.C.1.). 
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Table 3.C.3. Current training quantity, distances and performance times 
quantities for FAMS and CON groups (Km/week, self reported training speed 
and 5 km personal best times for runners only). 
FAMS CON 
Age started (y) 27.1 ± 9.4 (18) 23.0 ± 12.8 (10) 
Days/week 3.7 ± 2.5 (19) 4.2 ± 1.5 (9) 
Km/week 34.3 ± 33.6 (14) 37.0 ± 14.6 (6) 
Training speed (km/h) 10.4 ± 2.4 (10) 11.4 ± 1.7 (6) 
Best 5 km time (min) 24.5 ± 5.5 (10) 23.6 ± 2.1 (5) 
Table 3.C.4. describes the training quantity and distances and performance 
times in the FAMS subjects prior to the onset of symptoms compared to 
values at the time of testing. The FAMS group trained for 10.9 ± 6.6 years 
(n=19) prior to the onset of FAMS symptoms. The time since the symptoms 
were noted was 4.1 ± 3.0 (n=14) years. There was a significant reduction in 
the number of times subjects trained per day, the distance trained per week, 
and training speed. The best 5 km time trial time of the runners was 
significantly slower in the runners in the FAMS group after onset of symptoms 
(Figure 3.C.1.). It must be noted that these times were only compared in 
FAMS runners who could compete, with several subjects not being able to 
compete or race to any degree after onset of FAI\IIS symptoms. These 
subjects were excluded from the statistical analyses. The squash player's 
training quantity decreased from 4 hours daily prior to the onset of FAMS 
symptoms to being unable to train after the onset of FAMS symptoms. One 
cyclist trained 300 km/week at a speed of -35 km/h prior to the onset of 
FAMS symptoms, and this was reduced to 14 km/week at a speed of-6 
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km/hour after the onset of FAMS syndromes. The other cyclist trained 500 
km/week at a speed of -30 km/h prior to the onset of FAMS symptoms, and 
this was reduced to being unable to train after the onset of FAMS symptoms. 
The rower trained 15 hours/week prior to the onset of FAMS symptoms and 
this was reduced to 8 hours/week after the onset of FAMS symptoms. The 
rower's times for a 500m rowing time trial decreased from 7:25 min prior to 
the onset of FAMS symptoms to 7:35 min after the onset of FAMS symptoms. 
Table 3.C.4. Self reported training quantities prior to (FAMSpre) and after 
onset (FAMSpost) of FAMS symptoms (Km/week; training speed and 5 km 
times for runners only). 
FAMSpre FAMSpost 
Days/week 5.8 ± 1.1 (19) 3.7 ± 2.5 (19)-
Km/week 83.2 ± 31.9 (14) 34.3 ± 33.6 (14)-
Training speed (km/h) 12.7 ± 1.3 (10) 10.4 ± 2.4 (10)-
Best 5 km time (min) 20.1 ±3.7 (10) 24.5 ± 5.5 (10)-
- - p < 0.01 FAMSpre vs. FAMSpost Days/Week 
FAMSpre vs. FAMSpost KmlWeek 
FAMSpre vs. FAMSpost Training speed 
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Figure 3.C.1. Differences in best S km time trial times (TT PB) between FAMS 
and CON groups and in the FAMS groups before (PRE) and after (POST) 
onset of symptoms (- - P < 0.01) 
Table 3.C.S: describes the type of training activity performed in FAMS 
subjects prior to their deterioration in performance, and in CON group at the 
time of testing. The majority of subjects performed a combination of speed 
and endurance training, and strength and flexibility sessions in a routine 
training week. There were no significant differences between F AMS and CON 
groups for these variables. 
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Table 3.C.5. Type of training activity performed by FAMS athletes prior to 
deterioration in performance and CON group at present. 
FAMS CON 
Yes No Yes No 
Speed 15 3 7 0 
Endurance 18 0 7 0 
Strength 10 6 6 1 
Flexibility 13 5 6 1 
Although both FAMS and CON group had one specific sport which they 
concentrated on, the majority of subjects participated in one or more other 
sports to some extent, either at the time of testing or at some point in their 
adolescent or adult lives. These different sports and the number of different 
subjects in FAMS and CON groups who participated in these sports are 
described below in table 3.C.6. 
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Table 3.C.S. Others sports participated in by FAMS and CON subjects. 
FAMS CON 
Swimming 7 3 
Walking 3 0 
Squash 5 1 
Badminton 0 1 
Netball 0 1 
Soccer 5 0 
Rugby 3 3 
Aerobics 1 2 
Martial arts 0 1 
Gym 3 2 
Hiking 3 2 
... 
Rockclimbing 0 1 
Tennis 4 0 
Golf 3 0 
Canoeing 3 0 
Dancing 0 1 
Cricket 2 0 
Hockey 2 0 
The self-reported medical histories of FAMS and CON subjects are described 
below in table 3.C.7. A significantly higher percentage of FAMS subject had a 
history of biomechanical problems and respiratory and viral illnesses than 
CON subjects (Figure 3.C.2). While a higher percentage of FAMS subjects 
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described a history of episodes of overtraining than CON subjects, these 
differences were not significant. There were no significant differences in 
psychological history scores between FAMS and CON groups. 
Table 3.C.7. Previous medical and injury history of FAMS and CON groups. 
FAMS CON 
YES NO % YES NO % 
Running Injury 13 7 65 5 4 56 
Overtraining 7 11 39 1 8 11 
Biomechanics 14 5 74* 3 6 33 
Medical 5 12 29 0 9 0 
Surgical 5 13 28 0 9 0 
Respiratory 14 4 78* 3 6 33 
Viral 6 12 33* 0 9 0 
Drugs 3 16 16 0 9 0 
Dietary 3 16 16 0 9 0 
Lifestyle 7 12 37 2 7 22 
Psychological 4 14 22 3 6 33 
P < 0.05 - Significant difference between FAMS and CON groups for 
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Figure 3.C.2. Differences in history of biomechanical problems (BIOMECH), 
respiratory (RESP) and viral (VIRAL) illnesses between FAMS and CON 
groups (- :- P < 0.01). 
Table 3.C.S. describes the differences in self-reported medical histories in the 
FAMS subjects prior to the onset of symptoms compared to values at the time 
of testing. A significantly higher percentage of FAMS subjects had a history of 
running injuries (P < 0.01), biomechanical injuries (P.< 0.01); and lifestyle 
changes (P < 0.05) prior to the onset of their symptoms. There were no 
significant differences in respiratory, viral, or psychological history prior to or 
after the onset of symptoms in the FAMS subjects (Figure 3.C.3). 
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Table 3.e.8. Differences in previous medical and running injury scores for 
FAMS group before (FAMSpre) and after (FAMSpost) onset of FAMS 
symptoms. 
FAMSpre FAMSpost 
YES NO % YES NO % 
Running Injury 13 7 65** 3 16 16 
Overtraining 7 11 39 7 11 39 
Biomechanics 14 5 74- 2 16 11 
Medical 5 12 29 5 11 31 
Surgical 5 13 28 1 17 6 
, ' 
.Respiratory 14 4 78 9 8 53 
Viral 6 12 33 8 10 44 
"Drugs 3 16 16 '. ~ t 3 14 18 
Dietary 3 16 16 4 15 21 
Lifestyle 7 12 37* 1 17 6 
Psychological 4 14 22 4 14 22 
* - P < 0.05 - Significant difference between FAMSpre and FAMSpost groups 
for lifestyle scores. 
** - p < 0.01 - Significant difference between FAMSpre and FAMSpost groups 
for biomechanics and running injury scores. 
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Figure 3.C.3. Differences in history of respiratory (RESP), viral (VIRAL) and 
psychological (PSYCH) illnesses between FAMSpre and FAMSpost groups. 
The Beck psychological score was significantly higher inFAMS (7.5 ±6.6; n = 














Figure 3.C.4. The Beck psychology score (Arbitrary Units, Au) for FAMS and 
CON groups (* - p < 0.05). 
Table 3.C.9. describes the differences in medical pathology found in the 
medical general examination between FAMS and CON group. There were no 
significant differences between groups for the number of subjects with 
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medical diagnoses. None of the medical diagnoses were of medical concern 
or precluded the subjects from continuing with the trial. Two subjects in the 
FAMS group had signs of lower limb pathology, one having visible muscle 
atrophy and the other myalgia in the lower limbs. No subjects in the CON 
group had signs of lower limb pathology. As described in the previous 
chapter, all 14 of 14 FAMS subjects tested positive for a previous EBV 
infection. However, 2 of 2 CON subjects also tested positive for previous EBV 
infection. 
Table 3.C.9. Medical diagnoses in FAMS and CON groups, according to 
systems tested (CVS - Cardiovascular; CNS - Central nervous system). 
FAMS CON 
Present Absent Present Absent 
General 1 18 2 8 
CVS 2 17 0 10 
Respiratory 0 19 0 10 
Abdominal 0 19 0 10 
CNS 1 18 0 10 
Musculoskeletal 2 17 0 10 
Table 3.C.10. describes the differences in resting supine HR, and resting 
systolic and diastolic blood pressure between FAMS and CON groups. There 
were no significant differences between groups for resting HR, systolic or 
diastolic blood pressure. 
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Table 3.C.10. Resting heart rate (Rest HR) and resting systolic blood 






63 ± 8 (20) 
124 ± 12 (20) 
76 ± 8 (20) 
CON 
64 ± 14 (10) 
135 ± 19 (10) 
83 ± 11 (10) 
There were no -significant differences in leg lengths, as measured from the 
anterior superior iliac spine to ankle malleolus, in the FAMS and CON group 
for either right and left legs (Table 3.C.11.). There was no significant 
difference in lower leg length, as measured from the tibial promontory to 
medial malleolus, in the FAMS group for either right dr left legs. 
Table 3.C.11. The absolute and difference in leg lengths for right and left legs 
in FAMS and CON groups (ASIS - anterior superior iliac spine; MM - ankle 
medial malleolus; IT - tibial promontory; R - right; L - left; ASISMMdiff -
difference between left and right leg ASIS-MM length; TTMMdiff - difference 
between right and left leg TT -MM length). 
FAMS Control 
RASIS-MM 91.1 ± 6.0 (18) 89.6 ± 4.6 (10) 
LASIS-MM 91.3 ± 6.2 (18) 89.4 ± 4.7 (10) 
ASISMMdiff 0.36 ± 0.48 (18) 0.21 ± 0.22 (10) 
RTT-MM 34.2 ± 3.0 (18) 33.8 ± 1.4 (10) 
LTT-MM 34.3 ± 3.0 (18) 33.8 ± 1.5 (10) 
ITMMdiff 0.18 ± 0.29 (18) 0.01 ± 0.03 (10) 
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The drop jump (OJ) data for FAMS and CON groups is described in table 
3.C.12. There was no significant difference between groups for standing 
height, absolute D,J height, or relative OJ height (DJdiff). The IEMG and 
MPFS data for the OJ is described in table 3.C.13. The DJ/MVC ratios for 
IEMG and MPFS data were not significantly different between FAMS and 
CON groups. The IEMG values during OJ was - 40% less than during MVC in 
both groups. The MPFS values were - 10% higher during OJ than MVC in 
both groups. 
Table 3.C.12. Differences in drop jump height between FAMS and Control 
groups (DJstand - drop jump standing height; DJactual - absolute drop jump 






227 ± 12 (20) 
252 ± 19 (20) 
24.7 ± 9.7 (20) 
CON 
227 ± 13 (10) 
253 ± 17 (10) 
25.8 9.4 (10) 
Table 3.C.13. IEMG (mV) and MPFS (AU) values for FAMS and control during 
the drop jump. Both values are derived from ratio between maximal voluntary 




0.59 ± 0.20 (18) 
1.13 ±0.23 (18) 
CON 
0.60 ± 0.17 (10) 
1.08 ± 0.09 (10) 
There was a similar negative correlation between age and DJdiff for FAMS (r 
= -0.63; P < 0.01) (Figure 3.C.5.a.) and CON (r = -0.69; P < 0.05) groups 
(Figure 3.C.5.b.). The correlation between DJdiff and LTV was positive and 
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higher in CON group (r = 0.62, NS) than FAMS group (r = 0.13, NS). There 
were no significant correlations between DJdiff and mass in FAMS (r = -0.4, 
NS) and CON (r = 0.11, NS) groups. 
50 (a) 
• 










20 30 40 50 60 
Age (Years) 
50 (b) 
40 • - • • E r = - 0.69* ~30 
= =c 





20 30 40 50 60 
Age (Years) 
Figure 3.C.5. The relationship between DJdiff and Age in FAMS (a) and CON 
(b) groups (- - p < 0.01; * - P < 0.05). 
The differences in force output data between FAMS and CON groups are 
described in table 3.C.14. There were no significant differences between 
FAMS and CON groups for 5 s MVC peak force output and time to peak force, 
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25 5 endurance test peak or mean force, or time to peak force during the 25 5 
end urance test. 
Table 3.C.14. Differences in force output data between FAMS and CON 
groups (5 5 - 5 5 isometric MVC force output; 25 5 - 25 5 isometric endurance 
force output; 1- test 1; 2 - test 2; PF - peak force; MF - mean force; TTP - time 
to peak; Diff - difference between test 1 and test 2). 
FAMS CON 
55 PF (N) 561 ± 160 (20) 530 ± 116 (1 0) 
55 PF TIP (5) 3.0 ± 1.4 (20) 2.7 ± 1.5 (9) 
2551 PF (N) 522 ± 150## (20) 499 ± 113 (10) 
2552 PF:(N) 493 ± 145 (20) .477 ± 93(9)" 
PT 1-2 Diff 29.5 ± 45.1 (20) 23.1 ± 35.7 (9) -
2551 TTP (5) 11.5 ± 9.0 (20) 7.4± 8.5 (10) 
2552 n,p (5) 10.9 ± 7.0 (20) 8.0± 8.0 (8) 
TIP 1-2 Diff 0.7 ± 6.8 (20) 1.0 ± 5:0 (8) 
2551 MF (N) 442 ± 125# (20) 430 ±92# (10) 
2552 MF (N) 420 ± 133 (20) 360 ± 61 (8) 
, . 
MT 1-2 Diff 21.5 ± 43.0 (20) 53.9 ± 58.2 (8) 
# - P < 0.05- FAMS 25 51 MF VS. FAMS 2551 MF 
CON 25 5 1 MF VS. FAMS 25s 1 MF 
## - P < 0.01 - FAMS 25 s 1 PF VS. FAMS 255 1 PF 
The FAMS group's peak force output during the first 255 endurance test was 
significantly higher than that during the second 25 5 endurance test (P < 
0.01). Although the peak force output was higher in the first 25 5 endurance 
test than second 25 5 endurance test in the CON group, the difference was 
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not significant. The mean force output during the first 25 s endurance test was 
significantly higher than that during the second 25 s endurance test in both 
FAMS (P < 0.05) and CON groups (P < 0.05). There was no significant 
. correlation with peak force output and age in both FAMS (r = - 0.13, NS) and 
CON groups (r = -0.06). The correlation between LTV and 5 S MVC peak 
force output was similar in FAM (r = 0.59, P < 0.05) and CON (r = 0.59, NS) 
groups. 
The normalized force output changes during the two 25 s isometric fatigue 
tests (End T1 epoch1-3, and End T2 epoch 1-3) in FAMS and CON groups 
are described below (Table 3.C.15.). Although the force output in the CON 
group decreased to a greater degree with time than in the FAMSgroup, the 
interaction effect between groups for changes in time were not significant, 
either for End T1and End T2, or when the two groups were combined (P = . 
0.056) (Figure 3.C.6). 
The normalized IEMG and MPFS changes during the two 25. s isometric 
fatigue tests (End T1 epoch1-3, and End T2 epoch 1-3) in FAMS and CON 
groups are described below (Table 3.C.1S.). The IEMG increased similarly in 
both FAMS and CON groups during both 25 s endurance tests, and were 
increased by - 25% by the end of the second endurance test. The MPFS 
decreased similarly in both groups during both 25 s endurance tests, and 





Table 3.C.15. Normalized force output changes during the two 25 s isometric 
fatigue tests (End T1 and End T2), and when the two test were examined as a 





















FAMS (20) CON (10) 
1.00 ± 0.00 1.00 ± 0.00 
0.96 ± 0.11 0.97 ±0.09 
0.98 ± 0.16 0.94 ± 0.11 
0.96 ± 0.10 0.97 ±0.08 
0.96 ± 0.14 0.89±0.09 
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Figure 3. C.6. Normalized force output changes during the 25 s endurance 
isometric tests for FAMS and CON groups. 
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Table 3.C.1S. Normalized IEMG and MPFS changes during the two 25 s 
isometric fatigue tests (End T1 and End T2), and when the two test were 
examined as a single entity (End ALL) in FAMS and CON groups. 
FAMS (20) CON (10) 
IEMG End T1-1 1.00 ± 0.00 1.00 ± 0.00 
End T1-2 1.10 ± 0.20 1.14 ± 0.19 
End T1-3 1.22 ± 0.28 1.13 ± 0.27 
, End T2-1' 1.0S±0.17 1.01 ±0.19 
End T2-2 1.21 ±0.24 1.13 ±0.27 
End T2-3 1.25 ±0.30 1.23 ±0.31 
MPFS End T1-1 1.00±0.00 1.00 ±O.OO 
End T1-2 0.98±0.03 0.97 ±0.03 
End T1-3 0.95±0.05 0.9S±0.04 
End T2-1 1.00 ±0.04 1.01 ± 0.03 
End T2-2 0.98 ± 0.05 0.98 ±O.OS 
End T2-3 0.95 ± 0.06 0.96 ±O.OS 
There were no significant differences in the IEMG/force ratio during the last 
epoch of the second 25 s endurance test in FAMS (1.37 ± 0.24, n=19) and 
CON (1.41 ± 0.25, n=9) groups. 
The PRTS, HRmax and V02max values during the maximall treadmill run are 
described in table 3.C.17. There were no significant differences between 
FAMS and CON groups for PTRS, HRmax and V02max. V02max was 
significantly negatively correlated with age in the FAMS group (r = 0.47; P < 
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0.05). Although there was a higher negative correlation between V02max and 
age in the CON group (r = - 0.60), this correlation was not significant. The 
relationship between PTRS and age was similar in FAMS (r = - 0.46; P < 
0.05) and CON groups (r = -0.44; NS). The relationship between V02max 
and DJdiff was lower in the FAMS group (r = 0.34; NS) (Figure 3.C.7.a.) than 
CON group (r = 0.65; P < 0.05) (Figure 3.C.7.b.). PTRS was significantly 
negatively correlated with DJdiff in the FAMS group (r = 0.49; P < 0.05). 
Although there was a higher negative correlation between V02max and age in 
the CON group (r = -0.62), this correlation was not significant. 
Table 3.C.17. Peak treadmill running speed (PTRS; km/h) , maximal heart 
rate (Hrmax; beats/min) and maximal aerobic Gapacity (V02max; ml 





15.1 ± 2.4 (20) 
185 ± 12 (20) 
49.6±9.1 (19) 
CON 
15.2 ±3.2 (10) 
1.87 ± 11 (10) 
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Figure 3.C.? The relationship between V02max and DJdiff in FAMS (a) and 
CON (b) groups (* - P < 0.05). 
The blood lactate concentration values prior to the start of the maximal run 
(LACpre), at the point of maximal exhaustion when the subject terminated the 
test (LACpost), and three minutes after the point of maximal exhaustion 
(LAC3min) are described in table 3.C.18. There were no significant 
differences between FAMS and CON groups for either LACpre, LACpost or 
LAC3min. As expected, blood lactate was significantly higher (P < 0.01) at 
both LACpost and LAC3min compared to LACpre in both FAMS and CON 
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groups. There was a significant positive correlation between LAC3min and 
HRmax (r = 0.69, P< 0.05) in the CON group, while the correlation between 
LAC3min and HRmax was not significant in the FAMS group (r = 0.24 NS). 
There were no significant correlations between LAC3min and age, LTV, DJdiff 
or V02max in either FAMS or CON groups.· 
Table 3. C.18. Blood lactate concentration values prior to the start of the 
maximal run (LACpre), at the point of maximal exhaustion when the subject 
terminated the test (LACpost), and three minutes after the point of maximal 




## - p < 0.01 
FAMS CON 
. 2.26 ± 1.59 (20) 2.19 ± 1.11 (10) 
9.77 ± 2.73 (20)## 8.67 ± 1.82 (10)## 
10.84 ± 2.70 (20)## 9.60 ± 2.86 (10)## 
FAMS group LACpre vs. LACpost 
FAMS group LACpre vs. LAC3min 
CON group LACpre vs. LACpost 
CON group LACpre vs. LAC3min. 
The treadmill speed, HR and stride frequency (SF) at 5, 10 and 15 minutes 
into the down~li" run are described in table 3.C.19. There were no significant 
differences between FAMS and CON groups for treadmill speed, HR or SF at 
any of these time points. Cardiac drift occurred in both FAMS and CON 
groups during the downhill run, as was evident by the increase in HR from 
time point 5 to time points 10 and 15, although this cardiac drift was not 
significant in either FAMS or CON groups (Figure 3.C.8.). SF was maintained 
at - 84 strides/min at all three measured time pOints in both FAMS and CON 
group. In the CON group, the relationship between SF at 5 minutes (SF5) and 
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age (r = 0.81, P < 0.01) (Figure 3.C.9.), SF5 and LTV (r = -0.76, P < 0.01), 
SF5 and DJdiff (r = -0.58, P < 0.05), SF5 and V02max (r = -0.58, P < 0.05) 
were all significant. In contrast, in the FAMS group the relationship between 
SF5 and age (r = -0.06, NS) (Figure 9), SF5 and LTV (r = -0.02, NS), SF5 
and DJdiff (r = 0.11, NS) and SF5 and V02max (r = 0.22, NS) were all not 
significant. The correlation between HR5 and HR at 15 minutes into the 
downhill run was higher in the CON group (r = 0.98, P < 0.01) than in the 
FAMS group (r = 0.71, P < 0.01). 
Table 3.C.19. Treadmill speed (Speed), heart rate (HR) and stride frequency 
(SF) at minutes 5, 10 and 15 during the downhill run performed at 70% of 
PTRS. 
FAMS CON 
Speed 10.68 ± 1.78 (20) 10.57 ±2.16 (10) 
HR5 140 ± 14 (20) 144 ± 17 (10) 
HR10 142 ± 13 (19) 146 ± 19 (10) 
HR15 142 ± 11 (18) 148±20 
SF5 84 ± 5 (20) 84 ± 5 (10) 
SF10 84 ± 5 (15) 84 ± 5 (10) 
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Figure 3.C.B. Heart rate changes dur'ing the 15 minute downhill run in FAMS 
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Figure 3.C.9. The relationship between stride frequency (SF5) and age during 
the downhill run in FAMS (a) and CON (b) groups (- - p < 0.01). 
The vastus lateralis fibre type morphology of the FAMS and CON group are 
described in table 3.C.20. There were no significant differences in fibre type 
between FAMS and CON groups. There were - 50% type I fibres in the 
muscle sample of both FAMS and CON subjects. There was a significant 
negative correlation between type I fibre % and LAC3min in the FAMS group 
(r = 0.45, P < 0.05). Although the correlation between type I fibre % and 
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LAC3min was higher in the CON group (r = - 0.55, NS), the relationship was 
not significant. There were no significant relationships between type I fibre % 
and age, LTV, V02max, DJdiff or SF5 in FAMS or CON group. There was a 
higher negative correlation between type I fibre % and DJdiff in CON (r = -
0.63, NS) than FAMS (r = - 0.30, NS) group, although these correlations were 
both not significant. 
Table 3.C.20. Vastus lateralis muscle fibre type percentages (%) for FAMS 
and CON groups. 
FAMS CON 
Type I 54.6 ± 17.1 (20) 50.2 ± 13.7 (9) 
Type IIA 38.0 ± 15.1 (20) 46.4 ± 15.2 (9) 
Type IIC 5.3 ± 7.8 (20) 2.2 ± 4.0 (9) 
Type liB 1.8 ± 2.5 (20) 1.0 ± 1.7 (9) 
The histology pathology scores of the vastus lateralis muscle sample for 
FAMS and CON groups are described in table 3.C.21. There was a 
significantly higher pathological score for the presence of staining 
abnormalities (P < 0.01), fibre size variation (P < 0.01), internal nuclei (P < 
0.01) and overall pathology score (P < 0.01) (figure 10) in the FAMS 
compared to CON group. Although there was a tendency for the pathology 
scores for presence of subsarcolemmal mitochondria and the presence of 
necrosislinflammation to be higher in theFAMS compared to CON group, 
these differences were not significant. Fifteen of the twenty subjects in the 
FAMS group had staining abnormalities, while no CON subjects had staining 
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abnormalities. Tbirteen of the twenty FAMS subjects had a pathological level 
of internal nuclei present in their muscle fibres, while no subjects in the CON 
group had a pathological level of internal nuclei. 
Table 3.C.21. Histological pathological changes in the vastus lateralis muscle 
sample for FAMS and CON groups (Mitochondria - subsarcolernmal 
mitochondrial aggregations) 
FAMS CON 
Mitochondria 2.2 ± 1.0 (20) 1.7 ± 0.9 (9) 
Staining abnormalities 0.8 ± 0.4 (20)- 0.0 ± 0.0 (9) 
Fibre size variation 1.7 ± 1.2 (20)** 0.3 ± 0.5 (9) 
Necrosis/Inflammation 0.8 ± 1.3 (20) 0.6 ± 0.7 (9) 
Internal nuclei 1.5 ± 1.3 (20)** 0.0 ± 0.0 (9)· 
Overall 6.9 ± 3.8 (20)- 2.6 ± 1.2 (9) 
- - P < 0.01 Staining abnormalities FAMS vs.CON 
Fibre size abnormities FAMS vs. CON 
Internal nuclei FAMS vs. CON 
Overall score FAMS vs. CON 
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Figure 3.C.1 O. The overall pathology score for the vastus lateralis muscle 
sample in FAMS and CON groups (** - p < 0.01) 
Discussion 
The first finding of this study was that the FAMS athletes had significantly 
higher pathological scores for the vastus lateralis muscle sample than the 
control athletes. Although there were no differences in fibre type percentages 
between the two groups, the FAMS subjects had significantly higher 
pathological scores for the presence of staining abnormalities, fibre size 
variation, presence of internal nuclei and overall score. The scores for 
subsarcolemmal mitochondrial aggregations and presence of 
necrosis/inflammation were also higher in the FAMS than the control group, 
although these differences were not significant. As the control subjects had 
none of the symptoms of excessive fatigue and no decrements in physical 
performance which were found in the FAMS group, these findings suggest an 
association between the muscle pathology and symptoms of excessive 
fatigue and performance decrements in the FAMS athletes. 
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A possible mechanism linking the symptoms of fatigue and the muscle 
pathology in the fatigued athletes may be that afferent signals from receptors 
in the damaged muscles are chronically activated in response to muscle 
pathology, and this afferent signaling induced the symptoms of fatigue as a 
protective mechanism to prevent further exercise activity and the possibility of 
further muscle damage. According to this model therefore, the decrements in 
performance are a response to this afferent signaling, and are part of 
protective mechanism. These afferent signals may be derived from 
nociceptors in the damaged muscle, from muscle spindle or golgi tendon 
organs activated by mismatches in neuromuscular efficiency due to the 
muscle damage (Sharwood et al 2000) or from type iii and iv chemoreceptors 
responding to continuous regenerative and metabolic changes in the 
damaged muscles. 
Another possible mechanism for the symptoms of fatigue is that humoral 
factors from the chronically damaged muscles induce symptoms of fatigue. In 
the "cytokine hypothesis" Smith (2000) suggested that high volume or high 
intenSity training, with insufficient rest, would produce muscle and possibly 
joint trauma. Circulatory cytokines are increased due to this trauma. These 
evoke a monocyte, and subsequently a systemic inflammatory response. The 
elevated cytokines would co-ordinate a whole body response, including 
communicating with the CNS and inducing a set of "sickness behaviors" which 
cause mood and activity changes. Fatigue and decrements in physical activity 
are examples that would enhance the resolution of the illness. Smith (2000) 
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suggested therefore that the symptoms of fatigue are part of an adaptation 
response which would be a protective mechanism in response to excessive 
physical or physiological stress. Although Smith (2000) was describing a 
relatively short term response to acute muscle micro-trauma which occurs in 
the overtraining syndrome and is reversed by rest, one may speculate that the 
long term excessive fatigue symptoms found in the FAMS athletes in our 
study may have a similar causal mechanism, albeit on a longer term basis. In 
accordance with this, one can also sllggest that if cytokines were responsible 
for the symptoms, and were caused by muscle microtrauma, then muscle 
damage was ongoing with every exercise bout. Possibly with time the muscle 
loses the ability to adapt and regenerate to this ongoing microtrauma. The 
validity of this theory will have to be tested in future research studies. 
The next finding of the study was a dissociation between physiological 
. variables in the FAMS subjects compared to the controls in activities that 
involved complex gait or movement patterns. For example, while there were 
significant correlations between stride frequency during submaximal treadmill 
running and age, lean thigh volume and V02max in the control subjects, these 
correlations were lower and not Significant in the FAMS subjects. The 
relationship between stride frequency at 5 and stride frequency at 15 minutes 
was also higher in the controls (r=0.98) than FAMS subjects (r = 0.71). 
Similarly, the relationship between drop jump height and lean thigh volume 
was higher in the control subjects compared to the FAMS subjects. In 
contrast, the relationship between more simple, absolute measurements such 
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as lean thigh volume and peak isometric force output was similar between 
FAMS and control groups. 
These findings indicate that there may have been a reduction in 
neuromuscular efficiency during complex movements in the FAMS subjects, 
produced possibly by the underlying muscle damage in the vastus lateralis 
and possibly other muscle groups which were not biopsied. This may have 
occurred because efferent neural command strategies had not taken into 
account the extent of the muscle damage, due to a mismatch in afferent input 
and central command strategies. Another explanation was that there were 
alterations in whole limb recruitment strategies during complex activities 
because of the damaged muscle, or to protect the affected muscle. 
Sharwood et al (2000) also described greater dissociation in neuromuscular 
efficiency after a downhill run to stimulate eccentric damage in veteran 
runners who had raced more than 5 000 krn pri,or to testing compared to less 
experienced runners. They suggested that the subjects who had raced more 
than 5000 km may have responded differently because of changes in whole 
limb recruitment. The causes were either underlying muscle damage as a-
result of years of racing activity, or alterations in muscle stiffness due to 
alterations in the viscoelastic properties of the muscle and tendons. These 
changes may have been caused by underlying muscle pathology or tendinous 
injury asa result of years of high volume training and racing. No muscle 
biopsies were performed on their subjects, leaving this interpretation as 
speculative. However, the results of this study would support the findings of 
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their trial. This loss of neuromuscular efficiency has also been observed in 
athletes competing in endurance running where towards the end of the race 
they appear to lose their "springiness" causing a "shuffling" gait (Noakes et al 
1992). A number of the fatigued athletes in trlis study reported that this loss of 
"springiness" was exacerbated with the onset of their symptoms and 
decrements in performance, and that this loss of "springiness" eventually 
occurred during routine training activity and not only in the latter stages of 
endurance events. 
In contrast to these findings during submaximal complex activities, there were 
no significant differences between FAMS and control groups for a number of 
maximal physiological tests. These included maximal aerobic capacity, 
maximal isometric force output, maximal drop jump height, neuromuscular 
activity during a 25 s isometric maximal endurance fatigue test, and blood 
lactate accumulation during maximal aerobic testing. Peak treadmill running 
speed was also similar between the two groups. This suggests that while the 
muscle pathology was significantly greater in the FAMS subjects than control 
subjects, the muscle damage did not affect maximal system capacity in these 
subjects. In athletes with mitochondrial myopathies and other classical 
inherited myopathies there is a profound reduction in performance capacity 
during these tests. Therefore, it is likely that while the muscle pathology 
caused the symptoms described in previous chapters, it did not cause 
breakdown of the different physiological systems, as occurs in the classical 
myopathies (McComas 1996). A point to consider is that control subjects were 
matched for current exercise activity, rather than level of activity the athletes 
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performed at prior to the development of their systems. If athletes were 
matched to this previous level of activity it is conceivable that there would 
have been significant differences in performances between groups. 
The next finding was that a significantly higher percentage of fatigued athletes 
had a history of biomechanical injuries and respiratory and viral illnesses than 
the control subjects prior to their deterioration in performance. However, the 
fatigued athletes reported significantly reduced running injuries and 
biomechanical problems after the deterioration in performance and reduction 
in their training intensity and volume. This finding indicates that while the high 
volume of training predisposed the athletes to a number of exercise related 
injuries and illness (MacKinnon 2000), reduction in volume and intensity of 
activity may have paradoxically been beneficial to the fatigued athletes. Thus, 
although the muscle had pathological changes, it is reasonable to suggest 
that the ongoing abnormal fatigue symptoms and reduction in athletic 
performance reduced the risk of more serious injury. This could be described 
as a teleoanticipatory strategy (St Clair Gibson et al 2001 (c); Ulmer 1996). 
However, there was no significant reduction in the incidence of viral or 
respiratory infections, indicating that the immune system of the fatigued 
athletes may have continued to be compromised even with the reduction in 
exercise activity. This would agree with the cytokine hypothesis of Smith 
(2000), as changes in immune function with increased fatigue syndrome 
would both be part of the "sicknesses" associated with this hypothesis, and as 
muscle pathology was still present at the time of testing, the increased 
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cytokine response may be ongoing, leading to chronic alterations in immune 
function. 
W~lile the fatigued athletes complained of symptoms of excessive fatigue and 
reduction in exercise performance, there were no significant differences 
between fatigued athletes and controls on medical examination of the 
cardiovascular, respiratory, central nervous system, abdominal or 
musculoskeletal systems. Similarly, there were no differences in resting heart 
rate, systolic or diastolic blood pressure, or lower limb biomechanical 
assessment. This perhaps explains why several of the subjects were 
misdiagnosed by other medical practitioners prior to being tested in our unit. 
The Beck psychological score was significantly higher in the fatigued athletes 
than in the control group. In the previous chapter a high proportion of 
psychological pathology was present in the fatigued athletes. In this study, i~ 
was sUggested that athletes may have abnormal psychological profiles which 
may have predisposed them to exercise excessively (De La Torre 1995; 
Noakes 1992; Weight and Noakes 1987). This obsessive behavior may have 
resulted in the development of their muscle pathology and fatigue symptoms. 
This finding is strengthened in this study where the control runners were also 
athletes who participated in exercise activities on a regular basis, and did not 
have similar levels of psychological abnormalities. However, this conclusion 
should be made with caution as the control group sample size was relatively 
small. While it is likely that the symptoms of fatigue are related to the muscle 
pathology described previously, the symptoms of fatigue may also be part of 
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an unrelated syndrome or clinical depression in the fatigued athletes (Gibson 
et al 1993). Indeed, a number of these fatigued athletes who had consulted 
medical doctors about their deteriorating athletic performances were 
diagnosed as being depressed and prescribed a variety of antidepressants. 
One may also postulate that changes in the brain structures themselves, 
unrelated to the muscle damage, caused by the chronic exercise activity, may 
lead to the abnormal symptoms of fatigue. This may be either "hardwiring" of 
the cortical irnpulses as a physiological protective mechanism, or pathological 
damage to either neurotransmitter release processes or to cortical or midbrain 
cellular structures caused by this chronic excessive exercise activity. 
In the previous chapter, it was suggested that infectious agents such as EBV 
may be responsible for the symptoms of excessive fatigue and muscle 
pathology. However, although 14 of 14 fatigued athletes had evidence of a 
previous EBV infection, 2 of 2 control subjects similarly had evidence of a 
previous EBV infection. Therefore, although the clinical symptoms of fatigue 
may be related to a subclinical undiagnosed or recurring viral infection, or 
other medical entity, it is unlikely that EBV infection is directly involved in the 
pathological processes generating the excessive symptoms of fatigue and 
muscle damage present in the fatigued athletes. 
During the 25 second isometric endurance test, the power output of the FAMS 
(- 0.94) group decreased less than the controls (- 0.86) , although these 
differences were not significant. This finding is surprising, as one would have 
expected greater decrements in force output in the fatigued athletes. The 
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IEMG increased to a higher level in the FAMS subjects during the same test, 
although these differences were not significant. As IEMG activity may be 
indicative of neuromuscular recruitment (Hakkinen and Komi 1983), these 
'findings indicated that a pacing strategy may have been active during the 
isometric "maximal" isometric endurance test. The subjects were required to 
begin the test with maximal force output, and attempt to maintain this force 
output throughout the trial. They were vocally encouraged during the trial. 
These 'findings would indicate that the subconscious teleoanticipation 
mechanism described previously in the literature review (St Clair Gibson et al 
2001 (c); Ulmer 1996), was demonstrated during this trial. The fact that the 
IEMG increased during the trial suggests that the subjects did not start the 
trial recruiting all the available muscle fibres. Rather, there was a reserve of 
muscle fibres not utilized at the start of the trial. This is an example of 
teleoanticipation as the recruitment strategy allowed the maintenance of the 
force output throughout the trial, despite the damaged muscles in the fatigued 
subjects. The subjects reported that they consciously attempted to produce 
maximal force throughout the trial, so this pacing strategy must have been 
regulated at a subconscious level. An alternate explanation was that different 
fibre recruitment patterns occurred during the contraction in the fatigued 
athletes. However, there was no differences between fibre type percentages 
in the muscles fibres of the vastuslateralis muscle sample between FAMS 
and CON groups. Further, changes in the EMG frequency spectrum reduction 
was similar. This is a surrogate measure of conduction velocity and fibre type 
recruitment and therefore indicates that neuromuscular firing rate 
transmission and fibre recruitment selection were similar. Therefore, one must 
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speculate that a teleoanticipatory pacing strategy occurred in the FAMS 
athletes, and to a lesser degree in the controls, as a protective mechanism to 
prevent further injury. 
Finally, there was some evidence of muscle pathology in the control subjects, 
though to a significantly lower degree than in the fatigued athletes. This 
included subsarcolemmal mitochondrial aggregations, muscle fibre size 
variation and the presence of muscle fibre necrosis/degeneration. It has been 
previously suggested that the muscle pathology in the fatigued athletes 
represent an "accelerated" aging phenomenon, and similar findings of muscle 
and mitochondrial damage has been found in elderly individuals as part of the 
normal aging process (Grabiner and Enoka 1995; Johnston et al 1995; 
Katayama et al 1991) and in athletes after endurance exercise activity 
(Goodman et al 1997; Hikida et a11983; Warhol et al 1985). This finding is 
therefore not completely surprising, and one could suggest that several of the 
control su/Jjects may develop the FAMS syndrome in the future if they 
continue with their exercise activity. An alternative conclusion is that these 
changes in muscle morphology in the control subjects were part of the normal 
ageing process. 
An apparent paradox of this study was that despite the presence of neural 
regulatory mechanism described previously, the athletes still developed 
muscle pathology. This would suggest that the central regulatory mechanisms 
can be over-ridden, or are not successful in certain circumstances. This may 
occur during some forms of exercise activity where individuals with greater 
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mental "toughness" may push themselves to complete an event despite the 
warning symptoms of excessive levels of exercise intensity. Thi s has been 
described previously as the cognitive discussion theory (St Clair Gibson et al 
2001 (a)), which s~ggests that conscious decision making processes may be 
able to over-ride the subconscious regulatory systems to a certain degree in 
competitive situations, when social and psychological factors such as financial 
and competitive pressures occur. 
It may also be suggested that muscle damage can occur without associated 
symptoms of fatigue, such as occurs during DOMS where the pain is first 
noticed only - 24 hours or longer after a relatively easily performed eccentric 
challenge (Chambers et al 1998; Semark et al 1999). Therefore, because of 
this delay in the onset of the pain sensation, cognitive processes may not 
directly "associate" the activity which caused the muscle damage and the 
resultant symptoms of pain, and therefore not initiate "avoidance" behaviors to 
prevent similar activity in the future. This may suggest a failure in the 
evolutionary design of the human system, or that evolution has not had 
sufficient time to react to the changes in human biomechanics which occurred 
with the onset of bipedal walking and which were associated with increases in 
eccentric muscle activity. Further research is needed to examine this 
hypothesis. 
The fatigued athletes in this study may also paradoxically not be the group of 
individuals most susceptible to muscle injury, despite the onset of their 
symptoms and decrements in at~iletic performance. As suggested by 
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Sharwood et al (2000), other athletes may also be vulnerable to develop 
muscle pathology in their muscles and may, as a result, cease running 
marathon and ultra-marathon races after relatively short careers. Also, many 
athletes may also be incapable of training and racing the volumes described 
by the fatigued athletes in this study because of biomechanical or 
physiological factors which predispose them to injury. Conversely, it is not 
clear why other athletes, with similar training and racing histories, do not 
report the excessive fatigue symptoms and decrements in force output 
described in the subjects in this trial. Possibly they have a greater resistance 
to muscle damage than the athletes in this trial. It may also be that they feel 
similar symptoms of fatigue, and decrements in performance, but perceive 
these changes to be age-related, and continue their activity but readjust their 
goals and expectations to a lower standard. Anecdotal evidence from 
discussion with athletes who have trained for several decades is that exercise 
activity at even reduced training pace cause a greater perception of effort with 
increasing age. One must speculate that these veteran athletes would also 
have chronic muscle damage, but are able to resist these changes either due 
to better physiological protective mechanisms or due to better psychological 
coping mechanisms. 
In conclusion, the findings of this study indicate that the fatigued athletes have 
a greater degree of muscle pathology than that found in control subjects, and 
one must speculate an association between the muscle changes and the 
symptoms of excessive fatigue and decrements in athletic performance in the 
FAMS subjects. The findings of this study suggest that while the symptoms of 
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fatigue and muscle pathology do not have an affect on maximal force output, 
maximal aerobic capacity, and other physiological parameters, there appear 
to be changes which occur during submaximal running and also jumping 
activity, where there is a dissociation between various physiological factors, 
particularly those related to stride frequency. These findings may indicate that 
the muscle damage may interfere with the ability to produce complex muscle 
activity or coordinated gait patterns, and the symptoms of excessive fatigue 
and poor physical performance may be related to these findings. One may 
also suggest that the symptoms of fatigue, and pacing strategies described 
during various maximal capacity testing, may be part of protective, exercise 
reducing strategies which are present as part of teleological mechanisms to 
reduce further muscle damage or "accelerated" aging processes. 
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3.0. Antioxidant therapy and fatigued athletes 
Introduction 
In the previous chapters, athletes with symptoms of excessive fatigue and 
decrements in physical performance were shown to have evidence of muscle 
pathology. It was suggested that this muscle pathology, and the associated 
symptoms, may be a form of "accelerated" aging, and that the changes were 
of a permanent nature. 
However, in this chapter, the aim was to examine whether the symptoms and 
pathology described in these fatigued athletes may be improved or attenuated 
with treatment aimed at reducing the muscle damage. It was previously 
suggested that the muscle pathology may have been caused by oxidative 
damage to muscle fibres and cellular organelles from increased free radical 
formation due to the increased metabolic rate associated with exercise activity 
(Ashton et al 1998; 8ejma and Li 1999; Poulsen et al 1996; Sen 1995). It has 
also been suggested that exogenous antioxidant supplementation may reduce 
exercise associated oxidative tissue damage (Dekkers et al 1996; Evans 
2000; Packer et al 1994). 
Therefore, in this study, a trial of antioxidant drugs were given to the 20 
fatigued athletes, to assess whether they reduced symptoms of excessive 
fatigue and decrements in physical performance described in these athletes. 
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Methods 
The twenty FAMS subjects described previously in this thesis were recruited 
for this study. All twenty subjects participated in a random, double blind, 
placebo controlled drug trial to investigate the effect of antioxidant drug 
therapy on their fatigue symptoms and exercise capacity. A combination of 
the following drugs were tested during this trial: vitamin C 500 mg (Golden 
Neo-Life Diamite International), vitamin E 200 IU (Golden Neo-life Diamite 
International), flavenoid complex (Golden Neo-Life Diamite International) and 
carotenoid complex (Golden Neo-Life Diamite International). The subjects 
were informed of the nature of the drugs to be ingested during the trial, and 
the possible side effects of these drugs, but were blinded as to whether they 
were taking drug or placebo in the different phases of the trial. All subjects 
signed an informed consent prior to starting the trial. The trial protocol was 
approved by the Ethics and Research Committee of the University of Cape 
Town. 
In the first part of the trial, 10 subjects orally ingested all the actual drugs in 
tablet form, and the other 10 subjects ingested the same number of identical 
looking placebo tablets. In the second part of the trial, the first 10 ten subjects 
who had ingested the actual drugs ingested the placebo tablets. The subjects 
who had ingested the placebo drug in the first part of the trial ingested the 
active drug in the second part of the trial. The subjects ingested either drug or 
placebo for 3 months, with a washout period of one week duration between 
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the two parts of the trial. The whole trial for each individual was of six months 
duration. 
Subjects were assigned either the drug or placebo groups randomly, and 
neither the subjects or investigators were aware of whether the subject was 
ingesting drug or placebo during either part 1 or part 2 of the trial. The drug 
and placebo tablets were supplied in identical cartons, labeled Product A 
(Placebo vitamin C), Product B (Placebo vitamin E), Product C (Placebo 
flavenoid complex), Product D (Placebo carotenoid complex), Product W 
(vitamin C), Product X (vitamin E), Product Y (flavenoid complex), and 
Product Z (carotenoid complex). The drug codes were kept by the trial 
sponsors in France, while the trial was performed in Cape Town, South Africa. 
The investigators were only made aware of the identity of the tablets after the 
completion of the testing phase, laboratory procedures, and basic data 
analysis of the entire group of 20 subjects was completed. 
The subjects were tested on three occasions during the drug trial. Visit 1 was 
their initial visit to the Unit, prior to beginning either phase of the drug trial. 
Visit 2 was at the end of the first phase of the drug trial, and visit 3 was at the 
end of the second phase of the trial, which corresponded with the end point of 
the trial. The subjects all underwent the same physical and medical testing at 
all three visits. 
At visit 2 and visit 3, all subjects completed a questionnaire (Appendix) 
assessing their subjective knowledge of whether they had ingested drug or 
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placebo during the previous phase of the trial, and whether they had noticed 
any symptom or training capacity improvement during the previous phase of 
the trial. At visits 2 and 3 all subjects also completed a questionnaire 
assessing the incidence of side effects during the previous phase, and 
whether they subjectively perceived that these side effects were directly 
related to ingestion of the drugs or placebo in the completed phase. 
The subjects also completed a Beck psychological questionnaire, as 
described in a previous chapter (Chapter 3.B.), at all three visits. Their 
anthropometrical measurements, resting heart rate and blood pressure, drop 
jump capacity, maximal and endurance isometric force output capacity, 
maximal aerobic uptake capacity and related physical and blood parameters, 
-and stride frequency and heart rate during a submaximal run was assessed in 
all subjects at all three visits. The methodology for all these test have been 
described in detail in previous chapters (Chapter 3.A.; Chapter 3.B.; Chapter 
3.C.). 
After the drug code was received, the data was analyzed as Drug and 
Placebo groups. This was calculated by subtracting the data from visit 2 or 
visit 3, as appropriate according to whether these were drug or placebo 
phases of the trial for each person, by the value for the same parameter at 
visit 1. Thus all data are described as relative, rather than absolute data, to 
assess improvement or decrement in performance which could be related to 
ingestion of either drug or placebo tablets. 
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Statistics 
All data are described as means ± standard deviation (SO). Differences 
between parametric data for Drug and Placebo groups were 'analyzed using 
the Student's t-test. All non-parametric data were analyzed using the 
Wilcoxon matched pairs test. The questionnaire data were analyzed using the 
non-parametric Chi-squared test. Statistical significance was accepted when 
P < 0.05). 
Results 
Four subjects withdrew from the trial before the end of the first phase of 
testing. One of these subjects stated that the number of pills to be taken on a 
daily basis were too many for him to tolerate and he withdrew for this reason. 
Two other subjects felt that taking the pills and being involved in the trial 
inconvenienced their daily lifestyle and withdrew for this reason. The fourth 
subject gave no specific reason for his withdrawal. The data for the remaining 
16 subjects, who all completed the entire trial, are described below. 
The subjective knowledge of the subjects of whether they were ingesting drug 
or placebo, and the effect of either of these on symptoms and training 
capacity, are described below in table 3.0.1. There were no significant 
differences in drug knowledge between Drug and Placebo groups. Less than 
half of the subjects in either Drug (36%) or Placebo (33%) groups correctly 
guessed the nature of the tablet they ingested. A similar percentage of 
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subjects in drug and placebo groups gave incorrect answers, or were unsure 
of the content of the tablets they had ingested (Figure 3.D.1.). 
The percentage of subjects who felt the tablets had improved their symptoms 
was higher in the Drug (43%) than Placebo group (31 %), although this 
difference was not significant. There was no significant difference in the timing 
of improvement of symptoms between those in the Drug and Placebo groups, 
with a similar number of individuals in both groups suggesting that the tablets 
had improved symptoms either in the first month, second and third month, or 
throughout the trial. Two subjects indicated that both drug and placebo tablets 
had improved their symptoms. 
There were no significant differences in rating of training capacity 
improvement scores between Drug and Placebo groups. The number of 
subjects who thought that ingesting the tablets had improved their training 
capacity and ranked this improvement with the highest positive score was 
higher in Drug (50%) than Placebo (20%) group, although these differences 
were not significant. 
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Table 3.0.1. Absolute (Abs, n) and relative (Rei, %) differences in the 
subjective knowledge of whether they were ingesting drug and placebo, the 
effect of the drug and placebo on symptom improvement, timing of symptom 
improvement and improvement in training capacity in Drug and Placebo 
groups. 
Drug Placebo 
Abs (n) Rei (%) Abs (n) Rei (n) 
Drug knowledge Correct 5 36 5 33 
Incorrect 4 28 4 27 
Unsure 5 36 6 40 
Symptom Yes 7 43 5 31 
improvement No 6 38 4 25 
Unsure 3 19 7 44 
Timing of Month 1 2 12 2 13 
improvement Month 2-3 3 19 2 13 
Trlroughout 3 19 3 20 
None 8 50 8 54 
Training 1 (Yes) 7 50 3 20 
Improvement 2 1 7 7 47 
3 1 7 2 13 
4 3 22 2 13 
5 (No) 2 14 1 7 
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Figure 3. D.1. Differences in the subjective knowledge of content of tablets in 
Drug and Placebo groups. 
Table 3.D.2. describes the subjective assessment of side effects in Drug and 
Placebo groups. There were no significant differences between groups for 
subjective assessment of side effects related to tablet ingestion. One subject 
in the Drug group thought that ingesting the tablets caused shortness of 
breath and headaches. A second subject in the Drug group thought that he 
may have had increased fatigue after ingesting the tablets, but was unsure if 
this was directly related to the tablets. 
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Table 3.0.2. Absolute (Abs, n) and relative (Rei, %) differences in the 
subjective assessment of side effects associated with drug (n= 14) and 
placebo (n=15) ingestion. 
Drug Placebo 
Abs (n) Rei (%) Abs (n) Rei (n) 
Side Effects Present 1 7 o o 
Absent 12 86 15 100 
Unsure 1 7 o o 
Tale 3.0.3 describes the changes in Beck psychological score in Drug and 
Placebo groups. In both groups, there was a decrease in the psychological 
score, but there were no significant differences between these changes in 
Drug and Placebo groups. 
Table 3.0.3. Differences in the Beck psychological scale (Arbitrary units, AU) 
between Drug and Placebo groups. 
Drug Placebo 
Beck score -1.69 ± 5.21 (16) -1.25 ± 3.80 (16) 
The changes in anthropometrical parameters are described in table 3.0.4. 
Body mass decreased (- 0.53 kg) in the Drug group and increased marginally 
in the Placebo group (- 0.06 kg), although these differences between groups 
were not significant. Percentage body fat, LTV and mid-thigh girth decreased 
similarly in both Drug and Placebo groups. 
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Table 3.D.4. Absolute (Abs) and relative (Rei) differences in change in mass 
(kg), percentage body fat (%), lean thigh volume (LTV, cm) and mid-thigh girth 
(Mid-thigh, cm) between Drug and Placebo groups. 
Drug Placebo 
Mass (Abs) -0.53 ± 1.79 (15) 0.06 ± 1.51 (15) 
Mass (Rei) 99.84 ± 2.54 (15) 100.00 ± 2.22 (15) 
Body Fat (Abs) -0.07 ± 2.06 (16) -0.44 ± 2. 1 0 (16) 
Body Fat (Rei) 99.55 ± 9.25 (16) 97.78 ± 10.64 (16) 
LTV (Abs) -57.56 ± 286.67 (16) -70.19 ± 298.60 (16) 
LTV (Rei) 99.39 ± 8.49 (16) 98.74 ± 7.64 (16) 
Mid-Thigh (Abs) . -1.13± 1.95 (16) -1.4 ± 2.40 (16) 
Mid-Thigh (Rei) 97.89 ± 3.94 (16) 97.36 ± 4.41 (16) 
The change in resting heart rate (HRrest) and systolic (SBP) and diastolic 
(DBP) blood pressure in Drug and Placebo groups is described in table 3.D.5. 
HRrest was increased in Drug and decreased in Placebo group, and the 
differences between groups for HRrest was significant (P < 0.05) (Figure 
3.D.2). SBP was decreased in Drug and increased in Placebo, but the 
differences between groups were not significant. DBP was decreased in Drug 
and increased in Placebo group, and the difference between groups for DBP 
was significant (P < 0.05) (Figure 3.D.2.). 
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Table 3.0.5. Absolute (Abs) and relative (Rei) differences in change in resting 
heart rate (HRrest, beats/min) systolic (SBP, mm Hg) and diastolic blood 







* - P < 0.05 
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3.92 ± 6.92 (12)* -1.75 ± 6.22 (12) 
107.40 ± 12.20 (12)* 97.74 ± 9.79 (12) 
-1.42 ± 10.78 (12) 1.42 ± 16.57 (12) 
99.39 ± 8.32 (12) 102.22 ± 13.59 (12) 
-1.25 ± 5.71 (12)* 5.33 ± 10.43 (12) 
98.70 ± 7.54 (12)** 108.05 ± 13.90 (12) 
HRrest (Abs) Drug vs; Placebo groups 
HRrest (Rei) Drug vs. Placebo groups 
DBP(Abs) Drug vs. Placebo groups 




Figure 3.0.2. Percentage (%) differences in change in resting heart rate 
(HRrest, beats/min) systolic (SBP, mm Hg) and diastolic blood pressure 
(DBP i mm Hg) between Drug and Placebo groups (* - P < 0.05; ** - P < 0.01 ). 
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Table 3.0.6: describes the changes in drop jump height between Drug and 
Placebo groups. The drop jump height increased in both Drug and Placebo 
groups, and there were no significant differences between groups. 
Table 3.0.6. Absolute (Abs) and relative (Rei) differences in change in drop 
jump height (cm) between Drug and Placebo groups. 
Drop Jump Abs (cm) 
Drop Jump Rei (%) 
Drug 
0.78 ± 3.66 (16) 
103.58 ± 18.21 (16) 
Placebo 
1.22 ± 3.63 (16) 
105.29 ± 19.52 (16) 
Table 3.0.7. describes the differences in changes in 5 s MVC force output 
between Drug and Placebo groups. Force output marginally increased in the 
Drug group and decreased in the Placebo group, although differences 
between groups was not significant. 
Table 3.0.7. Absolute (Abs) and relative (Rei) differences in 5 s maximal 
voluntary contraction between Drug and Placebo groups. 
MVC (Abs) N 
MVC (Rei) % 
Drug 
-4.13 ± 79.65 (16) 
100.85 ± 15.00 (16) 
Placebo 
-21.06 ± 83.34 (16) 
97.20 ± 17.08 (16) 
The changes in force output during the two 25 s isometric force output tests 
are described in table 3.0.8. These values were examined as absolute values 
for visit 2 and visit 3, and not relative to values for visit 1. The force output 
decreased by - 6-9 % in both endurance test 1 and endurance test 2 in both 
Drug and Placebo groups. There were no significant differences between 
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Drug and Placebo group for these decrements in force output during the 
endurance tests. 
Table 3.0.8. Absolute (Abs) and relative (Rei) differences in the two 25 s 
endurance maximal force output tests (End 1 - test 1, End 2 - test 2, N) 
between Drug and Placebo groups. 
End 1 (Abs) 
End 1 (Rei) 
End 2 (Abs) 
End 2 (Rei) 
Drug 
-5.29 ± 13.45 (16) 
94.98 ± 13.02 (16) 
-6.03 ± 15.27 (15) 
93.87 ± 16.03 (15) 
Placebo 
-7.56 ± 13.29 (16) 
91.96 ± 14.85 (16) 
-5.02 ± 14.64 (15) 
94.91 ± 15.20 (15) 
Table 3.0.9. describes the changes in V02max, HRmax, PTRS and LAC3min 
during the maximal aerobic uptake test in Drug and Placebo groups. While 
V02max (- 1 %) and HRmax (- 0.5 %) decreased marginally, PTRS 
increased (- 3%), but the difference in these changes between Drug and 
Placebo groups was not significant. LAC3min decreased by - 15 % in Drug 
and - 5 % in Placebo group, although the differences in these changes was 
not significant between groups (Figure 3.0.3.). 
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Table 3.D.9. Absolute (Abs) and relative (Rei) (%) differences in V02max (ml 
02/kg/min), maximal heart rate (Hrmax; beats/min) and peak treadmill running 
speed (PTRS; km/h) and blood lactate (LAC; mmol/L) between Drug and 



















-0.85 ± 4.42 (14) 
98.87 ±9.18 (14) 
-0.60 ± 6.87 (15) 
99.72 ± 3.60 (15) 
0.38 ± 0.96 (16) 
102.61 ±6.78 (16) 
-1.62 ± 2.15 (15) 
85.57 ± 20.30 (15) 
Placebo 
-0.69 ± 3.55 (14) 
99.16 ± 6.65 (14) 
-0.87 ± 9.50 (15) 
99.56 ± 5.05 (15) 
0.56 ± 0.96 (16) 
104.07 ±6.40 (16) 
-0.71 ± 2.59 (15) 




Figure 3.D.3. Differences in changes in V02max (ml 02/kg/min), peak 
treadmill running speed (PTRS, km/h) and blood lactate (LAC3min, mmollL) 
between Drug and Placebo groups during the V02max test 
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Table 3.D.10. describes the changes in HRS and SFS during the downhill run 
performed at 70% of PRTS in Drug and Placebo groups. While HRS 
decreased in both groups, HRS decreased to a significantly lower value in 
Placebo compared to Drug group (P < O.OS) (Figure 3.D.4.). SF5 decreased in 
both groups (- 2 %), but the differences between Drug and Placebo groups 
was not significant. 
Table 3.D.1 O. Absolute (Abs) and relative (Rei) differences in changes in 
submaximal downhill run heart rate (HRS) and stride frequency (SFS) 





* - P < O.OS 
Drug Placebo 
-6.18 ± 10.67 (11)* -12.64 ± 13.76 (11) 
9S.93 ± 7.02 (11)* 91.2S ± 9.33 (11) 
-1.SS±3.93(11) -2.36 ± 4.67 (11) 
98.36 ± 4.39 (11) 97.41 ± 5.13 (11) 
HR (Abs) Drug vs. Placebo groups 

















Figure 3.0.4. Differences in changes in submaximal downhill run heart rate 
(HR5) and stride frequency (SF5) between Drug and Placebo groups. (* - P < 
0.05). 
Discussion 
The first 'finding of this study was that antioxidant therapy consisting of vitamin 
C 500 mg, vitamin E 200 IU, flavenoid complex and carotenoid complex 
caused no significant improvement in the symptoms of excessive fatigue or 
physical performance of the fatigued athletes tested in this trial. There were 
no significant differences between antioxidant and placebo groups for 
subjective perception of improvement, subjective perception of training 
improvement, Beck psychological scores, drop jump height, maximum 
voluntary contractions, 25 s maximal isometric endurance test, peak aerobic 
capacity, peak treadmill running speed, maximal heart rate attained at peak 
treadmill running speed, or blood lactate concentrations 3 minutes after the 
termination of the peak treadmill running speed test. These findings suggest 
either that oxidative processes may not be involved in the generation of the 
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abnormal fatigue symptoms and decrements in performance in these athletes, 
or that the muscle damage and other physiological pathology in these 
subjects was too profound, or was of a permanent nature, and could therefore 
not be improved by the antioxidant therapy used in this trial. 
As described in the literature, it has been speculated that during exercise the 
endogenous antioxidant system is overwhelmed by the increased ROS 
production associated with the increased metabolic rate, and that exogenous 
antioxidant supplementation may have a beneficial effect in reducing ROS 
associated muscle damage (Clarkson and Thompson 2000; Dekkers et al 
1996; Jones and Round 1990; Packer et aI1994). Atalay et al (2000) and 
Coombes et al (2000) described that supplementation with vitamin E and 
other antioxidants improves scavenging of ROS. Jakemen and Maxwell 
(1993) showed that vitamin C, but not vitamin E, exerted a protective effect 
against eccentric exercise-induced muscle damage. 
In contrast, Kanter et al (1993) showed that an antioxidant vitamin mixture of 
- 600 mg vitamin E, 1000 mg and 30 mg B carotene for 6 weeks did ,not 
prevent exercise-induced increases in lipid peroxidation. Warren et al (1992) 
showed no effect of vitamin E supplementation on eccentric exercise 
associated skeletal muscle damage in rats. Piercy et al (2000) similarly found 
no effect of vitamin C, vitamin E and B carotene on muscle damage in sled 
dogs, and Thompson et al (2001) showed no effect of vitamin C 
supplementation on muscle damage in habitually active humans. The findings 
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of our study would support these findings that antioxidant suppl ementation 
has no effect on muscle damage. 
As suggested previously, the symptoms of fatigue may be caused by changes 
in the brain structures themselves, either related or unrelated to the muscle 
pathology, such as alteration in the "hardwiring" or cortical impulses in either 
the cortical or brainstem structures (Enoka and Stuart 1992; Gandevia 1998; 
St Clair Gibson et al 2001 (a); Taylor et al2000 (c)). It has also been 
suggested previously in this thesis that fatigue as a sensory entity may be a 
cognitive representation and exist outside of recognized cortical structures or 
neurophysiological processes. If these hypotheses are correct, it is highly 
unlikely that the antioxidant therapy would have any beneficial effect. Further 
work is necessary to assess which of these reasons is responsible for the lack 
of effect of the antioxidant drug therapy on these physiological and 
psychological parameters. 
The next finding was that resting diastolic blood pressure was significantly 
lower in the antioxidant compared to placebo group. Systolic blood pressure 
was also lower in the antioxidant group, although the differences were not 
significant. Based on these findings, one may speculate that these changes 
may indicate a positive effect of the antioxidant therapy on the cardiovascular 
system. Chen et al (2001) showed that vitamin C and vitamin E 
supplementation prevented increases in blood pressure associated with 
hypertension by modulating activity of NADPH oxidase and superoxide 
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dismutase. Therefore, the blood pressure changes in our study may have 
been mediated through these mechanisms. 
The resting heart rate, and heart rate during submaximal treadmill running at 
70% of peak treadmill running speed were both significantly higher in the 
antioxidant compared to placebo group. Again the mechanism for these 
changes are not clear, but may be related to the reduced resting diastolic· 
blood pressure, and the need to maintain cardiac stroke volume because of 
the reduced blood pressure. Unfortunately, blood pressure or other 
cardiovascular haemodynamic tests were not performed during exercise 
activity or submaximal treadmill running, thus it is difficult to assess the 
validity of this hypothesis. 
There may have been a placebo effect related to the use of drug therapy in 
the fatigued athletes. On both drug and placebo parts of the trial, there was a 
decrease in Beck psychological score reported by the fatigued athletes. This 
finding indicates that the subjects perceived both drug and placebo improved 
their psychological profile. Similarly, several subjects on both antioxidant and 
placebo therapies described a subjective improvement in fatigue symptoms 
and an improvement in training capacity, although, as described previously, 
this perception of improvement was not significantly different for antioxidant 
and placebo groups. These findings may have been related to the observation 
that the fatigued athletes had generally endured their symptoms for a long 
time period, and had consulted medical practitioners widely with little success. 
Therefore, they were probably desperate for a cure, and merely being part of 
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an organized trial attempting to improve their symptoms lead to this placebo 
affect. These findings would further indicate that there was a psychological, or 
pyschophysiological component to the symptoms of fatigue. However, not all 
subjects reported improvements in symptoms of fatigue with either drug or 
placebo, thus a psychological reason cannot be the only explanation for their 
symptoms of excessive fatigue and decrements in athletic performance. 
Four subjects withdrew during the trial due to problems either with the length 
of the trial, which was six months in duration for each subject, or with the 
number of pills required to be ingested on a daily basis throughout the trial. In 
an email correspondence declaring his withdrawal from the trial, subject #14 
stated" I have decided to no longer continue with the trial due to financial and 
work pressures. I have stopped taking the pills as I could not swallow 
anymore". There was no way to prove that the subjects ingested all tablets on 
a daily basis for the entire period of both the antioxidant and placebo 
components of the trial. All subjects were asked to ingest their tablets on a 
daily basis, and return all pills not used at the end of the trial, but there was no 
clear way of determining if the subjects had adhered to these requests. 
Therefore, the findings of a lack of effect of the antioxidants on the symptoms 
of fatigue and performance capacity of the fatigued athletes must:be 
interpreted with a degree of caution, as the lack of affect may have been a 
result of failure to ingest adequate tablets. 
In conclusion, the findings of this study suggest that a three month trial of self-
administered antioxidant therapy consisting of Vitamin C 500 mg, Vitamin E 
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200 IU, Flavenoid complex and Carotenoid complex did not improve the 
symptoms of excessive fatigue and decrements in performance in the fatigued 
athletes described previously. This may have been because the muscle 
damage or physiological changes in these athletes were of a permanent 
nature, and therefore could not be improved by any therapy. The findings may 
also indicate that oxidative processes may not be involved in the generation of 
the excessive fatigue symptoms, and supports indirectly the hypothesis that 
there was a cognitive or psychological component to the sensation of fatigue. 
A decrease in resting diastolic blood pressure and increased resting heart rate 
and heart rate during submaximal treadmill running was found, and which 
may have been attributed to the use of the antioxidant treatment, but a 
mechanism for these changes is unclear. 
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3.E. Age related changes in athletic performance 
Introduction 
The findings of the case report study (Ch. 3.A.) suggested that the 
decrements in running performance and muscle pathology in the competitive 
runner was possibly the result of "accelerated" aging of the muscles recruited 
during running after several years of high volume training and racing. This 
conclusion was reached as the muscle pathology described in this athlete was 
found in the quadriceps vastus lateralis muscle, but not in the same athletes 
triceps muscle. 
If the repeated contractions of the locomotor muscles during running was the 
cause of "accelerated" aging, it can be expected that the performance of a 
group of runners would also show changes in performance consistent with the 
changes shown with aging. This would become most apparent if a 
comparison was made with athletes participating in different sports which 
recruited the same muscle groups repetitively. An example would be cycling 
wrlich is characterized by repetitive contractions, but with less eccentric 
activity and less biomechanical stress on the lower limb muscles as compared 
to running, as cycling is a non-weight bearing activity. Should this theory be 
correct it would be expected that muscle performance would decline with age 
at a faster rate in a group of runners compared to a group of cyclists. 
Therefore, the aim of this study was to examine the age-related decrements in 
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performance in a group of runners versus cyclists, to assess whether running, 
which is a weightbearing sport with greater eccentric activity, caused greater 
decrements in performance, or decrements in performance at an earlier age 
than cycling. 
Methods 
The results for the 1999 Comrades 90 km running race and Argus 103 km 
cycle race were obtained from the respective race organizers. The results for 
each event were categorized into groups for each year of age from 18 to 70. 
The fastest running or cycling speed for each year were used for subsequent 
analysis and plotted. 
The relationship which described the line of best fit between age and running 
or cycling speed was calculated using GraphPad Prism v.3 software 
(GraphPadSoftware Inc., San Diego, CA, USA). In both running and cycling 
events, a 4th order polynomial equation was used to calculate the line of best 
fit. 
The derivative of the 4th order polynomial function defining the relationship 
between age and running speed was subsequently determined. Using the 
derivative, the slope of this relationship for each year was calculated. A slope 
above zero indicated that running or cycling speed increased, while a slope 
below zero indicated that the running speed had decreased compared to the 
previous year of age. The magnitude of the slope (positive or negative) 
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indicates the extent of the change in speed compared to the previous year. 
Results 
The number of individuals who completed the 1999 Comrades 90 km running 
marathon was 11 285 and Argus 103 km cycling race 28 440. The fastest time 
for the 90 km running marathon was 5h 30 min 10 s by a 32 year old 
competitor. The fastest time for the cycling race was 2 h 31 min 26 s by a 24 
year old competitor. Because of the bunch nature of cycling, 12 other age 
categories were given similar finishing times for the cycling race, the oldest 
being a 36 year old individual. 
The equation describing the line of best fit for race time vs. age for the running 
marathon was y = 1173 - 67.82X + 1.919X2 - 0.02229X3 + 0.0001226X4 using 
a 4th order polynomial function (R2 = 0.85; Figure 3. E.1.a.). The equation 
describing the line of best fit for race time vs. age for the cycle race was 317 -. 
19.01X + 0.7605X2 - 0.01257X3 + 0.00007571X4, also using a 4h order 
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Figure 3.E.1. Age-related changes in race time (min) for the Comrades 90km 
running marathon (a) and Argus 1.03 km tour (b). 
Using the derivative of the 4th order polynomial function, the rate of change of 
race time was calculated for each year. The differentiated equations were 
solved for age and the resulting curves for the running marathon (Figure 
3.E.2.a.) and cycle tour (Figure 3.E.2.b.) were plotted. The rate of decline 
occurred at an earlier age (- 32 years) during the running race as compared 
to the cycling race (- 55 years). While the rate of improvement in running time 
was maintained until age - 32, and declined at an increasing rate after this 
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age, there was minimal change in cycling time until age - 55, after which time, 
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Figure 3. E.2. Using the derivative of the rate of change of running speed 
(slope) was calculated for each year for the Comrades 90 km running 
marathon (a) and the Argus 103 km Cycle tour (b). The differentiated 
equations were solved for age and the resulting curves were plotted. A 
positive slope represents a slower time compared to the previous year. 
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Discussion 
The important finding from this study was that the age related decrements in 
performance began at an earlier age in runners compared to cyclists. In the 
runners, there was an improvement in performance until age 32, and 
thereafter there was a marked decrement in performance, with the rate of 
decrease in performance increasing with increasing age. In contrast, the 
cyclists generally maintained performance until age 55. Thereafter, 
performance declined, with the rate of decline increasing with increasing age, 
similar to that found in the runners at an earlier age. 
One may therefore postulate that running may cause more profound changes 
in anatomical structures and physiological mechanisms necessary to maintain 
pacing strategies during racing, and may lead to "accelerated" aging. Another 
interpretation is that the stresses associated with training and racing induce 
changes which prevent the athlete from sustaining a high training volume, and 
it is trlis reduced training volume which causes the reduction in performance. 
Cycling is a non-weightbearing activity, with little or no eccentric activity as 
compared to that found during running, where marked eccentric activity is 
necessary to maintain an upright posture against gravitational forces, and 
where eccentric activity is part of the stretch-shortening cycle (SSC) which 
makes up part of the normal energy transfer during weight-bearing activity 
(Nicol et al 1991). A large body of work has shown that eccentric activity 
causes muscle damage, and that this muscle damage is found after marathon 
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and ultra-marathon running (Chambers et al 1998). In contrast, no studies 
have shown similar pathology in cyclists after endurance cycling events. 
Therefore, it is reasonable to speculate that the decrements in age-related 
running times may have been caused by chronic muscle or musculoskeletal 
damage and perhaps "premature aging" of the older runners lower limb 
muscles, due to the cumulative effects of years of biomechanical stress and 
eccentric activity related to running training and racing. Interestingly, Spirduso 
(1995) showed that age-related decrements in rowing performance occur at 
age - 45 years. As rowing is also a nonweightbearing activity using 
predominantly upper body muscles, and as the age-related decrements in 
performance also occurred at a later age than in the runners in our study, the 
findings of Spirduso (1995) support the hypothesis that running as a sport in 
particular may cause "accelerated" aging. 
A further reason for the decrement in performance may have been that the 
veteran runners trained less than the younger runners, and that this difference 
in training volume may be the cause of the decrements in their performance. 
Lambert and Key tel (2000) similarly showed that the age-related decrements 
in performance during a 56 km marathon began at age 28 in men and age 32 
in women. They suggested that these decrements in performance were 
related to training volume, with the older runners training less distances per 
week than the younger runners. However, if a decrease in training was 
responsible for the decrease in performance times in runners, there should 
have been no differences in the results for runners and cyclists, as there is no 
reason to suggest that cyclists would train for a greater length of time than 
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runners at older ages. However, further work is needed to assess whether 
veteran cyclists do maintain similar training distances to younger cyclists, and 
thus are able to maintain the performance to a later age, as found in this 
study. 
Another reason for the differences in age-related decrements in performance 
between running and cycling activities may be due to the nature of cycling 
racing itself. Bunch riding and drafting (slipstrearning) is common in cycling 
and thus the older cyclists may have been able to produce the maintained 
level of performance by drafting behind younger cyclists, or by staying in a 
competitive bunch which would require less absolute work to be performed by 
the veteran cyclists (Spirduso 1995). Further work is needed to assess this 
hypothesis by studying whether age-related cyclist performance decrements 
are greater during laboratory based or time trial performances where no 
bunch or drafting strategies are available. 
It must be noted that the duration of the cycling and running tests were 
different, with the winning times of the cycle race being 2h 31 min and running 
marathon 5 h 30 min. Therefore, the greater decrements in performance in 
the runners may have been related to the larger distances covered in the 
running race. The older runners may have adopted different pacing strategies 
during the longer running race, which may have been more similar if the race 
times of the two events been more similar. However, Lambert and Key tel 
(2000) showed that the performance decrements occurred in runners at age 
40 or younger in race distances ranging from 10 km to 56 km, which would be 
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of the same time period or shorter than that of the cycle race in this study. 
Therefore, it is unlikely that the differences in race time between runners and 
cyclists were due solely to the differences in duration of the two races. 
Finally, a further finding was that the rate of improvement in performance was 
greater at younger age categories in runners compared to cyclists. It is not 
clear whether these differences were also caused by the ability of younger 
cyclists to benefit from the different pacing strategies involved in cycling, or 
was due to more time being necessary for a younger individual to adapt to the . 
biomechanical and physiological stresses associated with running. 
In conclusion, this study shows that age-related decrements in performance 
occur at an earlier age in running compared to cycling in the specific races 
used in this study. It is tempting to speculate therefore that running causes 
more muscle damage and leads to premature aging earlier than cycling, as 
running involves more weight-bearing and eccentric activity. It is not clear 
whether pacing strategies, training volume or duration of these different 
events may be an explanation for the findings of this study. Further work is 
necessary to examine these different causes of age-related decrements in 
performance found in this and other studies. 
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3.F. Age related changes in arm and leg muscles 
Introduction 
In the previous chapter, it was shown that athletic performance was decreased at 
a faster rate with age in runners as compared to cyclists. This accelerated rate of 
decline in runners may have been caused by the cumulative effect of years of 
running activity on muscle function. Due to increased weightbearing and 
eccentric muscle activity associated with running as compared to cycling activity 
it is reasonable to assume that the cumulative damage after years of running 
training and racing is more severe than after years of cycling training and racing. 
It was suggested that cumulative damage may be responsible for "accelerating" 
the agi ng process. 
The neuromuscular system is affected by the aging process, with decreased 
muscle mass, muscle function and specific tension of the peripheral muscles 
associated with increased age (Grabiner and Enoka 1995; Cannon et al 2001). 
Muscles of the upper and lower limbs may be affected differently by both the 
aging process and different levels of weightbearing and eccentric activity during 
the normal life span. For example, if weightbearing was important in 
"accelerating" the aging process, one would expect the muscles of the lower 
limbs to be more affected than the muscles of the upper limbs, as they are more 
involved in weightbearing during routine activities of daily living, and eccentric 
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activity forms a larger component of the walking and running gait cycle 
(Sharwood et al 2000). 
The aim of this study, therefore, was to examine the force output and 
neuromuscular activity differences in the arm and leg muscles of individuals of . 
different ages, to assess the affect of age on these variables. The hypothesis 
was that if exercise activity reduced speed and athletic ability, as described in the 
previous chapter, then the leg muscles would show a greater decrement in force 
output with age than the arm muscles which are not actively used in walking and 
running athletic activities or activities of daily living. If the hypothesis was 
incorrect, and in contrast exercise attenuated the loss of force output and muscle 
mass associated with aging, then the muscles of the legs should maintain the 
force output capacity with age, and the arm muscles, which would be relatively 
less used during activities of daily living, would suffer a "relative" disuse atrophy 
with age, and would show a greater decrement in force output with age than that 
found in the leg muscles. Accordingly, the knee extensor and arm flexor strength 
were assessed in individuals with a range of ages who were either currently 




Seventy four subjects were recruited from the Sport Science Institute of South 
Africa staff and gym members to participate in this study. Exclusion criteria 
included if the subjects had a recent injury to their right arm or right leg, or had 
any major medical illness which would be aggravated by participation in the 
study. Inclusion criteria were that subjects had previously been involved in, or 
were currently involved in sporting activities. A wide range of subject ages (16-
71) were selected so the effect of age as a continuum on the parameters tested 
could be assessed. The study was approved by the Ethics and Research 
Committee of the University of Cape Town and all subjects signed an informed 
consent prior to their participation in the study. 
Each subject's age, height, mass and LTV was recorded as described previously 
(Ch 3.A.; Ch. 3. S.). The bicep skinfold measurement andsub-deltoid, mid-arm 
and above-elbow circumferences were recorded in the left upper arm and used 
to calculate the lean volume (LV) of the upper arm. It was also assumed that the 
upper arm had the shape of a truncated cone. 
The subjects completed a subjective activity questionnaire, detailing subjective 
assessment of current activity level, body part involved in sport activity (either 
upper or lower body or both), previous sport activity and length of time they were 
sedentary if they were not currently participating in sport but previously active. 
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Force output of the knee extensors and elbow flexors was measured using a Kin-
Com isokinetic dynamometer (Chattanooga Group Inc., USA). Subjects were 
secured to the dynamometer via shoulder and waist strapping. To avoid 
interference with the placement of EMG electrodes the active limb was not 
stabilized. In the lower limb, the axis of rotation of the dynamometer was visually 
aligned with the lateral femoral epicondyle, with the lower leg attached to the 
lever arm Slightly above the level of the lateral malleolus. In the upper limb, the 
axis of rotation of the dyn~mometer was aligned with the lateral epicondyle of the 
humerus, with the lower part of the upper limb attached to the lever arm slightly 
above the level of the right wrist. For the knee extensor trials, the knee was 
positioned at an angle of 60° of flexion, with the reference point being full knee 
extension. For the elbow flexor trials, the elbow was positioned at 30° of flexion, 
with the reference point being full elbow extension, thus ensuring that the knee 
extensors and elbow flexors were tested at the same relative anatomical position. 
All subjects performed isometric maximal voluntary contractions (MVC) and 25 s 
fatigue protocols for both knee extensors and elbow flexors. The order of knee 
extensor and elbow flexor testing was randomized so that half of the subject's 
knee extensors were tested before the elbow flexors, and the other ha.lf of the 
subjects had knee extensors tested after the elbow flexors. 
Prior to MVC testing, the subjects performed four sub-maximal familiarization 
trials of both knee extensors and elbow flexors. EMG and force output data were 
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subsequently collected during four MVC trials. Subjects were verbally 
encouraged throughout all trials to exert maximal effort. The force output and 
EMG data from the MVC trial which had the greatest force output was used for 
subsequent analysis. 
After performing the MVC tests, the subjects rested for a five minute period and 
then performed the isometric 25 s fatigue tests. The knee extensor fatigue tests 
were performed after the knee extensor MVC testing, and the elbow flexor 
fatigue tests performed after the elbow flexor MVC testing. The subjects were 
instructed to begin maximal effort immediately, and not to "save" effort for the 
final seconds of the test. Subjects were again verbally encouraged throughout all 
trials to exert maximal effort. The subjects performed two 25 s isometric fatigue 
tests, with a one minute rest between tests. The force output and EMG data from 
both fatigue tests was used for subsequent analysis. ThroUghout all sessions, 
force output (N) was recorded using the Kin-Com data analysis software, at a 
capture rate of 100 HZ. 
The peak force (PF, N) and time to peak force (TTP, s) was measured during the 
MVC. In addition, a relative peak force was calculated by dividing each subject's 
peak force value by their mass (PF/Kg, N/Kg). The PF, TIP and mean force (MF, 
I'J) attained during both 25 s isometric test was also measured. These values 
were measured in both knee extensors and elbow flexors. 
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Prior to MVC and fatigue testing on the dynamometer, active EMG electrodes 
with a bandwidth of 20-500 Hz and sensitivity of < 0.08 'tlVN were attached to 
the belly of the rectus femoris muscle in the leg and biceps brachii muscle in the 
arm. The EMG was recorded as described previously (Ch. 3.C.). 
Corresponding data for force output, IEMG and MPFS during the fatigue tests 
were subsequently divided into three 5 s epochs. The first epoch included all 
data collected between 2 and 6 s, the second epoch all data from 11 to 16 s, and 
the third epoch all data from 20 to 25 s of the fatigue test. The first second of 
data was not analyzed because of the possibility that there may have been a 
variation, or a possible lag phase, in the time to peak force output in the first 
second of the test. Mean values for torque and IEMG were calculated for these 
time epochs. All data from the first epoch was described as 1.00, with all 
subsequent data from epochs 2 and 3 being normalized by using this first epoch 
as the denominator. In this manner, the relative fatigue data from arm and leg 
fatigue tests in old and young individuals could be analyzed. 
The EMG/Force fatigue ratio was calculated for both knee extensors and arm 
flexors. This was calculated by dividing the normalized IEMG value for the third 
epoch of the second 25 s isometric fatigue test by the normalized force output for 
the same third epoch of the second 25 s isometric fatigue test. 
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Statistics 
All data are presented as means ± standard deviation (SO). An analysis of 
variance (ANOVA) with repeated measures was used to detect differences 
between knee extensors (LEG) and elbow l1exors (ARM) for 25 s fatigue data. A 
Scheffe's post hoc test was used to detect significant differences between 
groups. A paired t-test was used to evaluate the differences between knee 
extensor and arm flexor MVC values and other parametric data. A Pearson's 
product moment correlation was calculated to determine relationships between 
variables. Statistical significance was accepted when p < 0.05. 
Results 
The general characteristics of the subjects are listed in table 3. F. 1. The mean 
age of the subjects was 37.3 ± 14.3 years, with a range of ages from 16 to 71 
years. Thirty three males and 38 females participated in the trial., 
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Table 3.F.1. General characteristics of the subjects (Sumskin - sum of skinfolds) 
(n = number of subjects in each group). 
Mean ± SD (n) Min Max 
Age (y) 37.3 ± 14.3 (71) 16 71 
Height (cm) 170 ±9 (71) 153 188 
Mass (kg) 70.5 ± 14.0 (71) 44 103 
Body fat (%) 24.3 ± 8.0 (71) 6.7 40.9 
Sumskin (mm) 73.0 ± 30.0 (62) 24.4 143.0 
Of all the subjects that answered the activity questionnaire, 7 subjects were 
currently inactive, 5 were active 1-2 times per week, and 58 were active 3 or 
more times per week. Of all the subjects that answered the questionnaire, 10 
subjects performed sport that involved only lower limb activity, 0 subjects 
performed sport that involved only upper limb activity, and 56 subjects played 
sport which involved both lower and upper limb activity. Of all subjects that 
answered the questionnaire regarding previous sport activity, 9 subjects 
performed sport that involved only lower limb activity, 0 subjects performed sport 
that involved only upper limb activity, and 57 subjects played sport which 
involved both lower and upper limb activity. Of all subjects answering the 
questionnaire, 66 had never been sedentary, 1 had been sedentary for a period 
of their lives of less than 5 years duration, and 4 subjects had been sedentary for 
a period of their lives of greater than 5 years duration. 
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Table 3.F.2. describes the lean volumes and mid-girths of the upper arm and 
upper legs. The lean volume in the LEG group was significantly greater than in 
the ARM group (p < 0.01) (Figure 3.F.1 J The mid-girth in the LEG group was 
significantly greater than in the ARM group (P < 0.01). 
Table 3.F.2. The lean volume (LV) and mid-girth values for lower limb thigh 
region (LEG) and upper limb bicep region (ARM) measurements (n = number of 
subject's data in each group). 
LEG (n) ARM (n) 
LV (cc) 3624 ± 1045 (61) 923 ± 312 (61)** 
Mid Girth (cm) 49.8 ± 5.2 (68) 28.7 ± 4.6 (61 )** 
** - P < 0.01 - Leg LTV vs. Arm LTV 
- Leg Midthigh vs. Arm Midthigh 
5000 
4000 





Figure 3.F.1. The lean volume (cc) values for ARM and LEG groups (** - P < 
0.01). 
Table 3.F.3 describes the mean force output data, relative peak force and time 
taken to reach peak force output during the MVC for ARM and LEG groups. The 
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peak force (P < 0.01) and relative peak force (P < 0.01) were both significantly 
greater in the LEG compared to ARM group. The time taken to reach peak force 
output was significantly longer in the LEG compared to ARM group (P < 0.01). 
Table 3.F.3. Peak force (PF), relative peak force (PF/Kg) and time to peak force 




LEG (n) ARM (n) 
511 ± 150 (69) 185 ± 88 (71)** 
7.4 ± 2.3 (69) 2.6 ± 0.9 (71)** 
, 
2.5 ± 1.3 (66) 1.6 ± 1.0 (71)** 
** - P < 0.01 - Leg Peak Force vs. Arm Peak Force 
- Leg PF/Kg vs. Arm PF/Kg 
- Leg TTP vs. Arm TTP 
The relationship between absolute peak force output during MVC and age for 
LEG (Figure 3.F.2.a.) and ARM (Figure 3.F.2.b.) is described below. There was a 
significant negative correlation for LEG (r = - 0.46, P < 0.05). There was also a 
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Figure 3.F.2. The relationship between absolute peak force output during MVC 
and age for LEG (a) and ARM (b) groups (* - p < 0.05). 
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The relationship between relative peak force output during MVC and age for LEG 
(Figure 3.F.3.a.) and ARM (Figure 3.F.3.b.) is described below. Although the 
relationship was lower in the ARM group, there was a significant negative 
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Figure 3.F.3. The relationship between relative force output during MVC and age 
for LEG (a) and ARM (b) groups (* - P < 0.05). 
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The relationsrlip between absolute peak force output during MVC and lean 
volume for LEG (Figure 3.FA.a.) and ARM (Figure 3.F.4.b.) is described below. 
There was a significant positive correlation for both LEG (r = 0.64, P < 0.05) and 
AR M (r = 0.74, P < 0.05) groups. 
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Figure 3.FA. The relationsrlip between absolute force output during MVC and 
lean volume (LV) for LEG (a) and ARM (b) groups (P < 0.05). 
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The relationship between lean volume (LV) and age for LEG (Figure 3.F.5.a) and 
ARM (Figure 3.F.5.b.) is described below. There was a significant negative 
correlation for LEG (r = - 0,46, P < 0.05). There was no significant correlation for 
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Figure 3.F.5. The relationship between lean volume (LV) and age for LEG (a) 
and ARM (b) groups (P < 0.05). 
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The values for the two 25 s isometric fatigue test peak force (End PF), time to 
peak force (End TIP) and mean force (End MF) are described below in table 
3.FA. End PF was significantly greater in LEG than ARM during both test 1 (P < 
0.01) and test 2 (P < 0.01). End Trp was significantly longer in LEG compared to 
ARM group in both test 1 (P < 0.01) and test 2 (P < 0.01). End MF was 
significantly greater in LEG than ARM group in both test 1 (P < 0.01) and test 2 
(P < 0.01). 
End PF was Significantly greater in test 1 compared to test 2 in the ARM grolJP (P 
< 0.01). Although End PF was greater in test 1 compared to test 2 in the LEG 
group, the difference was not significant. End MF was significantly greater in test 
1 compared to test 2 in both LEG (P < 0.05) and ARM (P < 0.01) groups (Figure 
3.F.6. 
End TIP was significantly shorter in test 1 compared to test 2 (P < 0.01) in the 
ARM group. There were no significant differences in End TTP in the LEG group. 
331 
Table 3.F.4. The values for the two 25 s isometric fatigue test peak force (End 
PF, N), time to peak force (End TTP, s) and mean force (End MF. N) for LEG and 
ARM groups (n = number of subjects in each group). 
LEG (n) ARM (n) 
End PF 1 483 ± 135 (69)** 171 ± 80 (71)## 
End PF 2 473 ± 137 (68)** 160 ± 74 (71) 
End TTP 1 9.4 ± 8.6 (66)** 2.4 ± 3.8 (71)## 
End TTP 2 8.9 ± 7.4 (58)** 4.3 ± 4.7 (67) 
End MF 1** 412 ± 133 (67)**# 128 ± 62 (71)## 
End MF 2* 386 ± 138 (59)** 119 ± 55 (66) 
** - P < 0.01 - Leg End Peak Force 1 vs. Arm End Peak Force 1 
- Leg End Peak Force 2 vs. Arm End Peak Force 2 
- Leg End TTP 1 vs. Arm End TIP 1 
- Leg End TIP 2 vs. Arm End TIP 2 
- Leg End Mean Force 1 vs. Arm End Mean Force 1 
## - P < 0.01 
- Leg End Mean Force 1 vs. Arm End Mean Force 2 
- Arm End Peak Force 1 vs. Arm End Peak Force 2 
- Arm End TIP 1 vs. Arm End TTP 2 
- Arm End Mean Force 1 vs. Arm End Mean Force 2 











Figure 3.F.6. The values for the two 25 s isometric fatigue mean force (End MF) 
in both ARM and LEG groups (** - p < 0.01; ## - P < 0.01: # - P < 0.05). 
The relationship between End MF in test 1 and test 2 for LEG (Figure 3.F.7.a.) 
and ARM (Figure 3.F.7.b.) groups are described below. A significant correlation 
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Figure 3. F. 7. The relationship between End PF test 1 and End PF test 2 for LEG 
(a) and ARM (b) groups. 
The normalized force output changes during the two 25 s isometric fatigue tests 
(End T1 epoch1-3, and End T2 epoch 1-3) are described below (Table 3.F.5.). 
There was a significant interaction effect for changes over time between LEG 
and ARM groups for END T1 (P < 0.01), End T2 (P < 0.01) and when the two 
tests were examined as a single entity (End ALL, P < 0.01) (Figure 3.F.8.). While 
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the force output decreased in both groups during both End T1 and End T2, the 
decrease in ARM force output was significantly greater (- 28 % at End T2-3) 
compared to the decrease in LEG force output (- 9 % at End T2-3). The force 
output was also significantly lower in the ARM group (- 6%) at the beginning of 
End T2 after a minutes rest than in the LEG group (- 2%) (P < 0.05). 
Table 3.F.5. Normalized force output changes during the two 25 s isometric 
fatigue tests (End T1 and End T2), and when the two tests were examined as a 




** - p < 0.01 
* - p < 0.05 
LEG (68) ARM (67) 
End T1-1 1.00 ± 0.00 1.00 ± 0.00 
End T1-2 0.96 ± 0.10** 0.84 ± 0.10 
End T1-3 0.94 ± 0.14** 0.76 ± 0.13 
End T2-1 0.98 ± 0.09* 0.94 ± 0.12 
End T2-2 0.95 ± 0.14** 0.80 ± 0.14 
End T2-3 0.91 ± 0.18** 0.72 ± 0.13 
Interaction effect LEG vs. ARM group End T1 
Interaction effect LEG vs. ARM group End T2 
Interaction effect LEG vs. ARM group End ALL 
LEG End T1-2 vs. ARM End T1-2 
LEG End T1-3 vs. ARM End T1-3 
LEG End T2-2 vs. ARM End T2-2 
LEG End T2-3 vs. ARM End T2-3 
LEG End T2-T1 vs. ARM End T2-1 
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Figure 3.F.S. The normalized force output changes during the two 25 s isometric 
fatigue tests (End T1 epoch1-3, and End T2 epoch 1-3) (** - p < 0.01; * - P < 
0.05) The dashed line indicates start of END T2. 
The normalized IEMG changes during the two 25 sisometric fatigue tests (End 
T1 epoch1-3, and End T2 epoch 1-3) are described below (Table 3.F.6.). There 
was a significant interaction effect for changes over time between LEG and ARM 
groups for END T1 (P < 0.05), End T2 (P < 0.05) and when the two tests were 
examined as a single entity (End ALL, P < 0.01) (Figure 3.F.9.). While the IEMG 
activity increased significantly in LEG during both End T1 and End T2 (P < 0.05), 
IEMG did not increase or decrease significantly in ARM during END T1 or End 
T2. 
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Table 3.F.6. Normalized IEMG activity during the two 25 s isometric fatigue tests 
(End T1 and End T2), and when the two test were examined as a single entity 
(End ALL) in LEG and ARM groups (n = number of subjects in each group). 
IEMG 
** - p < 0.01 
* - p < 0.05 
LEG (68) ARM (67) 
End T1-1 1.00 ± 0.00 1.00 ± 0.00 
End T1-2 1.12 ± 0.23 1.05 ± 0.20 
End T1-3 1.11 ± 0.34* 0.99 ± 0.24 
End T2-1 1.06±0.19 1.02 ± 0.17 
End T2-2 1.16 ± 0.35* 1.05 ± 0.24 
End T2-3 1.14 ± 0.38** 0.99 ± 0.26 
Interaction effect LEG vs. ARM group End ALL 
LEG End T2-3 vs. ARM End T2-3 
Interaction effect LEG vs. ARM group End T1 
Interaction effect LEG vs. ARM group End T2 
LEG End T1-3 vs. ARM End T1-3 
LEG End T1-2 vs. ARM End T1-2 
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Figure 3.F.9. The normalized IEMG changes during the two 25 s isometric 
fatigue tests (End T1 epoch1-3, and End T2 epoch 1-3) (** - P < 0.01; * - P < 
0.05) The dashed line indicates start of END T2. 
The normalized MPFS changes during the two 25 s isometric fatigue tests (End 
T1 epoch1-3, and End T2 epoch 1-3) are described below (Table 3.F.7.). There 
was a significant interaction effect for changes over time between LEG and ARM 
groups for END T1 (P < 0.01), End T2 (P < 0.01) and when the two tests were 
examined as a single entity (End ALL, P < 0.01) (Figure 3.F.10.). While the 
MPFS decreased in both groups during both End T1 and End T2, the decrease in 
ARM MPFS was significantly greater (- 18 % at End T2-3) compared to the 
decrease in LEG force output (- 13 % at End T2-3). 
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Table 3.F.7. Normalized MPFS activity during the two 25 s isometric fatigue tests 
(End T1 and End T2), and when the two tests were examined as a single entity 
(End ALL) in LEG and ARM groups (n = number of subjects in each group). 
MPFS 
** - p < 0.01 
LEG (68) ARM (67) 
End T1-1 1.00 ± 0.00 1.00 ± 0.00 
End T1-2 0.93 ± 0.04** 0.89 ± 0.05 
End T1-3 0.88 ± 0.06** 0.84 ± 0.06 
End T2-1 0.98 ± 0.04 0.97 ± 0.05 
End T2-2 0.91 ± 0.07** 0.86 ± 0.07 
End T2-3 0.87 ± 0.07** 0.82 ± 0.08 
Interaction effect LEG vs. ARM group End T1 
Interaction effect LEG vs. ARM group End T2 
Interaction effect LEG vs. ARM group End ALL 
LEG End T1-2 vs. ARM End T1-2 
LEG End T1-3 vs. ARM End T1-3 
LEG End T2-2 vs. ARM End T2-2 
LEG End T2-3 vs. ARM End T2-3 
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Figure 3. F.1 O. The normalized MPFS changes during the two 25 s isometric 
fatigue tests (End T1 epoch1-3, and End T2 epoch 1-3) (** - P < 0.01) The 
dashed line indicates start of END T2. 
The EMG/Force ratio for LEG (1.24 ± 0.32) was significantly lower (P < 0.05) 
than for ARM (1.38 ± 0.30) using the final epoch of the second 25 s fatigue to 
calculate both change in IEMG activity and change in force output (Figure 
3.F.11). 













Figure 3.F.11. The EMG/Force ratio at the final epoch of the second 25 s fatigue 
(* - P < 0.05). 
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The relationship between age and change in force output, IEMG and MPFS 
fatigue ratios during the 25 s endurance tests for ARM and LEG groups is shown 
in table 3.F.8. Age was correlated against the last epoch value from the second 
25 s endurance in all cases. There were no significant relationships found for any 
of the variables in either LEG or ARM groups. 
Table 3.F.8. Correlations between age and force, IEMG and MPFS fatigue ratios 
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Age related declines in muscle strength and size is well documented (Connelly et 
a11999; Grabiner and Enoka 1995; Lexe1l1995; Tracy et al1999, Trappe et al 
1995). In this study, the age-related decline in force output was greater in the 
knee extensors than elbow flexors. With increasing age, lean volume also 
decreased more in the knee extensors than elbow flexors. The age rel.ated peak 
force changes were Significantly positively correlated wit~llean volume, indicating 
that the loss of muscle mass in the knee extensors may be a cause of the age 
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related greater decrements in force output in knee extensors compared to elbow 
flexors. These finding appear to support the hypothesis that the lower limb 
muscles are more affected by aging than the upper limb muscles. 
In a previous study, Annianson et al (1988) performed strength testing and 
histopathological analysis of muscle samples from the vastus lateralis in - 75 
year old men on two separate occasions separated by 7 years. They found that 
strength output in the knee extensors decreased by 10-22 % during this 7 year 
period, and was associated with a reduction in vastus lateralis fast twitch muscle 
fibre area and evidence of histopathologic changes, including muscle fibre 
atrophy, 'fibre grouping, and the presence of moth eaten 'fibres, abnormal 
quantities of internal nuclei and fibre splitting. Klitgaard et al (1990) found a 
-10% greater decrease in age-related force output in leg compared to arm 
muscles, and Lynch et al (1999) found greater age-related decline in force output 
in leg compared to arm muscle in woman but not in men. Poulin et al (1992) 
found similar age related declines in force output in arm and legs muscles. The 
reason for these different findings is not immediately clear. 
Annianson et al (1988) suggested that age-related muscle pathology may be the 
cause of the decreases in strength and size in the vastus lateralis muscles in 
their study. Unfortunately, longitudinal studies of upper limb muscles force output 
or histopathology was not performed in their study. However, as there was less 
age associated declines in force output and lean volume in the upper limb flexors 
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in our study, one must assume that if the 'findings described by Annianson et al 
(1988) of muscle pathology and decreased muscle force output are related, then 
muscle histopathology of a similar degree to the knee extensors is unlikely to be, 
present in the elbow flexor muscles in our study as the force decrements were 
not as great in the elbow flexors. As the lower limb muscles are used more in 
walking and other activities of daily living than the upper limbs, and there is more 
associated weightbearing and eccentric muscle function during these activities, 
one must suggest a relationship between previous activity using the lower limb 
and the presence of muscle atrophy and reduced force output in the lower limb 
muscles in our study and in the study of Annianson et al (1988). Trappe et al 
(1995) described histochemical changes in middle aged runners who were 
biopsied in their late twenties and again 30 years later. They suggested that 
these changes were a result of both years of training and aging. Their findings 
would support the findings of this study and the findings described previously in 
fatigued athletes. 
A second reason for the greater decreases in force output and lean volume in the 
knee extensors may be a relative disuse atrophy which occurs in the lower limb 
muscles. Disuse or immobilization has been shown to cause muscle atrophy and 
decrements in force output capacity (Semmler et al 2000; Veldhuizen et aI1993). 
Similarly, arthrogenic changes in the lower limb joints have been shown to lead 
to inhibition of quadriceps function and related muscle atrophy (Hurley and_ 
Newham 1993). Therefore, the findings of reduced lower limb force output in our 
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study may be related to age-associated musculoskeletal pathology in the lower 
limb, or due to a relative decrease in exercise activity associated with qging 
(Lambert and Key tel 2000) which affected the knee extensors to a greater 
degree than the elbow flexors. 
A high correlation was found between endurance peak force in the first and 
second 25 second isometric tests for both leg (r = 0.95, P < 0.01) and arm (r = 
0.98, P < 0.01) muscles, indicating that the findings described previously could 
not be due to different learning effects, or due to lack of motivation to put out 
maximal capacity in either arm or leg muscles. Therefore, the differences in force 
output with age between knee extensor and elbow flexor muscles are more likely 
due to absolute changes in muscle size or muscle pathology in the knee 
extensors. 
There were no significant correlations between age and either force output, 
IEMG and MPFS during the fatigue tests. This indicates that age had no effect on 
neuromuscular activity associated with fatigue, and that neural mechanisms 
controlling force output in fatigue are not altered with age, as also reported by 
Cannon et al (2001). Similarly, Neder et el (2000) found that time to fatigue was 
less affected by age than maximal force output capacity. 
Force output during the 25 second isometric endurance test decreased 
significantly more in knee flexors than elbow extensors when the data for all 
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subjects were examined as an entire group. IEMG activity during the 25 second 
isometric contractions in the elbow flexors was maintained at a relatively constant 
level t~lroughout the test, whereas in the knee extensor IEMG activity increased 
by 11 % during the endurance test. This indicates that knee extensor force output 
may have been relatively submaximal at the start of the test, explaining the lower 
percentage decrement in force output in the knee extensors compared to elbow 
flexors during the endurance test. The increasing IEMG may also have been 
related to different fibre types in the knee extensors compared to the arm flexors, 
with less type II fibres found in the vast us lateralis muscle compared to biceps 
brachii muscle (Aniannson et al 1988). Therefore, due to the greater degree of 
slow-twitch type I fibres, the knee extensors may take longer to reach maximum 
contraction and hence produce increasing IEMG activity in the early stages of the 
contraction. The MPFS decreased in both knee extensors and elbow 'flexors, but 
to a significantly lower level in the elbow flexors compared to knee extensors. As 
described previously, MPFS decrements are correlated with muscle fibre 
composition, with greater decrements in:'MPFS being associated with a greater 
quantity or percentage of type II fibres (Gerdle et al 1997; Hulten 1975; Kupa et 
al 1995). Therefore, the findings of greater decrements in MPFS and force output 
in the elbow flexors may also have been due to a greater percentage of type II 
muscle fibres in the elbow flexors compared to knee extensor muscles, or 
because the elbow extensors had a relatively higher maximal force output at the 
onset of the test, thus having greater capacity for fatigue during the endurance 
test. 
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The EMG/force ratio at the final time point of the second 25 s isometric 
endurance test was higher in the elbow 'flexors than the knee extensors of all the 
subjects, indicating a higher degree of "fatigue" in the arm muscles (Hakkinen 
and Komi 1983; Taylor et al 1997). As described above, this finding may qe 
related to possibly rligher relative force output in the arm flexor muscles at the 
start of the endurance test, or greater decrements in force output relative to 
IEMG recruitment in the arm, compared to that found in the leg, which may also 
be caused by different muscle fibre types and resultant difference in fatigue 
resistance capacity in the arm compared to the leg, or to different neuromuscular 
recruitment patterns in the arm compared to the leg muscles during the fatiguing 
process. 
The time to peak force was longer in knee extensor muscles compared to elbow 
flexor muscles during both maximal isometric voluntary contraction testing and 
25 second isometric endurance testing. This was probably also related to 
different fibre types present in the knee extensor compared to elbow flexor 
muscles, or to absolute lean volume differences. As the elbow flexors and knee 
extensors were tested, it would mean both arm and legs were producing force 
output against gravity. As the legs are heavier than the arms, it may be that more 
effort is needed to move the larger mass against gravity when beginning the 
contraction, and thus the slower time to peak force output in the legs may be 
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related to the effect of different physical size of the upper and lower limbs and 
resultant different capacity for acceleration against gravity. 
Finally, as expected, the force output during maximal voluntary isometric testing 
was significantly greater in the knee extensors than elbow flexors. This was 
related to the differences in lean volume and therefore muscle mass between the 
arms and legs, with significantly smaller lean volumes in the arm then the leg 
muscles. 
A possible weakness of the study were that it was difficult to quantify the exact 
training status of different individuals, and the numbers of subjects did not allow 
investigation of differences between purely arm trained as compared to only leg 
trained individuals. However, as activities of daily living such as walking require 
lower limb activity, it is perhaps not possible to find a cohort which performs only 
upper limb activity. 
In conclusion, age related force decrements are greater in the knee extensors 
compared to elbow flexors. These findings were related to decreases in lean 
volume of the limbs. These findings may be due to pathological changes in the 
knee extensor muscles from excessive use, or because of a greater effect of 
decreased activity on the lower limb muscles associated with aging. A further 
finding of this study was that neuromuscular processes associated with fatigue 
were not altered by the aging process. 
347 
3.G. Veteran athlete performance during continuous and intermittent 
intensity activity 
Introduction 
In the previous chapters, it was suggested that age-related decrements in 
physical performance may be caused by skeletal muscle pathology as well as 
other age-related factors. Although this muscle pathology did not appear to 
affect maximal aerobic capacity or maximal force output, it did ap pear to affect 
musculoskeletal performance during complex activities such as jumping and 
stride frequency during submaximal treadmill running. This finding can be tested 
further by assessing whether complex, intermittent intenSity sports such as 
squash rackets, are affected similarly or to a greater degree than continuous 
intenSity sports such as running with aging. 
It was also suggested in the previous chapters that veteran atrlletes may adopt a 
pacing strategy during exercise activity to reduce the potential for damaging 
muscles. This theory can be tested during both continuous and intermittent 
intenSity activity by measuring heart rate, duration and other parameters of 
performance during these events. 
Heart rate is used in a number of clinical and investigative studies as an indirect 
measurement of exercise intenSity (Lambert et al 1998). Heart rate can also be 
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measured to assess cardiac function in diseased states (Paninaet al 1995) and 
the heart rate responses to an exercise challenge in normal and diseased 
subjects (Karvonen et al 1984; Sheldahl et al 1992). Heart rate data can also be 
used as an indirect predictor of energy expenditure during field testing once 
values have been extrapolated from the heart rate - oxygen consumption 
relationship determined in the laboratory (Li et al 1993; Boyle et al 1994). 
The telemetric heart rate (HR) monitor has replaced the electrocardiogram 
(ECG) as the equipment of choice for heart rate monitoring during laboratory 
testing, because the HR monitor has been proven to be as reliable and sensitive 
as the ECG (Leger and Thivierge 1988; Seaward et al 1990). 
The telemetric HR monitor is used in a number of field tests and sporting 
activities to assess the athlete's level of activity (Oi Carlo et al 1991; Ritchie and 
Hopkins 1991; Johnston and McNaughton 1994; Palmer et al 1994), and studies 
have shown the HR monitor to be a reliable instrument for the assessment of HR 
during athletic performance in the field (Treibe et a11989; Durant et al 1993). 
However, despite the extensive use of HR monitors for exercise prescription and 
for assessment of heart rate changes during field sporting activity (Hopkins and 
Hawley, 1989; Ali and Farrally 1991; Robinson et ai, 1991), no study has 
assessed the repeatability of recording heart rate with a telemetric HR monitor 
during field sporting activity such as squash rackets, where environmental 
conditions are variable. 
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It is known that the day-to-day variability of HR, in controlled conditions, is -3 
beats.min-1 (Astrand and Saltin, 1961). It is not known, however, what the 
variation is during a field test where the exercise intensity and environmental 
conditions are not tightly controlled. 
The aim of this study therefore was to assess the repeatability of both the mean 
and maximal HR of individuals of varying ages in two different sporting 
disciplines. Veteran and senior individuals were chosen because the HR 
response to exercise is different in these groups (Trappe et ai, 1995). Individuals 
trained in squash and long distance running were chosen for the study because 
the physical demands of the sport are varied, ranging from steady state, high 
intensity exercise in runners (Selley et ai, 1995) to intermittent, rligh intensity 
activity with many postural changes in squash players (Montpetit, 1990). The 
hypothesis of the study was that if heart rate was reduced similarly and in a 
repeatable manner in veteran athletes competing in different types of exercise 
activity, this would suggest the presence of a feedforward pacing strategy in 
these veteran athletes. 
Methods 
Male senior league squash players (n = 10), veteran league squash players 
(n=10), senior club long distance runners (n = 10) and veteran club long 
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distance runners (n = 10) were recruited to participate in this study. Veteran 
participants were defined as being between 45 and 65 yr and who competed in 
their sport two or more times a week. All subjects were required to train in their 
preferred discipline> 2 times a week, and to have maintained this level of 
training for at least a year prior to the testing period. Exclusionary criteria were 
any active medically diagnosed medical condition or musculoskeletal injury in 
any participant. The study was approved by the Ethics and Research Committee 
of the Faculty of Medicine of the University of Cape Town. The descriptive 
characteristics of the subjects are shown in Table 3.G.1. Prior to the start of the 
study, each subject's body fat percentage was recorded as described previously 
(Ch.3.A.). 
Each subject in the running groups performed two 5 km time trials on the same 
course under racing conditions. No attempt was made to control environmental 
conditions during testing, except that aI/ tests were performed within 14 d of 
each other to ensure no fitness level changes occurred. This lack of 
environmental control was deliberate in order to ensure that sporting activity 
during the trial was performed in similar conditions to the subjects routine 
activities. During the running time trials, each runner was supplied with a 
telemetric HR monitor (Sport-Tester heart rate monitor, Polar Electro, Kempele, 
Finland) which was worn around the chest. The squa&h players' heart rates vvere 
similarly recorded during two league matches within a 14 day period. Squash 
players had no control over their opposition. HR was recorded continuously 
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every 5 seconds during each test by the telemetric HR monitor. Subjects were 
allowed to warm up on their own prior to their respective trials to keep testing 
conditions as normal as possible. The sUbjects recorded their times using the 
stop-watch feature built into the HR monitor. The maximal HR (HRmax) was 
defined as the maximal HR attained during the subjects' entire period of sporting 
activity. The mean HR (HRmean) was defined as the average heart rate for the 
entire period of exercise activity. The duration of the sporting activity (TIME) in 
squash players was defined as the time period between the first and last 
competitive points of the match, and for the runners as the time period between 
the start and finish of the race. 
Statistics 
All of the data are expressed as mean ± standard deviation (SO), or maximum ± 
SO. A repeated measures analysis of variance was used to detect differences in 
subjects' HR for the two trials. Statistical significance was accepted when P < 
0.05. When significant F values occurred a Scheffe's post-hoc test was 
performed to determine where these differences occurred. Pearson's product 
moment correlation coefficient was used to determine relationships between the 
HR data obtained from the two trials. Repeatability and agreement between 
variables was determined using the procedure described by Bland and Altman 
(1986). This procedure defines the agreement between heart rate measured 
during test one and test two. According to this definition, 95% of the differences 
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between heart rate measured in test one and test two lie between the average 
HR differences between tests one and test two ± 2 SD. 
Results 
The veteran runners (VR) and veteran squash players (VS) were significantly 
older than both the senior runners (SR) and senior squash players (SS) (p < 
0.01) (Table 3.G.1). Although the height and mass of all subjects was not 
significantly different, the percentage body fat was significantly higher in the VR 
and VS groups than both the SR and SS groups (P < 0.01). 
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Table 3.G.1. Descriptive characteristics of the veteran runners (VR). including 
age (years), height (em), mass (kg) and percentage body fat (%) of the veteran 
squash players (VS), veteran runners (VR), senior squash players (SS) 
andsenior runners (SR). 
Age 
VR (n = 10) 49 ± 3** 
VS (n = 10) 50 ± 5** 
SR (n =10) 22 ± 3** 
SS (n = 10) 22 ± 2** 
P < 0.01 :Age: 
Body Fat (%): 
Height 
177 ± 3.1 
175.0 ± 7.3 
181.1±8.1 
179.1 ± 3.3 
SS vs. VS 
SSvs. VR· 
RS vs. VS 
RS vs. VR 
SS vs. VS 
SS vs. VR 
RS vs. VS 
RS vs. VR 
Mass Body Fat 
75.4 ± 6.3 21.9 ± 3.7** 
80.5 ± 15.7 23.9 ± 4.7** 
69.2 ± 7.8 10.4 ± 2.6** 
73.4 ± 7.2 12.5 ± 4.7** 
There were no significant differences in HRmax, HRmean and TI ME for all 
groups between test 1 and test 2 (Table 3.G.2.). TIME was Significantly longer in 
the SS group than in the VR, VS and SR groups (p < 0.01), while TIME was 
significantly shorter in the SR than in the VS groups (p < 0.01). (Fig 3.G.1.). The 
HRmax (Figure 3.G.2) and HRmean (Figure 3.G.3) values were significantly 
lower in both the VR and VS groups than in the SR and SS groups (p <0.01). 
However, there were no significant differences in HRmax between veteran 
runners and squash players, or senior runners and squash players. Similarly, 
there were no signi'ficant differences in HRmean between veteran runners and 
squash players, or senior runners and squash players. 
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Table 3.G.2. Mean values for HRmax (beats.min-\ HRmean (beats.min") and 
time trial time (TIME) (min) for the veteran runners (VR), veteran squash players 
(V8), senior runners (8R) and senior squash players (88) during time trial 1 
(TT1) and time trial 2 (TI2) (n=10 in each group). 
HRmax Hrmean TIME 
VR - TT1 170 ±. 11 * 158 ±. 9* 22.28 ± 2.04 
VR - TT2 170 ±. 12* 159 ± 8* 22.02 ± 2.02 
V8-TI1 176 ± 10* 159 ± 12* 27.48 ±. 9.63 
V8 - TT2 174± 14* 157 ± 11* 29.40 ± 4.55 
8R - TT1 192 ±. 8 180 ±. 11 17.65 ±. 2.02 
8R-TI2 191 ±. 7 181 ± 8 18.11±0.95 
88 - TT1 193 ±. 6 175± 7 43.87 ± 15.15 
88-TI2 193± 6 174±4 45.81 ± 16.81 
p < 0.01: HRmax: VR vs. 8R 
VR vs. 88 
V8 vs. 8R 
V8 vs. 88 
HRmean: VR vs. 8R 
VR vs. 88 
V8 vs. 8R 
V8 vs. 88 
TIME: VR vs. 88 
V8 vs. 8R 
V8 VS. 88 




















Figure 3.G.1. Time taken for the two running time trials (a) and squash games 
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Figure 3.G.2. Maximal heart rate (Hrmax) in veteran (a) and senior (b) runners 
and squash players for both time trial 1 (TT1) and time trial 2 (TT2). 
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Figure 3.G.3. Mean heart rate (Hrmean) in veteran (a) and senior (b) runners 
and squash players for both time trial 1 (TT1) and time trial 2 (TT2). 
The correlation coefficients for the different groups are described in table 3.G.3. 
The entire group of subjects (ALL) showed highly significant correlations for 
HRmax (Figure 3.G.4.), HRmean (Figure 3.5.2.) and TIME (P < 0.01) between 
TT1 and TT2. Similarly the runners and squash players combined groups 
showed highly significant correlations between TT1 and TT2 for all tests (P < 
0.01). All groups showed significant correlations for both HRmax and Hrmean 
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between TT1 and TI2, except for the V8 group. The VR and 8R groups showed 
significant correlations for TIME (P < 0.01) between TI1 and TI2 , whereas both 
V8 and 88 showed poor overall correlations. 
Table 3.G.3 Correlations between time trial 1 (TI1) and time trial 2 (TI2) for 
HRmax (beats.min-1), HRmean (beats.min-1) and time trial time (TIME) (min) in all 
subjects combined (ALL), combined veterans (V), combined seniors (8), 
combined squash players (8P), combined runners (R), veteran runners (VR), 
veteran squash players (V8), senior runners (8R) and senior squash players 
(88). 
HRmax HRmean TIME 
ALL (n=40) 0.86** 0.87** 0.51** 
R (n=20) 0.94** 0.96** 0.98** 
8P (n=20) 0.76** 0.76** 0.43* 
V (n=20) 0.69** 0.70** 0.23 
8 (n=20) 0.74** 0.81** 0.59** 
VR (n=10) 0.93** 0.93** 0.96** 
V8 (n=10) 0.48 0.54 -0.16 
8R (n=10) 0.72** 0.89** 0.93** 
88 (n=10) 0.73** 0.66* -0.27 
* - P < 0.05; ** - P < 0.01 
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Figure 3.GA. The correlation between HRmax during TT1 and TT2 for all 















, , , , 
, , 





100 150 200 250 
TTl 
Figure 3.G.5. The correlation between HRmean during TT1 and TT2 for all 
subjects (n=40). The dashed line represents the line of unity 
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Figure 3.G.6. describes the limits of agreement for the entire group between TT1 
and TT2 for HRmax. Figure 3.G.7. describes the limits of agreement for the 
entire group between TI1 and TI2 for HRmean. One subject was outside the 
limits of agreement for HRmax and 3 subjects were outside the limits of 
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Figure 3.G.6. The limits of agreement for the entire group between TI1 and TT2 











iii ------------------------- Mean+2SD 
~ 10 •• _ • 
-; 0 ---------.-:~t!---------------· Mean 
~ -.. . 
E -10 N, 
~ ------------------------- Mean-2SD • • .£ -20 
'+-5 -30 
-40~-----L------~----~ 
100 150 200 250 
Mean HRmean TTl-TT2 (beats.min -1) 
Figure 3.G.7. The limits of agreement for the entire group between TI1 and TT2 
for HRmean (n=40). 
Discussion 
The first finding was that maximal and mean heart rate testing was repeatable 
during field testing in this study, as shown by the high correlation between time 
trial 1 and time trial 2 . The limits of agreement, as defined by Bland and Altman 
(1986) showed that all except 1 athlete for HRmax and 3 athletes for HR mean 
were within the limits of agreement. It has been suggested that using limits of 
agreement is a more relevant test of repeatability than the more routinely used 
correlation analysis (Bland and Altman 1986; Nevill 1996). If so, our first finding 
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indicates that field heart rate monitoring is repeatable for assessment of maximal 
and mean intensity of effort in both intermittent intensity and steady state 
spoliing activities. During the field testing, the HRmax, as expected, was 
significantly lower in veteran than in senior subjects, as maximal HR decreases 
with age (Trappe et al 1995). This finding indicates that the field testing results 
are also sensitive when assessing maximal HR capacity. 
The correlation for HRmax between TI1 and TI2 was lower in the entire group 
of squash players (r=0.76) than in the runners (r=0.94), although both values 
were significant (P < 0.01). This finding is perhaps related to the fact that during 
the running time trial, the course and conditions were essentially identical and 
the subjects self-selected their running pace. The squash players, however, had 
no control over the level of skill of their opponent or the level of intensity at 
which the game was played. This may account for the differing maximal 
intensities recorded during competition. 
The veteran runners (- 22 min) were significantly slower (P < 0.01) than the 
senior runners (- 18 min), and the times for each group were not significantly 
different for the two time trials. In contrast, the time taken for the veteran squash 
players games (- 28 min) were significantly shorter (P < 0.01) than the time 
taken for the senior squash players games (- 44 min), and the time taken for 
each of these groups was also not significantly different for the two games. As 
described previously, the maximum heart rates were similar in both veteran 
363 
squas~1 players and veteran runners (- 173 beats/min) and were significantly 
lower (P < 0.01) than the maximal HR in both the senior squash players and 
senior runners (- 192 beats/min), which were also not significantl y different. 
Similarly, the mean heart rates were not significantly different in veteran squash 
players and veteran runners (- 158 beats/min) in both trials, and was also 
significantly lower than the mean HR in the senior squash players and senior 
runners (- 178 beats/min), which were also not significantly different in running 
and squash groups. These findings indicate that level of activity in veteran 
athletes was reduced in both continuous and intermittent intensity exercise 
activity. 
The findings that times were slower in the veterans participating in continuous 
intensity activity (running) and that time played was shorter in intermittent 
intensity activity (squash) where hand-eye coordination and proprioceptive skills 
are important may indicate that the aging process occurs in all body systems, as 
a generalized pathological process. However, the finding that both maximum and 
mean HR were similar in the veteran athletes participating in both continuous 
and intermittent activity can be interpreted in two ways. Firstly, afferents from 
weakened or damaged peripheral musculoskeletal systems may reduce activity 
in the veteran population to a "safe" limit, with secondary reduction in athletic 
performance times based on a calculation using HR as a determining factor. An 
alternative interpretation is that these reductions in activity were part of an age-
associated pacing strategy, where feedforward commands would restrict activity 
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in veteran athletes to a "safe" relative maximal limit based on HR and/orother 
variables, as part of protective teleological mechanisms. The findings of similar 
mean HR in the different veteran groups playing different sporting activities 
would in particular support the latter hypothesis. 
Although the repeatability of field HR testing was generally acceptable when the 
data from all subjects were pooled, when individual groups were assessed there 
was no obvious pattern to the repeatability results of the different groups. This is 
indicated by the finding that while the correlations were generally higher in the 
runners than squash players, the Bland and Altman (1986) test shpwed that 
some tests were acceptable in runners while others reached higher levels of 
acceptability in squash players. This is perhaps related to the numbers being 
tested. It has been suggested that for repeatability studies at least 30 or more 
subjects should be used (Schabort et al 1997), which may explain why results 
were more acceptable for the entire group (n=40) than when assessing the 
individual groups (n=10). Perhaps when assessing repeatability in small groups 
of subjects, three or more tests should be performed to more accurately assess 
the coefficient of variability. Nevertheless, the findings described earlier for the 
repeatability of the entire group can be accepted with some degree of certainty, 
given the relatively large numbers used. 
In conclusion,this study showed that maximal and mean heart rate in both 
veteran and senior athletes participating in running and squash rackets was 
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shown to be repeatable, despite uncontrolled environmental conditions and 
variation in competition. The next main finding was that veteran athletes have 
reduced duration of activity in both continuous (running) and intermittent 
(squash) activities. Both maximum and mean heart rates were similar in veteran 
athletes participating in these different activities, indicating that either afferents 
from weakened or damaged peripheral musculoskeletal systems may reduce 
activity in the veteran population to a "safe" limit, with secondary reduction in 
athletic performance times based on a calculation using HR as a determining 
factor, or that these reductions in activity were part of an age-associated pacing 
strategy. 
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3.H. Veteran athlete performance during stress ECG and field testing 
Introduction 
In the previous studies, athletes with symptoms of excessive fatigue and 
reductions in athletic performance were found to have vastus lateralis muscle 
pathology, and it was suggested that these findings may be a form of 
"accelerated" aging caused by their previous high volume and ~Iigh intensity 
athletic activity. These findings were present in athletes who had participated in 
sport at different competitive levels, from club athletes to Olympic competitors. 
Based on the work described in later chapters, it was suggested that the 
reduction in performance of these athletes may be part of a pacing strategy 
designed to reduce or prevent further muscle damage. It was also suggested 
that veteran athletes involved in continuous and intermittent activities may 
similarly adopt pacing strategies to prevent further muscle damage. An 
extension of this finding is to determine whether these pacing strategies are 
present in "maximal" laboratory testing procedures, and whether athletes of 
different competitive abilities have similar pacing strategies or physiological 
responses to exercise activity. 
As described in the introduction to this thesis, regular habitual physical activity 
reduces the risk of cardiovascular disease in the general population 
(paffenbarger et al 1986; Hardman 1996). However, the possibility that apart 
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from musuloskeletal damage, sudden death may occur during exercise remains 
a concern to physicians promoting a higher level of physical activity to their 
patients (Blanksby et a11973; Winget et aI1994). This is particularly important 
in middle-aged athletes in whom there is an increased prevalence of coronary 
artery disease and associated sudden de~th (Noakes et al 1979; Noakes 1987; 
Noakes and Rose 1.984; Noakes 1991; Northcote et al 1986; Maron et al 1986). 
The stress electrocardiogram (sECG) is routinely used to screen individuals for 
undiagnosed cardiac disease before a safe and effective exercise program is 
prescribed (Cheitlin 1993). Although false positive results due to the athletic 
heart syndrome have been described (Alpert et al 1989), it is accepted that a 
positive test is a risk factor for overt cardiac disease (Fuller et al 1997; Northcote 
et al 1986; Pashkow et al 1997). A normal sECG allows practitioners to 
prescribe exercise in the patient's chosen activity (ACSM guidelines 1991). T~lis 
is based on the assumption that the cardiac response during a typical sECG is 
similar to that which the individual experiences during sports activity. But, it 
seems unlikely that the cardiovascular responses during a sECG will be identical 
to those induced by all sporting activities (Blanksby et al 1973; Winget et al 
1994), since the phYSical demands of different sporting activities are varied, 
ranging from steady state, ~Iigh intensity exercise in runners (Selley et al 1995) 
to intermittent, high intensity activity with many postural changes in for example 
squash (Montpetit 1990). 
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Accordingly, the aim of this study was to determine whether the cardiovascular 
response elicited during a routine "maximal stress" sECG performed during a 
clinical examination is similar to the cardiovascular responses du ring different 
sporting activities. Veteran runners and squash players were chosen to 
participate in this study because of the interest of this thesis in aging and pacing 
strategies in veteran populations. Another reason for selecting these subjects 
was because of the increased prevalence of cardiac risk factors and 
cardiovascular-related sudden death in this particular age group of athletes 
(Blanksby et a11973; Noakes 1991; Northcote et a11984; Winget et aI1994). 
Methods 
Male veteran league squash players (n=10) (LSP), social squash players (n=10) 
(SSP), league runners (n=10) (LR), social runners (n=1 0) (SR) and sedentary 
subjects (n=10) (SED) were recruited for the study. Veteran participants were 
defined as being aged between 45 and 60 years who participated in their 
respective sports two or more times per week. League participants were involved 
in competitive sporting events on a regular basis, whereas social participants 
were not. After the risks and procedures involved in the study were explained, all 
subjects signed an informed consent. The study was approved by the Ethics and 
Research Committee of the Faculty of Medicine of the University of Cape Town. 
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A comprehensive questionnaire of cardiovascular risk factors was completed by 
each participant. All subjects underwent a full medical examination performed by 
the same physician. Each subject's body fat was estimated from the sum of four 
skinfold measurements (Durnin and Womersley 1974). The subjects then 
underwent a sECG according to the modified Bruce protocol (ACSM guidelines 
1991 ). 
The LSP and SSP groups subsequently played two squash matches in their 
normal environment, while the LR and SR groups ran two five km time trials. 
During all field tests, the subject's heart rate was recorded using portable 
telemetric HR devices (Polar Electro, Kempele, Finland). The portable telemetric 
HR devices have been shown to be reliable (Leger and Thivierge 1988) and are 
used to study heart rate responses in different sporting disciplines (Lambert et al 
1998). All testing was performed in the early evening and completed within 6 
weeks of the initial sECG. 
A modification of the Bruce protocol using a stationary cycle ergometer (Tunturi 
Pro, Finland) was used to perform the sECG (ACSM guidelines 1991). The cycle 
ergometer protocol was used to ensure that the testing procedures were similar 
to those of a routine sECG performed by physicians (ACSM guidelines 1991). A 
twelve channel sECG monitor (Hellige EK53, Germany) was used to perform the 
sECG. Electrodes were placed over the subjects' praecordium after the skin at 
each site had been shaved and cleaned with alcohol. Resting blood pressure 
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and HR were measured from the right arm while the subjects were in a supine 
and standing position. Diastolic blood pressure was defined as the pressure at 
the fourth Korotkoff sound. 
The test began after the subject had familiarized himself with the cycle 
ergometer. Thereafter, the subject started pedaling at 60 revolutions/min (RPM) 
at a power output of 50 W. Power output was increased by 50 W every two 
minutes. The test was terminated when the subject was unable to maintain a 
cadence of 60 RPM. Blood pressure (BP), HR and sECG were recorded every 
two minutes during the test and at the point coinciding with the termination of the 
test. BP, HR and sECG were also measured three and six min after termination 
of the test. 
The sECG traces were assessed independently and retrospectively by two 
physicians, one of whom was a cardiologist. The physicians were unaware of the 
identity of the different patients' sECG traces. The sECG traces were assessed 
for baseline abnormalities and exercise-induced ST segment changes. The 
exercise test was considered positive when ~0.1 mV of new ST segment 
depression at 80 milliseconds after the J point occurred (Chaitman 1997). 
Resting blood pressure and exercising blood pressure were measured at every 
incremental stage increase during the sECG by means of audible 
sphygmomanometry using a calibrated mercury column sphygmomanometer with 
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an appropri.ately sized cuff. Korotkoff phase I and IV were measured at all time 
periods representing systolic and diastolic blood pressure readings. The blood 
pressure recordings were all performed by the same physician using the same 
apparatus on the right arm of all subjects during all testing procedures. The 
measurement of diastolic blood pressure during exercise is sometimes difficult. 
However, jf phase IV of the Korotkoff sounds is recorded as the reference, the 
results are reproducible (Derman 1995). Also, any possible residual error is the 
same under all conditions. 
HR was recorded at 5 s intervals during the field tests. Subjects were allowed to 
warm up on their own prior to the field tests to keep test conditions as normal as 
possible. Heart rates were recorded in league matches in the LSP group. 
Subjects had no control over the playing quality of their opposition. The SSP 
played against their regular partners. Both LR and SR ran the same five km time 
trial. The subjects were allowed to warm up on their own prior to the time trial. 
Subjects then ran at their own pace after instructions to run the five km as 
quickly as possible. 
Statistics 
All data are expressed as mean ± standard deviation (SO). An analysis of 
variance (ANOVA) was used to detect differences in the subjects' general 
characteristics. HR and BP for the laboratory and field tests. Statistical 
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significance was accepted when P < 0.05. When significant F values occurred, a 
Scheffe's post-hoc test was performed to determine where these differences 
occurred. Pearson's product moment correlation coefficient was used to 
determine relationships between the HR data obtained from the sECG and the 
field tests. A chi-squared test was used to assess differences in the nominal and 
frequency data from the questionnaire. 
Results 
No significant differences were found in age or height between the LSP, SSP, 
LR, SR or the SED groups (Table 3.H.1). The subjects in the SED group had a 
greater degree of body fat (P < 0.01) and weighed more (P < 0.05) than the 
subjects in the LR group (Table 3.H.1). 
373 
Table 3.H.1. Descriptive characteristics, including age (years), height (cm), mass 
(kg) and percentage body fat (%) of the veteran league runners (LR) (n=10), 
social runners (SR) (n=10), league squash players (LSP) (n=10), social squash 
players (SSP) (11=10), and sedentary subjects (SED) (n=10). 
Age Height 
LR 49±3 179.1 ±3.8 
SR 52±6 179.1 ± 6.3 
LSP 49±5 178.0 ± 4.3 
SSP 53±5 173.2 ± 7.1 
SED 53±5 175.9 ± 5.9 
* P < 0.05: Mass: LR v SED 
** P < 0.01: Body fat (%): LR v SED 
Mass Body fat 
76.0 ± 6.3* 21.4 ± 3.7** 
83.4 ± 9.0 24.2 ± 3.2 
78.7 ± 11.4 23.0 ± 3.7 
79.8 ± 13.1 25.2 ± 3.3 
91.4±11.0 28.1 ± 3.9 
Retrospective analysis of the resting ECG traces revealed that one sedentary 
subject and one social squash player had a right bundle branch block at rest; 
one sedentary subject a bifasicular block at rest; one social squash player 
diffuse T wave inversion at rest; and one sedentary subject anterolateral T wave 
inversion with voltage criteria for left ventricular hypertrophy at rest. No further 
exercise-induced ST segment changes occurred in any subject. 
Table 3.H.2 shows the differences between pre-test resting HR, SBP and DBP 
for the different groups. The LR group had a significantly lower resting HR than 
the SSP (P < 0.05) and SED (P < 0.01) groups. The resting HR of the SR group 
was significantly lower than that of the SED group (P < 0.01). There was a 
significant difference in pretest HR between a combined runners group (n=20) 
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and combined squash players group (n=20) (56 ± 6 vs. 62 ± 6 beats/min, P < 
0.05). There were no differences in resting SBP or DBP between groups (Table 
3.H.2). 
Table 3.H.2. Pre-test standing heart rate (HR) (beats/min) and systolic (SBP) 
and diastolic (DBP) blood pressure (mmHg) of the veteran league runners (LR) 
(n=10), social runners (SR) (n=10), league squash players (LSP) (n=10), social 
squash players (SSP) (n=10), and sedentary subjects (SED) (n=10). 
HR 
LR 54 ± 10** 
SR 58 ± 6** 
LSP 59 ± 7 
SSP 66 ± 8* 
SED 72 ± 8** 
* P < 0.05: HR: 
** P < 0.01: HR 
SBP 
148 ± 28 
130 ± 15 
127 ± 8 
140 ± 16 
137 ± 15 
LR v SSP 
LR v SED 
SR v SED 
DBP 
90 ± 7 
84± 7 
81 ± 7 
88 ± 10 
87 ± 9 
Table 3.H.3. shows the maximal HR (HRecg), and maximal systolic (SBPmax) 
and diastolic (DBPmax) blood pressure reached during the sECG test. No 
significant differences in HRecg were found between any of the groups. The 
SBPmax was significantly higher in the LR group compared to the SED group 
(210 ± 21 vs. 185 ± 18 mmHg, P < 0.05, table 3). Exercise time to fatigue in the 
sECG was shortest in the SED group (6.4 ± 1.7 min), and longest in the LR 
group (9.2 ± 1.4 min P < 0.01, Table 3). 
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Table 3.H.3. Maximal heart rate (HRecg) (beats/min), maximal systolic 
(SBPmax) and maximal diastolic (DBPmax) blood pressure achieved during the 
sECG, and time taken for the sECG test (Tecg) (min) by the veteran league 
runners (LR) (n=10), social runners (SR) (n=10), league squash players (LSP) 
(n=10), social squash players (SSP) (n=10), and sedentary subjects (SED) 
(n=10). 
HRecg 
LR 148 ± 16 
SR 154± 9 
LSP 153± 8 
SSP 156 ± 12 
SED 151 ± 14 
* P < 0.05: SBPmax: 
Tecg: 
** P < 0.01 Tecg: 
SBPmax 
210±21* 
201 ± 17 
200 ± 16 
196 ± 13 
185 ± 18* 
LR v SED 
SR v SED 
LR v SED 
DBPmax Tecg 
91 ± 10 9.2 ± 1.4** 
84±8 8.8 ± 1.4* 
85±8 8.4 ± 1.3 
91 ± 8 7.8 ± 1.5 
92 ±8 6.4 ± 1.7** 
No significant differences were found between the average HR attained during 
the first and second field tests for all subjects (172 ± 10 vs. 173 ± 12 beats/min). 
Therefore, the data from the second test were used for further evaluation, except 
in three subjects where 10 or more HR data points were lost as a result of a poor 
HR signal from the transmitter. In these subjects, the first field test was used for 
analysis. In two squash players and one runner, both tests showed excessive 
electrical interference and could not be interpreted; thus these subjects were not 
used for subsequent analysis. 
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Table 3.H.4. shows that there were no significant differences between the LR, 
SR, LSP or SSP groups for maximal HR attained (HRmax) and mean HR 
(Hrmean) attained during the field test, or for the time taken to complete the field 
test (TT). 
Table 3.H.4. Maximal heart rate (HRmax) (beats/min) and mean heart rate 
(HRmean) attained during the field test and time taken for the field test (TT) 
(min) by the veteran league runners (LR) (n=8), social runners (SR) (n=10), 
league squash players (LSP) (n=1 0), and social squash players (SSP) (n=9). 
HRmax HRmean TT 
LR 167 ± 16 156 ± 14 21.8 ± 2.3 
SR 170 ± 9 158± 9 25.0 ± 3.9 
LSP 177 ± 8 159 ± 10 26.0 ± 4.8 
SSP 172 ± 15 155 ± 12 26.0 ± 5.0 
Figure 3.H.1. shows the relationship between the maximum heart rate attained 
during the sECG and field tests (HRecg and HRmax respectively). A significantly 
higher maximal HR was attained in the HRmax test than in the HRecg test for 
the LR (148 ± 16 vs. 167 ± 16; P < 0.01), SR (154 ± 9 vs. 170 ± 9; P < 0.01), 
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Figure 3. H.1. The relationship between the maximum heart rate achieved during 
the stress ECG (HRecg) and field test (HRmax) for the league runners (LR), 
social runners (SR) league squash players (LSP) and social squash players 
(SSP) Values are expressed as mean (SO) (** - P < 0.01). 
Figure 3.H.2. shows the relationship between the maximum heart rate in the 
sECG (HRecg) and the average heart rate in the field tests (HRmean). No 

















Figure 3.H.2. The relationship between the maximum heart rate achieved during 
the sECG (HRecg) and the average heart rate of the field test (HRmean) for the 
league runners (LR), social runners (SR), league squash players (LSP) and 
social squash players (SSP). 
The correlation coefficient between HRecg and HRmax for the LSP group was 
r=0.93 (P < 0.01), the SSP group r=0.60, the LP group r=0.69 (P < 0.05) and the 
SR group r=0.82 (P < 0.01). The correlation coefficient for combined runners 
was r=0.83 (P < 0.01) (Figure 3.H.3.) and for squash players was r=0.73 (P < 
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Figure 3.H.3. The correlation between HRecg (beats/min) and HRmax 
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Figure 3.H.4. The correlation between HRecg (beats/min) and HRmax 
(beats/min) for the combined squash players group (n=17). The dashed line is 
the line of unity. 
Discussion 
The important finding of this study was that the maximal heart rate of the 
subjects while playing squash or running, either socially or competitively, were 
significantly higher than the heart rates attained by the subjects when 
undergoing a sECG to exhaustion. This HR response was neither sport nor 
competition specific. The finding that all subjects were able to exercise to a 
relatively high HR without symptoms during the stress test is a good prognostic 
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indicator (Bogaty et aI1989). But, the significant difference in maximal heart rate 
in the field compared to the laboratory sECG indicates that a maximal sECG as 
described in exercise testing manuals (ACSM guidelines 1991) is not indicative 
of the level of maximal HR achieved by individuals wl"lile exercising in either 
squash rackets or running activities. 
There was no significant difference between the mean HR attained during the 
field test and the maximal heart rate attained during the sECG. Tilis suggests 
that the subjects were exercising at a similar intensity to the maximal heart rate 
achieved during sECG for the major part of the field test. The significantly higher 
maximal heart rates described during the field tests must therefore have 
occurred during short periods of high intensity activity during the exercise 
performance, similarly described by others (MerCier et aI1987). 
The sECG test procedures followed those of a routine sECG as performed by a 
physician according to ACSM guidelines (ACSM guidelines 1991). Thus, it 
cannot be argued that the reason for the differences between the HRecg and 
HRmax values was that the subjects were unfamiliar with the testing procedure. 
The HRecg data are valid because all subjects satisfied the criteria for an 
acceptable sECG. In addition, similar field values for HRmax have been 
previously described in veteran athletes (Blanksby et al 1973; Bogaty et al 1989; 
Lynch et al 1992). Furthermore, the fact that moderately good correlations 
occurred between HRecg and HRmax in both runners (r=0.83) (P < 0.01) and 
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squash players (r = 0.73) (P < 0.01), indicates that performance in the two tests 
was related and not a spurious finding. Therefore, the difference between 
HRecg and HRmax in all groups in this study must be a real finding. 
The veteran athletes from both social and competitive levels of activity perform 
exercise at similar heart rate intensities. l'f heart rate can be accepted as a proxy 
for exercise intensity (Lambert et al 1998), the findings suggest that both 
competitive and social athletes have adopted similar pacing strategies. 
Therefore, possibly athletes compete or train at similar relative intensities, and 
have similar levels of stress during exercise activity, despite having different 
racing speeds. 
As described previously, the mean heart rate achieved during athletic activity 
was similar to the maximal heart rate attained during a stress ECG. This may 
indicate that veteran athletes adopted a pacing strategy during both these tests, 
and one must therefore suggest that the stress ECG is not a truly "maximal" test. 
It must be noted that the major reason for performing a sECG test would be to 
screen sedentary individuals prior to starting an exercise program. However, this 
study showed that individuals who are already training are exercising at a HR 
significantly higher than that achieved during a sECG test. It remains to be seen 
at which HR level sedentary individuals perform when exercising for the first time 
in either rehabilitation or sporting activities. 
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It has been shown that with aging, the incidence of cardiac ECG abnormalities 
increases (Brady et a11989), and that cardiac ECG abnormalities may indicate 
an increased risk of exercise-induced sudden death (Noakes 1991). It must be 
noted that five subjects in this study had abnormal resting ECG's, although none 
showed signs of ischaemia during the sECG test. 
The resting HR of the runners was signi'ficantly lower than that of the squash 
players. Whether the runners had an increased stroke volume, reduced 
sympathetic tone or increased parasympathetic tone compared to the squash 
players is beyond the scope of this study. 
In conclusion, the mean heart rate attained during squash and running was 
significantly higher than that attained during a sECG . This finding was not sport 
specific nor related to the level of competitiveness of the athletes. Possibly 
athletes compete or train at similar relative intensities, and have similar levels of 
stress during exercise, despite having different absolute training and racing 
speeds. Although no subjects in the study had ischaemic symptoms or exercise-
induced sECG changes, it must be noted that the maximal HR attained during 
the sECG was lower than the maximal HR during the squash or running field 
tests. These data show that the routine sECG using a cycle ergometer is a 
submaximal test of exercise performance. Finally, physicians should therefore 
be aware that veteran athletes participating in squash rackets or running 
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activities are exercising intermittently at higher maximal HR than during routine 
sECG testing. 
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CHAPTER 4. SUMMARY 
The overall aim of this thesis was to investigate the relationship between long 
term participation in high volume and high intensity exercise activity and the 
development of symptoms of chronic fatigue and deterioration in exercise 
performance. The underlying hypothesis of the thesis was that excessive 
exercise or athletic activity may lead to a form of "accelerated" aging, where 
different physiological systems are permanently damaged by the crlronic and 
repetitive stresses induced by exercise activity, and eventually lose their 
ability to regenerate fully with pathological consequences. The second 
hypothesis of the thesis was that veteran athletes may adopt pacing 
strategies where physical activity is reduced as a protective strategy to 
prevent further damage and further "accelerated" aging. The following ;s a 
. summary of the main findings of the series of studies described in this thesis. 
After the exposition of the summary of the main findings, there follows a 
discussion of future studies which are warranted as a result of these current 
findings. 
The first study showed that muscle pathology was found in a 28 year old 
international level runner who presented with symptoms of excessive fatigue, 
decrements in physical performance and lower limb muscle "weakness." The 
muscle damage, which included mitochondrial pathology, was present in the 
vastus lateralis muscle but not present in his triceps muscle. The muscle 
pathology was still present in a repeat vastus lateralis biopsy performed four 
months after the first sample. Mitochondrial DNA analysis showed no 
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evidence of deletions associated with Kearns-Sayre syndrome or any other 
syndrome pathognomonic of classical mitochondrial myopathy. The 
conclusion of this study was that the muscle pathology was either i) acquired 
as a result of his prolonged physical activity, or ii) was acquired as a result of 
unknown infective or toxic agents, or iii) existed previously undiagnosed, 
although this was unlikely given his athletic competitive success. 
The next study showed similar muscle pathology was present in the vastus 
lateralis muscles of 19 of 20 athletes of different levels of competitive ability, 
who presented with similar symptoms of excessive fatigue and decrements in 
athletic performance after several years of training and racing. A high 
proportion of these athletes also suffering from clinical depression, or had 
suffered from lifestyle stresses or psychological disorders prior to being tested 
in our Unit. It was not clear if these were a cause or a consequence of the 
excessive exercise, muscle pathology and symptoms of fatigue. The 
symptoms of fatigue were poorly related to physical testing performed in our 
laboratory. This finding was interpreted that fatigue is not a physiological 
entity, but rather a sensory manifestation of underlying cognitive or afferent 
sensory input integration processes. 
The next study showed there was a significantly greater degree of muscle 
pathology in the fatigued subjects than in 10 control age and current exercise 
matched subjects who had no symptoms of excessive fatigue or deterioration 
in exercise performance. Although the study was not designed to establish 
causality between the muscle pathology and the symptoms of excessive 
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fatigue and associated decrements in athletic performance, it is tempting to 
speculate that this relationship does exist. In this study it was also found that 
while there were no differences between fatigued athletes for maximal force 
output, or maximal aerobic capacity, there was a dissociation between various 
physiological factors and stride frequency during submaximal running and 
during jumping activities. These findings may indicate that the muscle 
pathology may interfere with the ability to produce complex muscle activity or 
coordinated gait patterns, and the symptoms of fatigue may be related to 
these findings. It was also found during this study that the fatigued athletes 
may adopt pacing strategies during the various exercise tests, which may, 
along with the excessive symptoms of fatigue, have been part of a strategy to 
protect their muscle against further damage or "accelerated" aging processes. -... 
The next study showed that a three month trial of antioxidant therapy did not 
improve the symptoms of excessive fatigue and decrements in performance in 
the fatigued athletes described previously. This may have been because the 
muscle damage or physiological changes in these athletes was too profound 
or was of a permanent nature, and therefore could not be improved by the 
antioxidant therapy. It may also indicate that oxidative processes may not be 
involved in the generation of the excessive fatigue symptoms, or that there 
was a larger psychological component to the fatigue symptoms. A decrease in 
resting diastolic blood pressure and increased resting heart rate and heart 
rate during submaximal treadmill running was found, and which may have 
been a positive benefit to the use of the antioxidant treatment, but a 
mechanism for this benefit remains unclear. 
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The next study showed that age related decrements in physical performance 
began at an earlier age in runners compared to cyclists. As running involves 
more weightbearing and eccentric activity than cycling it was hypothesized 
that running causes more musculoskeletal damage, and leads to premature or 
"accelerated" aging at an earlier age than cycling. 
The next study showed that age related decrements in force output were· 
greater in leg compared to arm muscles. The changes were related to 
decreases in lean volume of the limbs, and were not due to neuromuscular 
changes associated with fatigue or force generation. These findings support 
the findings described in the previous study of fatigued athletes, and may be 
due to pathological changes in lower limb muscles from excessive use (i.e. 
weightbearing activities), or because of the greater effect of decreased activity 
on the lower limb of older individuals. 
The next study showed that veteran athletes have reduced duration of activity 
in both continuous (running) and intermittent (squash) activities. Both 
maximum and mean heart rates were similar in veteran athletes participating 
in these different activities. This may indicate athletic activity was reduced in 
the veteran population to a "safe" limit, with secondary reduction in athletic 
performance times based on a calculation using HR as a determining factor, 
or that these reductions in activity were part of an age-associated pacing 
strategy, where feedforward commands would restrict activity in veteran 
athletes to a "safe" relative maximal limit based on HR and/or other variables, 
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as part of protective teleological mechanisms. The findings of similar mean 
HR in the different veteran groups playing different sporting activities would in 
particular support the latter hypothesis. 
The final study showed that veteran athletes from both social and competitive 
levels of activity perform exercise at similar heart rate intensities. Therefore, 
possibly athletes compete or train at similar relative intensities, and have 
similar levels of stress during exercise activity, despite having different racing 
speeds. It was also found that the mean heart rate achieved during athletic 
activity was similar to the maximal heart rate attained during a stress ECG, 
which may indicate that veteran athletes adopted a pacing strategy during 
both these tests, and that the stress ECG is not a truly "maximal" test. This 
idea was supported by the finding that maximal heart rate attained during both 
squash and running activities in these veteran athletes was Significantly 
higher than during the stress ECG, which may indicate that at intermittent 
periods during exercise activity, veteran athletes perform exercise activity at a 
level of activity which may predispose them to cardiovascular crisis, and 
which cannot be diagnosed by clinicians during routine ECG testing. 
In summary, this thesis has described the findings of pathological muscle 
changes in the vastus lateralis muscles of athletes with symptoms of 
excessive fatigue and decrements in athletic performance, which were not 
present in age and current exercise matched· control studies. The findings of 
this thesis appear to support the hypothesis that prolonged exercise activity 
may lead to pathological changes in muscle which may be described as an 
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"accelerated" aging process. The 'findings suggest that fatigue is an emotional 
sensation and not a physical process, and is only loosely related to underlying 
physiological processes. Finally, the findings of this thesis suggest that the 
decrements in physical activity associated with aging may be a consequence 
of pacing or "teleoanticipatory" strategy to protect the musculoskeletal system 
from further damage which may result from ongoing athletic activity. 
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Future directions 
Future research in this field should include: 
i) A study of why are some runners more vulnerable to the 
development of muscle pathology than others. 
ii) A study of whether the vulnerability to muscle pathology is related 
to poor biomechanics which results in the athletes having to sustain 
higher impact stresses when they train. 
iii) A study of whether muscles lack the ability to fully regenerate after 
an exposure to damaging exercise. 
iv) A study of whether runners who have been running for 3 decades 
without developing FAMS represent runners who are 
biomechanically perfect, or do these runners have muscle and 
connective tissue which is resistant to the long term changes which 
have been described above. 
v) A study of whether the physical decrements in performance 
associated with aging are a result of a generalized aging process of 
all physiological systems, or whether they are a teleoanticipatory 
pacing strategy to reduce the biomechanical changes associated 
with aging. 
vi) A study of the role of complex system controls of different 
physiological systems, and resultant non-linear dynamic activity in 
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young and veteran athletes during resting and exercising 
conditions. 
vii) A study of whether the complex system control mechanisms are 
pathological or teleological in chronic fatigue and the fatigued 
athlete myopathic syndrome. 
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· CHAPTER S. POSTSCRIPT 
The role of medicine in society and the Sisyphus paradox 
"Because they wage a losing battle against death, al/ physicians resemble 
Sisyphus, etemally condemned to perform an impossible task" (Peschel and 
Peschel 1989) 
The dillemma facing medical practitioners regarding their social contract and a 
patient's individual rights have been discussed previously (St Clair Gibson 1998). 
We suggested that in the postmodern view, all ethics or morals in medicine are 
relative and that there is no such thing as absolute truth. From this perspective, 
doctors need only be concerned about the fulfillment of their own chosen ethical 
standpoint and whether this goes against the current laws of the land (St Clair 
Gibson and Hopkins 2000). This concept generated some controversy (Larsen 
2000, London 2000; Driver-Jowett 2000). But what has not been analyzed and is 
crucial to any debate on the issue of medical ethics, is precisely the role of a 
medical practitioner in society. 
The role of a physician may perhaps be defined as firstly. to save or prolong an 
individual's life, and secondly to alleviate a patient's pain and suffering during 
their life. Since recorded history, doctors have fulfilled this role. or were allocated 
this task. The equipment for diagnosing illnesses has improved, and medicines 
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and surgical techniques have become more advanced. But, the physician's 
primary tasks remain those mentioned above. 
It may appear immediately self evident why it is important to save or prolong 
human life. However, on doser examination the reasons why doctors perform 
these tasks are not so clear. As previously discussed (St Clair Gibson 1998), one 
cannot know where or how the tenet that human life is sacrosanct was derived. 
As much as it is difficult to logically defend any "truth," it is as difficult to logically 
argue that human life is 'precious" or "special," or that the right to life is an 
inviolate principle which needs to be defended. The reasons for believing t~lis 
must be selfish and derived from a fear in most individuals of their own mortality 
and death. It is difficult to even begin to argue, and perhaps it is not necessary to 
do so, that a religious belief or some supernatural or metaphysical world exists 
where life is considered "sacred." It requires faith to believe that a deity exists 
and even greater faith that such a deity has created rules, and no logical 
argument can defend this line of reasoning. 
Thus there is no abstract or p~lilosopl"lical reason why physicians should either 
save or prolong human life. Similarly, there is no man made law which can ever 
be described as being a complete truth or universal legal determinant. All laws, in 
the postmodern sense, are only truly correct for those that believe in them. Also, 
laws are never immutable and are always changing. Thus there are no fixed or 
absolute laws that say that a doctor must save or maintain life in every 
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circumstance. Thus to answer the question of whether doctors have any moral or 
legal obligation to perform their function, the logical as opposed to the emotional 
response would be that no such obligation exists. 
If no obligation exists for physicians to perform their perceived role in society, 
one needs to further assess if they perform a significantrole in society. Peschel 
and Peschel (1989) previously described that being a physician is akin to being 
Sisyphus. In Greek mythology, Sisyphus attempted to cheat death to remain on 
earth. His punishment from the Gods for this was to roll a heavy object up to the 
top of a hill. Each time he reached the top of the hill, the object rolled down 
again, and the task had to be repeated continuously for eternity. An analogy can 
be drawn from this to the physicians work, namely that no matter what a 
physician does, they can never "cheat" death. Even if a patient is cured of one 
disease, they will eventually die of something else (Koeslag 1993). Thus to 
suggest that physicians "save" lives is not logical. If this were true, medicine must 
represent the ultimate failure as a profession, as every single person treated by a 
physician eventually dies. Thus any treatment for any disease eventually has a 
hundred percent mortality rate. As in the myth of Sisyphus, physicians are caught 
in an absurdist paradigm. Tiley are "saving" people to face eventual death. Thus 
doctors from this perspective have what is ostensibly a purposeless function and 
like Sisyphus are condemned to perform tasks with no successful conclusion. 
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Why then, does society still feel that physicians are socially relevant, and why do 
doctors feel that they are fulfilling a useful role? The first reason may be that 
doctors are indoctrinated from early in their training that they are performing an 
important function, and are not actively taught to question their own "reason for 
being." It is uncomfortable for anyone to realize that their own career choice is 
inherently futile. The second reason is that society has bought into this dogma, 
and all people, because of a basic fear of their own mortality and death, place 
doctors on a pedestal, as they feel physicians are the only people staving off the 
inevitable for as long as possible. The third reason, and perhaps the most 
important, is financial. Physicians have a vested interest in maintaining this 
mythical status in order to maintain an affluent or comfortable lifestyle. Very few 
people would pay for a service if it could never be completed or was never 
successful. Thus obviously, physicians need to maintain or propagate the 
concept that they have a valid "reason for being" in order to maintain their 
livelihood. 
What can a physician do to live a relevant life in an ultimately futile existence? 
The first would be, instead of concerning oneself with maintaining life, to educate 
individuals on the certainty of death and to better prepare for this inevitability. If 
one could educate individuals or remove their fear of dying, people may perhaps 
no longer feel a need to seek out medical assistance but would rather embrace 
or be comfortable with their own dying. Patients themselves therefore have a role 
to play. Just as a physician needs to accept the ultimate redundancy or futility of 
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their existence, so do all individuals have to accept the futility of their own 
existence, and that dying is in itself the culmination of life, however paradoxical 
tl"lis observation may be. Therefore, education of patients about this perspective 
on their own mortality would be a positive role for medical practitioners. 
The second would be to create a pain or illness free environment for ones 
patients. While there may be a teleological reason for pain and suffering, possibly 
in the context of learning some perspective not understood in routine life, there is 
clearly comfort produced in one's patients by reduction of their pain and 
suffering. 
The third would perhaps be to incorporate scientific analysis into their medical 
practice. If there is a chance of "cheating" death, science will do so by phYSically 
answering the questions surrounding the meaning of what thought, 
consciousness and eternity are. SCience, as opposed to medicine, philosophy 
and theology, may be the only vehicle with which to physically answer the 
questions that will explain what physiological and anatomical mechanisms are 
related to tile "life" and "death" forces. 
In conclUSion, much like the life of Sisyphus, phYSicians are condemned forever 
to perform a task which has no long term success. Perhaps before a physician 
can decide on a moral or clinical standpOint, they first need to understand their 
own reason for being, and from where their own interpretation of "life" is derived. 
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If physicians can accept the limits of their chosen career, and perhaps educate 
their patients likewise, they may enhance their own "reason for being". 
Cognizance should be taken of this philosophical perspective when assessing 
the conclusions and impact of this thesis. While the primary function of this thesis 
is to contribute to research, it is hoped that an equally important result will be an 
ability to use these data to educate athletes and patients about the possible 
harmful effect of excessive athletic activity, and the possibility that their athletic 
careers may not continue forever. 
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FAMS TRIAL INFORMED CONSENT 
I, the undersigned, have been fully informed about the dangers inherent in 
participation in this trial. I also understand that the following measurements/tests 
may be conducted on myself prior to, during and after participation in the trial or 
any of its components: 
• Routine medical examination 
• Routine haematological investigations, including viral screen 
• Lifestyle and sporting history questionnaire 
• Performance testing - 1 DOm time trial; 4DOm time trial; 5 km time trial; graded 
high intensity test to exhaustion for the measurement of maximal oxygen 
consumption (V02max test) 
• Anthropometrical testing 
• Isokinetic dynamometer muscle strength testing 
• Skeletal muscle biopsies of the left vastus lateralis and triceps muscles will be 
performed at 0,3 and 6 months 
• Three and six month intervention trial, in which I will receive, in random order, 
either the placebo or the following medications: Vitamin C (Sustained release 
19 - 1 tablet daily); Vitamin E (200 iU/cap'- 2 capsules daily); Carotenoid 
complex (15 mg/cap - 2 capsules); Flavenoid complex (Complex tabs - 1 
tablet daily). 
I understand that some of the above tests are invasive and have certain risks. I 
also understand that the investigators undertake to inform me of any negative 
side effects or findings as soon as results of tests become available. The 
University of Cape Town or any of the investigators is in no way liable for any 
harm or damage suffered by me during the course of the trial or arising from the 
trial. 
I understand that I will be free to withdraw from the study at any time and that I 
will not be subjected to any pressure whatsoever to remain in the trial. All the 
information that is collected during the course of the investigation will be treated 
VJith the strictest confidentiality and will only be used for scientific research 
purposes. Names and personal particulars will not be released under any 
circumstances. I will be free to ask any questions about the procedures and 
results of the study. 
Subject_,, _______ _ 
Signature: ________ _ 
Date: ---------------
Investigator: _______ _ 
Signature: _________ _ 
Witness: -------------
Signature: ________ _ 
3EeK DEPRESSION INVENTORY: SUGGESTIONS FOR USE 
"'In community nursing, the nurse often encounters family members who are 
jepressed. The Beck Depression Inventory can be used to assess the serious-
ness of the family member's state of depression. 
Depression is a common problem that is manifested in many ways. It- ap-
pears in varying degrees of i"tensity and dnration. The nurse may first iden-
tify depression during the home visit or during a clinic visit, based on observed 
behaviors and described behavior .and feelings. Depression is defined on a 
continuum from mild transitory affects of feeling low to a severe psychotic 
depressive state (Haber, 1978, pp. 307-315). 
The student can successfully administer the Beck Depression Inventory by 
{ollowing suggestions in the "InStructions {or Interviewer Administration of· 
. the Beck Depression Inventory." There is no arbitrary score that can be used 
for all purpol!eS to classify different degrees of depression. However, the follow-
ing guidelines have been suggested to interpret the scale (Beck, 1978): 
....... to 9 normal range 
, .0 to 15 mild depr~ion 
• 16 to 19 mild-moderate depression 
. • 20 to 29 moderQ.te-severe depression 
i • 30 to 63 severe depression 
I~------~----~------------------------------------------------~----------------~ 
. INSTRUCTIONS FOR JNTERVlEWER ADMINISTRA110N OF THe BECK DEPRESSION INVENTORY 
The following insrruC?tions have been developed in oreler to 
standardize ttle adrninisrration of the Depression Inventory. 
II is important !hal tnev De iollowed in order to prO'llide 
unitormity and minimile interviewer effects. 
I. Routine of Administr;ltion 
Say to the patient "This is a questionnaire. On ttle ques-
tionnaire are groups of statements. I will read a group of 
statements. Then, I want you to pick out the one statement 
in that group which best describes !he way you've been 
'eeting In the PAST WEEK including TODAY:' 
. At this point hand a copy of the queStionnaire to the r .... ·' patient and say, "Here is a copy for you. so that you can 
11 follow along as I read." Read the entire group of statements 
II in the first category (do not read the numbers appearing 
i be/ore me statements): men say, "Now. wtlieh one of the 
! statements best describes the·way you've been feeling in 
[ the PAST WEEK Including TODAY," 
If the palienl indicates his choice by responding with a 
number. read back tne slatement corresponding 10 Ihe 
number given by me patient. in order to avoid confusion as 
to which statement i$ selected. When the patient says, "the 
first statement." he may mean 0 or 1, Atter it ;s apparent 
that the patient understands the nlJmbering system, the 
numerical answer should tie SUfficient to Indicate his 
choice. . 
II. Additional Notes 
A. Make sure that each choice is indeed the patient'S 
choice and not wordS you have put in his mOlJth. Gel the 
patient to express. on his own, which statement is his 
choiee. 
B. " me palient indicates ttlat there are IWQ or more 
statements wnich fit Ihe way he feels. tnen record ttle higher 
ot the two values. : 
C. If ttle patient indicates that the way he feels is be-
tween say. 2 and 3. being mere lhan 2 but not Quite 3. then 
record the value he is closer to. or 2. 
O. Generally, the inrerviewer should continue to read 
aloud ttle statements comprising each calegory. Some-
times me patient will take !he initiative and read !he state-
ments in a calElgory silendy, ahead of the interviewer, and 
start giving his preference. If the patient is alert and appar-
endy knowfedgeable. let him read ttIe statements silendy 
and then make his choice. Explain to such a patient that the 
reason you read !he statements aloud is so you can be 
5ure he had read ali the statements in the category before 
making his chDlce. TeR the patient that if M will be lure to 
read. ell stIJ.tell'Ulllbr in each group Otfore making his 
choice. he may read silentlY. Use tact and diplcmac:y to 
encourage the patient to reflect suffiCiently before making 
a choice. . 
E. The depression score should be entered on record 
sheet. It is simply the $IJtn of the nighest weighted re-
sponse selected in each group of statements from 1 
through 21, The weight is me numerical value adjacent to 
each statement 
F. Group 19 (weight loss) was designed to assess an 
anorellic symptom. If the patient resj:)Onds aHirmal.ively to 
the Question. "Are you trying to lose weight by eating tess." 
rhe score on tMt group is net added 10 the total score. 
Copyright @ 1978 by AUOll T. Beck. M.D. Reproc:hlctioQ wichou; ,.athol's expreas tm~ consent is forbidden. A4d1tiona1 eopi .. 
andJDt pennillaion to "lie thill-ue 113IY be obtained £tom: CENTER FOR COGNl.'TlVi! THERAPY.:Room 602, 133 South 36th Street, 
Philadelphia. Pa. 19104 . .Reprodu.ced with the permissian of AAroD T. Beck. M.D. 
So~! Young, R.X., Community Nursin~ Workbook: Family as Client, Norwalk, Conn., 
Appleton, Century-Crofts, 1982, page 159. ----
lEeK INVENTORY 
~ame ___________________________________________________ Da~ ________________________ __ 
)n this questionnaire are groups of statements. Please read each group of statements carefully. Then pick 
.mt the one statement in eacb group which best describes the way you have been feeling the PAST WEEK. 
NCLUI>ING TODAY! Circle the number beside the; Si.~H~rnCn£ you picked. If several statements in the group 
;eem [0 apply equally well, circle each one. Be sure to read all the statements in each group before 
making your choice. 
o I do nor feel sad. 
I I (I;el sad. 
2 t am sad all Ihe lime and I can 'I snap out of It. 
l I am so sad or unhappy Ihat I can 'Uland it. 
2 0 I am nO[ panicu!l'lrly discoUI'lIBCd about till: future. 
I r fed discouraged aboul Ihe fulure. 
... I fc~1 I have nOlhing 10 look forwllrd [0 • 
. feel thai Ihe future is hopeless and lhal Ihings callnor 
-- mprovc. 
3 1I I do nOI feel like a failure. 
I I feel I have failed more Ihan fhe average person. 
2 As t look bade Oil my life, aliI tan sec is a lOt of failures. 
3 I feel I am a t:omple~ failure as a penon. 
4 0 r ge[ as much salisfacrion DUI of fhings as I used 10. 
I. I don 'I cnjoy Ihings Ihe way ( used to. 
2 r don'l gel I"C:)I uli5(aecio/l CUI G( anything anymore. 
3 I am dissatisfied or bored with everything. 
5 0 I don'l feci p~rticularly guilly. 
I J feel 81Jihy a good pon of Ihe time. 
~ I feel ~.mc guiley mu~t of the lime. 
3 I feel guillY aU of lh.: time. 
6 0 I don'l fccl , am being punished. 
I I feel I may be punished. 
2 I expecl 10 be punished. 
3 , fcell 2m being punished. 
7 0 I don't feel di5Dppointed in myself. 
. I am disappointed in myself. 
, am disgusted with myselr. 
'--" : hate myself. 
lor don', feel I am any worse than anybody else. 
I I am critical of mys~lf for my weaknesses Dr mislakes. 
2 J blame myself all the lime for my faults. 
3 I blame myself for e·verylhing bad Ihal happens. 
9 0 I don'l have any thoughts of killing myself. 
I I havc Ihoughts or killing m·yself. bUI I would nOl catty 
Ihem oUI. 
2 I would like to kill mystlr. 
J I would kill myself If I had Ihe chlnee. 
10 0 I don'l cry any more Ihan usual. 
I I cry more now Ihan I used 10. 
2 I cry allihe lime now. . 
3 I Wicd 10 be able 10 cry. bill now I t:lln'l cry even [hough I 
wanllO. . 
11 0 I am no more irrilaled now Ihan I ever am. 
I I gel :annoyed or inir.:ared more e:uily lhan I used to. 
2 (fl!l!l irrilalcd ali the time now. 
3 I don 'r ger irriraled a.,,/I by .he things Ih.:al used to irrilate 
me. 
12 0 I have nOllosl inreresc fn orber people. 
t I am less in.eI'Csted ill other people than I u$Cd to be. 
2 I have \OSI moS( of my iDlCfal ill other people. 
J I have lost all of /Dy itJterC$I in otber peop~. 
1l 0 I make decisions abou. as well as I ever cO\Jld. 
I I pUI off making dec;sions $!'lore tIIan 1 usccl to. 
2 I have grcal&!r diffic:ufly in making decisions tban before. 
] I can', make d&!cisiolls ar aU anymore. . _ .. _ ....... ... _. __ ., ... 
14 0 I don'l (eel IlooIr. lilY worse Ihan r used to, 
I r am worried thll f 1m 100ItinS old or unaurac:ave, 
2 I fccl fha. there ate permanent changes in my appearance 
.hal make me look unllrractiVe. 
1 I believc Iha. r look ugly. 
IS 0 I can wort. aboul as wellu befote. 
t II lakes an elua cffon 10 &fl startecf al doing sOlllCthing. 
2 I hllve ro push myself very hard 10 do anything. 
J l.:an·1 do any work II all. 
16 0 I can sleep as well as usual. 
I ,. dOli 't sleep IS well as I used 10. 
: I wake up 1·2 houn earlier tban usual and find it pard 10 get 
back 10 s~ep. 
J I wake up several hours eadier than r II5Cd to and QMOr get 
back 10 sleep. 
17 0 I don', 8el more tired thlll usual. 
I I get lired more easily dian I used 10. 
2 I gel lired rrom doial aimosr anything. 
J I am 100 lirec1lo do anythiag. . 
18 0 My appetile is no wane lban usual. 
I My appelite is 1101 as IOOd as il u$ed to be. 
2 My appetile is muc:Jl wone now. 
3 r have no appetite: at all anymore., 
19 0 I haven', 1051 much weight, if any, 'arely, 
I I have los. more min .5 poullds. I am PUJ1)OSCJy lI'Ying to lose weisht 
2 'have los. more Ihan 10 pounds, by caoftSiess. Yes NCL---
J [have losr more than " pounds. 
lO 0 lam no more worried aboul my heallh ihln usual. 
I I am worried about physical problems such as a~es and 
pains: or upset stomlch: or consripltion. 
2 I am very worried aboul physical problems qd it's hard 10 
Ihink of mur:ll else . 
. 3 I am so worried about my physical problems that I cannat 
Ihink aboul anyehing else. 
21 0 I have 110( noliced Iny recent chance iD my intetat in SClt. 
I I am less interested in sex Ih-an I used to be. 
2 I am much less inleresled in sell now. 
l I have lasl inle(CS1 in sell completely. 
Reproduction without aUlhor's express written consenl is nOI permi[led. AddiciOflill copies andlor pennission 10 usc this sc:ale may be obtained 
from: CE/'t'TER FOR COGNmVE THERAPY, Room 602. 133 South 36th SIt\:I!I, Philadelphia. PA 19104 
"-' 
RUNNING HISTORY· 
1. At what age did you start running:> 40 km/week? yrs 
2. For how many years did you train before you noticed problems starting which 
led you to volunteer for this trial? yrs 
3. How many years has it been since YOti wci'6Iast.·able to run at your perceived 
optimal capacity? yrs 
4. How many days a week did you train prior to your performance deterioration? 
___ days 
5. How many days a week do you train at present? days 
6. What was your average weekly training distance prior to your performance . 
deterioration? km 
7. What is your weekly training distance at present? ____ km 
8. What was your average training speed prior to your performance 
deterioration? kmlhr 
9. What is your average training speed at present km/hr 
10. What was your best 5 km time trial time prior to your performance 
deterioration? ______ min year: ______ _ 
11. \(IIhat is your best 5 km time trial result in the month prior to starting the trial? 
min ---
12. PRIOR TO YOUR PERFORMANCE DETERIORATION. how many time a 
week did you train specifically for: 
Speed (FartleklSprints) 
Endurance (Long runs) 
Strength (Gymnasium) 
Flexibility (Stretching) 
..-___________ ~ANeek . 




13.AFTER YOUR PERFORMANCE DETERIORATION, how many time a week 
did you train specifically for: 
Speed (FartleklSprints) 






________ .... _ .. :..;.. . . ...;;..Jw.eek_. 
14.PRIOR TO YOUR PERFORMANCE DETERIORATION, how regularly did 
you train on the following surfaces? 
(Always = 100%; Mostly:;: 60-99%; Seldom < 60%) 




Right side of road 
Left side of road 
Other 
14. PRIOR TO YOUR PERFORMANCE DETERIORATION, which of the 
following did you include in your training and to what extent? 
(Always:;: 100%; Mostly = 60-99%; Seldom < 60%) 
Flat ground 
Some hills 
Lots of hills 
Always Mostly Seldom Never 
15. PRIOR TO YOUR PERFORMANCE DETERIORATION, did you perform a 
wann up routine before training? Y N 
4 
16. If yes to number 15, please indicate the type ofwann up routine and duration 
of each: 
Duration (min) 
...... '-- -.. ,~' 
Slow jog 
Stretching ".'.- .. - .'":.- .. --- ..... ".~ ..... 
Rubbing muscles 
other 
Do not warm up 
17. PRIOR TO YOUR PERFORMANCE DETERIORATION, did you perform a 
warm down routine after training? Y N 








Plen:se complele/he data as accurately as possible. Please cross out the queslion if you do not 
have the information requested All information will be treated confidentially and used only 
for research purposes. 
o 
-Name: _________ _ 
DO MM YY 
Date of birth: 000000 
DD MM YY 
Date: 000000 
Age you started running consistently (more than approximately 40km per week) 
OOyrs 
.Please complete the relevant sections ofthls table; 
Year Best 10km Best 21.lkm Best 42.2 kIn Best Total training 
Comrades distance per year 
miD kmO 
mm: ss h: mm: 58 h: mm: S5 h: mm: ss 
1998 [10000 00000 00000 00000 00000 
1997 000[10 00000 00000 00000 00000 
1996 00000 00000 00000 00000 . mmo 
1995 00000 00000 00000 00000 00000 
1994 00000 00000 00000 00000 00000 
1993 00000 00000 00000 oOCIOO 00000 
1992 00000 00000 00000 00000 00000 
1991 oomo 00000 00000 00000 00000 
1990 00000 00000 00000 00000 DOOrn 
1989 00000 00000 00000 00000 00000 
1988 00000 00000 00000 mODO 00000 
1987 00000 00000 OOOIJO mooD 00[1[10 
1986 00000 00000 oooon OOODO . 00000 
1985 00000 00000 00000 00000 00000 
Year Best IOkm Best 21.1km Best 42.2 Best Total training 
km Comrades distance per year 
miD kmD 
, ... ,. 
mm: 55 h: mm: 5S h: mm: S5 h: mm: 55 
1984 00000 ODDCIO 00000 00000 OCIDDD 
1983 DDDDO 00000 00000 00000 00000 
1982 00000 00000 D[IDDD 00000 [10000 
1981 ..... , .' DOIJDO 00000 DOOrn DOOOU . 00000 
1980 00000 00000 DOODo 00000 00000 
o List the years during which you stopped training more than 21 consecutive days for injuries or 
other reasons? . 
19 DO 19 DO 19 [10 19 DO 1900 19 DO 
19 DO 1900 19 DO 19 DO 19 DO 1900 
19 00 19 DO 1900 1900 1900 19 00 







I still bel ieve I can run a personal best 0 
I still believe I can nm a personal best 0 
I still believe I can nm a personal best 0 
4:} Can you identify a race or event that seemed to cause your decline in running perfonnance 
over the yearS? 
noD 
absoiutely yes 0 ................. year 19 DO 
maybe 0 ......................... year 19 DO 
does not apply 0 
Thankyouforyourtime!~ 
MRC/UCT BIOENERGETICS OF EXERCISE RESEARCH UNIT 
Training History 
Narne:~ __________ ~ ____ ~ 
Date: _ 
Subject Code: ~ ___ ~ 
Study Code: " 
.. .~. . .. 
Instructions: We are interested in finding out more about your history "Of sports ... 
participation and physical activity. Please complete the following questionnaire as 
accurately as possible.· Ust any activities in which you have partidpated regularly in 
the past, and estimate for how long and how often you partidpated. 
LEISURE ACTIVITY HISTORY 
Time/ Age Period 
15-20vrs 20-25 vrs 25-30 vrs 35-40 vrs 
Activitv/ yrs mos hrs/ yrs . mas hrsl yrs mosl hrs/ yrs mas hrsl 
Soon Iyr wk Iyr wk yr wk /yr wk 
For office use 
Time-/Age Period -
40-45yrs 45-50 vrs 50-55 vrs >55vrs 
Activify/ yrs mos hrs/ yrs mos hrs/ yrs. mosl hrsl yrs mas hrs/ 
Sll.ort /yr wk fyr wk yr wk /yr wk 
For office use 
Examples of sporting activities include: 
1. jogging 10. aerobic dance/step 19. dancing 
2. swimming 11. martial arts 20. skating 
3. cycling 12. volleyball 
4. walking 13. strength& resistance training 
5. squash 14. hiking 
6. badminton 15. rock climbing 
7. netball 16. tennis 
8. football/soccer 17. golf 
9. rugby 18. canoeing 
RETROSPECTIVE TRAINING HISTORY 
Sporting Activity: ,-I ______ _ Age sporting activity began: 
Complete the fol/owing table for each sporting activity that you have partiopated in 
where: 
* Distance where applicable; 
**Races or matches; 
***Competitive or social; 
# Interval or high-intensity training included, yes or no; 
## Injuries lasting more than 3 months 
Sporting Activity: '----______ --.JI Age sporting activity began:! '-_-' 
Complete the fol/owing table for each sporting activity that you have participated in 
where: * Distance where applicable; 
**Races or matches; 
***Competitive or SOCial; 
# Interval or high-intensity training included, yes or no; 
## Injuries lasting more than 3 months 
RUNNING AND MEDICAL HISTORY 
. .:" 
Please answer all questions with as much detail as possible 




PRIOR TO DETERIORATION IN PERFORMANCE 
1. Did you suffer a running injury which caused you to stop training for a time 
period in your career. Y N 
2. If yes please" name"the injUries and the dates they occurred arH:H'low they..,. -." 
were treated 
INJURY DATE TREATMENT 
AT THE TIME AND DIRECtLY RELATED TO DETERIORATION IN 
PERFORMANCE 
3. Did you suffer a running injury at the time of your deterioration in your career. 
Y N 
4. If yes please" name the injury and the date. it occurred and how it was treated 
INJURY DATE TREATMENT 
AFTER DETERIORATION IN PERFORMANCE 
5. Did you suffer a running injury after the time of your deterioration in your 
career. Y N 
6. If yes please name the injury and the dates they occurred and how they were 
treated 
INJURY DATE TREATMENT 
7 
END OF STUDY QUESTIONNAIRE 
I 
1. Which part of the trial did you feel was the placebo: 
Part 1 Part 2 
2. During the trial did you feel an improvement in symptoms? 
YES NO 
3. If you did notice an improvement in symptoms, was this during 
Part 1 of the trial 
Part 2 of the trial 
Throughout the entire trial 
Did not improve during the trial 
Part 1 
1. Did you feel the supplement was helping you to train harder? 
1 2 3 4 5 
No Yes 
2. Did you notice an improvement in your symptoms? 




1. Did you feel the supplement was helping you to train harder? 
12 3 4 5 
No Yes 
2. Did you notice an improvement in your symptoms? 
1 
No 
2 3 4 5 
Yes 
29 
DRUG TRIAL HISTORY 
VISIT 1: 
VISIT 2: 
Side effects last 3 months: 
VISIT 3: 
Side effects last 3 months: 
Number of pills handed back: 
2 
